var thePage = new Array();

st=0; thePage[st]=new Array("2273_feb_6.pdf","pdf/2012_2/","February 6","BUSINESS,1,CMIC,to,Set,Up,Profit,Generating,Mechanism,for,Ultra,orphan,Drugs,Chairman,Nakamura,2,JPWA,Calls,on,Members,to,Negotiate,Prices,by,Product,Category,Conclude,MOU,3,Growing,Concerns,that,Premium,for,New,Drug,Development,May,Violate,Antimonopoly,Act,Products,with,Kairi,ritsu,Below,8.4%,to,Be,Eligible,JFTC,to,Judge,on,Case,by,Case,Basis,4,Number,of,MRs,Breaks,60,000,Could,Become,Major,Topic,in,Light,of,Strained,Healthcare,Finances,Continued,Decline,in,Percentage,of,MRs,with,Pharmacy,Degree,Average,Productivity,per,MR,?151,Million,MRs,Rank,6th,in,Average,Annual,Pay,6,Novartis,to,Stress,Long,term,Maintenance,of,Good,QOL,in,pNET,Patients,in,Promoting,Afinitor,Sutent,to,Shrink,Tumors,Afinitor,to,Ensure,Long,term,QOL,Stabilization,Prof.,Ito,6,BUSINESS,NEWS,IN,BRIEF,Abbott,Sets,Up,New,Unit,with,MRs,Specializing,in,CNS,Anesthetics,Sosei,Announces,Collaboration,with,CEOLIA,Pharma,REGULATORY,8,16,APIs,Including,Aricept,Lyrica,to,Be,Re,Priced,Following,Market,Expansion,2nd,Re,pricing,for,Aricept,Re,pricing,for,Lyrica,in,Less,Than,2,Years,Premium,for,True,Clinical,Benefits,to,Be,Granted,to,Avastin,Alimta,50,APIs,to,Be,Exempted,from,Re,Pricing,due,to,Change,in,Rule,NHI,Price,Cut,Method,to,Be,Changed,for,Aricept,Flolan,11,PHARMA,JAPAN,Lexicon,101,Ordinary,NHI,price,revision,price,revision,based,on,market,prices,Re,pricing,following,market,expansion,Special,extraordinary,price,cut,reduction,hoc,additional,NHI,price,cut,12,PAFSC's,1st,Committee,Recommends,Approval,for,Zyprexa,for,Depression,in,Bipolar,Disorders,13,Guidance,for,FY2012,NHI,Price,Revisions,Approved,by,Chuikyo,Chuikyo,Approves,Premium,for,Generic,Name,based,Prescriptions,13,REGULATORY,NEWS,IN,BRIEF,Eisai,Insomnia,Treatment,Lunesta,Approved,Astellas,Regnite,Approved,for,RLS,MSD,Cancidas,Approved,for,Treatment,of,Deep,Mycoses,MSD,Rotavirus,Vaccine,RotaTeq,Oral,Solution,Approved,Otsuka,Abilify,Obtains,Add'l,Indication,for,Manic,Symptoms,in,Bipolar,Disorder,OD,Tablets,as,Well,Teijin,Pharma,Bonalon,IV,Infusion,Approved,as,Japan's,1st,Once,a,Month,IV,Drug,for,Osteoporosis,Lipitor,Crystal,Form,Patent,Validated,by,JPO,Sandoz,Appeals,to,IP,High,Court,PMDA,to,Introduce,Direct,ADR,Reporting,System,for,Patients,on,Trial,Basis,Revised,Basic,Plan,against,Cancer,to,Include,Pediatric,Cancer,Measures,Korosho,to,Issue,Revised,Notifications,in,Preparation,for,Application,to,PIC/S,Companies,Should,Be,Required,to,File,Notifications,for,Package,Inserts,Subcommittee,JPA,Supports,Ban,on,Dispensing,Point,Services,at,Pharmacies,GENERICS,18,Nichi,Iko,sanofi,aventis,to,Jointly,Develop,Remicade,Biosimilar,18,GENERICS,NEWS,IN,BRIEF,Domestic,Companies,Should,Get,Involved,in,Development,of,Biosimilars,Dr,Nambu,of,Nippon,Kayaku,Sawai,Refrains,from,Promoting,Aricept,Generic,due,to,Tough,Price,Competition,Taiyo,Teva,Kowa,to,Merge,as,Teva,Pharma,Japan,in,April,US,DOJ,Files,Consent,Decree,of,Permanent,Injunction,Against,Ranbaxy,Korosho,Grants,Fast,Track,Review,Status,to,Applications,for,Switch,to,Generic,Name,based,Trade,Names,R&D,20,R&D,NEWS,IN,BRIEF,Takeda,Begins,Domestic,PIII,Trials,for,New,Prostate,Cancer,Drug,Baxter,to,Begin,New,Global,PIII,Trial,of,Immunoglobulin,for,AD,Korosho,Presents,New,5,Year,Plan,to,Promote,Clinical,Trials,21,Survey,Current,Pollinosis,Treatments,Least,Effective,at,Relieving,Nasal,Congestion,MSD,21,NEW,PRODUCTS,Pfizer,Japan,Zithromac,for,IV,Drip,Infusion,SELF,MEDICATION,22,SELF,MEDICATION,NEWS,IN,BRIEF,Explanations,Provided,in,Writing,in,Only,31.5%,of,Pharmacies,Korosho's,Undercover,Survey,JSMI,to,Expand,Range,of,OTC,Drugs,by,Stressing,Preventive,Effects,MEDICAL,FACILITIES,&,NURSING,CARE,22,MEDICAL,FACILITIES,&,NURSING,CARE,NEWS,IN,BRIEF,Demand,for,Celecox,Expected,to,Increase,for,Acute,Pain,Relief,Prof.,Ishiguro,","No.2273 Contents")

st++; thePage[st]=new Array("2272_jan_30.pdf","pdf/2012_1/","January 30","BUSINESS,1,Mochida,to,Ease,Impact,of,NHI,Price,Cuts,with,New,Drugs,President,Mochida,2,Takeda,Doesn,t,Expect,Non,Japanese,President,in,the,Near,Future,President,Hasegawa,To,Cut,2,800,Jobs,in,the,US,Europe,3,Pfizer,Spins,Off,Manufacturing,Unit,Considers,Use,of,Contract,Manufacturing,Considering,Outsourced,Manufacturing,of,Established,Products,4,Growell,May,Sue,Korosho,Over,Ban,on,Dispensing,Point,Service,President,Takada,4,JPWA,NPhA,Hold,Talks,to,Improve,Distribution,Business,Practices,5,Major,Dispensing,Pharmacies,Moving,toward,M&As,Selling,Offers,to,Increase,due,to,Lack,of,Pharmacists,6,BUSINESS,NEWS,IN,BRIEF,Hisamitsu,Acquires,15%,Stake,in,Yutoku,Pharmaceutical,Dispensing,Point,Services,Should,Continue,Mr,Arai,of,Sugi,HD,6,TOPICS,BTMU,Forecasts,1%,Growth,in,Domestic,Ethical,Drug,Market,in,2012,REGULATORY,8,27,New,Drugs,Receive,Formal,Approval,Takeda,Next,Core,Product,Azilva,Approved,Daiichi,Sankyo,to,Copromote,1st,Antibody,Drug,with,AZ,Senju,Glaucoma,Treatment,Aiphagan,9,JPMA,to,Discuss,Pricing,of,Long,listed,Products,in,Preparation,for,FY2014,NHI,Price,Revision,Setting,GL,to,Increase,Transparency,of,Relationship,with,Patient,Groups,10,Korosho,to,Revise,Re,pricing,Policy,in,Response,to,Makers,Orphan,Drug,Development,Strategy,Prof.,Nakamura,11,Senior,Vice,Minister,of,Health,Tsuji,to,Support,Creation,of,3rd,party,Organization,11,REGULATORY,NEWS,IN,BRIEF,GSK,Paxil,CR,Tablet,Approved,to,Comarket,with,DSP,Meiji,Seika,Pharma,Submits,Application,for,ME2080,to,Treat,Dravet,s,Syndrome,Alveolar,Pyorrhea,Removed,from,Lysozyme,s,Indications,PAFSC,s,Second,Committee,on,Drugs,to,Review,Kyowa,Kirin,s,ATL,Treatment,PMDA,to,Expand,PGx,Biomarker,Consultation,System,Proposed,Amendment,of,PAL,Would,Require,Submission,of,Package,Inserts,PFSB,Director,General,Bayer,Submits,Rivaroxaban,in,EU,US,for,Add,l,Indication,EMA,Initiates,Review,of,Oral,MS,Treatment,Gilenya,Following,Reports,of,Heart,Problems,GENERICS,14,Nichi,Iko,to,Decide,Soon,on,PI,Trial,for,Remicade,Biosimilar,President,Tamura,Reducing,Dependence,on,Long,listed,Products,from,Other,Companies,New,Formulation,Facility,to,Boost,Production,Capacity,to,7,8,Billion,Tablets,a,Year,15,Ain,Pharmaciez,s,Generic,Drug,Wholesale,Subsidiary,Showing,Steady,Growth,Expanding,Business,Outside,Ain,Group,to,Be,Future,Challenge,15,GENERICS,NEWS,IN,BRIEF,Astellas,to,Transfer,3,Drugs,to,Choseido,Wakamoto,Shelves,Tie,up,with,Taiwanese,Generics,Maker,16,TOPICS,100th,Acquisition/License,Support,Agreement,Reached,through,LSIP,Fund,R&D,17,R&D,NEWS,IN,BRIEF,Seikagaku,Begins,PII,Trial,of,SI,614,for,Dry,Eye,in,the,US,Tivozanib,Significantly,Improves,PFS,Compared,to,Sorafenib,in,RCC,Astellas,17,Survey,Astellas,Website,Most,Frequently,Accessed,by,Doctors,Seed,Planning,COMMENTARY,18,Maurer,s,Healthcare,Insight,(140),You,ve,Got,to,Love,This,Market,P.,Reed,Maurer,19,PHARMA,JAPAN,Lexicon,Foreign,exceptional,approval,system,,Appointed,marketing,authorization,holder,MEDICAL,FACILITIES,&,NURSING,CARE,20,Korosho,s,Study,Groups,Exclude,Serious,Concerns,Over,4,Vaccines,20,AZ,Stresses,Effectiveness,of,Faslodex,in,Second,line,Therapy,21,Specialists,Debate,Pro,Cons,of,Early,Pharm.,Intervention,in,Dementia,21,TOPICS,JDS,to,Switch,to,NGSP,HbA1c,in,Clinical,Practices,from,April,SELF,MEDICATION,22,SELF,MEDICATION,NEWS,IN,BRIEF,Nicotine,Patch,Products,Should,Remain,Class,1,OTC,Drugs,PAFSC,Subcommittee,22,Survey,38%,of,Doctors,Will,Attend,Company,sponsored,Events,Only,if,Full,Costs,Are,Paid","No.2272 Contents")

st++; thePage[st]=new Array("2271_jan_23.pdf","pdf/2012_1/","January 23","Bayer,Yakuhin,Xarelto,VEGF,Trap,Eye,Guth,Long,Listed,Products,Biosimilars,Nucleic,Acid,Drugs,to,Be,One,of,the,Next,Mainstays,Hudson,Bessho,Aricept,Overtakes,Blopress,to,ARB,CCB,Combination,Products,Biopharmaceuticals,for,RA,Continue,to,Show,Solid,Growth,6,Two,Copromoted,Nexium,Brands,Ranked,No.,1,No.,2,in,HP,Market,RepTrack,Survey,Number,of,Calls,Increase,Sharply,for,Anti,flu,Drugs,10,BUSINESS,NEWS,IN,BRIEF,Otsuka,to,Focus,on,CNS,Field,Ending,Tie,up,in,Immunology,Inflammation,with,UCB,Interprotein,Takeda,to,Collaborate,on,Molecular,Designing,of,PPI,Modulators,MTPC,Licenses,Hib,Vaccine,from,Nuron,Biotech,Astellas,Terminates,License,Agreement,for,VIBATIV,Injection,Asahi,Kasei,Pharma,Launches,Flivas,in,South,Korea,through,Dong,A,DSP,to,Change,Brand,Name,of,Almarl,to,Avoid,Confusion,Barclays,Capital,Raises,Astellas',Target,Stock,Price,GENERICS,12,JGA,Members,United,to,Ensure,Stable,Supplies,Meet,Increasing,Demand,President,Sawai,13,Nichi,Iko,Posts,Record,High,Sales,Profits,in,FY2011,NHI,Price,Listing,Expected,for,Nu,lotan,Paxil,Generics,in,June,2012,13,GENERICS,NEWS,IN,BRIEF,Nipro,to,Set,Up,Contract,Manufacturing,Plant,in,Vietnam,12,TOPICS,Sanofi,aventis,Selected,for,METI,Subsidy,to,Build,Regional,HQ,in,Japan,REGULATORY,14,Korosho,Considering,Partial,Introduction,of,Medico,economic,Evaluation,in,FY2014,14,US,Industry,Opinion,Divided,on,Japan's,Participation,in,TPP,Talks,15,Commentary,Industry,Should,Prepare,Arguments,in,Advance,to,Ward,Off,Possibility,of,3,Consecutive,NHI,Price,Revisions,16,REGULATORY,NEWS,IN,BRIEF,EC,Approves,Revised,Product,Labeling,for,Actos,Takeda,Arena,Submits,Response,to,FDA,CRL,for,Lorcaserin,Eisai,PAFSC,Committee,to,Review,Zyprexa,for,Depression,in,Bipolar,Disorders,CanBas',CBP501,Receives,Orphan,Drug,Designation,from,US,FDA,PFSB,Calls,For,Revision,of,Package,Inserts,for,15,Products,Korosho,Revises,Ministerial,Ordinance,to,Prohibit,Dispensing,Point,Services,by,Pharmacies,R&D,18,Korosho,to,Strengthen,Support,for,Ultra,orphan,Drug,Development,18,Statistics,Sales,of,Ethical,Drugs,Up,5.2%,in,November,Crecon,Report,19,R&D,NEWS,IN,BRIEF,Takara,Bio,Mie,Univ.,to,Collaborate,in,Clinical,Trial,of,Cancer,Treatment,Observation,Period,Ended,in,PII/III,Trial,of,Elpamotide,OncoTherapy,Administration,of,OTSA101,Started,in,Trial,for,Synovial,Sarcoma,OncoTherapy,DWTI's,Antiplatelet,Agent,Enters,Late,PII,Stage,Sanofi,aventis,Completes,Patient,Enrollment,for,Int'l,Study,of,Lantus,NEW,PRODUCTS,20,Nobelpharma,Eisai,Launch,Anticonvulsant,Fostoin,SELF,MEDICATION,20,SELF,MEDICATION,NEWS,IN,BRIEF,Rohto's,Mentholatum,Medi,Quick,H,on,Track,to,Become,Hit,Product,in,1st,Year,20,PHARMA,JAPAN,Lexicon,99,MEDICAL,FACILITIES,&,NURSING,CARE,22,Korosho,Proposes,New,Fee,for,Medical,Management,of,Treatment,resistant,Schizophrenia,22,Pre,Symptomatic,Medical,Intervention,May,Create,a,New,Industry,Prof,Kawakami,Prevention,of,Diabetes,by,Basen,Offers,Great,Value,to,Society,","No.2271 Contents")

st++; thePage[st]=new Array("2270_jan_16.pdf","pdf/2012_1/","January 16","Isao,Teshirogi,Ira,Wolf,Japan,Representative,Philippe,Fauchet,Chairman,of,EFPIA,Japan,Shoda,Will,Ilaris,orphan,Drug,Peak,Sales,Otsuka,to,Ophthalmic,Formulation,Sales,of,Diquas,Growing,Taiyo,to,Be,Core,of,Teva,Domestic,AD,Market,Memary,Sales,Total,Nesina,Anticoagulants,contraindicated,RaQualia,Licenses,Out,COX,2,Meiji,Seika,Licenses,Safinamide,from,Newron,Seikagaku,Changes,Supartz,in,US,Toray,to,Mitsui,Subsidiary,Chugai,Inaugurates,cliff,Ophthalmology,Pfizer,Kyowa,Kirin,Novartis,pNET,Novo,Nordisk,Pharma,Submits,NDA,for,Insulin,Degludec,JPO,Pfizer's,Website,Accessed,by,Largest,Takeda,Osaka,Nano,particle,Vaccines,SymBio,Initiates,SyB,0501,SGN,35,for,Treatment,Lymphoma,Proteasome,Inhibitor,Takeda,Valeant,Onychomycosis,Study,of,Efinaconazole,NanoCarrier,Fuji,Pharma,Mochida,Apply,for,Biosimilar,Nippon,Kayaku,Remicade,Biosimilar","No.2270 Contents")

st++; thePage[st]=new Array("2269_jan_9.pdf","pdf/2012_1/","January 9","BUSINESS,1,ReproCELL,to,Commercialize,World's,1st,iPS,Cell,derived,Hepatocytes,in,April,2,MTPC,Novartis,Pharma,Focused,on,Promoting,Proper,Use,of,MS,Treatment,Imusera/Gilenya,2,Takeda,to,Acquire,Intellikine,to,Enhance,Oncology,Pipeline,3,BUSINESS,NEWS,IN,BRIEF,Meiji,Seika,Pharma,Licenses,BPH,Treatment,from,Dong,A,Pharm.,of,South,Korea,JT,Licenses,Anti,HIV,Drug,Booster,from,Gilead,Daiichi,Sankyo,Grants,Marketing,Rights,for,Cravit,to,Ranbaxy,in,Malaysia,SMBC,Nikko,Securities,Includes,Astellas,Pharma,in,20,Stocks,to,Watch,in,2012,Sanofi,aventis,Appeals,to,IP,High,Court,Claiming,Validity,of,Allegra's,Use,Patents,4,Nexium,Takes,No.,1,Position,in,Both,HP,GP,Markets,RepTrack,Survey,REGULATORY,6,Long,listed,Drugs,to,See,0.9%,Add'l,NHI,Price,Reduction,6,Chuikyo,Approves,Additional,Price,Reduction,for,Long,listed,Drugs,in,FY2012,7,?25,Bil.,to,Be,Saved,through,Add'l,NHI,Price,Cuts,for,Both,Long,listed,Generic,Drugs,in,FY2012,Korosho,8,Tougher,Restrictions,on,Reimbursement,of,Vitamins,to,Cut,?15,Bil.,from,Med.,Expenditure,8,PFSB,Draft,Budget,Includes,?2.1,Bil.,to,Improve,Review,Safety,Measures,Just,?160,Mil.,to,Promote,Joint,Use,of,Aseptic,Dispensing,Rooms,9,Ranbaxy,Settles,with,US,FDA,Commits,to,Improvements,in,GMP,Compliance,Data,Integrity,Daiichi,Sankyo,FDA,to,Reexamine,Lifting,Ban,on,Imports,10,REGULATORY,NEWS,IN,BRIEF,BMKK,Pfizer,Japan,Apply,for,Apixaban,for,SPAF,in,Japan,GSK,Applies,for,Add'l,Indication,of,Axillary,Hyperhidrosis,for,Botox,Applications,Based,on,Data,in,the,Public,Domain,Recommended,for,6,APIs,Bill,Payers,Seek,Revision,of,Ryotan,kisoku,to,Increase,Generic,name,Prescriptions,Chuikyo,Approves,Plan,to,Revise,DPC,System,Cancer,Patient,Groups,Submit,Petition,Calling,For,Introduction,of,a,Compendia,System,Over,60%,of,Doctors,Support,Exclusion,of,Anticancer,Drugs,from,Current,Relief,System,CareNet,73%,of,Applications,for,ADR,Relief,Processed,within,8,Months,in,April,October,PMDA,GENERICS,12,GENERICS,NEWS,IN,BRIEF,MTPC,to,Seek,Strategic,Alliance,to,Expand,Its,Generic,Business,President,Tsuchiya,R&D,14,Chugai,to,Participate,in,Multinational,Study,of,Avastin,in,Breast,Cancer,Virtual,Accelerated,Approval,14,R&D,NEWS,IN,BRIEF,Shionogi,Embarks,on,Biomarker,Discovery,Research,through,US,Subsidiary,Chugai,to,Set,Up,New,Subsidiary,in,Singapore,for,Antibody,Drug,Discovery,Toray,JT,Torii,Terminate,Agreement,to,Codevelop,Add'l,Indication,for,Nalfurafine,86%,of,Patients,Show,Objective,Responses,in,PII,Trial,of,CD30,Monoclonal,Antibody,Takeda,Ibandronate,Shows,Non,inferiority,to,Risedronate,Chugai,Taisho,Development,Request,Withdrawn,for,Mitoxantrone,ELD,Issues,Fully,Revised,GL,for,Clinical,Evaluation,of,Sleep,Medications,16,TOPICS,GSK,President,P.,Fauchet,Appointed,New,Chairman,of,EFPIA,Japan,17,SURVEY,DODA,Survey,Shows,MRs,Average,Annual,Income,at,?6.61,Mil.,6th,Highest,paid,Occupation,17,PHARMA,JAPAN,Lexicon,97,Exploratory,study,Confirmatory,study,Superiority,study,Non,inferiority,study,Equivalence,study,Bioequivalence,study,Parallel,group,comparative,study,Active,placebo,controlled,study,MEDICAL,FACILITIES,&,NURSING,CARE,18,2010,Survey,Shows,Rise,in,Numbers,of,OB/GYN,Doctors,Surgeons,Number,of,Female,Doctors,Continues,to,Increase,Number,of,Pharmacists,up,3.3%,to,215.9,per,100,000,Population","No.2269 Contents")

st++; thePage[st]=new Array("2268_dec_26.pdf","pdf/2011_12/","December 26","Maurer,Mochida,Grants,Rights,to,Potential,Diabetes,Merck,Kissei,CabaserPfizer,Japan,Takeda,Decides,Peginesatide,OncoTherapy,Receives,Milestone,Payment,from,Kyowa,Kirin,5,ubcommittee,Penalty,on,Companies,with,300,500,Million,Premium,Long,listed,Drugs,7,Industry,4,6,Year,Extension,of,Trial,of,Premium,for,New,Drug,Development,2,More,Years,is,Mr,hoda,8,Endo,Drug,Pricing,Policy,ACDS,Engaged,in,Petition,Drive,GSK,ubmits,NDA,for,Pazopanib,GSK,Pazopanib,Designated,as,Orphan,Drugs,Takeda,Peginesatide,FDA,Committee,to,Extend,Temporary,R&D,Tax,JPWA,President,Bessho,Calls,For,Elimination,of,Bundling,11,TOPICS,Osaka,Bio,Fund,Chooses,Tokyo,Drug,Discovery,Venture,as,Its,Project,GENERICS,12,Chuikyo,Approves,Draft,Measures,to,Promote,Generic,Drug,Use,12,Mr,awai,of,JGA,Announces,Absolute,Opposition,to,Add,l,Price,Reduction,for,Generics,13,Towa,Pharm.,to,Expand,Business,with,Regional,Core,Hospitals,Will,New,Drug,Makers,Dominate,Domestic,Biosimilars,Market,16,OPINION,Pharmaceutical,Industry,alary,urvey,2011,Phillip,Carrigan,Nakamura,Premature,Retirement,to,Affect,Drug,Discovery,upport,Organization,Project,18,R&D,NEWS,IN,BRIEF,Kyowa,Kirin,Aims,to,Make,RNAi,Drugs,Its,Future,Pillar,Dr,hitara,Ono,to,Jointly,Develop,GPCR,Antagonists,with,Receptos,Ohara,Pharm,to,for,Leukemia,Treatment,Erwinia,L,asparaginase,","No.2268 Contents")

st++; thePage[st]=new Array("2267_dec_19.pdf","pdf/2011_12/","December 19","BUSINESS,1,AZ,to,Bolster,Its,Top,Position,in,Breast,Cancer,Drugs,Market,2,ASKA,Aims,at,20,Billion,Sales,in,Generics,Business,President,Yamaguchi,Aiming,at,Top,Market,Share,for,Lipidil,3,Domestic,Ethical,Drug,Market,Up,7.7%,in,July,Sept.,IMS,Japan,DPP,4,Inhibitors,Boost,Sales,Actos,Drops,from,1st,to,2nd,Domestic,Vaccine,Market,Showing,Strong,Growth,4,Nexium,Led,HP,Market,in,September,RepTrack,Survey,GP,Market,Led,by,Bonoteo,6,Sanofi,Expected,to,Overtake,Pfizer,as,World's,Top,Drug,Maker,in,2012,Evaluate,Pharma,7,Pharmacies,Satisfied,Wholesalers,Dissatisfied,with,Price,Negotiations,Yano,Research,Survey,97%,of,Wholesalers,Dissatisfied,with,FY2011,Results,7,BUSINESS,NEWS,IN,BRIEF,26,Major,JPMA,Member,Companies,Report,Declines,in,Sales,Profits,with,8.8%,Drop,in,Overseas,Sales,Novartis,Eisai,to,Copromote,Onbrez,for,COPD,MTPC,JRCS,to,Postpone,Integration,of,Plasma,Fractionation,Business,JACDS,Discusses,Problems,Expected,from,Ban,on,Dispensing,Point,Services,GENERICS,9,Record,101,Generics,from,30,Companies,Listed,for,Aricept,12,Sanofi,aventis,Nichi,Iko,to,Copromote,Nichi,Iko's,Generics,12,6,Indian,Generic,Makers,Form,an,Association,in,Japan,13,Sawai,Growth,in,Sales,Slows,Due,to,Waning,Effect,of,Premiums,for,Generics,Dispensing,Systems,More,Effective,Measures,Expected,to,Promote,Use,of,Generics,Mr,Sawai,14,Towa,Pace,of,Growth,in,Sales,Slows,New,Mid,term,Business,Plan,Calls,For,Consolidation,of,Infrastructure,Developing,OD,Tablets,of,Lipitor,REGULATORY,15,Chuikyo,to,Discuss,Additional,Price,Cuts,for,Long,listed,Drugs,15,Policy,Screening,WG,Proposes,Major,Cutbacks,in,Long,listed,Drug,Prices,16,Increase,Patients',Copayment,Rate,for,OTC,like,Drugs,on,a,Trial,Basis,Policy,Screening,16,Consider,Obligatory,Use,of,Generics,by,Welfare,Recipients,Policy,Screening,17,Former,Chuikyo,Chairman,Prof.,Endo,Concerned,about,Increasing,Drug,Expenditure,37,Makers,Not,Requested,to,Develop,New,Drugs,Indications,Despite,Receipt,of,Premium,of,?6.8,Bil.,17,JSMO,Issues,33,Development,Requests,for,Unapproved,Drugs,Indications,18,PHARMA,JAPAN,Lexicon,Drug,cost,ratio,National,healthcare,expenditure,Wards,for,recuperation,under,health,insurance,Wards,for,recuperation,under,nursing,care,insurance,Ward,charging,special,admission,fee,Ward,for,rehabilitation,during,convalescence,19,Korosho's,Study,Group,Postpones,Decision,on,Relief,of,Victims,of,Health,Damage,Due,to,Anticancer,Drugs,19,Subcommittee,to,Study,Notification,System,for,Access,to,Unapproved,Drugs,Transfer,of,Priority,Review,Rights,to,Other,Companies,to,Be,Discussed,20,REGULATORY,NEWS,IN,BRIEF,Iressa,Approved,for,EGFR,Mutation,Positive,NSCLC,AZ,Takeda,Applies,for,Fixed,Dose,Combination,of,Alogliptin,Metformin,with,US,FDA,Novartis,Files,NDA,for,NVA237,for,COPD,in,Japan,US,FDA,Accepts,NDA,for,Once,monthly,Depot,Formulation,of,Abilify,JDA,Requests,Add'l,Indication,of,Pustular,Psoriasis,for,Humira,R&D,22,Astellas,President,Hatanaka,Entertains,High,Hopes,for,Bio,Lead,Project,22,intellim,Corp.,to,Strengthen,Contract,Research,System,in,Field,of,Oncology,23,Council,Approves,New,10,Year,Strategy,for,Hepatitis,Research,Aiming,to,Raise,VR,Rate,to,40%,24,R&D,NEWS,IN,BRIEF,Ajinomoto,Interprotein,Sign,Joint,R&D,Agreement,for,PPI,Inhibitors,Takeda,Starts,PII,Trials,of,4,in,one,Vaccine,TAD,361S,in,Japan,SymBio,Begins,PII,Trial,of,SyB,L,0501,for,Refractory,Relapsed,MM,MEDINET,Initiates,Clinical,Study,of,DC,Vaccine,Favorable,Results,from,PII,Trial,of,Ono's,Ca,Receptor,Agonist,Announced,in,US,NEDO,to,Subsidize,4,Biopharmaceuticals,Manufacturing,Technology,Development,Projects,23,NEW,PRODUCTS,GSK,Daiichi,Sankyo,Launch,Rotarix,for,Prevention,of,Rotavirus,Gastroenteritis,in,Children,SELF,MEDICATION,25,SELF,MEDICATION,NEWS,IN,BRIEF,Committee,on,OTC,Drugs,Recommends,SSP,Vaginal,Candidiasis,Treatment,for,Approval,Korosho,Approves,3,Switch,OTC,Products,Containing,Pemirolast,26,OPINION,Plan,Like,Your,Life,Depended,on,It,It,Just,Might,Phillip,Carrigan,","No.2267 Contents")

st++; thePage[st]=new Array("2266_dec_12.pdf","pdf/2011_12/","December 12","BUSINESS,1,AZ,to,Bolster,Its,Top,Position,in,Breast,Cancer,Drugs,Market,2,ASKA,Aims,at,?20,Billion,Sales,in,Generics,Business,President,Yamaguchi,Aiming,at,Top,Market,Share,for,Lipidil,3,Domestic,Ethical,Drug,Market,Up,7.7%,in,July,Sept,IMS,Japan,DPP,4,Inhibitors,Boost,Sales,Actos,Drops,from,1st,to,2nd,Domestic,Vaccine,Market,Showing,Strong,Growth,4,Nexium,Led,HP,Market,in,September,RepTrack,Survey,GP,Market,Led,by,Bonoteo,6,Sanofi,Expected,to,Overtake,Pfizer,as,World's,Top,Drug,Maker,in,2012,Evaluate,Pharma,7,Pharmacies,Satisfied,Wholesalers,Dissatisfied,with,Price,Negotiations,Yano,Research,Survey,97%,of,Wholesalers,Dissatisfied,with,FY2011,Results,Major,JPMA,Member,Companies,Report,Declines,in,Sales,Profits,with,8.8%,Drop,in,Overseas,Sales,Novartis,Eisai,to,Copromote,Onbrez,for,COPD,MTPC,JRCS,to,Postpone,Integration,of,Plasma,Fractionation,Business,JACDS,Discusses,Problems,Expected,from,Ban,on,Dispensing,Point,Services,GENERICS,9,Record,101,Generics,from,30,Companies,Listed,for,Aricept,12,Sanofi,aventis,Nichi,Iko,to,Copromote,Nichi,Iko's,Generics,12,6,Indian,Generic,Makers,Form,an,Association,in,Japan,13,Sawai,Growth,in,Sales,Slows,Due,to,Waning,Effect,of,Premiums,for,Generics,Dispensing,Systems,More,Effective,Measures,Expected,to,Promote,Use,of,Generics,Mr,Sawai,14,Towa,Pace,of,Growth,in,Sales,Slows,New,Mid,term,Business,Plan,Calls,For,Consolidation,of,Infrastructure,Developing,OD,Tablets,of,Lipitor,REGULATORY,15,Chuikyo,to,Discuss,Additional,Price,Cuts,for,Long,listed,Drugs,15,Policy,Screening,WG,Proposes,Major,Cutbacks,in,Long,listed,Drug,Prices,16,Increase,Patients',Copayment,Rate,for,OTC,like,Drugs,on,a,Trial,Basis,Policy,Screening,16,Consider,Obligatory,Use,of,Generics,by,Welfare,Recipients,Policy,Screening,17,Former,Chuikyo,Chairman,Prof,Endo,Concerned,about,Increasing,Drug,Expenditure,37,Makers,Not,Requested,to,Develop,New,Drugs,Indications,Despite,Receipt,of,Premium,of,?6.8,Bil,17,JSMO,Issues,33,Development,Requests,for,Unapproved,Drugs,Indications,18,PHARMA,JAPAN,Lexicon,Drug,cost,ratio,National,healthcare,expenditure,Wards,for,recuperation,under,health,insurance,for,recuperation,under,nursing,care,insurance,Ward,charging,special,admission,fee,Ward,for,rehabilitation,during,convalescence,19,Korosho's,Study,Group,Postpones,Decision,on,Relief,of,Victims,of,Health,Damage,Due,to,Anticancer,Drugs,19,Subcommittee,to,Study,Notification,System,for,Access,to,Unapproved,Drugs,Transfer,of,Priority,Review,Rights,to,Other,Companies,to,Be,Discussed,20,REGULATORY,NEWS,IN,BRIEF,Iressa,Approved,for,EGFR,Mutation,Positive,NSCLC,AZ,Takeda,Applies,for,Fixed,Dose,Combination,of,Alogliptin,Metformin,with,US,FDA,Novartis,Files,NDA,for,NVA237,for,COPD,in,Japan,US,FDA,Accepts,NDA,for,Once,monthly,Depot,Formulation,of,Abilify,JDA,Requests,Add'l,Indication,of,Pustular,Psoriasis,for,Humira,R&D,22,Astellas,President,Hatanaka,Entertains,High,Hopes,for,Bio,Lead,Project,22,intellim,Corp,to,Strengthen,Contract,Research,System,in,Field,of,Oncology,23,Council,Approves,New,10,Year,Strategy,for,Hepatitis,Research,Aiming,to,Raise,VR,Rate,to,40%,24,R&D,NEWS,IN,BRIEF,Ajinomoto,Interprotein,Sign,Joint,R&D,Agreement,for,PPI,Inhibitors,Takeda,Starts,PII,Trials,of,4,in,one,Vaccine,TAD,361S,in,Japan,SymBio,Begins,PII,Trial,of,SyB,L,0501,for,Refractory,Relapsed,MM,MEDINET,Initiates,Clinical,Study,of,DC,Vaccine,Favorable,Results,from,PII,Trial,of,Ono's,Ca,Receptor,Agonist,Announced,in,US,NEDO,to,Subsidize,4,Biopharmaceuticals,Manufacturing,Technology,Development,Projects,23,NEW,PRODUCTS,GSK,Daiichi,Sankyo,Launch,Rotarix,for,Prevention,of,Rotavirus,Gastroenteritis,in,Children,SELF,MEDICATION,25,SELF,MEDICATION,NEWS,IN,BRIEF,Committee,on,OTC,Drugs,Recommends,SSP's,Vaginal,Candidiasis,Treatment,for,Approval,Korosho,Approves,3,Switch,OTC,Products,Containing,Pemirolast,26,OPINION,Plan,Like,Your,Life,Depended,on,Itc,It,Just,Might,Phillip,Carrigan","No.2266 Contents")

st++; thePage[st]=new Array("2265_dec_5.pdf","pdf/2011_12/","December 5","BUSINESS,1,AZ,to,Bolster,Its,Top,Position,in,Breast,Cancer,Drugs,Market,2,ASKA,Aims,at,20,Billion,Sales,in,Generics,Business,President,Yamaguchi,Aiming,at,Top,Market,Share,for,Lipidil,3,Domestic,Ethical,Drug,Market,Up,7.7%,in,July,Sept.,IMS,Japan,DPP,4,Inhibitors,Boost,Sales,Actos,Drops,from,1st,to,2nd,Domestic,Vaccine,Market,Showing,Strong,Growth,4,Nexium,Led,HP,Market,in,September,RepTrack,Survey,GP,Market,Led,by,Bonoteo,6,Sanofi,Expected,to,Overtake,Pfizer,as,World's,Top,Drug,Maker,in,2012,Evaluate,Pharma,7,Pharmacies,Satisfied,Wholesalers,Dissatisfied,with,Price,Negotiations,Yano,Research,Survey,97%,of,Wholesalers,Dissatisfied,with,FY2011,Results,7,BUSINESS,NEWS,IN,BRIEF,26,Major,JPMA,Member,Companies,Report,Declines,in,Sales,Profits,with,8.8%,Drop,in,Overseas,Sales,Novartis,Eisai,to,Copromote,Onbrez,for,COPD,MTPC,JRCS,to,Postpone,Integration,of,Plasma,Fractionation,Business,JACDS,Discusses,Problems,Expected,from,Ban,on,Dispensing,Point,Services,GENERICS,9,Record,101,Generics,from,30,Companies,Listed,for,Aricept,12,Sanofi,aventis,Nichi,Iko,to,Copromote,Nichi,Iko's,Generics,12,6,Indian,Generic,Makers,Form,an,Association,in,Japan,13,Sawai,Growth,in,Sales,Slows,Due,to,Waning,Effect,of,Premiums,for,Generics,Dispensing,Systems,More,Effective,Measures,Expected,to,Promote,Use,of,Generics,Mr,Sawai,14,Towa,Pace,of,Growth,in,Sales,Slows,New,Mid,term,Business,Plan,Calls,For,Consolidation,of,Infrastructure,Developing,OD,Tablets,of,Lipitor,REGULATORY,15,Chuikyo,to,Discuss,Additional,Price,Cuts,for,Long,listed,Drugs,15,Policy,Screening,WG,Proposes,Major,Cutbacks,in,Long,listed,Drug,Prices,16,Increase,Patients',Copayment,Rate,for,OTC,like,Drugs,on,a,Trial,Basis,Policy,Screening,16,Consider,Obligatory,Use,of,Generics,by,Welfare,Recipients,Policy,Screening,17,Former,Chuikyo,Chairman,Prof.,Endo,Concerned,about,Increasing,Drug,Expenditure,37,Makers,Not,Requested,to,Develop,New,Drugs,Indications,Despite,Receipt,of,Premium,of,6.8,Bil.,17,JSMO,Issues,33,Development,Requests,for,Unapproved,Drugs,Indications,18,PHARMA,JAPAN,Lexicon,93,Drug,cost,ratio,National,healthcare,expenditure,Wards,for,recuperation,under,nursing,care,insurance,Ward,charging,special,admission,fee,Ward,for,rehabilitation,during,convalescence,19,Korosho's,Study,Group,Postpones,Decision,on,Relief,of,Victims,of,Health,Damage,Due,to,Anticancer,Drugs,19,Subcommittee,to,Study,Notification,System,for,Access,to,Unapproved,Drugs,Transfer,of,Priority,Review,Rights,to,Other,Companies,to,Be,Discussed,20,REGULATORY,NEWS,IN,BRIEF,Iressa,Approved,for,EGFR,Mutation,Positive,NSCLC,AZ,Takeda,Applies,for,Fixed,Dose,Combination,of,Alogliptin,Metformin,with,US,FDA,Novartis,Files,NDA,for,NVA237,for,COPD,in,Japan,US,FDA,Accepts,NDA,for,Once,monthly,Depot,Formulation,of,Abilify,JDA,Requests,Add'l,Indication,of,Pustular,Psoriasis,for,Humira,R&D,22,Astellas,President,Hatanaka,Entertains,High,Hopes,for,Bio,Lead,Project,22,intellim,Corp.,to,Strengthen,Contract,Research,System,in,Field,of,Oncology,23,Council,Approves,New,10,Year,Strategy,for,Hepatitis,Research,Aiming,to,Raise,VR,Rate,to,40%,24,R&D,NEWS,IN,BRIEF,Ajinomoto,Interprotein,Sign,Joint,R&D,Agreement,for,PPI,Inhibitors,Takeda,Starts,PII,Trials,of,4,in,one,Vaccine,TAD,361S,in,Japan,SymBio,Begins,PII,Trial,of,SyB,L,0501,for,Refractory,Relapsed,MM,MEDINET,Initiates,Clinical,Study,of,DC,Vaccine,Favorable,Results,from,PII,Trial,of,Ono's,Ca,Receptor,Agonist,Announced,in,US,NEDO,to,Subsidize,4,Biopharmaceuticals,Manufacturing,Technology,Development,Projects,23,NEW,PRODUCTS,GSK,Daiichi,Sankyo,Launch,Rotarix,for,Prevention,of,Rotavirus,Gastroenteritis,in,Children,SELF,MEDICATION,25,SELF,MEDICATION,NEWS,IN,BRIEF,Committee,on,OTC,Drugs,Recommends,SSP's,Vaginal,Candidiasis,Treatment,for,Approval,Korosho,Approves,3,Switch,OTC,Products,Containing,Pemirolast,26,OPINION,Plan,Like,Your,Life,Depended,on,It,Just,Might,Phillip,Carrigan,","No.2265 Contents")

st++; thePage[st]=new Array("2264_nov_28.pdf","pdf/2011_11/","November 28","BUSINESS,1,Fujifilm,Kyowa,Kirin,to,Set,Up,Joint,Venture,for,Biosimilars,in,2012,New,Drugs,Will,Remain,Kyowa,Kirin,s,Top,Focus,Dr,Matsuda,Collaboration,Will,Benefit,Society,Mr,Komori,2,Zeria,Aims,at,50%,Domestic,Market,Share,for,UC,Treatment,Asacol,in,FY2011,3,Nihon,Chouzai,Planning,to,Open,150,200,Stores,a,Year,President,Mitsuhara,New,Drug,Makers,Acting,to,Discourage,GE,Drug,Substitution,Income,from,New,Incentives,Would,Be,Used,to,Increase,Number,of,Stores,4,Eli,Lilly,Amylin,to,Terminate,Collaboration,in,Field,of,Diabetes,End,of,Domestic,Marketing,Expected,by,End,of,2013,Eli,Lilly,Japan,4,1st,Half,Business,Results,Kissei,Pharm.,Sales,Down,0.5%,Profits,Up,Zeria,Tillotts,Prop,Up,Overall,Business,Torii,Double,digit,Decreases,in,Profits,Due,to,Increases,in,R&D,Expenses,ASKA,Sales,Down,8.4%,Due,to,Rebound,from,a,Spike,at,Last,Fiscal,Year,End,Seikagaku,Sharp,Increases,in,Profits,Due,to,Increases,in,Gross,Profits,Wakamoto,Sales,Up,2.1%,Resulting,in,Smaller,Losses,Teijin,New,Drugs,Drive,Medical,Pharmaceutical,Business,Sales,Up,2.4%,Meiji,Seika,Pharma,Sales,Up,1%,Driven,by,Good,Sales,of,Mainstay,Products,Asahi,Kasei,Pharma,Sales,Up,6%,Due,to,Doubling,of,Recomodulin,Sales,8,BUSINESS,NEWS,IN,BRIEF,Santen,Sends,Expert,Researchers,to,US,Europe,to,Assess,Candidate,Compounds,for,In,licensing,Nippon,Shinyaku,Licenses,Gaslon,N,OD,Tablets,to,Taejoon,in,South,Korea,Synix,to,Establish,Oncology,Market,Research,Division,in,December,Top,JPWA,Officials,Stress,Importance,of,Wholesalers,in,Urgent,Press,Conference,9,TOPICS,Breast,Cancer,Project,Selected,for,Health,Science,Research,Grant,3,D,Matrix,REGULATORY,10,Chuikyo,Recommends,Listing,of,9,Products,Including,Imusera,Premium,for,Usefulness,(II),Granted,to,Otsuka,s,Dry,Eye,Treatment,Mucosta,Approval,on,Hold,for,Novartis,Pharma,s,CAPS,Treatment,Ilaris,12,After,Delay,Chuikyo,Recommends,Listing,of,Ilaris,for,Treatment,of,CAPS,13,Chuikyo,Subcommittee,Approves,Special,Price,Reductions,for,Oral,Combination,Drugs,Application,of,the,80%,Price,Rule,to,Ophthalmic,Solutions,Discussed,14,Exceptions,from,Re,pricing,Following,Market,Expansion,to,Be,Made,on,Case,by,Case,Basis,from,FY2012,Chuikyo,Re,pricing,of,Essential,Drugs,Discussed,15,Industry,Rep,Reiterates,Call,For,Perpetuation,of,Premium,for,New,Drug,Development,15,High,Court,Turns,Down,Iressa,Appeal,Case,in,Favor,of,Gov,t,AZ,Government,s,Legal,Immunity,Clarified,Health,Minister,Komiyama,Unprecedentedly,Unjust,Ruling,Plaintiffs,16,Applications,for,Regulatory,Strategy,Consultation,Increasing,Rapidly,Dr,Isobe,of,PMDA,PMDA,Draws,Up,Global,Vision,Aimed,at,Becoming,a,World,Class,Regulatory,Agency,17,REGULATORY,NEWS,IN,BRIEF,Korosho,Announces,Add,l,Indications,Eligible,for,Applications,Based,on,Data,in,Public,Domain,Add,l,Indications,Filed,for,Viccillin,Taxol,Based,on,Data,in,Public,Domain,PAFSC,Committee,Approves,Extension,of,Reexamination,Period,for,DSP,s,Lonasen,US,FDA,Accepts,Filing,for,Astellas,Pharma,s,Mirabegron,Merck,Withdraws,MAA,for,Sitagliptin,Pioglitazone,Combination,Korosho,Calls,For,Package,Insert,Revisions,for,Bisphosphonates,4,Drugs,Excluded,from,Reimbursement,Under,DPC,System,GENERICS,19,Teva,to,Create,Teva,Pharma,Japan,in,Mid,2012,by,Combining,Taiyo,Teva,Kowa,19,Kyowa,Pharm.,to,Acquire,I,rom,Pharm.,to,Boost,Sales,to,DPC,Hospitals,20,7,Drug,Rule,Should,Be,Relaxed,or,Eliminated,to,Promote,GE,Name,Prescribing,Dr,Adachi,of,Chuikyo,Dr,Adachi,Conditionally,Accepts,New,Prescription,Form,20,Mr,Sawai,of,JGA,Opposes,Reduction,in,NHI,Prices,of,First,Generics,21,PHARMA,JAPAN,Lexicon,drug,rule,7,drug,restriction,R&D,22,Antibody,Drugs,to,Support,Kyowa,Kirin,s,Growth,Over,Next,10,Years,Dr,Oshima,22,R&D,NEWS,IN,BRIEF,Shionogi,Shire,to,Codevelop,ADHD,Treatments,CMIC,to,Develop,Orphan,Drugs,With,Partners,Funds,Chairman,Nakamura,SymBio,Initiates,Domestic,PII,Trials,of,Bendamustine,for,Add,l,Indications,Astellas,Completes,Administration,of,New,Investigational,Flu,Vaccine,in,PII,Trial,Anti,androgen,Drug,MDV3100,Significantly,Improves,OS,in,PIII,AFFIRM,Trial,Astellas,24,Commentary,Drug,Discovery,Support,Organization,Faces,Doubts,Can,It,Pick,Winners?,SELF,MEDICATION,25,SELF,MEDICATION,NEWS,IN,BRIEF,PSJ,Preparing,for,Exchange,of,Views,with,JAMS,on,Switch,OTC,Drug,Candidates,JUA,Opposed,to,Switching,Propiverine,to,OTC,Status,Kobayashi,Pharm.,to,Create,3,Subsidiaries,in,Southeast,Asia,MEDICAL,FACILITIES,&,NURSING,CARE,26,MEDICAL,FACILITIES,&,NURSING,CARE,NEWS,IN,BRIEF,Teriparatide,Strongly,Recommended,for,Non,vertebral,Fracture,JOS,Draft,GLs,Complaints,of,Side,Effects,from,Lyrica,Up,Sharply,Nextit,Research,Medical,Benefits,Rose,4.2%,in,FY2009,Breaking,?30,Tril.,for,1st,Time,","No.2264 Contents")

st++; thePage[st]=new Array("2263_nov_21.pdf","pdf/2011_11/","November 21","BUSINESS,1,Otsuka,Allies,with,Lundbeck,in,CNS,Field,Looking,at,Post,Abilify,Business,Model,Pharm.,Sales,Up,1.7%,Driven,by,Abilify,3,Astellas,Will,Be,Able,to,Continue,on,Growth,Path,Through,2014,President,Hatanaka,Availability,or,Non,availability,of,Subsidies,Will,Not,Affect,Vaccine,Business,Policy,3,1st,Half,Business,Results,3,Shionogi,Strong,Domestic,Business,Overshadowed,by,Slack,US,Results,Overall,Sales,Down,13.5%,Aiming,for,US,Launch,of,Vaginal,Atrophy,Treatment,Ospemifene,in,2013,4,Ono,Glactiv,Emend,Drive,Growth,Sales,Ratio,for,Long,listed,Products,Down,to,Mid,60%,Range,Glactiv,Expected,to,Continue,to,Enjoy,Advantage,of,First,Comer,President,Sagara,Emend,Sales,to,Top,10,Billion,Good,Market,Responses,to,Rivastach,6,Santen,5.3%,Increase,in,Sales,Driven,by,Strong,Domestic,Overseas,Sales,6,Kyorin,HD,Both,Sales,Profits,Remain,Virtually,Unchanged,7,Kaken,Mainstay,Products,Generics,Pull,Business,Enhancing,Detailing,Activities,Targeting,GPs,8,Mochida,Epadel,Lexapro,Drive,Growth,in,Sales,Profits,8,Nippon,Shinyaku,Both,Sales,Profits,Up,Driven,by,New,Products,NS,11,to,Be,Submitted,for,Alcohol,Dependence,in,March,2012,9,Sales,of,Actos,Down,22%,in,1st,Half,Due,to,Bladder,Cancer,Concerns,Generic,Competition,Takeda,Takeda,Announces,Actos,Lawsuits,in,US,AD,Treatment,Reminyl,Will,Need,More,Time,to,Penetrate,the,Market,Mr,Iwasaki,10,Medipal,HD,Near,90%,Decline,in,Operating,Profits,10,Further,Deterioration,in,Sales,Prices,Unlikely,in,2nd,Half,President,Watanabe,of,Mediceo,11,Alfresa,Operating,Profits,Down,70%,in,Wholesale,Business,Despite,Growth,in,Sales,New,Distribution,Center,in,Ichinomiya,Prices,Should,Remain,Stable,in,2nd,Half,President,Ishiguro,12,Suzuken,Largest,Semiannual,Operating,Loss,from,Drug,Wholesale,Business,Recovery,of,Wholesale,Business,Crucial,President,Ohta,12,PHARMA,JAPAN,Lexicon,91,Profits,on,inventory,13,Toho,HD,Dispensing,Pharmacy,Business,Props,Up,Overall,Business,We,Must,Defend,Our,Prices,by,Ourselves,Chairman,Matsutani,13,BUSINESS,NEWS,IN,BRIEF,Daiichi,Sankyo,Licenses,AKT,Inhibitor,from,ArQule,Daiichi,Sankyo,Obtains,Rights,to,OAB,Treatment,Uritos,in,Brazil,intellim,Ties,Up,with,Iberica,Aiming,to,Enter,US,Market,14,Statistics,Sales,of,Ethical,Drugs,Up,5.6%,in,September,Crecon,Report,14,JPWA,Seminar,on,Drug,Wholesale,Management,Elimination,of,Package,Deals,Essential,to,Wholesalers',Recovery,Mr,Bessho,of,JPWA,Premium,for,New,Drug,Development,Fiscally,Neutral,Mr,Kamo,of,JPMA,Premium,for,New,Drug,Development,Should,Be,Increased,Mr,Miyoshi,of,IMS,Japan,Promote,Category,based,Negotiations,Instead,of,Package,Deals,Mr,Hasegawa,2007's,Emergency,Proposal,for,Distribution,Reform,Needs,Review,Korosho,Councilor,Mr,Takeda,REGULATORY,17,High,Court's,Ruling,in,Iressa,Appeal,Extremely,Fair,and,Proper,Attorney,for,AZ,17,JMA,JDA,and,JPA,Issue,Joint,Statement,Calling,For,Caution,on,Participation,in,TPP,US,Calls,For,Monthly,Listing,of,New,Drugs,18,REGULATORY,NEWS,IN,BRIEF,UCB,Otsuka,to,Apply,for,Certolizumab,for,RA,in,Japan,in,2012,Pfizer,Japan,Applies,for,pNET,as,Additional,Indication,for,Sutent,19,TOPICS,No,Major,Ethnic,Differences,in,Pharmacokinetics,of,3,Drugs,Reported,GENERICS,20,Top,3,GE,Makers,Report,10.4%,Increase,in,Sales,Pace,Down,from,Year,Before,22,Korosho,Proposes,Raising,GE,Dispensing,Rates,to,Receive,Upper,Premiums,for,GE,Dispensing,Systems,22,Healthcare,Reps,at,Chuikyo,Call,For,Quality,Assurance,to,Promote,GE,Use,23,Mr,Kobayashi,of,Kyokai,Kenpo,Proposes,Measures,to,Promote,GE,Drug,Use,No,Substitution,Permitted,Column,Remains,a,Problem,COMMENTARY,24,Maurer's,Healthcare,Insight,(138),Local,Companies,Want,to,Buy,P.,Reed,Maurer,R&D,25,R&D,NEWS,IN,BRIEF,Asahi,Kasei,Pharma,to,Accelerate,Development,of,ART,123,Astellas,RIKEN,to,Jointly,Search,for,Novel,Drug,Targets,for,AD,Yakult,LivTech,Enter,into,Option,Agreement,for,Anti,Cancer,Monoclonal,Antibody,Development,Program,MediciNova,to,Start,Repeated,Dose,PIb,Clinical,Trial,of,MN,221,in,US,Solasia,Begins,PI,Trial,of,Darinaparsin,for,PTCL,MEDICAL,FACILITIES,&,NURSING,CARE,27,Korosho,to,Ask,Doctors,to,Exercise,Caution,in,Co,prescribing,3,or,More,Psychotropics,","No.2263 Contents")

st++; thePage[st]=new Array("2262_nov_14.pdf","pdf/2011_11/","November 14","BUSINESS,1,Japan,China,to,Become,Key,Battlefields,for,Aricept,President,Naito,of,Eisai,Reapplying,for,Perampanel,by,End,of,FY2011,Double,digit,Declines,in,1st,Half,Sales,Profits,Halaven,Off,to,a,Good,Start,3,8,of,10,Leading,Drug,Makers,Report,Declines,in,1st,Half,Sales,5,1st,Half,Business,Results,5,Takeda,Sales,Profits,Down,due,to,Strong,Yen,Double,digit,Decrease,in,Sales,of,Actos,Full,Integration,of,Nycomed,to,Be,Completed,in,3,Years,?570,Billion,Debt,to,Be,Repaid,in,5,Years,Takeda,Reinstates,Request,to,Probe,into,Transfer,Pricing,Taxation,6,Astellas,Sales,Profits,Up,Driven,by,Vesicare,7,Daiichi,Sankyo,Sales,Profits,Down,due,to,Slump,of,Ranbaxy,Return,of,Marketing,Rights,8,MTPC,Sales,Profits,Down,Despite,Growth,in,Sales,of,Remicade,Generics,Marketing,of,Imusera,Telavic,to,Be,Limited,to,Specialists,at,First,9,DSP,Strong,Yen,Contributes,to,5.6%,Decline,in,Sales,Boosting,Domestic,CNS,Sales,Force,for,Early,Maximization,of,Lonasen,Sales,More,MRs,in,US,to,Beef,Up,Sales,of,Latuda,10,Operating,Profit,Rate,for,Top,4,Wholesalers,Slips,to,0.39%,in,April,September,11,Chuikyo,Approves,Plan,to,Ban,Use,of,Dispensing,Point,Cards,by,Pharmacies,Drugstores,Chuikyo,Takes,A,Step,Forward,to,Banning,Points,for,Dispensing,Mr,Kodama,of,JPA,JACDS,Issues,Urgent,Communication,on,Dispensing,Point,Ban,Qol,to,Discontinue,Dispensing,Points,in,March,2012,12,BUSINESS,NEWS,IN,BRIEF,Abilify,Posts,3rd,Quarter,Sales,of,US$983,Mil.,in,US,Sales,of,Top,30,Drug,Wholesalers,Up,1.9%,in,2010,Yano,Research,Institute,GENERICS,13,Meiji,Seika,Pharma,Planning,to,Develop,Biosimilars,for,Infectious,Diseases,Cancer,and,RA,REGULATORY,14,1st,PAFSC,Committee,Recommends,Approval,for,Products,Including,Eisai's,Lunesta,Modified,Administration,and,Dosage,Approved,for,Warfarin,Potassium,15,Chuikyo,Subcommittee,Approves,Proposal,to,Expand,Range,of,Drugs,Subject,to,Re,pricing,16,Trial,of,Premium,for,New,Drug,Development,Should,Continue,Dr,Suzuki,of,JMA,Industry's,Cooperation,Needed,to,Secure,Financial,Resources,16,Korosho,Study,Group,Surveying,Drug,Makers',Regulatory,Compliance,Systems,17,Groups,of,Care,Providers,Patients,Against,Creating,Compensation,System,for,Injury,from,Anticancer,Drugs,18,Commentary,Perpetuation,of,Premium,for,New,Drug,Development,Faces,Hurdles,19,REGULATORY,NEWS,IN,BRIEF,Applications,Based,on,Info,in,Public,Domain,Recommended,for,3,APIs/Specifications,FDA,Assigns,Action,Date,of,Jan,25,2012,for,Takeda's,Alogliptin,NDA,Filed,for,Combination,Tablet,Containing,JT's,Anti,HIV,Agent,JTK,303,in,US,New,Rules,for,Application,of,GCP,Ordinance,to,Take,Effect,April,1,2012,20,Commentary,Further,Research,Needed,to,Advance,the,Use,of,Regulatory,Science,in,Regulatory,Affairs,R&D,21,R&D,NEWS,IN,BRIEF,Daiichi,Sankyo,Discontinues,PII,Trials,of,Edoxaban,in,US,Europe,for,Postoperative,VTE,Prevention,Japan,China,S.,Korea,Agree,to,Draft,GL,on,Joint,Clinical,Trials,Regorafenib,Increases,OS,in,PIII,Trial,Bayer,HealthCare,22,OPINION,Interviewing,and,Hiring,Strong,Character,Plus,Good,Attitude,Equals,Great,Potential,Philip,Carrigan,","No.2262 Contents")

st++; thePage[st]=new Array("2261_nov_7.pdf","pdf/2011_11/","November 7","BUSINESS,1,Sales,of,Teribone,Could,Reach,?10,Billion,President,Asano,of,Asahi,Kasei,Pharma,2,NBI,Eli,Lilly,Japan,to,Establish,Special,Position,for,Trazenta,in,DPP,4,Inhibitor,Market,2,Perpetuation,of,Premium,for,New,Drug,Development,Discussed,at,IMS,Japan,Symposium,Manufacturers,Should,Reconsider,the,Way,They,Sell,Drugs,EAD,Director,Kamata,3,Vaccine,Industry,Must,Continue,to,Present,Proposals,to,Gov,t,Mr,Fushimi,of,JAVI,4,Nihon,Chouzai,Aims,to,Triple,Home,Healthcare,Nursing,Facility,Business,in,2,Years,4,BUSINESS,NEWS,IN,BRIEF,IBL,Licenses,Napsin,A,Monoclonal,Antibody,Producing,Cells,to,Ventana,GSK,CEO,Witty,Expects,Premiums,for,New,Drug,Development,to,Make,Japan,More,Attractive,No.,of,Latuda,Prescriptions,Likely,to,Exceed,Forecast,Nomura,Securities,Growell,to,Introduce,T,Point,Service,for,Copayments,of,Ethical,Drugs,REGULATORY,6,Committee,Recommends,Approval,of,3,Products,Including,MSD,s,Rota,Teq,3,Drugs,Recommended,for,Orphan,Drug,Designation,7,FPMAJ,to,Present,Petition,on,Next,NHI,Pricing,System,Reform,to,DPJ,8,Subcommittee,to,Recommend,Use,of,Most,recent,3,year,Averages,in,Drug,Cost,Calculation,Subcommittee,Approves,Optimized,Evaluation,of,Clin.,Trial,Costs,8,Chuikyo,Subcommittee,Approves,Revision,of,Foreign,Price,Adjustment,Rule,Savings,Expected,by,Application,of,Revised,Rule,9,Korosho,to,Take,Stricter,Look,at,Companies,Market,Scale,Forecasts,10,Wholesalers,Expecting,Some,Increase,in,Price,Gap,in,Next,Market,Price,Survey,11,Korosho,Aims,to,Balance,Encouragement,of,Innovation,and,Cost,Curtailment,in,FY2012,Medical,Fee,Revision,Higher,Fees,Needed,for,Hospitals,with,More,Pharmacists,in,Wards,11,Patent,Office,to,Revise,Rules,for,Granting,Patent,Extensions,12,DPJ,Lawmakers,Opposed,to,TPP,Criticize,Korosho,at,Hearings,More,Information,Needed,Korosho,13,Drug,induced,Hepatitis,Victims,Petition,Against,Creation,of,Korosho,Proposed,Third,Party,Organization,13,PHARMA,JAPAN,Lexicon,90,anjo,iinkai,Article,3,based,commission,Hachijo,iinkai,Article,8,based,commission,14,REGULATORY,NEWS,IN,BRIEF,Nitto,Denko,Applies,for,Relief,of,Pain,Associated,with,Removal,of,MS,US,FDA,Extends,Action,Date,for,SGLT,2,Inhibitor,Dapagliflozin,EMA,Confirms,Usefulness,of,Pioglitazone,Containing,Medicines,as,2nd,3rd,Line,Treatment,Options,Takeda,JMA,JPA,Oppose,Increase,in,Patients,Copayments,for,OTC,like,Drugs,FPMAJ,Drafting,GLs,on,Radiation,Testing,for,Crude,Drugs,Supreme,Court,Upholds,Ban,on,Reimbursement,in,Mixed,Healthcare,Korosho,Calls,For,Package,Insert,Revisions,for,6,Products,Including,Strattera,Korosho,Warns,against,Driving,While,Taking,Champix,JMA,Openly,Opposes,TPP,JPA,JDA,JNA,Express,Concern,TPP,Could,Have,Major,Impact,on,NHI,Price,System,Ms,Weatherall,of,University,of,Queensland,GENERICS,18,JSGM,Calls,For,Elimination,of,GE,Drug,Refusal,Option,in,Prescriptions,18,Survey,Finds,Slight,Increase,in,Generic,Drug,Dispensing,Rate,More,Generic,name,Prescribing,Needed,to,Promote,GE,Substitution,19,TOPICS,Osteoporosis,Patients,Interested,in,Monthly,BP,Formulation,Survey,JDF,Eli,Lilly,Japan,Create,Subsidy,Program,for,Basic,Incretin,Research,R&D,20,R&D,NEWS,IN,BRIEF,OncoTherapy,Science,to,Start,Clinical,Trial,of,OTSA101,for,Synovial,Sarcoma,in,France,Kyowa,Kirin,s,KW,0761,Shows,Promise,for,ATL,Prof.,Tsukasaki,of,Nagasaki,Univ.,Otsuka,Confirms,Efficacy,of,Rotigotine,for,RLS,in,Domestic,PIII,Clinical,Study,Chugai,Tops,Patent,Asset,Ranking,with,Teijin,Jumping,to,Second,Place,SELF,MEDICATION,21,SELF,MEDICATION,NEWS,IN,BRIEF,SSP,Aims,for,10%,Market,Share,with,Switch,OTC,Alesion,10,Hisamitsu,Sets,Up,Subsidiary,to,Enter,OTC,Market,in,China,MEDICAL,FACILITIES,&,NURSING,CARE,22,No,Major,Differences,Between,4,AD,Treatments,More,Evidence,Needed,Prof.,Hanyu,22,MEDICAL,FACILITIES,&,NURSING,CARE,NEWS,IN,BRIEF,HSC,Subcommittee,Considering,Review,of,Refractory,Diseases,Eligible,for,Treatment,Subsidies,Cost,of,Advanced,Healthcare,Services,Totaled,13.2,Billion,in,FY2010,Korosho,","No.2261 Contents")

st++; thePage[st]=new Array("2260_oct_31.pdf","pdf/2011_10/","October 31","BUSINESS,1,Japan,a,Strategic,Country,with,Strong,Growth,Potential,New,AZ,K.K.,President,Hudson,Confident,about,Benefits,of,Iressa,for,NSCLC,2,Takeda,Appoints,Enbrel,MRs,to,Enhance,Cooperation,with,Pfizer,3,MTPC,Introduces,3,Tier,Scheme,for,Priority,Products,3,CMIC,Medipal,Set,Up,Joint,Venture,to,Develop,Market,Orphan,Drugs,Cash,Hog,to,Become,Cash,Cow,Medipal,to,Deal,with,20,Orphan,Drugs,in,3,Years,5,Biggest,Challenge,Is,Decline,in,R&D,Productivity,President,Hasegawa,of,Takeda,Acquisition,of,Nycomed,Might,Have,Been,Difficult,with,Japanese,Staff,Alone,5,BUSINESS,NEWS,IN,BRIEF,Astellas,Recalls,Tacrolimus,in,Japan,Europe,due,to,Failure,to,Meet,Dissolution,Test,Standards,MSD,Mylan,Terminate,Promotional,Agreement,for,Lipovas,Renivace,Pfizer,Japan,to,Split,Up,Domestic,Manufacturing,Sector,to,Establish,New,Company,UCB,Japan,Reorganizes,Sales,&,Marketing,Division,to,Enhance,Specialization,Nihon,Chouzai,Introduces,Catalog,Retailing,at,All,Its,Stores,Mr,Hasegawa,of,Keizai,Doyukai,Appointed,National,Strategy,Council,s,Private,Sector,Member,JPMA,to,Draw,Up,Its,Opinions,on,TPP,in,October,8,Prazaxa,Ranked,No.,1,in,Both,HP,GP,Markets,RepTrack,Survey,8,Survey,Otsuka,Leads,in,Slate,PC,Use,in,HP,Market,Takeda,in,GP,Market,Internet,Survey,REGULATORY,10,Korosho,to,Review,Premiums,to,Stimulate,Development,of,Drugs,for,Pediatric,Use,10,Korosho,Proposes,80%,Price,Rule,for,Single,enantiomer,Drugs,Industry,Asks,for,Additional,Exception,11,Dispensing,Fees,May,Be,Cut,to,Enable,Hike,in,Medical,Fees,Mr,Urushibata,of,Chuikyo,70%,Rule,Likely,to,Be,Reduced,to,60%,for,First,Generics,12,Korosho,Receives,270,Requests,for,Development,of,Unapproved,Drugs,Indications,in,2nd,Round,12,REGULATORY,NEWS,IN,BRIEF,SymBio,s,Bendamustine,Approved,in,Taiwan,Nexium,Applied,for,Prevention,of,Peptic,Ulcers,due,to,Low,dose,Aspirin,Chuikyo,Recommends,Fee,for,Service,Reimbursement,for,2,High,priced,Drugs,Korosho,Presents,Direction,for,PAL,Amendment,in,2012,PMDA,Presents,Warnings,on,Its,Website,to,Prevent,Mistaken,Use,of,3,Taxane,Drugs,GENERICS,14,Korosho,Presents,Data,at,Chuikyo,Supporting,Reduction,in,70%,Rule,for,New,Generics,14,PHARMA,JAPAN,Lexicon,88,GE,rule,NHI,price,listing,by,generic,name,NHI,price,listing,by,brand,name,15,Mr,Kobayashi,of,Chuikyo,Insists,on,NHI,Price,Reductions,for,New,Generics,Prices,of,Long,listed,Original,Drugs,Also,Need,Discussion,15,JGA,President,Sawai,Insists,on,Retention,of,70%,Rule,for,New,Generics,16,60%,Rule,Likely,to,Replace,70%,Rule,for,New,Generics,Mr,Kikuchi,of,Nichi,Iko,MPI,Nichi,Iko,MPI,Proposes,50%,Rule,for,First,Generics,and,Limit,on,NHI,Price,Reductions,16,PHARMA,JAPAN,Lexicon,89,Reference,price,system,R&D,18,R&D,NEWS,IN,BRIEF,Takeda,Initiates,PIII,Trials,for,Antidiabetic,TAK,875,in,the,US,Europe,Eisai,Johns,Hopkins,Univ.,Agree,on,Neurological,Drug,Discovery,Collaboration,Sanofi,aventis,Signs,Comprehensive,Joint,Research,Agreement,with,Kyoto,Univ.,R,Tech,Ueno,to,Resume,Development,of,Treatment,for,Dry,Eye,JT,to,Stop,Developing,JTT,305,for,Osteoporosis,following,Termination,of,Agreement,with,Merck,Otsuka,to,Set,Up,Joint,Venture,to,Develop,Artificial,Pancreatic,Islet,Cells,Drug,Discovery,Support,Agency,Will,Not,Compete,with,Private,Sector,Mr,Tsuchiya,MEDICAL,FACILITIES,&,NURSING,CARE,20,2,HPV,Vaccines,Competing,for,Public,Subsidies,Are,Parents,Avoiding,Vaccination,by,OB/GYN,Doctors,A,Painful,Experience,Concern,about,Vaccination,at,Non,OB/GYN,Departments,21,Korosho,Task,Force,Discusses,Upcoming,Switch,to,Inactivated,Polio,Vaccine,Percentage,of,People,Receiving,OPV,Down,17.5%,in,April,June,2011,22,Association,managed,Pharmacies,Should,Become,Home,Healthcare,Support,Centers,Mr,Kodama,of,JPA,JPA,to,Conduct,Survey,on,Aseptic,Dispensing,Services,at,Home,Healthcare,Support,Pharmacies,MEDICAL,DEVICE,22,MEDICAL,DEVICE,NEWS,IN,BRIEF,Otsuka,Medical,Devices,to,Acquire,KiSCO,Group,Companies,IBL,Launches,ANGPTL2,Assay,Kit,23,TOPICS,JPA,Announces,FY2010,Results,of,Drug,Event,Monitoring,for,SU,Drugs","No.2260 Contents")

st++; thePage[st]=new Array("2259_oct_24.pdf","pdf/2011_10/","October 24","BUSINESS,1,Novartis,Expects,7%,Growth,in,Sales,in,2011,Driven,by,New,Products,President,Mitani,Novartis,to,Withhold,New,Vaccine,Production,Facility,Construction,Plan,2,Ono,Merck,KGaA,Enter,into,License,Agreements,to,Boost,Priority,Fields,3,Takeda,to,Focus,on,Doctors,Who,Prescribe,Actos,in,Detailing,Type,2,Diabetes,Treatment,Liovel,3,Takeda,Will,Be,Able,to,Weather,Power,Shortages,Mr,Hasegawa,Japan,Should,Announce,Participation,in,TPP,Talks,at,APEC,Meeting,4,Mediceo,Aiming,for,20%,Market,Share,in,Hokkaido,within,3,Years,President,Watanabe,4,BUSINESS,NEWS,IN,BRIEF,Eisai,Sets,Up,Aricept,Dept.,to,Further,Boost,Sales,in,Japan,Ranbaxy,Starts,Selling,Daiichi,Sankyo,s,Drugs,in,Italy,Maruho,Establishes,US,Subsidiary,Rating,Companies,Downgrade,Takeda,following,Acquisition,of,Nycomed,Korosho,Plans,Project,to,Increase,Domestic,Self,sufficiency,in,Anti,HBs,Human,Immunoglobulin,Pfizer,Starts,New,Online,Promotion,with,MedPeer,Astellas,Pharma,Debuts,on,DJSI,Asia,Pacific,Index,Number,of,MRs,in,Japan,Breaks,60,000,for,1st,Time,MREAC,6,Statistics,Sales,of,Ethical,Drugs,Up,11.7%,in,August,Crecon,Research,&,Consulting,REGULATORY,8,Industry,to,Submit,Additional,Data,to,Ensure,Full,Introduction,of,Premium,for,New,Drug,Development,Mr,Negi,8,Korosho,to,Set,Up,New,System,to,Support,Ultra,orphan,Drug,Development,9,REGULATORY,NEWS,IN,BRIEF,Takeda,Withdraws,sNDA,for,Velcade,Eli,Lilly,Japan,Applies,for,Fast,acting,IM,Injection,of,Zyprexa,COPD,Treatment,NVA237,Filed,in,Europe,by,Novartis,Sosei,Avastin,Recommended,as,1st,line,Treatment,for,Advanced,Ovarian,Cancer,in,Europe,Roche,11,Commentary,Discussions,on,Amendment,of,PAL,Now,in,Final,Stages,R&D,12,Innovation,Can,Take,Place,in,Developing,Countries,Takeda,President,Hasegawa,Takeda,s,Research,Strategy,to,Focus,on,Open,Innovation,BioJapan,2011,Openness,Must,Be,Balanced,with,IP,Protection,Mr,Hasegawa,Eyes,Joint,Research,with,Chinese,Companies,13,JPMA,to,Support,Infrastructure,Development,for,Innovative,Drug,Discovery,Dr,Teshirogi,13,R&D,NEWS,IN,BRIEF,Asahi,Kasei,Pharma,tella,Announce,Joint,R&D,Agreement,for,Cell,Processing,Equipment,Leading,Biotech,Clusters,in,Osaka,Munich,Sign,Partnership,Agreement,Korosho,Issues,GLs,for,Clinical,Evaluation,of,Renal,Anemia,Drugs,Novartis,Announces,New,PIII,Data,for,Inhaled,Therapy,NVA237,at,ERS,Congress,Afinitor,Significantly,Increased,PFS,in,Women,with,Advanced,Breast,Cancer,Novartis,Imatinib,Significantly,Improves,Walking,Distance,in,Patients,with,PAH,Novartis,Over,95%,of,Patients,Agree,to,Investigational,Use,of,Removed,Tissues,NCC,Chief,Director,Kayama,COMMENTARY,16,Maurer,s,Healthcare,Insight,(137),Negatives,of,the,Japan,Pharma,Market,P.,Reed,Maurer,17,PHARMA,JAPAN,Lexicon,86,Premiums,for,generics,dispensing,systems,Premiums,for,generics,use,systems,GENERICS,18,GE,Drug,Makers,Will,Need,Flexibility,to,Survive,Shift,to,Biosimilars,Mr,Matsubara,of,Office,Medisearch,18,Med.,Institutions,Prefer,GE,Anticancer,Drugs,from,Companies,with,Better,Support,Systems,Ms,Matsui,of,NCC,Hospital,East,19,Korosho,to,Require,Self,Evaluation,by,Generic,Drug,Makers,to,Ensure,Stable,Supply,19,Number,of,Pharmacies,Qualifying,for,Premiums,for,GE,Drug,Dispensing,Systems,Down,in,2010,MEDICAL,FACILITIES,&,NURSING,CARE,20,Nat,l,Healthcare,Expenditure,Rose,3.4%,to,Record,Bil.,in,FY2009,Korosho,Pharmacy,Dispensing,Fees,Up,7.9%,20,Decision,to,Prescribe,Prazaxa,Should,Be,Left,to,Specialists,for,Now,JCS,Press,Seminar,Administration,Frequency,Likely,to,Affect,Choice,of,Treatment,Latest,EPPV,Data,for,Prazaxa,Released,NBI,21,JASSO,to,Announce,New,Diagnostic,Guidelines,for,Obesity,22,Korosho,to,Support,Pharmacies,Participation,in,Home,Healthcare,22,MEDICAL,FACILITIES,&,NURSING,CARE,NEWS,IN,BRIEF,No,Correlation,Between,Drowsiness,and,Efficacy,of,2nd,Generation,Antihistamine,Drugs,HIRS,Record,Number,of,New,AIDS,Cases,Reported,in,2nd,Qtr.,of,2011,SELF,MEDICATION,23,SELF,MEDICATION,NEWS,IN,BRIEF,JACDS,to,Propose,Reforms,to,Promote,Switch,OTC,Drugs,in,Japan","No.2259 Contents")

st++; thePage[st]=new Array("2258_oct_17.pdf","pdf/2011_10/","October 17","BUSINESS,1,Novartis,Expects,7%,Growth,in,Sales,in,2011,Driven,by,New,Products,President,Mitani,Novartis,to,Withhold,New,Vaccine,Production,Facility,Construction,Plan,2,Ono,Merck,KGaA,Enter,into,License,Agreements,to,Boost,Priority,Fields,3,Takeda,to,Focus,on,Doctors,Who,Prescribe,Actos,in,Detailing,Type,2,Diabetes,Treatment,Liovel,3,Takeda,Will,Be,Able,to,Weather,Power,Shortages,Mr,Hasegawa,Japan,Should,Announce,Participation,in,TPP,Talks,at,APEC,Meeting,4,Mediceo,Aiming,for,20%,Market,Share,in,Hokkaido,within,3,Years,President,Watanabe,4,BUSINESS,NEWS,IN,BRIEF,Eisai,Sets,Up,Aricept,Dept.,to,Further,Boost,Sales,in,Japan,Ranbaxy,Starts,Selling,Daiichi,Sankyo,s,Drugs,in,Italy,Maruho,Establishes,US,Subsidiary,Rating,Companies,Downgrade,Takeda,following,Acquisition,of,Nycomed,Korosho,Plans,Project,to,Increase,Domestic,Self,sufficiency,in,Anti,HBs,Human,Immunoglobulin,Pfizer,Starts,New,Online,Promotion,with,MedPeer,Astellas,Pharma,Debuts,on,DJSI,Asia,Pacific,Index,Number,of,MRs,in,Japan,Breaks,60,000,for,1st,Time,MREAC,6,Statistics,Sales,of,Ethical,Drugs,Up,11.7%,in,August,Crecon,Research,&,Consulting,REGULATORY,8,Industry,to,Submit,Additional,Data,to,Ensure,Full,Introduction,of,Premium,for,New,Drug,Development,Mr,Negi,8,Korosho,to,Set,Up,New,System,to,Support,Ultra,orphan,Drug,Development,9,REGULATORY,NEWS,IN,BRIEF,Takeda,Withdraws,sNDA,for,Velcade,Eli,Lilly,Japan,Applies,for,Fast,acting,IM,Injection,of,Zyprexa,COPD,Treatment,NVA237,Filed,in,Europe,by,Novartis,Sosei,Avastin,Recommended,as,1st,line,Treatment,for,Advanced,Ovarian,Cancer,in,Europe,Roche,11,Commentary,Discussions,on,Amendment,of,PAL,Now,in,Final,Stages,R&D,12,Innovation,Can,Take,Place,in,Developing,Countries,Takeda,President,Hasegawa,Takeda,s,Research,Strategy,to,Focus,on,Open,Innovation,BioJapan,2011,Openness,Must,Be,Balanced,with,IP,Protection,Mr,Hasegawa,Eyes,Joint,Research,with,Chinese,Companies,13,JPMA,to,Support,Infrastructure,Development,for,Innovative,Drug,Discovery,Dr,Teshirogi,13,R&D,NEWS,IN,BRIEF,Asahi,Kasei,Pharma,tella,Announce,Joint,R&D,Agreement,for,Cell,Processing,Equipment,Leading,Biotech,Clusters,in,Osaka,Munich,Sign,Partnership,Agreement,Korosho,Issues,GLs,for,Clinical,Evaluation,of,Renal,Anemia,Drugs,Novartis,Announces,New,PIII,Data,for,Inhaled,Therapy,NVA237,at,ERS,Congress,Afinitor,Significantly,Increased,PFS,in,Women,with,Advanced,Breast,Cancer,Novartis,Imatinib,Significantly,Improves,Walking,Distance,in,Patients,with,PAH,Novartis,Over,95%,of,Patients,Agree,to,Investigational,Use,of,Removed,Tissues,NCC,Chief,Director,Kayama,COMMENTARY,16,Maurer,s,Healthcare,Insight,(137),Negatives,of,the,Japan,Pharma,Market,P.,Reed,Maurer,17,PHARMA,JAPAN,Lexicon,86,Premiums,for,generics,dispensing,systems,Premiums,for,generics,use,systems,GENERICS,18,GE,Drug,Makers,Will,Need,Flexibility,to,Survive,Shift,to,Biosimilars,Mr,Matsubara,of,Office,Medisearch,18,Med.,Institutions,Prefer,GE,Anticancer,Drugs,from,Companies,with,Better,Support,Systems,Ms,Matsui,of,NCC,Hospital,East,19,Korosho,to,Require,Self,Evaluation,by,Generic,Drug,Makers,to,Ensure,Stable,Supply,19,Number,of,Pharmacies,Qualifying,for,Premiums,for,GE,Drug,Dispensing,Systems,Down,in,2010,MEDICAL,FACILITIES,&,NURSING,CARE,20,Nat,l,Healthcare,Expenditure,Rose,3.4%,to,Record,Bil.,in,FY2009,Korosho,Pharmacy,Dispensing,Fees,Up,7.9%,20,Decision,to,Prescribe,Prazaxa,Should,Be,Left,to,Specialists,for,Now,JCS,Press,Seminar,Administration,Frequency,Likely,to,Affect,Choice,of,Treatment,Latest,EPPV,Data,for,Prazaxa,Released,NBI,21,JASSO,to,Announce,New,Diagnostic,Guidelines,for,Obesity,22,Korosho,to,Support,Pharmacies,Participation,in,Home,Healthcare,22,MEDICAL,FACILITIES,&,NURSING,CARE,NEWS,IN,BRIEF,No,Correlation,Between,Drowsiness,and,Efficacy,of,2nd,Generation,Antihistamine,Drugs,HIRS,Record,Number,of,New,AIDS,Cases,Reported,in,2nd,Qtr.,of,2011,SELF,MEDICATION,23,SELF,MEDICATION,NEWS,IN,BRIEF,JACDS,to,Propose,Reforms,to,Promote,Switch,OTC,Drugs,in,Japan","No.2258 Contents")

st++; thePage[st]=new Array("2257_oct_11.pdf","pdf/2011_10/","October 10","BUSINESS,1,BMS,to,File,for,Apixaban,for,SPAF,in,Japan,US,and,Europe,Before,Year,end,CEO,Andreotti,BMS,Ono,Announce,Strategic,Agreement,for,Orencia,and,Anti,PD,1,Antibody,2,Mochida,s,New,3,Year,Business,Plan,Aims,for,Sales,of,?100,Bil.,in,FY2013,3,Takeda,Completes,Acquisition,of,Nycomed,Making,It,World,s,12th,Biggest,Drugmaker,3,BUSINESS,NEWS,IN,BRIEF,Santen,to,Acquire,French,Drugmaker,to,Bolster,Its,R&D,Kowa,NanoCarrier,Announce,License,Agreement,for,Epirubicin,Micelle,MediciNova,Announces,Private,Sale,of,Stock,to,Kissei,GSK,to,Supply,Cervarix,for,Vaccination,at,Vaccinees,Expense,Novartis,Pharma,Donates,?21,Mil.,for,Free,Medical,Exams,for,Disaster,Victims,in,Soma,City,JPMA,to,Work,with,IFPMA,to,Tackle,Non,communicable,Diseases,in,Developing,World,REGULATORY,6,Chuikyo,to,Focus,on,Financial,Effects,of,Premium,for,New,Drug,Development,Reliability,of,Sales,Forecasts,Questioned,List,of,Issues,to,Be,Discussed,on,Generics,New,Drugs,and,Existing,Drugs,Approved,by,Chuikyo,(Excerpt),7,Permanent,Introduction,of,Premium,for,New,Drug,Development,Still,Premature,Dr,Adachi,8,Mr,Miura,of,JPA,Expresses,Qualified,Support,for,Full,Introduction,of,Premium,for,New,Drug,Development,Industry,s,Concern,About,Revision,of,Prices,for,Essential,Drugs,Reasonable,9,Korosho,Asks,Committee,to,Discuss,Re,pricing,of,Combination,Drugs,with,Long,listed,APIs,9,Chuikyo,to,Focus,on,NHI,Price,Reduction,for,Long,listed,Drugs,Dr,Adachi,10,Korosho,to,Request,Budget,of,?29,588.2,Bil.,Special,Framework,Budget,of,?105.9,Bil.,for,FY2012,10,METI,s,Budget,Request,Includes,?3.3,Bil.,to,Promote,Healthcare,Industry,Creation,11,Korosho,to,Request,Perpetuation,of,Add,on,Credits,Credits,for,High,level,R&D,Investment,11,Proceed,Cautiously,on,Proposed,Compensation,System,for,Adverse,Effects,from,Anticancer,Drugs,Mr,Shoda,of,FPMAJ,12,REGULATORY,NEWS,IN,BRIEF,Telavic,Approved,for,Chronic,Hepatitis,C,MTPC,Anti,emetic,Proemend,IV,Infusion,150,mg,Approved,Ono,Ilaris,Approved,as,Japan,s,1st,CAPS,Treatment,Novartis,Pharma,Teribone,Approved,for,Osteoporosis,with,High,Fracture,Risk,Asahi,Kasei,Pharma,TachoSil,Tissue,Sealing,Sheet,Approved,CSL,Behring,Avastin,Receives,Add,l,Indication,for,Breast,Cancer,Chugai,PAFSC,Withholds,Approval,of,Additional,Indication,for,Epogin,Takeda,Files,NDA,for,Hyperlipidemia,Treatment,TAK,085,in,Japan,Onyx,Submits,NDA,in,US,for,Carfilzomib,in,MM,Ono,Eisai,Abbott,Japan,File,for,Additional,Indication,for,Humira,CHMP,Issues,Positive,Opinion,on,New,ARB,Edarbi,Takeda,PFSB,s,Safety,Division,Calls,For,Revision,of,Tegretol,Package,Insert,Korosho,Announces,Revision,of,Precautions,in,Prazaxa,Package,Insert,Korosho,to,Survey,Family,Pharmacy,Functions,Toward,Next,Revision,of,Dispensing,Fees,NEW,PRODUCTS,12,Cubicin,350,mg,IV,Inj.,Launched,for,MRSA,Infections,MSD,R&D,16,Astellas,Terminates,Global,Development,of,Factor,Xa,Inhibitor,Darexaban,16,MTPC,to,Start,PIII,Trial,of,Telaprevir,in,China,17,Shionogi,Announces,International,Industry,Academia,Collaboration,Programs,17,Speed,Quality,of,Clinical,Trials,Have,Increased,Mr,Kawaguchi,of,JPMA,18,R&D,NEWS,IN,BRIEF,Ono,Todai,Sign,Joint,Research,Agreement,for,Drug,Discovery,Target,Identification,Results,of,PIII,Trial,of,Rotarix,Published,in,US,Journal,Vaccine,GSK,Afinitor,Meets,Primary,Endpoint,for,AML,in,Int,l,PIII,Trial,for,TSC,patients,Novartis,Decline,in,Research,by,Univ.,Hospital,Doctors,Presents,Alarming,Situation,MEXT,Official,19,Commentary,Pinning,Hope,on,Academia,in,Seeking,a,Radical,Cure,for,AD,GENERICS,20,Meiji,Seika,Pharma,to,Ally,with,Dong,A,of,South,Korea,in,Biosimilars,20,PHARMA,JAPAN,Lexicon,85,???υ?J,??˜,R&D,tax,credit,system,-D???˜,Preferential,taxation,system,??zT?,Tax,deduction,tax,exemption,SELF,MEDICATION,21,Tsuruha,HD,to,Establish,Drugstore,Joint,Venture,in,Thailand,MEDICAL,FACILITIES,&,NURSING,CARE,22,Nexium,Significantly,Reduces,Incidence,of,Acid,Reflux,Compared,to,Omepral,Study,Report,22,Prof.,Uchiyama,Stresses,Need,for,Caution,with,Prazaxa,Even,at,Low,Dose,23,Seller,s,Market,for,Pharmacists,Expected,to,Continue,Over,Next,Few,Years,","No.2257 Contents")

st++; thePage[st]=new Array("2256_oct_3.pdf","pdf/2011_10/","October 3","BUSINESS,1,Kaken,Aims,for,20,Bil.,in,Operating,Profits,in,2015,New,President,Onuma,2,Pain,Treatment,at,Turning,Point,with,Advent,of,Lyrica,3,BUSINESS,NEWS,IN,BRIEF,Astellas,to,Transfer,Distribution,of,Tagocid,Maalox,to,sanofi,aventis,Toyobo,Biologics,Partners,with,Catalent,to,Strengthen,Contract,Manufacturing,Business,MSD,Hisamitsu,to,Terminate,Copromotion,of,Fosamac,in,February,2012,Barclays,Raises,MTPC,s,Target,Share,Price,on,Telavic,Survey,Nichi,Iko,to,Put,Off,Merger,with,Nichi,iko,Pharma,Factory,Until,June,2012,4,Nesina,Ranked,No.,1,Both,in,HP,GP,Markets,RepTrack,Survey,Lamictal,Ranked,2nd,in,HP,Market,REGULATORY,8,18,New,Products,Approved,Japan,s,1st,Oral,MS,Treatment,Imusera,Gilenya,Approved,MTPC,Novartis,Faslodex,Approved,to,Treat,Breast,Cancer,AZ,Mucosta,Ophthalmic,Suspension,Approved,for,Dry,Eye,Otsuka,9,6,APIs,10,Products,Including,EpiPen,Added,to,NHI,Price,List,10,FPMAJ,Outlines,Policy,on,Provision,of,Information,for,Off,label,Drug,Use,Report,Also,Specifies,Info.,Acceptable,Prior,to,Approval,11,FPMAJ,Seeks,Improved,System,for,Orphan,Drug,Development,12,HSC,Subcommittee,Agrees,on,Need,for,New,System,to,Promote,Access,to,Unapproved,Drugs,Controversial,Views,Reported,on,Package,Inserts,and,Third,Party,Organization,12,Continuation,of,Premium,for,New,Drug,Development,to,Depend,on,Its,Effects,Mr,Shirakawa,of,Kenporen,13,Mr,Akagawa,of,ELD,Stresses,Need,for,Closer,East,Asian,Cooperation,to,Promote,Multinational,Trials,Supports,Increased,Role,for,Regulatory,Science,14,Commentary,New,Ideas,Needed,to,Address,Insurance,Lag,for,GE,Drug,Makers,That,Submit,Applications,Based,on,Info.,in,Public,Domain,15,REGULATORY,NEWS,IN,BRIEF,Sitagliptin,Approved,for,Use,in,Combination,with,Insulin,MSD,Ono,Shanghai,Genomics,Receives,New,Drug,Certificate,for,the,Treatment,of,IPF,in,China,Health,Insurance,Committee,Unable,to,Agree,on,Proposed,Fixed,sum,Examination,Fee,JPMA,Asks,for,Continued,R&D,Tax,Credit,System,GMP,Team,to,Begin,Mock,GMP,Inspections,in,Kinki,Region,from,Next,February,Obama,Administration,s,Deficit,reduction,Plan,Calls,For,Shorter,Exclusivity,Period,for,Biologics,GENERICS,17,GENERICS,NEWS,IN,BRIEF,Teva,to,Resolve,Joint,Venture,with,Kowa,Acquire,100%,Stake,in,Teva,Kowa,R&D,18,Support,of,Gov,t,Industry,Essential,for,Development,of,RNA,based,Drugs,PMRJ,Seminar,18,R&D,NEWS,IN,BRIEF,Takeda,Initiates,Domestic,PIII,Trials,for,Successor,to,Takepron,Nihon,Medi,Physics,Begins,PIII,Trial,of,Neuro,Imaging,Agent,SGLT2,Inhibitor,Ipragliflozin,Significantly,Reduced,HbA1c,in,PIII,Study,Astellas,Anti,HIV,Drug,JTK,303,Achieves,Primary,Endpoint,in,Overseas,PIII,Study,JT,Weight,Gain,with,Lantus,Lowest,in,Patients,with,HbA1c,Below,8%,Sanofi,OncoTherapy,to,Receive,Milestone,Payment,from,Shionogi,for,S,288310,20,NEW,PRODUCTS,NBI,Eli,Lilly,Japan,DPP,4,Inhibitor,Trazenta,Tablets,5,mg,for,Type,2,Diabetes,Taiho,CTCL,Treatment,Zolinza,Capsules,100,mg,Takeda,Type,2,Diabetes,Treatment,Liovel,LD,and,HD,Novartis,Pharma,COPD,Treatment,Onbrez,Inhalation,Capsules,Ono,Corebeta,for,Inj.,12.5,mg,for,Improving,Image,Quality,in,Coronary,CT,Angiography,21,PHARMA,JAPAN,Lexicon,84,?w???O??r?,A1c,Hemoglobin,A1c,(HbA1c),NGSP,l,(HbA1c,(NGSP)),HbA1c,determined,by,the,NGSP,(National,Glycohemoglobin,Standardization,Program),method,JDS,l,(HbA1c,(JDS)),HbA1c,determined,by,the,JDS,(Japan,Diabetes,Society,?-{,?,Aoa?wρ?),method,MEDICAL,FACILITIES,&,NURSING,CARE,22,Council,Approves,2,Senshin,iryo,Including,Small,Bowel,Transplantation,from,Living,Donors,2,Kohdo,iryo,Including,Paclitaxel,Concurrent,Therapy,Approved,22,Daiichi,Sankyo,Unable,to,Ship,2.36,Million,Vials,of,Flu,Vaccine,Due,to,Virus,Contamination,23,Korosho,Asks,Prefectural,Authorities,for,Cooperation,to,Ensure,Stable,Supply,of,Flu,Vaccine,23,TOPICS,JSTC,Asks,for,Cigarette,Price,Increase,to,1,000,per,Pack,","No.2256 Contents")

st++; thePage[st]=new Array("2255_sep_26.pdf","pdf/2011_9/","September 26","Prime,Minister,Noda,METI,Cancer,Tissues,Fukushima,Korosho,Disaster,PIC,Early,GMP,Good,Manufacturing,Practice,compliance,inspections,Daiichi,Sankyo,Silodosin,China,Aims,Launch,Vibativ,Approved,Europe,Nosocomial,Pneumonia,Astellas,Everolimus,Obtains,EU,Approval,SEGA,Novartis,Afinitor,Approved,Pancreatic,NET,Europe,Novartis,US,FDA,Issues,Warning,Letter,Daiichi,Sankyo,Subsidiary,US,TPP,Prescriptions,Prazaxa,Blue,Letter,Some,Precaution,Required,with,Prazaxa,Sales,Daiichi,Sankyo,Announces,Delay,Flu,Vaccine,Shipment,Ono,Licenses,Ca,Receptor,Agonist,Inhibitor,Ivabradine,Servier,DSP,Discontinue,Shipments,Melbin,ASKA,Initiate,Transparency,GL,Project,Full,Scale,October,Keizai,Doyukai,Chairman,Hasegawa,NPhA,Takeda,Invest,Supreme,Court,Patent,Extension,Eisai,Aricept,Ajinomoto,Files,Suit,Actonel,Generic,Insurers,Favor,OncoTherapy,Angiogenesis,Inhibitor,OCV,101,Astellas,UMN,Pharma,Complete,Flu,Vaccine,Trans,Genic,Files,Patent,Antibody,against,Novel,Lung,Cancer,Marker,AnGes,MG,Janssen,Pharma,Launch,RA,Treatment,Simponi,Remicade,20,AZ,Daiichi,Sankyo,Aim,Nexium,PPI,Market,20,Ono,Astellas,Once,Every,Four,Weeks,Recalbon,Bonoteo,20,Astellas,OAB,Treatment,Betanis,Tablets,21,Actos,List,Recommended,Diabetes,Kenporen,Nexavar,Sutent,Naito,Kyushu,Univ,Deaths,Exceeded,Births,by,Over,125,000,Korosho,","No.2255 Contents")

st++; thePage[st]=new Array("2254_sep_19.pdf","pdf/2011_9/","September 19","Sector,Co-op.,2,METI,Minister,Edano,Says,NHI,Price,Listing,15,API,Products,EpiPen,Be,Covered,by,Insurance,Some,Chuikyo,Members,Question,NHI,Pricing,of,Nexium,Priced,Lower,Omepral,Isomers,Actos,Novartis,Pharma,s,Onbrez,Raised,15%,High-Priced,DPC,Re-pricing,Umeda,White,Paper,Calls,Participatory,Novartis,Flu,Vaccine,Gardasil,Gardasil,Wrong,Labeling,Omission,Off-label,Novartis,Applies,Tobramycin,Cystic,Fibrosis,of,Pancreas,BMKK,Files,Hepatitis,Rivaroxaban,Anticancer,Agents,Sunitinib,Oxaliplatin,Regulatory,Eisai,Accelerate,NIBIO,Project,Making,Progress,Biomarkers,Takeda,Initiates,PIII,Trials,of,Antidiabetic,TAK-875,Japan,Takeda,Initiate,Domestic,PIII,Trial,Once-weekly,DPP-4,Inhibitor,NBI,Initiates,PIII,Trial,BIBF1120,Perampanel,Partial,Epilepsy,Seizures,Zonegran,Partial,Epilepsy,Eisai,NanoCarrier,pH-Responsive,Micelle,China,Refund,Ethical,Drugs,Up,0.1%,July,Crecon,&,Research,Consulting,GENERICS,18,Sandoz,Use,Its,Unique,Anticancer,Drug,Container,More,Anticancer,Drugs,18,Dispensing,of,Generics,Not,Increasing,Pharmacies,Chuikyo,19,JGA,Prepare,Transparency,GLs,19,Nichi-Iko,Pfizer,Apply,Add,l,Indication,Generic,Cisplatin,Using,Data,from,Public,Domain,BUSINESS,20,Price,Settlement,Rate,Down,73.9%,of,Sales,June,Close,Pre-emergency,Recommendation,Levels,20,M3,Start,Web,Lecture,Service,Drug,Discussions,Continue,Relief,System,Victims,of,ADRs,Due,Anticancer,Drugs,22,No,Direct,Correlation,Between,HPV,Vaccine,and,Reported,Death,Colorectal,Cancer,Erbitux,Merck,Serono,22,TOPICS,Nippon,Shinyaku,Discloses,Details,Halcion-Laced,Liquor,Incident,","No.2254 Contents")

st++; thePage[st]=new Array("2253_sep_12.pdf","pdf/2011_9/","September 12","Medical,Nursing,Care,Fees,Hasegawa,Keizai,Doyukai,Welcomes,Masuyama,Takeda,Eisai,Resubmit,T,614,Nichi,Iko,Cefotaxime,Domain,Tarceva,Roche,PfizerNovel,NSCLC,Crizotinib,Bayer,Alpharadin,Eiki,Bayer,Antihypertensives,Antidiabetics,Prazaxa,Posts,Sales,Fuji,Keizai,Strong,Mizuho,Nomura,Securities,Kissei,Anthracycline,Extravasation,Agent,Astellas,Licenses,Fully,Human,Antibody,against,Infectious,Diseases,Haneda,Airport,Start,Sanki,23.1%,Drugs,Sales,Volume,April,June,JGA,JPMA,Publishes,GL,Compiling,eCTDs,Daiichi,Sankyo,Other,Anticancer,Drugs,NCC,Aims,Become,World,s,Leading,Early,Clinical,Development,Center,19,Chugai,,Antibodies,Licensed,from,Roche,Takeda,Leuplin,TAK,385,Helsinn,Initiates,Global,PIII,Program,Anamorelin,Eisai,Discontinues,Development,Pariet,Extended,release,Capsules,Intensive,Therapy,with,Rosuvastatin,Effective,Inhibiting,Progression,IMT,JART,Study,Apixaban,Superior,Warfarin,Risk,Major,Bleeding,Down,30%,ESC,JAK,Inhibitor,May,Be,as,Effective,as,Biologics,Lower,Cost,Prof.,Takeuchi,Keio,University,Medinet,Granted,Patent,on,Cancer,Antigen,Peptide,11,European,Countries,Takara,Bio,Supply,Plasmid,Vectors,iPS,Cell,Production,Kyoto,University,21,TOPICS,Tablet,Terminals,Effective,Changing,Doctors,Prescribing,Behavior,M3,MEDICAL,FACILITIES,&,NURSING,CARE,22,Dispensing,Fees,per,Prescription,Down,FY2010,1st,Time,4,Years,Korosho,Insurance,Covered,Medical,Expenditures,Reach,Record,high,36.6,Tril.,22,An,Anticancer,Drug,Prescribed,Instead,a,Generic,Ca,Antagonist,Korosho,Report,Generics,Brand,Names,Should,Be,Based,on,Generic,Names,Almarl,and/or,Amaryl,Should,Be,Renamed,Prevent,Mistakes,23,TOPICS,Sales,Class,1,OTC,Drugs,Recovering,Since,January,2010,JSMI,","No.2253 Contents")

st++; thePage[st]=new Array("2252_sep_5.pdf","pdf/2011_9/","September 5","EAD,Kamata,Asia,Cooperation,Conference,Next,March,CSD,Biopharmaceutical,Market,2010,Sanwa,Kagaku,Anagliptin,Kowa,China,Taiwan,MSD,Gardasil,Cervical,Cancer,Takeda,M&A,Talks,Indian,Companies,Local,Paper,Otsuka,TS-1,Europe,Eisai,s,DSP,s,Growth,Scenario,Tachibana,Securities,Takeda,Flu,Vaccines,Hikari,Plant,Kitasato,Daiichi,Sankyo,Vaccine,New-type,Flu,Vaccine,Sogo,Medical,OTC,Drugs,KIX-Medica,BMKK,Hybrid,Cars,Otsuka,noue,Seishodo,Branch,Illegal,Drug,Avastin,Breast,Cancer,Telavic,Mucosta,Ruxolitinib,Orphan,Drug,Fingolimod,Sitagliptin,Tetrabenazine,Riociguat,FPMAJ,PhRMA,EFPIA,Japan,Freeze,NHI,Prices,FPMAJ,Premium,New,Drug,Development,PhRMA,Re-pricing,Industry,Inflexibility,FY2012,Budget,Natural,Increases,Social,Security,Spending,without,Cuts,Vemurafenib,Melanoma,Daiichi,Sankyo,Combination,Therapy,BMS,Patent,Extension,System,Astellas,Mirabegron,Lurasidone,PIC/S,Membership,Early,FY2012,New,CND,Director,Nakaigawa,Unit,Price-based,By-product,Deals,Mr,Bessho,JPWA,FPMAJ,NHI,Prices,All,Generics,JSGM,Generic,Makers,Cost,Burden,f,Public,Domain,Univ,Tokyo,Hospital,Initiate,PI,Trial,Radical,AD,Treatments,Keio,Univ,PI,Trials,New,Drugs,Refractory,Immunological,Diseases,Osaka,Univ,Hospital,Discover,Globally,Competitive,Drugs,Switched,Generic,Actos,Nextit,Minimum,NHI,drug,price,JCS,Dabigatran,i,CHADS2,Score,1,Reduce,Dose,Renal,Impairment,JCS,METI,Medical,Tourism,from,Overseas,Legal,Prescription,Rate,JPA,","No.2252 Contents")

st++; thePage[st]=new Array("2251_aug_29.pdf","pdf/2011_8/","August 29","Nexium,Takeda,China,Globalization,President,Hasegawa,NBI,Prazaxa,Global,Megapharmas,Merck,2%,JPWA,Teijin,Pharma,Astellas,Sign,New,Marketing,Febuxostat,Chugai,Licenses,Melanoma,Vemurafenib,Roche,BI,Licenses,ADCC,Enhancing,Technology,ProBioGen,Eisai,Mexico,Shionogi,Acquires,24,17%,Stake,in,C&O,of,China,US,Argatroban,Patent,Dispute,US,Actelion,to,Pay,Damages,Asahi,Kasei,Pharma,Fasudil's,Development,Radioactive,Cesium,Ashes,at,Chugai's,Research,Lab,Concrete,Disclosure,Standards,Should,Have,Been,Included,JPMA's,GLs,COI,Prof,Miyata,Actos,RepTrack,Survey,Use,Medicoeconomic,Evaluation,NHI,Drug,Pricing,Korosho,Study,Group,Korosho,Orders,Revision,Package,Insert,Prazaxa,5,Deaths,Celsentri,HIV-Infected,Patients,ViiV,Healthcare,Remicade,Partial,Changes,in,Dosage,for,Crohn's,Disease,Hisamitsu,to,Apply,for,Transdermal,Oxybutynin,for,OAB,Chugai,Kytril,Astellas,Kyowa,Kirin,Apply,Amoxicillin,Pfizer,Withdraws,NDA,for,Fesoterodine,Caffeine,Citrate,Designated,as,an,Orphan,Drug,Commentary,Avastin's,Breast,Cancer,JGA,Kyowa,Pharm,Ind,M&A,Biosimilars,President,Sakamoto,of,Toyobo,Kenporen,St,Marianna,Univ,Eisai,Subsidiary's,CT,Colonography,New,Flu,Vaccines,Novartis,Pharma,Vaccine,Grant,Foreign-affiliated,PFSB,NanoCarrier,Kyoto,Univ,Nucleic,Acid,Drugs,AnGes,MG,to,HPV,Vaccine,with,GenoLac,Mitsubishi,Chemical,Medience,Radiolabeled,Compounds,Seikagaku,SI-6603,Kyowa,Kirin,Initiates,PIII,Trial,of,ARQ197,for,NSCLC,in,Asian,Countries,AnGes,MG,Granted,Ets-1,in,US,Mr,Wolf,of,PhRMA,E,VICP,Pemirolast,K,JAMS,Acarbose,Saitama,Pharm,Association,Revlimid,Dr,Hatake,Anticoagulants,Welcomed,","No.2251 Contents")

st++; thePage[st]=new Array("2250_aug_15&22.pdf","pdf/2011_8/","August 15&22","RaQualia,Innovator,Kyowa,Kirin,Aims,ProStrakan,by,2013,Anticancer,Drugs,Humira,Surges,Aricept,Mr,Honda,Yakult,Proacta,Bayer,CreateQol,Opens,Dispensing,Pharmacy,at,Major,Electronics,Retail,Store,FIRM,Crecon,&,Research,Kowa,Antiplatelet,RoACTEMRA,Europe,Roche's,Tarceva,,NSCLC,Therapy,EC,Nycomed,by,Takeda,Korosho,Taking,Public,Comments,on,Proposed,GL,for,Development,of,Prototype,Pandemic,Flu,Vaccines,Korosho,Announces,Revised,Precautions,Diabetes,Metgluco,Methods,Annexed,Nichi,Iko,to,Strengthen,Relationships,with,Wholesalers,Research,oriented,Companies,to,Become,Daiichi,Sankyo,Generic,Business,President,Tada,17,Fuji,Pharma,Sales,Up,7%,Driven,Merck,Makes,Largest,R&D,Investment,in,2010,20,Takeda,Discontinues,Development,of,Anti,obesity,Drug,in,US,20,NCCHD,Creates,Pediatric,Clinical,Trial,Network,of,Shionogi,Completes,New,Core,Research,Facility,in,Toyonaka,Tella,Announces,Research,Results,for,Dendritic,Cell,Vaccine,Therapy,Korosho,Starts,Taisho,Malaysian,Company,Asahi,Kasei,to,Asahi,Kasei,Kuraray,NCVC,to,Expand,Prof.,Kaku,of,Kawasaki,Medical,School,Dementia,in,2026,26,M3,Survey,of,","No.2250 Contents")

st++; thePage[st]=new Array("2248_aug_1.pdf","pdf/2011_8/","August 1","Daiichi,Sankyo,Espha,Halaven,Oncology,Daiichi,Sankyo,Lixiana,VTE,RaQualia,JASDAQ,Aims,to,Raise,Astellas,Vice,Deputy,Chairman,Ishii,Chugai,Equa,Japanese,Pharm,EFPIA,Japan,Astellas,Viremia,Vaccine,Vical,Shionogi,Victory,Pharma,LTT,Bio-Pharma,t,Inhalant,PC-SOD,CKD,Taiho,Nordic,Group,Commercialize,TS-1,Europe,Mochida,Lexapro,Aug.,22,Nihon,Chouzai,Finger,Vein,Authentication,Ain,Pharmaciez,Smart,Phones,Pfizer,Matsumori,Biosimilars,Optimize,Healthcare,Costs,Biosimilars,JSGM,JGA,Compiles,Ethics,Standards,MTPC,Ordered,to,Stop,Operations,Subsidiary,Plant,Council,Starts,Discussing,How,to,Realize,Proposed,Social,Security,Reform,Plan,EMA,Takeda,Revise,Package,Inserts,for,Pioglitazone,Medicines,Bladder,Cancer,Takeda,New,Epidemiological,Study,PMDA,PIC/S,Membership,Generic,Drugmakers,Public,Domain,Premium,for,New,Drug,Development,Mr,Wolf,of,PhRMA,FDA,Advisory,Committee,Does,Not,Recommend,Approval,of,Dapagliflozin,art,of,PMDA,Osaka,Proposed,Kansai,Sogo,Tokku,Plan,Chugai,Pulmozyme,Cystic,Fibrosis,Sodium,Phenylbutyrate,CMIC,Orphan,Drug,NPhA,US,FDA,Simultaneous,Development,of,Therapeutics,and,Companion,Diagnostic,Devices,Rivaroxaban,Safety,Warfarin,J-ROCKET,AF,Data,Dr,Hori,AZ,NCC,Anticancer,Drugs,Shionogi,HIV,Treatment,S-349572,Maurer,Healthcare,Insight,134,Takeda,to,OTC,Drugs,Asia,Japan,Federation,of,Non-prescription,Medicines,Industry,PAFSC,Crude,Drugs,as,Class,OTC,Drugs,Vaccines,PAFSC,Study,Groups,Eisai,Halaven,Dr,Iwata,of,Aichi,Cancer,Center,Halaven,President,Naito,JPA,JCQHC-initiated,Accident,Reporting,Project,Asahi,Kasei,Emergency,Care,Aiming,Korosho,PMDA,Websites,","No.2248 Contents")

st++; thePage[st]=new Array("2247_jul_25.pdf","pdf/2011_7/","July 25","Merck,Serono,President,Smith,Erbitux,Head,and,Neck,Cancer,New,Indication,Cladribine,NBI,Prazaxa,Long,term,Prescription,BMKK,CML,Sprycel,Medium,sized,Alan,Thomas,IMS,Japan,Wholesalers,Medipal,Increase,Mizuho,Shionogi,IPF,Treatment,Pirfenidone,Ildong,Eisai,Obtains,Orion,in,China,Astellas,Pfizer,Caduet,Astellas,Files,Suit,Sandoz,Prograf,Chugai,Utsunomiya,Plant,Survey,Drug,Production,in,March,Down,APIs,Lixiana,Added,NHI,Price,List,Halaven,List,Accredited,Foreign,Drug,Manufacturers,Orphan,Drug,Development,Health,Minister,Hosokawa,Yoshida,Dispensing,Fees,LDP,Subcommittee,Unification,Dispensing,Fees,PIC,raberg,Rivaroxaban,DVT,Avastin,Xeloda,Roche,SEGA,by,CHMP,Novartis,Application,Dacogen,for,AML,Eisai,EPPV,Rasuritek,sanofi,aventis,Aricept,Generics,Lipitor,DSP,Aricept,Generics,15,Nippon,Chemiphar,Uric,Acid,Lowering,Agent,Nichi,Iko,Radicut,Generic,sanofi,aventis,Biosimilars,Voluntary,Recall,Variation,Biosimilars,Revision,GLs,Equivalence,Testing,Generic,Drugs,Uneasy,about,Prescribing,Generics,MedPeer,Biosimilars,Era,Mr,Sawai,JGA,Teva,Taiyo,Pharm.,HPB,Tohoku,Univ,ALS,Sanofi,Rib,X,Antibiotics,Lyrica,Fibromyalgia,in,PIII,Pfizer,Lantus,Apidra,Aspart,Sanofi,Novo,Nordisk,Ultra,Long,Acting,Insulin,Hypoglycemia,Orencia,Bristol,Myers,Chugai,Tarceva,Pancreatic,Cancer,2,Human,Stem,Cells,Health,Insurance,for,First,Time,CPhI,Japan,Vaccination,Rates,Psychiatric,Disease,Designated,Diseases,in,Healthcare,Planning,System,Korosho,t,Anti,HTLV,1,Measures,State,Subsidy,Recommended,for,MSD,HPV,Vaccine,Gardasil,Avoidance,APEX,CKDI,Dialysis,Daiichi,Sankyo,Handheld,Mother,Child,Notebook,Schizophrenia","No.2247 Contents")

st++; thePage[st]=new Array("2246_jul_18.pdf","pdf/2011_7/","July 18","Bayer,VEGF,Trap-Eye,Approval,Integration,Nycomed,tTakeda,Mr,Matsutani,Hire,Graduates,in,2012,Ryukaikon,Bar,Code,Labeling,SymBio,MDS,Hisamitsu,Norspan,Tapei,August,Roche,SGLT-2,Inhibitor,to,Chugai,Mr,Ubunuki,Yano,Research,Kyowa,Kirin,to,Education,New,MRs,Korosho,Copayments,OTC-like,Drugs,JACDS,JPA,tUnification,Basic,Dispensing,Fees,Basic,Dispensing,Fee,Pres.,Kodama,JPA,Unification,Basic,Dispensing,Fees,Chuikyo,Matter,Dr,Adachi,Online,OTC,Drug,Sales,in,FY2011,Mr,Hirayama,Korosho,PMDA,Victims,Health,Hazards,Caused,Anticancer,Drugs,Takeda,Recalls,Actos,Competact,in,France,Takeda,Respond,Mr,Yamanaka,Senju,Next-generation,Strategic,Product,Pancreatic,Cancer,Tarceva,Chugai,GSK,Rotarix,GSK,Daiichi,Sankyo,Tie,Up,for,Copromotion,4-Valent,HPV,Vaccine,Gardasil,Approved,MSD,Takeda,Liovel,Combination,Onbrez,COPD,Novartis,Rufinamide,Approved,in,Canada,Eisai,Avastin,,Crecon,Research,Consulting,Sandoz,Nipro,Team,Up,Bristol-Myers,AZ,Report,Breast,Bladder,Cancer,Takeda,s,TAK-875,Presented,at,ADA,Lyrica,in,PIII,Trial,Pfizer,Lixisenatide,Decreases,HbA1c,Eisai,to,Biomarker,Subsidiary,EIDIA,Lexicon,71,Taisei,Kako,Co-develops,Suzuken,Nippon,Kayaku,Gelpart,from,Astellas,DPC,Fixed-sum,Reimbursement,HbA1c,Hepatitis,B,Settlements,HPV,Vaccine","No.2246 Contents")

st++; thePage[st]=new Array("2245_jul_11.pdf","pdf/2011_7/","July 11","Sanofi,Aventis,Aiming,Growth,Upper,Single,Digits,Pres.,Moulding,Sanofi,aventis,Nichi,Iko,Later,Lasix,Launched,Eisai,Liver,Disease,Franchise,Pfizer,Adding,Indications,Nippon,Kayaku,Pharm,Up,1.3%,50,339,Mil.,Yen,Maruishi,KHK,Matsuda,Astellas,DPP,Inhibitor,Patent,Estate,US$609,Mil.,CMIC,Daiichi,Sankyo,Sogo,Medical,Mentaio,Mediceo,Orphan,Drugs,Pfizer,APIs/34,Astellas,Betanis,Daiichi,Sankyo,AZ,Nexium,DPP,Inhibitor,Tradjenta,Approved,NBI,Eli,Lilly,Dasen,Withdrawn,Copayments,Partial,Changes,Acceptable,Crystal,Form,Lexicon,69,(Application,Korosho,Reimbursement,Medicoeconomic,Assessment,Dr,Morita,PIC/S,GMP,Package,Inserts,MAA,Accepted,Perampanel,Eisai,,Protect,NHI,Prices,Mr,Matsumori,Pfizer,Regenerative,Medicines,Pfizer,Application,Axitinib,RCC,DPJ,Lawmakers,Ono,Evotec,Iron,Channel,Sanofi,aventis,Tohoku,Univ.,Kyowa,Hakko,Kirin,KW,3357,AnGes,MG,Peptide,Sawai,Antibody,Drugs,Sawai,Hybrid,Business,Model,Towa,Kobayashi,Maurer,Healthcare,Insight,Herceptin,Stomach,Cancer,Chuikyo,DPC,Subcommittee,Rivastigmine,Prof.,Nakamura,Rivastigmine,Dr,Endo,of,NCGG,Homecare,NST,Muto,Celecoxib,Ulcers,Loxoprofen,JES,Monotherapy,with,Novel,Antiepileptic,Agents,Lexicon,Online,Sales,Joel,Peterson,Appointed,New,President,UCB,Japan","No.2245 Contents")

st++; thePage[st]=new Array("2244_jul_4.pdf","pdf/2011_7/","July 4","Pfizer,MTPC,MTPC,JCRS,FUJIFILM,Mitsubishi,Tie,up,Manufacture,Biopharmaceuticals,March,Korosho,Saiseikai,RepTrack,Survey,Anti,tumor,Agents,8.6%,Wakamoto,Ophthalmic,Surgical,Adjuvant,Kyushu,Univ,Bioventure,Astellas,Transfers,Luvox,Abbott,Japan,Sosei,Gifu,Pharm,Univ,Tsuruha,HD,Eisai,Mebiopharm,Anticancer,Metabolic,Diseases,Fuji,Keizai,Actos,Generics,Launched,Nihon,Chouzai,Invest,FDA,Approves,Generics,Levofloxacin,Freeze,Prices,Essential,Drugs,METI,Advisory,Committee,Proposes,OTC,Insurance,Coverage,Cancer,Takeda,Revise,Korosho,Instructs,Revision,Pioglitazone,Bladder,Cancer,Risk,from,Actos,Actos,Takeda,SGN,Merck,Serono,Global,Approval,Cladribine,Sprycel,CML,Bristol,Myers,Otsuka,Korosho,Dornase,Orphan,Drugs,Largest,Deaths,Reached,Post,war,Actos,Bladder,Cancer,Risk,Safety,Measures,Multinational,Trials,Mr,Morimoto,CMIC,Korosho,Select,Hub,Med,Institutions,for,AnGes,MG,Obtains,Patent,HVJ,Cancer,SELF,Telemarketing,OTC,Drugs,Reconfirm,Opposition,Deregulating,OTC,Drugs,JPA,Lexicon,Takeda,Appoints,Shinobu,Leslie,Head,CNS,Drug,Discovery,Unit,Otsuka,Appoints,First,Female","No.2244 Contents")

st++; thePage[st]=new Array("2243_jun_27.pdf","pdf/2011_6/","June 27","Novartis,Ono,Rivastigmine,Beneficial,Daiichi,Sankyo,Confident,Janssen,Takeda,Reminyl,Promotion,Code,HeW,CO-OP,JAPAN,Taiho,Announce,Vorinostat,GenomIdea,Ties,Up,with,TSD,Japan,Licensing,HVJ-E,Nycomed,Takes,Over,Bisphosphonate,Roche,NanoCarrier,Patent,pH-Responsive,Micelles,Bladder,Cancer,Hosokawa,Korosho,Remains,Cautious,about,Reference,Price,System,Alternative,HFA,Rhinitis,DSP,Novoseven,Approved,Glanzmann,Thrombasthenia,Bayer,HealthCare,Applies,VEGF,Trap-Eye,Europe,Sanofi,Apply,Zaltrap,mCRC,Europe,US,2011,14,TOPICS,JACDS,Draws,Up,GL,Power,Takeda,Start,PIII,Trial,Hib,Vaccine,Otsuka,Start,OCV-105,Japan,NCC,Shimadzu,Tie,Up,Develop,Advanced,Cancer,Treatment,Technology,Sangi,Develops,Oral,Formulation,Cisplatin,Pfizer,Conduct,First-ever,Virtual,Eisai,Lenvatinib,Shows,ORR,59%,Global,PII,Eisai,PIII,Study,Confirms,Safety,Efficacy,Rotigotine,Patch,Otsuka,TS-1,Non-Inferior,Gemcitabine,Pancreatic,Cancer,Taiho,Sanofi,Lyxumia,Plus,Insulin,Shows,Promise,PIII,Study,Zeria's,Z-338,Effective,3,Major,Meal-related,Symptoms,Radioactive,Anticancer,Agent,Significantly,Extends,OS,PIII,Study,Bayer,HealthCare,Further,Analysis,Confirms,Usefulness,Terumo,Expand,into,Infusion,Products,Market,China,22,Miraka,Eiken,Disaster,Takara,Takeda,Sues,Actos,Patent,Infringement,Taiyo's,Acquisition,by,Teva,Provides,New,Opportunity,GE,Ind.,Mr,Honda,Mylan,Aratani,Family,Excluded,Teva-Controlled,Taiyo,Merck,Enbrel,Hanwha,South,Korea,Mr,Yoshida,Relieving,Victims,Health,Damage,Due,Anticancer,Drugs,26,Rheumatism,Allergy,Revise,","No.2243 Contents")

st++; thePage[st]=new Array("2242_jun_20.pdf","pdf/2011_6/","June 20","Amgen,Cancer,Strength,Biotech,Interest,Biosimilars,Bayer,Medicoeconomic,Evidence,ASKA,Radiation,Iwasaki,Top-Dispensing,Pharmacy,Chains,Record-high,Store,Openings,FY2011,Drugstore,Chains,Report,Crecon,Research,Consulting,PAFSC,Committee,Epogin,Anemia,Cancer,Nonapproval,Epogin,Ms,Katagi,SMILEY,ESAs,Actos,Bladder,Cancer,Chuikyo,Resume,Stable,Supplies,FPMAJ,Premium,Price-Based,Grouping,PIC/S,11,Copayment,Fuso,ApHemostatic,Epithelial,Corneal,Regeneration,Pfizer,Diflucan,Novartis,pNET,Sutent,Pfizer,MediBIC,Glufosfamide,Granted,Orphan,DE,Revlimid,Safety,exicon,ehabilitative,care,Merger,Kyorin,Towa,PHirayama,PIC/S,Anti-obesity,Contrave,SeattleADC,ASG-22ME,Astellas,DSP,Univ.,of,Tokyo,AIM,Fujitsu,Univ.,Tokyo,LMW,Compounds,OncoTherapy,OTS102,Biliary,Tract,Cancer,Intranasal,Granisetron,SNBL,MediBIC,Takeda,PI,Data,on,MLN4924,ASCO,Axitinib,PFS,Compared,Sorafenib,RCC,Patients,ASCO,Healthcare/Nursing,Expenditure,FY2015,21,Korosho,Expert,Committee,Pediatric,Cancer,Hub,Hospitals,PSJ,JAMS,Switch,OTC,Telemarketing,Residents,Takeda,Sonias,Diabetes,Daiichi,Sankyo,Novel,AD","No.2242 Contents")

st++; thePage[st]=new Array("2241_jun_13.pdf","pdf/2011_6/","June 13","Nippon,Shinyaku,Eisais,FY2011,Nomura,Securities,Teijin,Bonalon,Onealfa,Meiji,HD,Pharmaceuticals,Up,2.3%,Yakult,Pharmaceutical,10.8%,Elplat,Gastric,Cancer,Ajinomoto,Down,32%,FY2015,Asahi,Kasei,Pharma,3.4%,3.5,Fold,Increase,Recomodul,ASKA,Merger,Earthquake,Torii,Double,Nippon,Chemiphar,Sales,Up,14%,Seikagaku,31.4%,JCR,EPO,Biosimilar,Props,Lilly,Evista,Takeda,Kyowa,Kirin,Ferring,ODT,Enuresis,6002,Kyowa,Kirin,Bendamustine,Marketed,by,Eisai,SymBio,Trisenox,Launched,BL&H,Nippon,Shinyaku,IMUC,POTELLIGENT,BioWa,DSP,JPMA,MSD,Violations,Mirabegron,OAB,Corebata,Tachyarrhythmia,Lexicon,65,Korosho,Medical,Fees,Copayments,OTC,FTC,GL,3,000,Food,Refreshments,CHMP,Astellas,Vibativ,PMDA,METI,Patent,Office,DDS,Drug,Discovery,Support,Institute,Ono,DSP,CTS,Limaprost,BMS,Roche,PI/II,Trials,Melanoma,Sanofi,Pasteur,antigen,IPV,Kyowa,Hakko,Bio,Amino,Acid,Manufacturing,NanoCarrier,Micelle,OPC,Antipsychotic,Otsuka,DSP,Kyorin,Announce,Ranirestat,KW,6002,PD,Kyowa,Kirin,JAK,Tofacitinib,RA,Pfizer,Inc.,Taiyo,Taiyo,Biosimilars,Taiyo,Pharm.,GE,Aricept,CSO,Association,on,June,1,SELF,MEDICATION,22,JAMS,PSJ,Switch,OTC,Korosho,Kowa,Menstrual,Prof.,Kadowaki,tncretin","No.2241 Contents")

st++; thePage[st]=new Array("2240_jun_6.pdf","pdf/2011_6/","June 6","Kantar,Health,Crizotinib,Nexavar,35%,HCC,Daiichi,Sankyo,40,Bil,Ranbaxy,Astellas,Global,Darexaban,Teijin,Feburic,Hyperuricemia,Accumulate,Synvisc,Santen,Regains,Glaucoma,Seikagaku,Preparing,to,Launch,Gel,Despite,Patent,Dispute,Genzyme,Files,Lawsuit,Seikagaku,Kyorin,HD,Double,Digit,Growth,Kipres,Kaken,Operating,Profits,Up,20%,Synvisc,to,Little,Artz,Mr,Konishi,Mochida,Net,Profits,Down,46%,Earthquake,Kissei,Sales,3.6%,Major,Products,Urief,New,3,Year,Plan,Aims,Accelerate,New,Drug,Development,9,Nippon,Shinyaku,Sales,Up,0.9%,to,63.5,Bil.,Driven,Cialis,Lunabell,Sales,Up,33.1%,Driven,CMO,Business,CMIC,CMIC,Acquires,Sugi,Clinical,Cervarix,Ranked,No.,1,GP,Market,Lyrica,Ranked,ASKA,Ulipristal,Laboratoire,HRA,Daiichi,Sankyo,AZ,Copromote,Denosumab,Matsutani,Toho,Nihon,Chouzai,Open,R&I,Takeda,Acquisition,Nycomed,Yoshiki,Bessho,Hiroyuki,Sawai,Reelected,JGA,HPV,Vaccine,Gardasil,Recommended,Approval,Tarceva,Recommended,for,Approval,Pancreatic,Cancer,Sprycel,Recommended,Approval,1st,line,Therapy,3,Drugs,Designated,as,Orphan,Drug,Emergency,Pill,Priced,10,000/Dose,JPA,Opposes,Drug,Price,Revision,Revision,Medical,Nursing,JMHA,Objects,Postponement,Medical,Nursing,Revision,Sitagliptin,Approved,aGI,MSD,Ono,Pfizer,Crizotinib,Chugai,Pediatric,Use,CellCept,BM,Files,Breast,Cancer,Paraplatin,Public,Knowledge,Korosho,Designates,Velaglucerase,Alfa,Orphan,Drug,Gaucher,Disease,Commentary,MSD,Promotion,Code,Violations,GENERICS,Actos,Generics,June,9,Delay,Listing,GE,Houses,Delay,Listing,Actos,Generics,Sawai,to,Launch,Actos,Generics,Towa,Ready,Actos,Commentary,GE,Makers,Make,Difficult,Decision,Actos,Generics,due,Combination,Patent,22,Toyota,Tsusho,Represent,GHL,Biosimilars,Contract,Manufacturing,Service,Eisai,UCL,Neurodegenerative,Disease,Pfizer,Comprehensive,Agreement,with,NCC,for,Clinical,Trials,Anticancer,Drugs,Nippon,Zoki,Teikoku,Seiyaku,to,Codevelop,Adhesive,PHN,23,45.5,Billion,Worth,of,New,type,Flu,Vaccines,Discarded,Health,Minister,Hosokawa,23,PHARMA,JAPAN,Lexicon,64,Asset,retirement,obligations,(ARO)","No.2240 Contents")

st++; thePage[st]=new Array("2239_may_30.pdf","pdf/2011_5/","May 30","Takeda,to,Acquire,Nycomed,for,9.6,Bil.,Euros,Hasegawa,Takeda,Patent,Expirations,Combined,Domestic,Sales,of,Ethical,Drugs,Up,1.4%,6,MTPC,Sales,Up,1.2%,Double-digit,Growth,in,Profits,5-Year,500,Bil,DSP,Up,28.1%,Acquisition,Sunovion,Latuda,Include,Candidates,fDepression,Mr,Tada,8,Shionogi,Net,Profits,Down,48.2%,Earthquake,Teshirogi,9,Taisho,Operating,Profits,Up,27%,SGA,Expenses,Taisho,Pharmaceutical,HD,Ono,Dependence,Long-listed,Products,Down,to,About,70%,Glaucoma,Santen,121,Bil.,in,FY2013,Otsuka,Announces,1st,Generics,Business,Higuchi,Takara,Bio,Aims,Sales,of,22.7,Bil.,in,FY2013,Takara,Bio,Vitrology,Biosafety,Testing,Services,Mediceo,Yakkasa,Reduction,Rate,Premium,Drugs,Down,High-Profit,Long-Listed,Drugs,Wholesale,Business,Mr,Hamada,Toho,HD,Reorganization,Premium,for,New,Drug,Development,PhRMA,Astellas,Completes,Acquisition,of,Perseid,Daiichi,Sankyo,Launches,Sprix,Nasal,Spray,US,NanoCarrier,NC-4016,Obtain,Substance,Patent,Lexicon,63,(Examiner),patent,Notice,allowance,Substance,patent,Process,,Formulation,patent,Use,patent,Postponement,Medical,Nursing,Fee,Revisions,Warning,Issued,MSD,Violations,of,Fair,Promotion,Code,Asahi,Kasei,Pharma,Obtains,Marketing,Approval,Flivas,South,Korea,Eisai,Novel,Anticancer,Drug,Halaven,Switzerland,BI,Eli,Lilly,Linagliptin,Lu,AA21004,MDD,Starts,Takeda,Ajinomoto,Mochida,tCodevelop,Fixed,Dose,CCB,+,ARB,Combination,PIII,Terumo,Starts,Domestic,Acetaminophen,Maurer,Healthcare,Insight,(132),P.,Reed,Maurer,21,Up,5.6%,Ethical,Drugs,Disaster,Crecon,Teva,Acquire,Majority,Stake,in,Taiyo,Teva,Expand,Tie-ups,M&As,Taiyo,Shimada,Teva-Taiyo,Strategic,Tie-up,No,Major,Impact,Sawai,President,Sawai,Korosho,Approves,2,Class,1,OTC,Anti-allergic,Eye,Drops,23,TOPICS,Sanofi-aventis,Changes,Corporate,Name,to,Sanofi","No.2239 Contents")

st++; thePage[st]=new Array("2238_may_23.pdf","pdf/2011_5/","May 23","Takeda,Aims,Recovery,Patent,Expiration,Strong,Yen,Hit,China,Takeda,Enters,Agreement,with,Canadian,Company,Detox,Agent,Takeda,NDA,fTAK-085,TG,Level,Anti-Xa,Agent,TAK-442,Otsuka,US$897,Mil.Daiichi,Sankyo,Double-digit,Rise,Astellas,Sales,Profits,Down,Prograf,Harnal,Mirabegron,Nogimori,Mirabegron,Solifenacin,Eisai,Sales,Down,100,Bil.,for,Aricept,Naito,CO2,Emissions,Target,JPMA,9,Foreign-affiliated,Drug,Companies,Outgrow,Wholesalers,Operating,Profit,Rate,Falls,Below,Worst-ever,Levels,Down,Alfresa,Suzuken,Toho,HD,Matsutani,First,European,Launch,Rivalo,Spain,Kowa,Iberica,HD,Fuji,Yakuhin,Drugstore,Growell,HD,Up,40%,Teva,Taiyo,for,37,Bil.,Korosho,Asks,Kyokai-kenpo,Further,Promote,Generics,PMDA,12-Team,System,ADR,Information,Lurasidone,Pan-Asia,Mucosta,Superior,Hyaluronate,Conjunctival,Damage,Otsuka,Dabigatran,Warfarin,Stroke,Risk,BI,Tofacitinib,RA,Reduced,Risk,MS,Disability,Progression,Novartis,T-DM1,PFS,HER2-Positive,Metastatic,Breast,Cancer,Roche,Dabigatran,Sub-Analysis,Similar,in,Japanese,Patients,vs,Overall,Study,Population,21,TOPICS,7,Diseases,to,Gain,Importance,in,Next,10,Years,JHSF,Report,Stresses,Good,Cost-effectiveness,of,Prazaxa,Levemir,Diabetes,Children,Aged,2-5,Novo,Nordisk,Lexicon,me-too,drug,Biosimilar,(similar,biological,medicinal,product),follow-on,biologics,23,Survey,39%,oHospitals,Return,Black,23,TOPICS,Takeda,Patents,Cited,Largest,Number,Notices,Patent,Refusal","No.2238 Contents")

st++; thePage[st]=new Array("2237_may_16.pdf","pdf/2011_5/","May 16","Astellas,Changes,Leadership,Prazaxa,Anticoagulant,Century,Wholesalers,Valuable,Emergency,MRs,METI,In,house,Power,Generators,Major,Drugstore,Chains,Hire,New,Graduates,Disaster,Areas,Pfizer,Special,Leave,Volunteers,Disaster,Area,Supreme,Court,Favors,Patent,Extension,Takeda,DDS,Formulations,Sawai,Takeda,Actos,Patent,Dispute,IP,GE,Makers,Topical,Analgesic,Maruho,Takeda,Daiichi,Sankyo,Launch,AD,MEMARY,Takahagi,Tech,Center,Astellas,Takara,Bio,22,700,Mil.,FY2013,Alfresa,HD,Losses,Caused,Quake,MatsumotoKiyoshi,HD,Nuclear,Accident,Mr,Igari,of,JPMA,Japan,China,Strengthen,Capability,Mr,Hasegawa,Liovel,Nexium,Januvia,Recommended,aGI,Simponi,PAFSC,OKs,Endoxan,Shire,Velaglucerase,Designated,Orphan,Gaucher,Disease,Kyowa,Kirin,Files,NDA,Anti,CCR4,Antibody,KW,0761,CCR4,Expression,Diagnostic,Agent,15,Korosho,Risk,Management,Long,Acting,ESA,Mircera,Approved,Chugai,Glubes,Type,2,Diabetes,Kissei,Once,Daily,Mirapex,Parkinson,Disease,NBI,Pancreatic,Digestive,Enzyme,LipaCreon,Approved,Abbott,Japan,Eisai,Tramcet,Combination,Tab,Approved,Relief,Chronic,Pain,Janssen,Suprane,Approved,Inhalation,Anesthesia,Baxter,Genzyme,Thymoglobulin,Additional,Indication,New,Dosage,Approved,Shionogi,Finibax,Takeda,Submits,NDAs,Velcade,US,Chugai,Indication,Herceptin,Actemra,SJIA,Additional,Indication,US,CHMP,Avastin,Xeloda,Combination,Roche,FDA,Aricept,Patch,Eisai,Yet,Considered,Postponing,Medical,Nursing,Fee,Revision,2012,Senior,Vice,Minister,Ohtsuka,Discussion,Ethical,GL,for,Genome,Analysis,21,Commentary,Industry,Concerned,About,Possibility,Consecutive,NHI,Price,Revisions,Legal,Prescription,Receipt,65%,Lexicon,Legal,prescription,house,prescription,receipt,rate,bungyo,rate,Taiyo,Strategic,Alliance,with,Teva,DSP,CiRA,Rare,Intractable,Disease,,Kaketsuken,GSK,Cell,Culture,based,Flu,Vaccine,Present,Views,on,Switch,OTC,Candidates,Sato,Pharm,Launches,Switch,OTC,Clotrimazole,Vaginal,Candidiasis,","No.2237 Contents")

st++; thePage[st]=new Array("2236_may_2&9.pdf","pdf/2011_5/","May 2&9","Meiji,Seika,Pharma,FY2020,2,Lilly,Alliances,Mr,Hasegawa,Class,1,OTC,Drugs,10%,OTC,Drug,Sales,FPMAJ,Finalizes,Voluntary,Energy-saving,Summer,FPMAJ,Quake-hit,Pravastatin,Daiichi,Sankyo,Radioactive,Contamination,FPMAJ,DSP,200,Pharmacist,Astellas,Pharma,Mitsui,Mercian,Chinese,Market,Restraint,Kongo-shinryo,Xyzal,GP,RepTrack,40%,MEMARY,Dasen,The,Great,East,Japan,Earthquake,MRs,Disaster,Zone,Wakamoto,s,Mid-term,Management,FY2011,Wakamoto,Taiwan,Kyowa,Kirin,Completes,Legal,Procedures,Acquisition,ProStrakan,Kaken,Mizuho,CoreMed,eCTD,Acronet,ICON,LIXIANA,Eisai,Halaven,Breast,Cancer,Daiichi,Sankyo,Edoxaban,VTE,Prevention,Mochida,Lexapro,Depression,Transdermal,Patch,AD,Rivastigmine,Novartis,Ono,Revision,Medical,Nursing,Fees,JMA,Board,Trustees,Disagree,Postpone,Revisions,Postponement,Dr,Nakagawa,Kenporen,Postponement,Revision,JPA,Postponement,FY2012,Medical,Fee,Revision,VP,Yamamoto,Consensus,Drugs,Cost-effectiveness,Anticancer,Drug-related,Adverse,Effects,Rheumatism,19,REGULATORY,NEWS,IN,BRIEF,Chugai,s,Pegasys,Granted,Priority,Review,CHB,Gov,Designates,Eribulin,as,Ad-restricted,Korosho,Consider,Allowing,Delivery,OTC,Drugs,by,Pharmacists,OTC,Ketotifen,Reclassified,Class,Lexicon,Advertisement-restricted,Phillip,Carrigan,Bayer,Starts,Multinational,PIII,Trial,VEGF,Trap-Eye,DME,Lixisenatide,HbA1c,Combination,SU,SU,Metformin,Toyobo,Kyowa,Medex,Comarket,Reimbursed,Disaster,Areas,Moratorium,Copayment,Quake,Victims,Extended,Korosho","No.2236 Contents")

st++; thePage[st]=new Array("2235_apr_25.pdf","pdf/2011_4/","April 25","Bayer,Yakuhin,Aims,Over,200,Bil.,Up,3%,to,181.4,Bil.,in,2010,New,Products,to,Account,for,60%,of,Total,Sales,Application,Filed,in,March,Rivaroxaban,Affected,Quake,Korosho,Power,Cut,Targets,East,Japan,Earthquake,MRs,in,the,Disaster,Zone,60%,Market,Share,sanofi-aventis,Lexicon,FJPWA,Rotational,Operations,FJPWA,President,Bessho,Teijin,Pharma,Announces,New,Global,Partners,TMX-67,8,Nomura,Securities,Predicts,Plummeting,Profitability,Daiichi,Sankyo,Yakult,4SC,Taiho,Antiemetic,Combination,Drug,Helsinn,New,ARB,EDARBI,US,Takeda,Tsumura,Mohrus,Tape,Production,Partially,Recovers,at,Hisamitsu,Infections,Disaster-hit,Areas,NIID,Kyowa,Kirin,Romiplate,Chronic,ITP,Xience,V,More,Reduces,MACE,Taxus,Abbott,Survey,Wholesalers,Manufacturers,Quake,Effects,on,Demand,REGULATORY,12,4,Unapproved,Indications,Considered,to,Have,Unmet,OK,Unapproved,Indications,Penalty,Failure,Designated,Unapproved,Drugs/Indications,2nd,Invitation,of,Listing,of,Drugs/Indications,Necessary,to,Be,Developed,in,PAFSC,1st,Committee,Liovel,Nexium,Simponi,Lexicon,59,ntractable,disease,Specified,disease,Orphan,Korosho,Draws,up,GL,for,R&D,Use,Donated,Should,Join,PIC/S,Harmonize,GMP,Dr,Sakurai,Volunteer,Disaster,Area,PMDA,Consultation,Services,OTC,Drugs.Switch,OTC,Candidates,Takeda,Samyang,Collaborate,RNAi,DDS,Takeda,AMG479,Metastatic,Pancreatic,Cancer,CytRx,TMRC,Tamibarotene,NSCLC,North,America,OPF,DIABECELL,with,LCT,for,Islet,Replacement,Therapy,Novartis,Discontinues,PIII,Tasigna,GIST","No.2235 Contents")

st++; thePage[st]=new Array("2234_apr_18.pdf","pdf/2011_4/","April 18","Barner,BI,Linagliptin,Be,Januvia,Mr,Willink,2,Takeda,Accelerating,CNSR&D,China,Mr,H.,Hirate,DSP,BBI,Strategic,Partnership,Anticancer,Eisai,President,in,China,Establishing,Sales,Subsidiary,in,Brazil,Operation,Cessation,Continues,April,7,Quake,6,Gov,to,Enforce,25%,Power,Cuts,Drug,Makers,Korosho,Calls,on,Industry,Energy,Conservation,Plans,ASKA,Begins,Shipments,of,Thyradin,Ajinomoto,IBD,Dr,Falk,BioWa,Licenses,Potelligent,to,OBT,Sanofi,aventis,Acquires,Additional,Nichi,Iko,Shares,Hisamitsu,Acquisition,Noven,Contributes,Sales,Operating,Net,Losses,Decrease,EPS,Establish,Wholly,Owned,Subsidiary,Korea,Quintiles,to,LBaxter,Storage,Temperature,Advate,Lexicon,56,Contract,Site,management,organization,(SMO),Clinical,research,associate,(CRA),or,monitor,Clinical,research,coordinator,(CRC),Basic,Dispensing,Fees,Draws,Up,New,GL,Drugs,for,Heart,Failure,Yellow,Letter,Lexicon,Dear,doctor,letter,warning,Blue,letter,Iressa,Case,FDA,Approves,Melanoma,QAB149,COPD,Maurer,Edirol,Capsules,Osteoporosis,Chugai,Taisho,Toyama,Takeda,Heptares,Announce,Collaboration,BI,201335,Hepatitis,C,BI,NA,Moves,Two,Hepatitis,Designation,17,Council,Environment,Drug,Discovery,Aiming,to,Conduct,First,humMotesanib,Non,SCC,NSCLC,APA,Elevates,Gastric,pH,RaQualia,Olmesartan,+,CCB,Suppress,CV,Events,Hypertensive,Patients,without,Type,II,Diabetes,Valsartan,Up,6.1%,Nippon,Chemiphar,Sawai,Cetirizine,OD,Tab,Receives,Generic,Drug,of,Year,Award,SELF,MEDICATION,21,Relaxation,of,,Agenda,May,President,Kodama,JPA,Taisho,Acquires,Hoepharma,Malaysia,Eiken,Licenses,LAMP,Technology,OptiGene,MCM,Clearstone,of,Canada,CLS,Services,FDA,Approves,HCC,Test,System,TASWako,i30,Wako,Pure,Chemical,22,TOPICS,Eisai,Subsidiary,Morphotek,Acquires,Tumor,Targeting,Assets,from,TransMolecular,MEDICAL,FACILITIES,&,NURSING,CARE,23,JP,16th,Edition,Published,with,106,More,Drugs,Added,","No.2234 Contents")

st++; thePage[st]=new Array("2233_apr_11.pdf","pdf/2011_4/","April 11","Wakamoto,Aims,FY2011,New,President,Kamiya,Takeda,DSP,Lurasidone,DSP,FY2010,Lurasidone,Tie-up,DSP,Stock,Target,Price,DSP,Licenses,Anti-MRSA,Takeda,DSP,Licenses,INT-747,Intercept,Lexicon,hospital-acquired,infection,or,nosocomial,Community-acquired,Opportunistic,infection,Eli,Lilly,Japan,New,Anti-AD,Drugs,Aricept,Utsunomiya,Plant,Chugai,Chugai,Epogin,Korosho,Asks,METI,Electricity,Outages,Earthquake,Disrupts,Raw,Materials,Sublood,Mid-April,Fuso,MTPC,Postpone,Eisai,Licenses,Bexarotene,Minophagen,Eisai,Enters,Collaborative,R&D,Agreement,PRISM,BioLab,Astellas,Cardeus,Ono,Peptide,Vaccines,OncoTherapy,AnGes,MG,Transdermal,MEDRx,AXIS,Pilocarpine,Kissei,Fibromyalgia,SNBL,Slovenia,Europe,Astellas,Sandoz,K.K.,Importing,Substitute,Thyradin,ProStrakan,Shareholders,AcquisitionbKyowa,Kirin,Abbott,Acquisition,Solvay,Pharm.,P&G,Teva,a-GIs,SUs,BGs,Generic,Reach,6.1%,Fuji-Keizai,April,AZ,Tokyo,High,Court,in,Iressa,Affair,GL,JPMA,Prohibits,Financial,Support,Patients,Groups,Korosho,Calls,Restraint,EN,Shortage,Ensure,Toyama,Chemical,T-750,Astellas,Pfizer,Additional,Indications,for,Celecox,FDA,Long-acting,OA,Knee,Pain,Seikagaku,Seikagaku,Withdraws,PMA,Supartz,Korosho,Revision,Package,Insert,Hib,Vaccine,Pneumococcal,Vaccines,Gov,Private,Sector,Dialogue,Postponed,Earthquake,Shionogi,Signs,Agreement,with,Denmark,Industry-Academic,Collaboration,OncoTherapy,Starts,PII,Trial,of,Angiogenesis,Cancer,Vaccine,Trial,Collategene,Shrinks,Ulcers,Buerger,AnGes,MG,Mirabegron,OAB,PIII,Trial,MEDICAL,DEVICES,MEDICAL,DEVICE,NEWS,IN,BRIEF,Meiji,Fujirebio,Terminate,Medical,Device,Bangladesh,Simultaneous,Vaccination,April,1,Korosho,Publishes,Q&A,Simultaneous,Aricept,Completes,Database,on,Antihyperlipidemics,PMAT,OPMA,Petition,MREAC,on,Pass/Fail,Criteria,for,MR,Exam,","No.2233 Contents")

st++; thePage[st]=new Array("2232_apr_4.pdf","pdf/2011_4/","April 4","Tokyo,District,Court,Holds,Both,Gov,AZ,Responsible,Iressa,Affair,Appealing,Higher,Court,Epochal,1,Month,Ex-company,Employees,PMDA,Re-employment,Takeda,Applies,for,Novel,ARB,Azilsartan,Daiichi,Sankyo,Direct,Xa,Inhibitor,Rixiana,PAC,Eisai,Halaven,Europe,Fingolimod,Novartis,CHMP,Benefit-Risk,Pioglitazone,ASKA,Thyradin-S,Fukushima,Plant,Ajinomoto,Sankyo,Abbott,Asahi,Kasei,XIAFLEX,Auxilium,Kowa,MEDRx,Etodolac,Patch,Meiji,Seika,Licenses,Ziprasidone,RaQualia,R-Tech,Ueno,Sucampo,Pharma,Design,Licenses,Cancer,Transcription,Factors,Yakult,BI,MorphoSys,Biopharmaceuticals,Oncology,Reminyl,for,AD,Takeda,Janssen,Prazaxa,CV,Specialists,Neurologists,NBI,MREAC,MR,Activities,Lexicon,Contamination,,Most,Admired,Pharma,Companies,in,2010,Maurer,,Philip,Carrigan,NIBIO,Next-generation,Adjuvants,New,Adjuvants,Enters,Vaccines,Vaccination,Prevnar,ActHIB,Resume,April,1,Kitasato,Daiichi,Sankyo,Vaccine,Co.,Ltd.,Inaugurated","No.2232 Contents")

st++; thePage[st]=new Array("2231_mar_28.pdf","pdf/2011_3/","March 28","Daiichi,Sankyo,MEMARY,Takeda,ASKA,Supply,Thyradin,Fuso,Replacement,Fluid,Electric,Power,FPMAJ,JPMA,Korosho,Sanofi,aventis,Gas,Shortage,Tohoku,Wholesalers,Requests,Frequent,Gasoline,Vidaza,MDS,Nippon,Shinyaku,Japanese,Market,Antimicrobials,Datamonitor,Nomura,Securities,Latuda,Astellas,Tarceva,Patents,Teva,JCROA,Drugstore,JACDS,Oncology,Strategies,JSMI,OTC,Hokoku,hinmoku,NHI,Price,List,PHARMA,JAPAN,Lexicon,Report,AZ,Plaintiffs,High,Court,Package,Insert,Defense,Counsel,Settlement,JAMS,COI,Transparency,Astellas,Bixalomer,Exal,LCH,Nippon,Kayaku,Higher,Dosage,Approved,for,Meropen,DSP,Advanced,Stomach,Cancer,Taiho,Baxter,PREFLUCEL,Chuikyo,Prescription,JSGM,Bioequivalence,Intravenously,Generics,NichiIko,Shares,Aprogen,Takeda,obesity,DSP,Kyoto,Univ,MTPC,Kidney,Disease,JMA,JMATs,NIRS,Fukushima,Insulin,Stable,Quake,Victims,Senshin,iryo,Epogin,Myocardial,Infarction,Kohdo,iryo,Sanko,Junyaku,RDKK,Cobas","No.2231 Contents")

st++; thePage[st]=new Array("2230_mar_21.pdf","pdf/2011_3/","March 21","Lechleiter,Eli,Lilly,Premium,Development,New,Drugs,Yakult,Perifosine,Aeterna,Zentaris,Pfizer,Infectious,Diseases,Carna,Biosciences,Kyowa,Kirin,ProStrakan,Citigroup,Nippon,Shinyaku,Vidaza,Januvia,RepTrack,Survey,Earthquake,Tsunami,Northern,Korosho,Ensure,Supply,VITAL,NET,Alfresa,Nihon,MediPhysics,Radiocesium,Decontaminating,Agent,Eisai,Epizyme,R&I,Terumo,CaridianBCT,JACDS,Antimonopoly,Act,Point,Cards,Nichiyakubo,Substance,Import,Astellas,Regenerative,Medicine,Shionogi,Obesity,Daiichi,Sankyo,NIBIO,Toxicogenomics,DB,Biomarkers,PHARMA,JAPAN,Lexicon,Pegfilgrastim,Janssen,Concerta,AD,HD,MediciNova,Patent,Ibudilast,Halaven,Lancet,Crecon,Research,Consulting,Prevnar,ActHIB,Simultaneous,Administration,BCG,Vaccine,PAFSC,Death,JMA,Cervarix,Recalled,Contamination,Inactivated,Polio,HPV,Akihiko,Otsuka,Otsuka,Pharmaceutical,MSD,NDA,Caspofungin,Gemzar,Ovarian,Cancer,Herceptin,Gastric,Stiripentol,Orphan,Stelara,Psoriasis,GSK,Arixtra,DVT,Acute,PTE","No.2230 Contents")

st++; thePage[st]=new Array("2229_mar_14.pdf","pdf/2011_3/","March 14","Eisai,East,Asia,Emerging,Markets,Aricept,AD,Honda,Warfarin,IFRS,Daiichi,Sankyo,Plexxikon,Nakayama,Bayer,Rivaroxaban,Drastic,Reform,Competitiveness,Mitani,Novartis,iPS,Cells,Discovery,Knee,OA,Yamanaka,Cervarix,Gardasil,Osteoporosis,Wholesalers,NHI,Pricing,System,Ethical,IMS,Japan,Takeda,PDE,ITI,Ajinomoto,Promotion,Zonegran,NerBlock,Eli,Lilly,Sawai,Kyorin,Ranbaxy,Levofloxacin,Ofloxacin,Singapore,Biosimilars,George,Sandoz,Memantine,Galantamine,List,Peak,Sales,Forecasts,PHARMA,JAPAN,Lexicon,method,Similar,efficacy,comparison,Cost,calculation,Reform,Regulations,JPMA,GL,Disclosure,Funds,EFPIA,Kato,Zyprexa,Depressive,Symptoms,Bipolar,Disorders,Limit,Sonias,Banzel,Oral,Suspension,EC,Avastin,Paclitaxel,Metastatic,Breast,Cancer,Elderly,Adachi,Terumo,CaridianBCT,DuraHeart,eluting,Stent,JTEC,Jace,Orphan,Medical,Device,Refractory,Erosions,Epidemolysis,Bullosa,Vaccination,Prevnar,ActHIB,DPT,Vaccine,Tumor,Lysis,Syndrome,ADR,Imatinib,Nilotinib","No.2229 Contents")

st++; thePage[st]=new Array("2228_mar_7.pdf","pdf/2011_3/","March 7","BMKK,Merck,Serono,Saizen,Tanaka,Daiichi,Sankyo,Plexxikon,Biomarkers,Therapeutic,Agents,Suzuki,Roche,China,Novartis,SOV,Equa,Comarketing,Sanofi,aventis,FUJIFILM,Biopharmaceuticals,Manufacturers,Antibody,Kyorin,Aclidinium,Almirall,Yakult,Proacta,Long,Listed,NichiIko,Mochida,Heparin,Ca,Osteoporosis,Korosho,Norspan,NorLevo,Nesina,SU,BG,Takeda,Xeloda,Stomach,Cancer,Chugai,Warfarin,Pediatric,Use,Eisai,Finibax,Chuikyo,Premium,Profits,Cost,Development,Unapproved,Drugs,PHARMA,JAPAN,Lexicon,NHI,drug,price,reimbursement,revision,survey,Actual,market,AZ,Iressa,Triall,High,Court,Azilsartan,NDA,Azilsartan,CLD,JPO,Actos,Patent,Aricept,IP,High,Court,Severe,AD,Yamanaka,Kondo,PMDA,Toxicity,Assessment,iPS,Cells,MAA,Cladribine,Vaccines,New,Type,Flu,Shionogi,GDO,Afinitor,NEJM,Avastin,PFS,Ovarian,JAMS,GLs,COI,Management,Nobuyuki,Kamiya,President,Wakamoto,Generic,Dasen,Data,Public,Domain,Welfare,Recipients,OTC,Switch,Version,Epadel,Fuji,Pharma,JGA,Prazaxa,Uchiyama,HbA1c","No.2228 Contents")

st++; thePage[st]=new Array("2227_feb_28.pdf","pdf/2011_2/","February 28","Novartis,Oncology,Mitani,Equa,Kyowa,Kirin,ProStrakan,Aloxi,Antiemetic,Otsuka,Abilify,Takeda,Covance,Quintiles,FUJIFILM,MTPC,JPMA,Korosho,Escitalopram,Mochida,Pfizer,CCB,Statin,Long,Term,Post,Marketing,Dasen,ARB,RepTrack,Survey,Osteoporosis,Cooperation,Boundaries,Asia,Hasegawa,Astellas,Tivozanib,AVEO,Vesicare,Nippon,Shinyaku,Gaslon,Lee's,China,Eisai,Halaven,Carna,Biosciences,KinoPharma,Neurodegenerative,Disorders,Bioventures,Yamazaki,IRI,Daiichi,Sankyo,Sanofi,aventis,Genzyme,Edoxaban,VTE,Fenofibrate,Maintenance,Adjuvant,Bipolar,Collaboration,Third,Parties,Clinical,Trials,Mo-99,Oral,Hypoglycemic,GSK,DMD,Lixisenatide,Mylan,WT1,mRNA,Assay,Kit,MDS,Medical,Devices,Takara,Bio,Research,Reagent,Joint,Venture,India,vitro,vivo,diagnostics,PHARMA,JAPAN,Lexicon,Healthcare,DB,Mori,PMDA,AIDS,Symbicort,PMS,Masahiko,Matsuo,Meiji,Seika","No.2227 Contents")

st++; thePage[st]=new Array("2226_feb_21.pdf","pdf/2011_2/","February 21","Chugain,Oncology,Nephrology,Bone,Joint,Nagayama,Taspoglutide,Tamiflu,DSP,Eisai,Teikoku,Seiyaku,Transdermal,Aricept,Medipal,ALCs,Price,Settlement,Rate,MSs,MR,Certificate,Wholesalers,Premium,Osteoporosis,Janssen,Fentanyl,Patch,Astellas,Fidaxomicin,Optimer,Australia,Santen,DBJ,Otsuka,IFN,Hayashibara,Withdraws,Darexaban,Dialogue,Compendium,System,Off,label,Use,Fujiwara,NCC,Halaven,Singapore,PAFSC,Rivastigmine,Edoxaban,Epoetin,Pegol,FDA,Actos,Risk,Safety,Measures,Court,Iressa,Ethical,December,Clinical,Trials,Gene,Therapy,Symposium,Emerging,Countries,Hasegawa,Takeda,Alogliptin,China,AZ,Zibotentan,PHARMA,JAPAN,Lexicon,Drugs,Quasi,Cosmetics,Medical,devices,Korosho,Promote,Generics,Differences,Impurity,Cisplatin,NIHS,Sawai,Kyorin,Hansha,Distributors,Classification,OTC,Toho,eHealthcare","No.2226 Contents")

st++; thePage[st]=new Array("2225_feb_14.pdf","pdf/2011_2/","February 14","Kyowa,Kirin,Marketing,Network,Biosimilars,Nesp,Espo,Allelock,Eisai,Eritoran,Naito,NDA,Aricept,Pfizer,Takeda,Tofacitinib,Enbrel,MSD,Recalls,Intron,Nitto,Denko,Avecia,Biotechnology,Operating,Profits,Wholesalers,Drugstore,Chain,Operators,Point,Services,JACDS,JPA,Sawai,Kyorin,Pharmarise,Generics,Urushibata,JPhA,Councilor,Settle,Prices,Korosho,Unapproved,Insurance,PhRMA,Premium,Umeda,Norspan,Ogawa,Public,NorLevo,Crizotinib,Orphan,Pegasys,Copegus,Priority,Review,CHC,Related,Compensated,Liver,Cirrhosis,FDA,CV,Safety,Contrave,AcipHex,Extended,Release,Capsules,General,Test,Methods,Court,Compromise,Lawsuit,Hepatitis,Relief,System,Deaths,Anticancer,ADR,Reports,Info,Diffusion,System,MTPC,Voluntary,Stability,Dasen,Kissei,EPO,Astellas,Applications,AZ,Shionogi,572Trii,Otsuka,OCV101,Pancreatic,Cancer,Bayer,Regeneron,VEGF,Trap,Eye,mCNV,Long,Term,Latuda,RDKK,Gene,Diagnostic,Agent,KRAS,Mutation,Sekisui,Genzyme,Dispensing,Fee,Prescription,TOS,PHARMA,JAPAN,Lexicon,Pharmaceuticals,Medical,Devices,Agency,PMDA","No.2225 Contents")

st++; thePage[st]=new Array("2224_feb_7.pdf","pdf/2011_2/","February 7","Pfizer,Umeda,Sunovion,Latuda,MTPC,Injectables,Quality,Tests,Korosho,Tochigi,Inspections,Kawabe,JPMA,Risk,Management,Committee,Taisho,Wholesalers,Price,Settlement,Yakkasa,JACDS,Points,Dispensing,Services,Torii,Allergy,Immunotherapy,ALK,Januvia,MSD,Yakult,Honsha,Eisai,Cancer,Discovery,Astellas,Kaketsuken,Encevac,AnGes,MG,Shionogi,NFkB,Oligo,Roflumilast,Nycomed,Hayashibara,Revitalization,ADR,Similar,Names,NBI,Mirapex,Nesina,SUs,BGs,Nakamura,Govt,Court,Compromise,Iressa,Lawsuits,PHARMA,JAPAN,Lexicon,Yakugai,MP424,Novartis,Canakinumab,CAPS,Eritoran,Otsuka,Bipolar,Disorder,Abilify,Chugai,Pegasys,Acetaminophen,Showa,Yakuhin,Kako,Perampanel,Europe,Halaven,CHMP,Gilenya,Positive,Opinion,GRU,Online,Sales,OTC,Basic,Dispensing,Fees,Office,Medical,Innovation,Kawakami,FJPWA,Resumption,Ryukaikon,Meiji,Seika,Fresenius,Kabi,Anticancer,Generics,Mochida,NichiIko,Public,Stock,Offering,Torii,Sublingual,Desensitization,Therapy,Cedar,Pollinosis,AMG386,Mechanism,Nerve,Cell,Protection,Cerebral,Infarction,Peretinoin,HCC,Kyowa,Kirin,KW6500,PD,Erbitux,FOLFOX,OS,Merck,Serono,Collategene,Philip,Carrigan,Nasivin,Spray,JSMI,Tax,Break,Recall,Teshirogi","No.2224 Contents")

st++; thePage[st]=new Array("2223_jan_31.pdf","pdf/2011_1/","January 31","NichiIko,Long,Listed,sanofi,aventis,Actos,UCSF,Yasuchika,Hasegawa,JPMA,President,Isao,Teshirogi,GL,Disclosure,Funds,Medical,Institutions,GSK,President,Fauchet,Charter,Good,Corporate,Conduct,Promotion,Code,Prescription,Fair,Competition,Code,Concerning,Distinction,Premium,s,Ethical,Pharmaceutical,Marketing,Industry,JACDS,Points,Copayments,Dispensing,Fees,GRU,JPA,GROWELL,Xyzal,RepTrack,Survey,ARB,CCB,Combination,Lyrica,aRigen,Novel,Anti,MRSA,GCC,South,Korea,Tokuhon,Adhesive,NSAIDs,China,Barclays,Alfresa,Toho,Venture,Nomura,Securities,CNS,Drugs,Korosho,Norspan,NBI,Anticoagulant,Prazaxa,Teijin,Feburic,Competitors,Aricept,AD,Drugs,Sonias,Takeda,Surepost,DSP,Vidaza,MDS,Nippon,Shinyaku,NerBloc,Cervical,Dystonia,Eisai,Stelara,Psoriasis,Janssen,Alvesco,Pediatric,Teijin,Pharma,PAFSC,Halaven,Formulation,Dasen,Reevaluation,Enzymes,AZ,Compromise,Courts,Iressa,Lawsuits,PHARMA,JAPAN,Lexicon,System,relief,victims,adverse,reactions,Kowa,Peretinoin,Botulinum,Toxin,PMDA,GMP,Compliance,Inspection,Prefectures,Roche,Diagnostics,HER,Gene,Amplification,Kit,Takara,Bio,HF,Ms,Science,Kyoto,Discovery,Kyowa,Kirin,AMG,Amgen,Daiichi,Sankyo,ArQule,ARQ,NIBIO,Hepatoblasts,iPS,Cells,Generics,TAIYO,Pharm,Recalls,Healthcare,Switch,OTC,Version,Loxoprofen,Direct,Western,Herbal,Medicine,Approved,EC,Patent,Settlement,Agreements,Diabetes,Treatment,Strategy,Incretin,Related,NICE,Aricept,Mild,AD,MSD,Allergy,Pollinosis,Dialysis,Kyokaikenpo,Vaccinated,Cervical,Cancer","No.2223 Contents")

st++; thePage[st]=new Array("2222_jan_24.pdf","pdf/2011_1/","January 24","AZ,Kato,Ticagrelor,Teijin,Pharma,TMX,FJPWA,Premium,Development,Chairman,Bessho,Incentives,Early,Price,Settlement,Qol,Point,Cards,Dispensing,Services,classA,JACDS,LSIP,Apoptosis,Stem,Cells,Takeda,Alzheimer,Zinfandel,Ono,BioFocus,Autoimmune,Disease,Astellas,Eligard,Daiichi,Sankyo,Kremezin,MTPC,GSK,Parkinson,Impax,Kenketsu,Venilon,Anact,Kyushu,Prosidion,Eisai,PPP,India,Kyowa,Kirin,GMP,Compliance,JMIRI,Web,Seed,Planning,Survey,Actos,Full,Indications,Pfizer,JGA,Sawai,PHARMA,JAPAN,Lexicon,Kowake,shinsei,applications,Hosokawa,Health,Minister,Kouhei,Ohtsuka,Osamu,Fujimura,Senior,Vice,Prevnar,Another,Shujutsu,Reed,Maurer,Simultaneous,Global,Office,Medical,Innovation,BI,Eli,Lilly,Antidiabetic,Linagliptin,AnGes,MG,Antibacterial,Spray,Hospital,Minodronate,Raloxifene","No.2222 Contents")

st++; thePage[st]=new Array("2221_jan_17.pdf","pdf/2011_1/","January 17","Perpetuation,Premium,FPMAJ,Shoda,Regulatory,Affairs,BI,NBI,Blopress,Sales,Ranking,Matsuda,Matsutani,Settle,Prices,Morishita,Jintan,Tech,Noven,Hisamitsu,Korosho,Drug,Lag,Okamoto,PAL,Amendment,Masugi,PMDA,Consultation,Strategy,Development,MED,Director,Cost,Effectiveness,HSB,Cancer,Budget,Data,Electronically,Clinical,Trials,Tasigna,CML,Novartis,FDA,Roche,Actemra,Bayer,JJ,Rivaroxaban,SPAF,US,Europe,Ex,Employees,Hasegawa,KEIZAI,DOYUKAI,Central,Social,Insurance,Medical,Council,Chuikyo,IBL,Antibody,Transgenic,Silkworm,Mizuho,Securities,Halaven,KW0761,Regeneron,VEGF,Trap,Eye,Japan,SymBio,Transdermal,Antiemetic,Simultaneous,Global,Recent,Anticancer,Keiji,Nakamura,AnGes,MG,Patent,NFkB,Decoy,Oligo,JPA,Unification,Basic,Dispensing,Fees,Govt,WG,Lifestyle,Diseases,New,Types,Influenza,Safety,Measure,Incretin,Related,Medwatcher,OTC,Cold,Medicines,WAKAMOTO,Vitreous,MaQaid,MINCLEA,GI,Peristalsis,ASKA,Nihon,Pharm","No.2221 Contents")

st++; thePage[st]=new Array("2220_jan_10.pdf","pdf/2011_1/","January 10","Hospira,Biosimilars,Safety,Wakunaga,MTA,ACUBE,MABs,Kyorin,Sawai,ViiV,GSK,Wholesalers,Cost,Effective,FJPWA,Corporate,Tax,Break,Rate,Osteoporosis,M3,MTPC,Bepotastine,DongA,South,Korea,Shionogi,NFkB,Decoy,Oligo,AnGes,MG,BMS,Festinavir,Oncolys,Bristol,Myers,Otsuka,Copromoting,Sprycel,Eisai,Analgesic,Poultice,China,Generic,Actos,Barclays,Forecasts,Upward,PHARMA,JAPAN,Lexicon,MS,Marketing,specialist,MR,representative,Chuikyo,Verification,Premium,Korosho,First,Human,Trials,Velcade,Naive,MM,Lunabell,Functional,Dysmenorrhea,Daiichi,Sankyo,Sevikar,HCT,Germany,FDA,Merck,Gardasil,Anal,Cancer,CHMP,Positive,Opinion,Taiho,TS-1,Additional,Analytical,Data,Ticagrelor,Yuki,Gosei,Kogyo,CGMP,Violations,Memantine,Package,Insert,Precaution,Aricept,Pricing,brand,name,generic,RaQualia,Eli,Lilly,Pain,Dalbavancin,Durata,METI,Life,Innovation,Budgets,NIBIO,TNF,TNFR,Complex,DSP,Chugai,MDS,Vaccine,Takeda,Obesity,Fulvestrant,Breast,Cancer,Anastrozole,AZ,Simultaneous,Global,Development,OPINION,Philip,Carrigan,Nippon,Kayaku,Antibody,Taiyo,National,Medical,Expenditure,Pharmacies,Dispensing,Fees,Association,Pharmarise,Home,Healthcare,Signatures,Expansion,Vaccination,Programs,JRIA,RI","No.2220 Contents")

st++; thePage[st]=new Array("2219_jan_3.pdf","pdf/2011_1/","January 3","Reed,Maurer,Otsuka,OPC34712,Abilify,Sawai,Kyorin,Eli,Lilly,Byetta,Victoza,Oral,Diabetes,Kadowaki,GLP-1,Receptor,Agonists,Insulin,JADEC,Rivaroxaban,NEJM,Inavir,RepTrack,Champix,Bayer,Yakuhin,Sebastian,Guth,President,Novartis,Alcon,Eye,Care,Nippon,Kayaku,Spanidin,Nordic,Pharma,Astellas,Seroquel,ER,MTPC,Anaphore,Autoimmune,Sanofi,aventis,Merck,Serono,DSP,Chinese,Subsidiaries,Shionogi,Wakamoto,Defendants,Appeal,Court,Patent,Abbott,Japan,Solvay,EPS,SMO,Taiwan,NanoCarrier,Asia,Oceania,Mochida,Gedeon,Richter,Biosimilars,Nippon,Kayaku,Nomura,Securities,Taiyo,GMP,Compliance,Measures,Medipal,Generic,IGPA,Annual,Conference,Apollo,Medical,Training,Program,Simultaneous,Global,Development,Seikagaku,NDA,SI6603,Ono,Carfilzomib,RG1678,Schizophrenia,Roche,Tasigna,Glivec,Zometa,Lancet,Seattle,Genetics,Millennium,SGN35,Hodgkin,Lymphoma,Brentuximab,ALCL,Hodanren,MINIREN,Premium,MTPC,FTY720,Pfizer,Solu,Medrol,Public,Domain,FDA,Breast,Cancer,Avastin,Elan,Zonegran,Off,Label,Sanko,Junyaku,Flu,Test,Kit,Eisai,Embolic,Beads,PHARMA,JAPAN,Lexicon,Invoice,price,system,Open,Structured,Resale,maintenance,system,ARBs,Albuminuria,DSP,M3,eDetailing,Oncology,PSJ","No.2219 Contents")

st++; thePage[st]=new Array("2218_dec_20.pdf","pdf/2010_12/","December 20 & 27","Sanofi,Pasteur,Perraudin,Kyorin,Sawai,Merger,Viehbacher,PhRMA,Chairman,Lipitor,Patent,Expiration,Umeda,Pfizer,Rifaximin,ASKA,Yamaguchi,NorLevo,Novartis,Rasilez,MCHC,Healthcare,Teijin,Genzyme,Synvisc,Senju,Glaucoma,Ain,Pharmaciez,Medical,Malls,Premiums,Otani,Astellas,Equity,Cytori,Kyowa,Kirin,LivTech,LIV,Daiichi,Sankyo,Luitpold,ROXRO,PHARMA,aventis,Tender,Offer,Genzyme,Mediscience,Tokyo,Clinical,CRO,MTPC,Confidence,Building,Measures,Rx,Point,Services,PHARMA,JAPAN,Lexicon,Medication,history,management,guidance,fee,Specific,premium,Crecon,Nakayama,Memantine,Aricept,BMS,SPRYCEL,Long,Term,ASH,NIH,NCGM,IIT,Antidiabetic,Investigator,Subinvestigators,Coordinating,Edoxaban,VTE,THR,Enoxaparin,DSP,Latuda,KW,Collategene,AnGes,MG,Anticoagulants,Yamashita,iPS,Cell,Yamanaka,JPMA,Hasegawa,Takeda,Astellas,Corporate,Image,PMDA,PAFSC,PAC,FPMAJ,GL,Off,Label,AZ,Ticagrelor,EC,Atherothrombotic,ACS,Sprycel,FDA,Advisory,Committee,Contrave,Obesity,Orphan,Drugs,Matsumori,Generics,Dispensing,Rate,Survey,Pharmacies,NPhA,Teva,Yuji,Orihara,Week,Limit,Prescription,Period,Lifted,ARB,CCB,Combination,SOV,JMA,Revolade,ITP,Ikeda,GSK,Iwasaki,Norspan,Opioids,Ogawa,Eye,Drops,Araie,Antidiabetic,GPs,Eisai,SymBio,TREAKISYM,Otsuka,Samsca,Volume,Overload","No.2218 Contents")

st++; thePage[st]=new Array("2217_dec_13.pdf","pdf/2010_12/","December 13","Merck,Serono,Smith,Infertility,Sawai,Merger,Kyorin,Astellas,Global,Oncology,Strategy,Unit,Acotiamide,Zeria,MTPC,Fingolimod,Tsuchiya,Acotiamide,Teijin,Feburic,Synvisc,Ohyagi,Blopress,IMS,Personnel,Downsizing,Cancer,Hereditary,Inoue,Drugstore,Chain,Operators,Points,Copayments,Services,JPA,NPhA,JACDS,Protopic,Maruho,AVEO,Takeda,Baxter,Vero,Cell,Flu,Vaccine,Shionogi,Ophthalmic,Peptide,OncoTherapy,NBI,Mobic,Daiichi,Sankyo,Otsuka,Market,Capitalization,Kitasato,JV,Ain,Pharmaciez,Cocokara,fine,Minari,Nihon,Chouzai,Qol,M3,EMS,UK,PHARMA,JAPAN,Lexicon,Rules,Professionals,Healthcare,Insurance,Programs,Ryotan,kisoku,Itochu,PRISM,BioLab,Library,Bayer,Regeneron,VEGF,Trap,Eye,Takeda,Hematide,Eight,Okinawa,OncoTherapy,Immunovaccine,Axitinib,mRCC,Pfizer,BMS,Inferiority,Orencia,BIBF,FVC,BI,Lubiprostone,Safety,Tolerability,Sucampo,Abbott,Reed,Maurer,JPMA,Nonapproved,Leuplin,Evidence,Eisai,SEP,Insomnia,Kyowa,Hakko,Bio,Hofu,Facility,GMP,Korosho,Ranbaxy,Generic,Aricept,Hospira,Eiki,Bayer,Yakuhin,Antifilarial,WHO,Gap,Plotkin,Sanofi,aventis,PMS,Lantus,Alzheimer,Disease,PhRMA,Ketotifen,OTC,JSMI","No.2217 Contents")

st++; thePage[st]=new Array("2216_dec_6.pdf","pdf/2010_12/","December 6","Bayer,Schering,Rivaroxaban,Andreas,Fibig,Warfarin,AF,inferiority,Talajic,Astellas,Vesicare,OD,Tablets,Inavir,Daiichi,Sankyo,Compliance,Kashiwagi,Ono,Emend,Injectables,Novartis,Toho,Yakkasa,PHARMA,JAPAN,Lexicon,Dispensing,pharmacy,Standard,system,Unit,dose,packaging,Automatic,Systems,EPS,CSO,Points,Payments,Unacceptable,JPA,Discounts,VP,Yamamoto,Welcia,Kanto,Korosho,Growell,Yoshida,sanofi,aventis,Equa,Shionogi,IP,Assets,Kyowa,Kirin,Janssen,Supply,Velcade,InCROM,NHI,Pricing,Xyzal,Byetta,Memantine,Galantamine,AD,Evidence,Pharmaceutical,Affairs,Sanitation,PAFSC,Central,CPAC,Council,PAC,Food,FSC,First,Committee,Drugs,Second,prescription,Takeda,SONIAS,Janssen,Stelara,Tasigna,First,Line,Therapy,ARB,CCB,PMDA,Generics,East,Asian,Review,Implantable,Heart,Assist,Systems,THMM,Efficacy,NV,FGF,AHA,Safety,Anacetrapib,BMS,Pfizer,Apixaban,ACS,Kyowa,Kirin,KW,ASH,BI,Dabigatran,OncoTherapy,Gastric,Tumor,Vaccine,PAFSC,Switch,OTC,Epadel,Western,Herbal,Voglibose,ACE,Inhibitors,Yasuchika,Hasegawa,Keizai,Doyukai,Kobayashi,Flu,Data,Falsification,Problem,Cawachi","No.2216 Contents")

st++; thePage[st]=new Array("2215_nov_29.pdf","pdf/2010_11/","November 29","Eisai,Eribulin,Dispensing,Pharmacy,Chains,National,Hospitals,Purchase,Prices,Long,Listed,Sakai,Credit,Suisse,Generics,Rasilez,RepTrack,Survey,Shionogi,AntiFlu,RAPIACTA,Otsuka,Abilify,Patent,Lawsuit,Tsumura,Kampo,JPMA,Asian,Liaison,Conference,BioWa,POTELLIGENT,Agensys,Rohto,GSK,Switch,OTC,Steroidal,Agent,Oral,Ketotifen,JPA,PHARMA,JAPAN,Lexicon,Premiums,generics,dispensing,systems,Amaryl,Daiko,Sawai,Taiyo,Towa,Fuji,Pharma,Nippon,Chemiphar,Biosimilars,JCR,LSDs,Ashida,JCR,Epoetin,Biosimilar,Korosho,Unapproved,Indications,Korosho,Dexamethasone,Public,Domain,Fluvoxamine,Proposes,RD,Tax,Break,PMDA,GTC,Mucosta,Eye,Drop,Dry,Levocarnitine,Evidence,Nippon,Kayaku,LCH,Exal,Maurer,Reed,DPC,Bristol,Myers,Hasegawa,AD,Iwai,Astellas,Indacaterol,Tiotropium,Novartis,Collaboration,FORMA,Sekisui,Chemical,Diagnostics,Business,Genzyme,Miraca,Eiken,Takara,Bio","No.2215 Contents")

st++; thePage[st]=new Array("2214_nov_22.pdf","pdf/2010_11/","November 22","Otsuka,HD,Sawai,Integration,Kyorin,MTPC,Generics,Kaken,JPMA,Kyorin,Kipres,Nippon,Shinyaku,Cialis,Zeria,Asacol,Fuso,Torii,ASKA,SELTOUCH,Seikagaku,JCR,GSK,Wakamoto,Meiji,Seika,Teijin,Asahi,Kasei,Recomodulin,JT,Yakult,Honsha,Elplat,Sato,Switch,OTC,Steroidal,Price,Settlement,Rate,CEO,Kumakura,MEDIPAL,Robinson,Patman,Alfresa,Suzuken,Toho,SAYWELL,VITAL,KSK,HOKUYAKU,TAKEYAMA,MSD,Long,Listed,Nichiko,Tsumura,Kyowa,Kirin,Astellas,Nycomed,Protopic,Patents,Takeda,Bioventures,Janssen,Velcade,Crecon,Report,Eribulin,Eisai,GRU,Korosho,OTC,like,Insurance,Coverage,Yoshida,Economic,Assessment,Chuikyo,Afinitor,Brain,Tumors,Novartis,Enroll,Global,Studies,EFPIAOver,Quality,Takeda,CNS,Sage,Bionetworks,Pfizer,Crizotinib,Obese,LTT,Bio,CSC,Differentiation,Inducer,PHARMA,JAPAN,Lexicon,Kampo,Chinese,herbal,Gel,patches,cataplasms,poultices,Curtailment,pocket,payment,Teva,Kowa,Taisho,Takata,Ecbarl,Shionogi,top,three,ministry,Minister,health,labor,welfare,Senior,vice,minister,Parliamentary,secretary,Social,Security,Council,Committee,Health,Insurance","No.2214 Contents")

st++; thePage[st]=new Array("2213_nov_15.pdf","pdf/2010_11/","November 15","Takeda,Hasegawa,Actos,Blopress,Nesina,Daiichi,Sankyo,Esomeprazole,Astellas,OSI,Mirabegron,Eisai,Aricept,MAA,KES,MTPC,Korosho,Medway,Shionogi,Nichia,Wholly,Owned,Subsidiary,Ono,Long,Listed,PHARMA,JAPAN,Lexicon,Long,listed,Established,Branded,generics,Prograf,Patent,Expiration,Taisho,Santen,Tapros,Kaken,Artz,Mochida,Kissei,Lurasidone,DSP,Tada,Kyorin,KRP,IBD,Novartis,Santen,Glaucoma,Diannexin,Assets,Alavita,Nippon,Kayaku,Celltrion,Herceptin,Remicade,Biosimilars,Masuhara,Mylotarg,Pfizer,Crohn,Disease,Ankylosing,Spondylitis,Humira,Abbott,Chuikyo,Unapproved,Indications,Lucentis,DME,Medication,history,management,guidance,fee,bungyo,Budget,screening,Government,Revitalization,Unit,GRU,Leuplin,Millennium,COP,Nagoya,Protocol,Natural,Resources,LATUDA,PIII,Zyvox,Vancomycin,Regorafenib,KRAS,Mutation,Bayer,Adjuvants,Sef,Kurstjens,Agensys,JPA,JACDS,JMA,Tourism,All,Patient,Survey,Osteoporosis,GSK,Cervarix,Canada","No.2213 Contents")

st++; thePage[st]=new Array("2212_nov_8.pdf","pdf/2010_11/","November 8","tella,CreaGene,MOU,Dendritic,Cell,Vaccine,Therapy,Half,Year,Settlement,Accounts,Takeda,S,Takepron,Patent,Expiration,Daiichi,Sankyo,Ranbaxy,Eisai,Aricept,MTPC,Remicade,DSP,Sunovion,AZ,Esomeprazole,Levofloxacin,Lawsuit,Shionogi,Sawai,Infringement,Flomox,Generics,Kyokaikenpo,Japan,India,EPA,Applications,Korosho,FDA,Schizophrenia,Lurasidone,Botulinum,Toxin,Repaglinide,Obescare,Combination,Data,Public,Domain,Precautions,OffLabel,Limit,Prescription,Chuikyo,Insurance,Covered,Healthcare,Services,KohdoIryo,Drug,Lag,Bendamustine,SymBio,Byetta,GLP,Agonist,Eli,Lilly,Samsca,Excess,Water,Retention,Otsuka,Invega,OneDuro,Patch,Cancer,Pain,Janssen,Eye,Drop,Nevanac,Alcon,Xyzal,GSK,Revolade,ITP,MINCLEA,Pretreatmentr,Endoscopy,Nihon,Lyrica,Peripheral,Neuropathy,Pfizer,Benesis,Venoglobulin,Botox,Limb,Spasticity,Injectable,Cravit,Degarelix,Bipolar,Disorders,Zyprexa,MSD,Sitagliptin,Insulin,Chugai,Pegasys,Copegus,Herceptin,Metastatic,Stomach,Roche,Actemra,sJIA,PhRMA,PHARMAJAPAN,Lexicon,healthcare,services,assessment,system,Reed,Maurer,Shionogi,Cephem,Antibiotics,Asahi,Shimbun,Reusable,MAb,Eldecalcitol,Hizentra,Erbitux,OS,Wild,Type,KRAS,Tumor,TAK422,Kobayashi,Medical,Implant,Products,compliance,inspection,Market,Share,Therapeutic,Category,Price,Settlement,NPhA","No.2212 Contents")

st++; thePage[st]=new Array("2211_nov_1.pdf","pdf/2010_11/","November 1","Catalent,Master,Cell,Bank,Takeda,China,Prime,Minister,Kan,JPMA,MSD,Violation,Promotion,Code,IMS,Health,Blockbusters,Astellas,Dysuria,ASKA,Teijin,Gout,Canada,Intal,sanofi,aventis,MSD,Higher,Strength,Asmanex,Shionogi,Swedish,Academia,Takara,Bio,Oncology,Ms,Science,Nobelpharma,Pfizer,Brazilian,Generic,Mediscience,BI,Inhaler,Factory,IP,Fund,Starts,Vidaza,US,FDA,Kyowa,Hakko,Bio,Korosho,Kirin,Minister,Hosokawa,Asahi,Kasei,Teriparatide,Takeda,Candesartan,FDA,Eisai,Lorcaserin,Dabigatran,SPAF,BI,Hypertension,EU,CDFS,Mylotarg,PMDA,PHARMA,JAPAN,Lexicon,Early,post,marketing,phase,vigilance,EPPV,surveillance,PMS,Daiichi,Sankyo,Flu,Inavir,NichiIko,Aprogen,Biosimilars,Share,Nakamura,Reference,Price,System,IMSUT,Asahi,Shimbun,JCA,JACI,OncoTherapy,Kitasato,University,Harvard,Public,Health,Symposium,Yoshikawa,Eli,Lilly,Diagnostic,Imaging,Sawada,Innovation,Scheme,Kayama,Uyama,Payments,HIV,Leukemia,Gene,Kowa,Peretinoin,AASLD,Cabazitaxel,Prostate,Cancer,Afinitor,Sandostatin,PFS,NET,Novartis,NV,FGF,Iressa,OS,NSCLC,Hub,Serious,event,SAE,Adverse,reaction,ADR,Side,effect,Allergic,Hydrolyzed,Wheat,Powder,Precaution,Ketoprofen,OTC,Recalls,Skin,Cream,OPINION,Phillip,Carrigan,Fixed,Dose,ARB,CCB,Hasebe,JMA,JAMS,JSLN,Cholesterol,GL,Longevity,COPD,Smoking,Cessation,Aids,Fuji,Keizai,Pollen","No.2211 Contents")

st++; thePage[st]=new Array("2210_oct_25.pdf","pdf/2010_10/","October 25","Chugai,Roche,Taspoglutide,Eli,Lilly,Orthopedic,Forteo,Self,Injection,Sugimoto,CSO,MIC,Research,CRO,Price,Settlement,Rate,NPhA,Gilead,HBV,GSK,CMIC,Fujirebio,FABP,Test,Champix,Tobacco,Tax,Sepracor,Sunovion,Takepron,RepTrack,Survey,Korosho,Blue,Letter,Victoza,Novo,Nordisk,Safety,Information,Bisphosphonates,Chuikyo,Prescription,Combination,PhRMA,Regulatory,Reform,Applications,Accreditation,Foreign,Manufacturers,NDA,Review,Period,Narita,Ketoprofen,CDFS,Itraconazole,Janssen,Control,Method,Takeda,Cervical,Cancer,Vaccine,JHSF,ESMO,BIBW,PFS,NSCLC,BI,BSI,mTNBC,JSH,Kyowa,Kirin,KW,ASH,Sprycel,PMS,Cohort,Analysis,ASH,Tasigna,CML,Daiichi,Sankyo,ArQule,Oncology,BSI,sanofi,aventis,Lixisenatide,Glucose,Control,Basal,Insulin,Maurer,Reed,Maurer,Participation,Multinational,Clinical,Trials,NICE,Aricept,Mild,AD,UK,Indacaterol,Breathlessness,Novartis,Allermist,Ophthalmic,Allergic,Kurono,Kohdoiryo,Health,Insurance,Programs,Free,Coupons,Women,Ethical,Crecon,PHARMA,JAPAN,Lexicon,Class,OTC,Designated,Risk,Classification,APIs,Package,Inserts","No.2210 Contents")

st++; thePage[st]=new Array("2209_oct_18.pdf","pdf/2010_10/","October 18","KCI,VAC,Therapy,Regenerative,Japan,Takeda,Global,Kyowa,Kirin,KW6356,Lundbeck,NBI,Astellas,Micamlo,Higher,Dose,Bayer,Women,Healthcare,Yaz,GSK,CNS,Hisamitsu,Noven,Paxil,DSP,Lonasen,Bukwang,South,Korea,Otsuka,Canada,SANTEC,CRO,Clio,ASKLEP,China,Apo,Plus,Station,MBO,NHI,Price,Listing,Generic,Aricept,Sandoz,Ramosetron,Ranbaxy,Exclusivity,Nobel,Prize,Chemistry,Negishi,Teijin,Ohyagi,Applications,Enoxaparin,ACS,PCI,Unmet,Medical,Needs,Premium,Prior,Assessment,Dialogue,Hosokawa,Korosho,TFs,Otsuka,Abilify,IM,Depot,Sucampo,Amitiza,Kapvay,AD,HD,Shionogi,Tasigna,CML,Ticagrelor,CHMP,Package,Insert,Victoza,PMDA,KFDA,data,public,domain,public,knowledge,Pfizer,Viviant,Postmenopausal,Osteoporosis,Takeda,Envoy,Schizophrenia,Asubio,Pharma,Regional,BI,BIBW2992,Advanced,Breast,Cancer,KW0761,PIIb,TNKCell,Lymphoma,LTT,BioPharma,PCSOD,HKT500,Zibotentan,OS,CRPC,Points,Payments,Dispensing,JPA,EASD,Annual,Meeting,Linagliptin,T2D,Linagliptin,HbA1c,Saxagliptin,Vaccination,HPV,Sakurai,Financial,Limit,Lifted,Reflex,Remeron,OTC,Kampo,PHARMA,JAPAN,Lexicon,prescription,period,Ban,longterm,prescription,lifting","No.2209 Contents")

st++; thePage[st]=new Array("2208_oct_11.pdf","pdf/2010_10/","October 11","Daiichi,Sankyo,Espha,Long,Listed,Generics,Astellas,Vaccines,UMN,Pharma,Flu,Abraxan,Taiho,ASKA,Senju,Ceolia,Pharma,CMIC,Ecallantide,HAE,Dyax,Ventures,BioJapan,PMDA,Mediceo,Watanabe,New,Premium,Price,Negotiations,Yonbyokyo,MSD,Eisai,Ravuconazole,Prodrug,Brain,Factory,Nippon,Shinyaku,Prulifloxacin,Algorithm,DSP,SB,SanBio,Takeda,JGC,CRO,Tokyo,PHARMA,JAPAN,Lexicon,Shimada,Taiyo,Kyokaikenpo,Anti,Flu,Virus,Inavir,NHI,Darexaban,FDA,Review,Period,Avastin,Advanced,Breast,Cancer,Zeria,Acotiamide,Revolade,Fingolimod,Novartis,Health,Insurance,Association,National,Federation,Societies,Industry,Supply,Molybdenum,LFABP,CMIC,Insight,Reed,Maurer,Roche,Anaeropharma,Anticancer,Nitto,Denko,siRNA,South,Korea,China,Ethnic,Differences,JPMA,Hasegawa,Tax,Break,System,Oral,Anticoagulants,Angel,tax,credit,JCA,Annual,Meeting,EML,ALK,Mutations,Lung,Stomach,Boku,Everolimus,Nippon,Kayaku,NK,Vadimezan,Taspoglutide,EASD,Sitagliptin,Takepron,f,NSAID,Induced,Ulcers,Soen,Asthma,COPD,Patients,Nagai","No.2208 Contents")

st++; thePage[st]=new Array("2207_oct_4.pdf","pdf/2010_10/","October 4","KW0761,Meiji,Seika,Pharma,Meiact,Kissei,Hyperphosphatemia,Vifor,Takeda,Formulation,Plant,Hikari,Dexilant,Canada,MTPC,BMS,ZymoGenetics,Tender,Offer,Daiichi,Sankyo,Zenotech,COI,Disclosure,System,Hirai,Lumbar,Canal,Stenosis,PHARMA,JAPAN,Lexicon,Fair,Trade,Council,Kotorikyo,Competition,Code,JPMA,Epileptic,EKeppra,Otsuka,UCB,Micamlo,NBI,Astellas,mTOR,Inhibitor,Torisel,Pfizer,Osteogenesis,Forteo,Eli,Lilly,Volibris,PAH,GSK,Biologic,RA,Orencia,Bristol,Myers,Albumin,Paclitaxel,Abraxan,Taiho,Cancer,Pain,Tramal,Nippon,Shinyaku,NHI,Price,List,Senior,Vice,Ministers,Banyu,Payment,Doctors,Januvia,Vicious,Violation,Communication,System,EMA,Suspension,FDA,Avandia,EASD,Bladder,Cancer,Actos,Ono,Antiemetic,Fosaprepitant,Dabigatran,Aricept,Transdermal,Patch,Eisai,Teikoku,Seiyaku,Lorcaserin,AnGes,MG,Collategene,NBI,Withdraw,Alotec,Liovel,Priority,Fast,track,review,Covance,Central,Lab,BML,COO,Barr,GLP,Liraglutide,Sitagliptin,HbA1c,Weight,Alogliptin,Lixisenatide,BI,SGLT,Dapagliflozin,SU,Canagliflozin,Smith,Otsuka,OPA,Glaucoma,Acucela,Takara,Bio,MsScience,Kyowa,Kirin,Peretinoin,HCC,Curative,Therapy,Kowa,Pletaal,Stroke,Hemorrhage,CI,Otsuka,Taspoglutide,Roche,Kenporen,Sanofi,aventis,Multinational,PIV,ATLAS,Lantus,JAOG,HTLV,Pregnancy,HIV,Korosho,Mylan,Customer,Support,Center","No.2207 Contents")

st++; thePage[st]=new Array("2206_sept_27.pdf","pdf/2010_9/","September 27","EKeppra,Otsuka,UCB,JCR,EPO,Biosimilar,Orphan,Novartis,Weighted,Average,Invoice,Price,Mitani,Tadaharu,Goto,JPMA,Director,General,Toyobo,Bulk,Manufacturing,Contract,iopharmaceuticals,Mediceo,MSs,MR,Certification,Sales,Long,Listed,Emerging,Countries,Chui,IMS,Prof,Morishita,Bioventures,SPA,Rozerem,RepTrack,Survey,DPP4,Inhibitors,Bendamustine,Singapore,SymBio,Eisai,Daiichi,Sankyo,Appellate,Court,Litigation,Mylan,Ritsuo,Hosokawa,Health,Minister,RePricing,Chuikyo,Yoshida,Harmonization,Device,Combination,Korosho,First,in,Class,Regenerative,Medicine,Officialss,Mochida,Escitalopramn,Fingolimod,Russia,Novartis,Aminolevulinic,Acid,HCl,PHARMA,JAPAN,Lexicon,Repricing,following,market,expansion,Symposiasts,GM,Mice,Kyowa,Kirin,Research,Center,Eszopiclone,Agensys,RCC,Abstract,CBP,IMIG,CanBas,Generics,Mitsuhara,Korosho,Nondiscrimination,Indian,Taiyo,Kyowa,Nichibyokyo,OPINION,Philip,Carrigan,Torisel,Horie,Actemra,Chugai,All,Patients,Post,Marketing,Avastin,LabCorp,Genzyme,Robot,Prostatectomy,Senshiniryo","No.2206 Contents")

st++; thePage[st]=new Array("2205_sept_20.pdf","pdf/2010_9/","September 20","MSD,Alvarez,TM,Marketing,Anterio,Zeria,Biofac,Denmark,Ono,Proteasome,Inhibitors,Onyx,Shionogi,SLIT,Stallergenes,ViiV,HIV,Area,Iriyama,Bayer,Esthetic,Dermatology,Overall,Price,Settlement,Rate,JMHA,Purchase,Drugs,Eisai,Glufast,China,Sawai,Biosimilars,Sandoz,Somatropin,Biosimilars,JGA,IV,Injectables,Pharmacists,ADRs,Substitution,JPA,Equivalence,Studies,APIs,NHI,Price,List,Self,Injection,Forteo,Enbrel,Chuikyo,Prescription,Combination,Flu,Virus,Inavir,Daiichi,Sankyo,Abbott,Norvir,Once,Monthly,Recalbon,Bonoteo,Chugai,Xeloda,Public,Domain,Ancaron,Multaq,First,Line,AF,ESC,GL,Earlier,Unapproved,Pfizer,Metronidazole,Takara,Bio,Nucleic,Acid,Refining,Reagent,Macherey,Nagel,Rivaroxaban,Bayer,SPAF,AHA,Apixaban,Aspirin,BMS,PET,JSNM,Korosho,Surveillance,MultiDrug,Resistant,Bacteria,JAFI,Taxotere,Taxol,TUS,Impurity,NSAIDs,Telmisartan,Amlodipine,PHARMA,JAPAN,Lexicon,Clinics,GPs,offices,Hospitals,Statistics,Ethical,Crecon","No.2205 Contents")

st++; thePage[st]=new Array("2204_sept_13.pdf","pdf/2010_9/","September 13","Orencia,BMKK,Apixaban,Dapagliflozin,Takeda,Contrave,Orexigen,Ono,Salirasib,Concordia,ViiV,HIV,Novartis,Scientific,Information,Cell,Culture,Flu,Vaccine,Baxter,RaQualia,Acid,Pump,Antagonists,CJ,Cheil,Jedang,Novartis,Alcon,Subsidiary,Daiichi,Sankyo,Fujifilm,Capital,JTEC,Computerization,Synthetic,DSP,Makoto,Hara,PFSB,Damage,Korosho,Budget,Life,Innovation,Cervical,Buried,Seeds,RePricing,Nippon,Kayaku,Hycamtin,Public,Domain,Lilly,Gemzar,Ovarian,Humira,JIA,Abbott,Eisai,FDA,Eribulin,SRSM,Regulatory,Sciences,Sawai,Medisa,Recall,Bromocriptine,Nippon,Chemiphar,Nihon,Chouzai,Keiji,Nakamura,Lexicon,Kongo,shinryo,ESC,Congress,Stockholm,ESC,CVBI,Dabigatran,SPAF,Edoxaban,PAR1,Antagonist,Atherothrombosis,Astellas,YM150,AF,DiovanMSD,Betrixaban,Genetic,Variability,Ticagrelor,PLATO,ACOS,Sutent,OS,NSCLC,Pfizer,BAN2401,ADRs,Avandia,Actos,HealthCore,Palivizumab,Watabe,Appeal,Trial,Online,Sale,1980,Koseisho,Notification","No.2204 Contents")

st++; thePage[st]=new Array("2203_sept_6.pdf","pdf/2010_9/","September 6","Merck,Serono,CNS,Cladribine,Infertility,Sanofi,aventis,Genzyme,Novartis,Rabies,Vaccine,Kaketsuken,Synvisc,Teijin,JCMOA,Diovan,IMS,IBD,Market,Datamonitor,JPMA,Tax,Kyowa,Kirin,Nesp,Plastic,Syringe,Ain,Pharmaciez,Prior,Assessment,Consultation,System,CDFS,Liovel,Invega,Treakisym,SymBio,Chuikyo,Reimbursement,Public,Domain,Korosho,CU,System,Nesina,Actos,Takeda,Takepron,NSAID,Associated,Ulcers,ImmuCyst,Adjuvant,TURBT,Revlimid,Myelodysplastic,Syndrome,Precedex,Denosumab,Metastases,Daiichi,Sankyo,Banyu,Daptomycin,Fuso,Buprenorphine,PHN,KW2246,PHARMA,JAPAN,Lexicon,Hyoka,ryoyo,Sentei,Senshin,Kohdo,iryo,Carna,Biosciences,Contract,Drug,Discovery,Tella,Jikei,University,JPMA,Takara,Bio,TCR,Gene,Perampanel,Refractory,Partial,Seizure,PIII,Eisai,Towa,Plant,Generics,Questionnaires,PMDA,Switch,OTC,Consumers,JSMI,PAL,Amendment,Shionogi,Antedrug,Steroid,Prevention,Ulcers,Sugano,MTPC,All,Patient,PMS,Remicade,Uveoretinitis,Homeopathy,Scientific,SCJ,Fatal,Familial,Insomnia,SSRI,M3","No.2203 Contents")

st++; thePage[st]=new Array("2202_aug_30.pdf","pdf/2010_8/","August 30","KW0761,Pfizer,Generics,Long,Listed,Products,DSP,Lurasidone,PI,Forum,Asano,Fujitsu,Cloud,Services,Industry,Nesina,Rep,Track,Survey,Wholesalers,Gross,Profit,Rate,Invoice,Prices,Teijin,Osteoporosis,Drugs,Meiji,Seika,Asahi,Kasei,Pharma,Torii,HIV,Yakult,Elplat,MSD,Takeda,Hasegawa,MTPC,Kerlong,sanofi,aventis,Pola,Teika,Bedsore,Sorenurse,RTech,Ueno,Arbitration,Amitiza,Human,Serum,Albumin,MTPC,Alfresa,Tampei,Nakata,Wholly,Owned,Subsidiary,Mebix,EDC,CDISC,Certification,Lexicon,Premium,development,eliminate,off,label,use,Korosho,Asonuma,Landmark,Reimbursement,Data,Public,Domain,Diaminopyridine,Pfizer,Shionogi,Chugai,Canakinumab,Orphan,Drugs,Prior,Assessment,JPMA,KRAS,Gene,Test,Merck,Serono,Sawai,Taiyo,Yakuhin,Towa,Nippon,Chemiphar,Fuji,Pharma,Diagnostics,Astellas,UMN,Pharma,Flu,Vaccines,Eli,Lilly,Semagacestat,AD,IPSN,INCJ,IP,Trials,Favorable,Industry-funded,PhRMA,Transparency,AnGes,MG,Research,siRNA,alphaGEN,Toxicity,LTT,Bio,Pharma,Inhalant,PC,SOD,IL,Receptor,Antibody,IBD,NIBIO,Osaka,Univ,Vectibix,OS,Head,Neck,Cancer,Terumo,Miraca,HD,Takara,Bio,Gene,Engineering,AT,ATWill,In,Vitro,Philip,Carrigan,Antipsychotics,Antidepressants,SASP,Immunotherapy,Renal,Cell,Carcinoma,Cervarix,JCQHC,Rest,MTX,JMA,Social,Security,Numbering,System,DB,ADR,Nagatsuma,Anti,Epileptic.,Nakasato,Rohto,Pollinosis,Metabolic,Syndrome,Reexamination,period,Reevaluation,system","No.2202 Contents")

st++; thePage[st]=new Array("2201_aug_16.pdf","pdf/2010_8/","August 16 & 23","Nippon,Kayaku,Daiichi,Sankyo,Vaccine,Emerging,Forteo,Osteoporosis,Sowa,Bone,Fractures,Hagino,Takeda,Lansoprazole,Patent,Expiration,Olmetec,Astellas,Eisai,Aricept,MTPC,DSP,Sepracor,Shionogi,Crestor,Taisho,Ono,Santen,Tapros,Kyorin,Tsumura,Kaken,Artz,Mochida,Epadel,Kissei,Nippon,Shinyaku,Cialis,Fuso,Zeria,Tillotts,ASKA,Seltouch,Seikagaku,JCR,GSK,Boosts,Wakamoto,Alfresa,Wholesalers,Medipal,Toho,Saywell,Asucome,Suzuken,Toho,Negotiations,Pharmacy,Chains,Hirate,Asian,Operations,RaQualia,EP,Antagonist,Maruishi,aRigen,Herpes,Treatment,ARYS,Centaur,India,Tender,Offer,Zenotech,Lawsuit,Evoxac,Apotex,Flu,Stocks,AnGes,MG,HFG,Gene,PD,Insomnia,Datamonitor,Crecon,Report,Antidepressants,APIs,Data,Public,Domain,Korosho,Assessment,Research,Projects,JAMS,GLs,COI,China,Authorities,Novartis,COPD,QAB,Degarelix,Prostate,Cancer,Hematide,Shionogi,CUVPOSA,PMDA,PASS,Interim,ADVATE,Welfare,Recipients,Psychotropics,JGA,Shortage,Taiyo,Yakuhin,Manufacturing,Website,ARQ,NSCLC,ArQule,SSP,Shiono,Asahi,Kasei,Medical,Cell,Culture,Fluid,Filter","No.2201 Contents")

st++; thePage[st]=new Array("2200_aug_9.pdf","pdf/2010_8/","August 9","Kyowa,Kirin,Nesp,Espo,KW0761,ARQ197,Stomach,BioWa,Lonza,POTELLIGENT,CHOK,SV,Cell,Daiichi,Sankyo,Kitasato,Institute,Joint,Venture,Vaccines,SPDS,ASKA,Actavis,Generics,Market,Prices,Premium,Wholesales,Gross,Profit,Margins,FPMAJ,CO2,Emissions,Antidepressants,NichiIko,DKSH,AnGes,MG,EPS,China,Merck,Sinopharm,Toho,Asucome,NPA,Family,JPMA,Tour,US,Europe,M3,Sues,Mebix,Inappropriate,Accounting,Taiyo,Recall,Theophylline,JGA,Anti,Flu,Greater,Strength,Aricept,Patch,Chuikyo,Notification,Antiepileptic,EKeppra,Otsuka,UCB,Yaz,Dysmenorrhea,Bayer,Viviant,r,Osteoporosis,Pfizer,Forteo,Lilly,Volibris,PAH,GSK,Onoact,Imaging,CT,CAG,TRIBENZOR,Olmesartan,Amlodipine,HCTZ,NDA,Rufinamide,Oral,Suspension,FDA,Eisai,Korosho,Rhabdomyolysis,ARBs,Ono,Oncology,High,Costs,Communication,Skills,English,Astellas,VelocImmune,Regeneron,Shionogi,HIV,Dexrazoxane,Fomepizole,Sanofi,aventis,Jez,Moulding,President,Nippon,Kayaku,Yoshihiro,Nanbu,Industry,Academia,Bioimaging,Yonekura,Safety,Furukawa,IMS,Teraoka,CU,Public,Funding,Cervical,Cancer,Vaccination,Disposal,Waste,Material,Gene,Recombinants","No.2200 Contents")

st++; thePage[st]=new Array("2199_aug_2.pdf","pdf/2010_8/","August 2","Nippon,Chemiphar,Generics,Biosimilars,IMS,Japan,Healthcare,Welfare,Cooperative,Union,Market,Psychoneurotics,Fuji,Keizai,US,Diabetes,Datamonitor,Sepracor,Sunovion,Pharmaceuticals,Early,Retirement,Program,Medipal,Lampion,Pack,Secondary,Eradication,Pylori,Pariet,Celgene,Multiple,Myeloma,Candidates,Nichiiren,Upper,House,Parliamentary,Secretary,Shinya,Adachi,Fujii,JPA,Yamamoto,1980,Notification,Chuikyo,Dosage,Limits,Premium,NPhA,Unapproved,OIG,FDA,Takeda,Actos,Data,Industry,Consensus,Terumo,Shintaku,Pfizer,Partnership,Agreement,NHO,Lorcaserin,Weight,Loss,Eisai,JELIS,CAD,Epadel,Dapagliflozin,Insulin,Glycemic,BMS,AZ,Everolimus,PFS,pNET,Iressa,NSCLC,Mutated,EGFR,Personalized,Cancer,Kobayashi,OTC,JPA,Erbitux,Severe,Infusion,Reactions,GL,First,Line,Treatment,CRC,Test,Predicting,IFN,Advanced,Technology,Cancer,Therapy,CareNet,Avastin,Colon,Sutent,Nexavar,RCC","No.2199 Contents")

st++; thePage[st]=new Array("2198_jul_26.pdf","pdf/2010_7/","July 26","Nippon,Chemiphar,Generics,Biosimilars,IMS,Japan,Healthcare,Welfare,Cooperative,Union,Market,Psychoneurotics,Fuji,Keizai,US,Diabetes,Datamonitor,Sepracor,Sunovion,Pharmaceuticals,Early,Retirement,Program,Medipal,Lampion,Pack,Secondary,Eradication,Pylori,Pariet,Celgene,Multiple,Myeloma,Candidates,Nichiiren,Upper,House,Parliamentary,Secretary,Shinya,Adachi,Fujii,JPA,Yamamoto,1980,Notification,Chuikyo,Dosage,Limits,Premium,NPhA,Unapproved,OIG,FDA,Takeda,Actos,Data,Industry,Consensus,Terumo,Shintaku,Pfizer,Partnership,Agreement,NHO,Lorcaserin,Weight,Loss,Eisai,JELIS,CAD,Epadel,Dapagliflozin,Insulin,Glycemic,BMS,AZ,Everolimus,PFS,pNET,Iressa,NSCLC,Mutated,EGFR,Personalized,Cancer,Kobayashi,OTC,JPA,Erbitux,Severe,Infusion,Reactions,GL,First,Line,Treatment,CRC,Test,Predicting,IFN,Advanced,Technology,Cancer,Therapy,CareNet,Avastin,Colon,Sutent,Nexavar,RCC","No.2198 Contents")

st++; thePage[st]=new Array("2197_jul_19.pdf","pdf/2010_7/","July 19","Victoza,Novo,Nordisk,OHARA,Erwinase,EUSA,Shionogi,Galderma,Acne,Banyu,Early,Retirement,Francois,Leger,General,Manager,Maruishi,Hire,Graduates,Ethical,Crecon,Rezaltas,Daiichi,Sankyo,Ranbaxy,NDDR,Toa,Eiyo,Alfresa,Tofranil,Novartis,AZ,Shionogi,Patent,Infringement,Lawsuit,Crestor,Astellas,Teva,Vesicare,MCI,NEJM,Welfare,Cooperative,Union,Joint,Purchase,JMA,DB,Generics,Pariet,NichiIko,Amaryl,sanofi,aventis,DKSH,Kowa,Sales,Cost,Nippon,Shinyaku,RNA,New,Type,Flu,Vaccines,Pfizer,ALK,Inhibitor,Wagner,Kantar,Health,Bio,Expo,Japan,Nishikawa,NBI,Odaka,Merck,Biosimilars,Wiederrecht,SymBio,Bendamustine,Multiple,Myeloma,Banyuf,MK,Torii,Sublingual,Desensitization,Pollinosis,GW,Otsuka,Cannabinoid,Linagliptin,Blood,Glucose,JZOLOFT,Inferior,Paxil,PMDA,Assessment,System,Public,Domain,JPMA,Development,Premium,Seikagaku,PMA,Gel,FDA,DPC,Hospitals,Korosho,Periodic,Payment,Subsidies,Vaccinations,GL,Hypoglycemic,Sonobe,Oxiconazole,OTC,Vaginal,Candida","No.2197 Contents")

st++; thePage[st]=new Array("2196_jul_12.pdf","pdf/2010_7/","July 12","Teijin,Marketing,Network,China,Shionogi,Asia,US,Headquarters,Eisai,Lorcaserin,Arena,ASKA,Early,Retirement,Nippon,Kayaku,AZ,Maibara,Plant,Korosho,Flu,Vaccines,Novartis,Takeda,Haruhiko,Hirate,NanoCarrier,Patent,Polymeric,Micelles,Europe,Banyu,Schering,Plough,GSK,MTPC,Copromotion,Adoair,RA,Biologics,Pfizer,Approval,PMDA,Review,Period,PMDA,Consultation,Procedures,New,Premium,Chuikyo,JPMA,Negotiating,Prices,Pretext,Yamamoto,JPA,Acute,Stage,Hospitals,Purchase,Costs,Hearing,Immunization,Programs,Yakult,XELOX,Colon,Cancer,Pariet,Non,Erosive,GERD,Janssen,Golimumab,Banyu,Vorinostat,CTCL,Joint,Acetaminophen,Dosage,Feraheme,Iron,Deficiency,Anemia,Takeda,ZERIA,NDA,Acotiamide,Tasigna,Ph+CML,Sawai,Biosimilars,Pfizer,Contract,Generics,India,Tako,Tsubo,Factor,Reed,Maurer,Astellas,Naoki,Okamura,OSI,OD,Tablet,Tester,Nipro,Discovery,Alliances,Merck,Serono,Stimuvax,NSCLC,Kissei,KUC,ASP,HbA1c,Omnaris,HFA,DSP,Hematide,Inferiority,Affymax,Anti,CCR,Antibody,Ueda,Interim,Analysis,PMS,Data,Nexavar,SU,Blood,Glucose,JADEC,JUPITER,Crestor,Hamazaki,JMHA,Advanced","No.2196 Contents")

st++; thePage[st]=new Array("2195_jul_5.pdf","pdf/2010_7/","July 5","Alexion,PNH,Bell,DSP,Celgene,Revlimid,Multiple,Myeloma,Korosho,Blopress,IFRS,Takeda,Subsidiary,South,Korea,Eisai,BioWa,COMPLEGENT,GSK,Tony,Alvarez,Banyu,Schering,Plough,Subcommittee,NHI,Pricing,System,Reform,Nagano,Xolair,Adachi,Premium,Sales,Prices,Isobe,Chuikyo,Lag,Growth,Strategy,Withdrawal,NDA,Mylotarg,Astellas,Mirabegron,Banyu,Ono,Sitagliptin,Alfa,GI,Epogin,SC,HP,Eradication,Remicade,Ulcerative,Colitis,Amaryl,Pediatric,Diabetes,Eribulin,Priority,Review,Herceptin,Vorinostat,Orphan,METI,Patent,Box,Taxation,Yakult,Water,Soluble,Elplat,JPMA,PDSC,Unapproved,Aldesleukin,Enrollment,Erbitux,SCCHN,Merck,MK,Sleep,Betaferon,Bayer,Actemra,sJIA,Ebata,MBL,MCM,STACIA,Flu,Virus,Eiken,Vital,Statistics,OTC,JPA,Kenkocom,OPINION,Philip,Carrigan,Hepatitis,Virus,Tisseel,Gammagard,Saruta,Stroke,tPA,Actos,Extended,Release,Metformin,Kowa,Livalo","No.2195 Contents")

st++; thePage[st]=new Array("2194_jun_28.pdf","pdf/2010_6/","June 28","Merck,Serono,Takeda,Oncology,Vectibix,Vercade,Daiichi,Sankyo,Vaccine,Bayer,MTPC,Korosho,JPMA,Marketing,Committee,Distribution,Kowa,Livalo,Abbott,Australia,New,Zealand,Asahi,Kasei,Zoledronic,Acid,Collaboration,CanBas,CBP501,GSK,Yoshitomi,Paxil,Pfizer,Rare,Disease,Research,Unit,Astellas,Brazilian,ACRONET,Chinese,CRO,NANDACRO,FTC,Nakazawa,Ujike,Anti,Monopoly,Act,MCI,Detailing,iPad,Novo,GLP,Victoza,Hisamitsu,Kyowa,Kirin,Fentos,Tape,Cancer,Pain,Otsuka,sanofi,aventis,NichiIko,Chocat,Original,Generics,Sawai,Masuhara,Anticancer,Sasaki,MR,MS,Urushibata,Crecon,FPMAJ,Premium,Development,Standard,operating,Profit,Rates,GLs,Strattera,LTT,BioPharma,IPF,Midismase,Actemra,Roche,NDA,Review,Process,FDA,Eisai,Sepracor,Promotional,Materials,CMIC,Sodium,Phenylbutyrate,ASCO,Tykerb,Stomach,Cabazitaxel,Prostate,Sutent,Breast,Rituximab,Lymphoma,Denosumab,Bone,Metastasis,Zometa,Multiple,Myeloma,Pfizer,Crizotinib,NSCLC,Sprycel,CML,CP,Sprycel,Meiji,Seika,Fibromyalgia,Mirtazapine,SymBio,Lupuzor,Cephalon,Unapproved,Afinitor,pNET,Novartis,Kansai,Bio,Promotion,Flanders,NBI,Meta,Analysis,Telmisartan,NCCHD,Gene,Therapy,Chronic,Granuloma,COPD","No.2194 Contents")

st++; thePage[st]=new Array("2193_jun_21.pdf","pdf/2010_6/","June 21","Kan,Economy,Finance,Social,Security,Nagatsuma,Growth,Strategy,Naoshima,MEXT,NDA,Review,Period,PMDA,ASCO,FDA,Website,Unapproved,Benefit,Sharing,CBD,Korosho,Applicants,DSP,Maximum,Daily,Meropen,Eribulin,Priority,US,GL,Evaluation,Malignant,Tumor,Pfizer,Eisai,Lyrica,Bayer,Packing,Line,Chewable,Tablets,Asahi,Kasei,Rezaltas,Hasegawa,Asian,Netupitant,Palonosetron,Helsinn,Ranbaxy,Prasugrel,India,Generic,Substitution,Nihon,Chouzai,Premium,JGA,Information,Supply,System,MSs,Exam,Certification,Costs,iPad,OTC,Consultation,Switch,Oncology,Multinational,Trials,Lag,Lowenthal,Lung,Roche,Hal,Barron,Merck,Serono,Personalized,Cancer,Wein,ASCO,Eribulin,ORR,cMet,NSCLC,TDM1,Pertuzumab,HER,Positive,Breast,Avastin,Stomach,HER,Negative,Erbitux,FOLFIRI,Eplerenone,Lubiprostone,Diovan,Hypotensive,Elderly,GenomIdea,Grant,DNA,Vaccines,Pandemic,Flu,Stroke,Intensified,Intervention,Diabetes,Radiotherapy,ROCA,Detection,Ovarian,Local,Hospitals,Leptin,Lipoatrophy,Advanced,Prevenar,Vaccination,Programs,Kindler","No.2193 Contents")

st++; thePage[st]=new Array("2192_jun_14.pdf","pdf/2010_6/","June 14","Merger,Wyeth,Pfizer,JPMA,Takeda,Lifestyle,Related,Disease,Astellas,Tender,Offer,OSI,Banyu,Cosopt,Bayer,Dermatology,Topical,Steroids,CMIC,CRO,MSNW,Pharmacy,Tajiri,IPO,Copromote,Kaketsuken,Vaccines,Kyushu,DSP,JCR,Growth,Hormone,Maruishi,RaQualia,EP4,Antagonist,Sanofi,aventis,Clexane,Kaken,GSK,Yoshitomi,Paxil,NBI,Holding,Company,Japanese,Reliable,China,Matsubara,Tsumura,Kampo,Nissui,Biofermin,Emmanuel,Blin,BMKK,Masao,Torii,Kobayashi,Rohto,NichiIko,Authorized,Generics,Hasegawa,Taiyo,Yakuhin,IPO,Aratani,Nihon,Chouzai,Naoto,Kan,Prime,Minister,APIs,NHI,Combination,Monodrugs,Novo,Victoza,Soliris,Vectibix,Viviant,EKeppra,Strattera,PMDA,Reviewers,Asian,Clinical,Trials,IND,Policy,METI,Tax,FDA,NDA,Eisai,AcipHex,Extended,Release,Amgen,BLA,Denosumab,Bone,Metastases,PhRMA,Shuji,Kondo,Scientific,Regulatory,Representative,Kyowa,Kirin,KW-6002,BLS,Novartis,Afinitor,Asakawa,Alfresa,Tetrabenazine,AZ,Arimidex,Premenopausal,Breast,Cancer,Asahi,Kasei,Pentosan,Osteoarthritis,Otsuka,CROee,BBK,Recruitment,Avastin,Ovarian,ASCO,Eribulin,OS,Breast,Terumo,Nipro,FALCO,SD,Miraka,Takara,Bio,Ohmiya,Transnasal,GLP1,Blood,Glucose,Control,JDS,HbA1c,NGSP","No.2192 Contents")

st++; thePage[st]=new Array("2191_jun_7.pdf","pdf/2010_6/","June 4","Sanofi,aventis,Viehbacher,NichiIko,Daiichi,Sankyo,Nakayama,Astellas,Oncology,MRs,US,China,Teijin,TMX,Patent,Home,Health,Care,Febuxostat,Takeda,DPP4,Nesina,Mark,Smith,Merck,Serono,Crecon,Operating,Profit,Rate,Wholesalers,Toho,Yakkasa,Zeria,Ibe,Asacol,Meiji,Seika,Ajinomoto,Asahi,Kasei,Yakult,Campto,Fuso,Dialysis,ASKA,Seikagaku,Artz,Wakamoto,JCR,NBI,Micardis,NanoCarrier,Substance,Polymer,Micelles,Eisai,Production,Facility,Hypotensives,Fuji,Keizai,APIs,Generics,Listed,Incentives,JGA,Biosimilar,EPO,Kissei,AGs,Cervarix,GSK,Revlimid,Torisel,Premium,Suzuki,JMA,AZ,JJ,CAPS,Takara,Bio,OPINION,Philip,Carrigan,Korosho,Otsuka,Amsilarotene,Riociguat,Pulmonary,Hypertension,Multaq,Permanent,AF,GL,Osteoporosis,JOINT","No.2191 Contents")

st++; thePage[st]=new Array("2190_may_31.pdf","pdf/2010_5/","May 31","Takeda,Yasuchika,Hasegawa,JPMA,President,Daiichi,Sankyo,Takashi,Shoda,FPMAJ,Growth,Strategy,Leaflets,Pricing,System,Industry,FTC,Code,Violation,Taisho,Toyama,Fujifilm,Ono,MS,Santen,Tapros,Hyalein,Tafluprost,Takakazu,Morita,Kyorin,Respiratory,Urological,Hiroko,Ogiwara,Kaken,Artz,Mochida,Epadel,Nippon,Shinyaku,Kissei,Kunio,Kanzawa,Medipal,Alfresa,Tampei,Nataka,Suzuken,Ota,Toho,Wholesalers,Matsutani,Korosho,Hearings,Pletaal,Shionogi,Moxifloxacin,Bayer,Yakuhin,Bufexamac,Universal,Zydus,Sawai,Towa,Chemiphar,Nihon,Pharm,Rufinamide,Eisai,Regorafenib,mCRC,Sosei,QVA,HPV,Vaccine,Banyu,Roche,Biogen,Idec,Ocrelizumab,RA,Reed,Maurer,Insurance,Covered,Asthma,Complince,Ohta,Insomnia,Watanabe,Crestor,EU,CV,AZ","No.2190 Contents")

st++; thePage[st]=new Array("2189_may_24.pdf","pdf/2010_5/","May 24","Astellas,OSI,Pharmaceuticals,Oncology,Joji,Nakayama,Daiichi,Sankyo,Takeda,Lansoprazole,Cancer,CNS,Patent,Expiration,for,Prograf,Nogimori,YM150,Olmesartan,Ranbaxy,Edoxaban,Xa,Aricept,Eribulin,Canada,MTPC,Remicade,Medway,Kuniaki,Kaga,DSP,PMC,STEDESA,Shionogi,Crestor,Irbetan,Avapro,Otsuka,Distribution,Practice,Janssen,VELCADE,Santen,Tafluprost,South,Korea,Recalls,Amplit,Biosimilars,CPhI,Optimal,Pricing,System,Biosimilars,Teva,Kowa,Taisho,Kissei,EPO,Biosimilar,Taiyo,Yakuhin,Generics,Market,AGs,Medical,Devices,GSK,Ofatumumab,Actemra,Korosho,ILD,Statins,GAMMAGARD,Cognitive,Function,AD,Baxter,Gaslon,Gastric,Ulcer,HP,Infection,Humira,Clinical,Remission,PMS,Equa,DPP,Kadowaki,Topical,Steroids,Horio,Erbitux,Hepatic,Metastasis,Colon,Sugihara,Cervarix,Immunological,Gardasil,Einstein,Japanese,Women,Konno","No.2189 Contents")

st++; thePage[st]=new Array("2188_may_17.pdf","pdf/2010_5/","May 17","BI,Dabigatran,SPAF,SSP,OTC,Spiriva,Chugai,Top,Oncology,MRs,Exforge,Takeda,Unisia,Anderson,Novartis,Janssen,Torii,Remitch,METI,Santen,ATL,Clinical,Data,Kissei,Proaerolysin,Protox,Actos,Patent,Infringement,Litigations,Korosho,METI,PMDA,Screening,GRU,Officials,Kondo,NIBIO,NIHN,Yamanishi,Modifying,Package,Inserts,WG,Regenerative,Medicine,Lifting,Ban,Supply,Unapproved,Blopress,Eisai,Reflux,Esophagitis,Pariet,Abbott,Kaletra,Once,Daily,DSP,Eslicarbazepine,FDA,Chemo,Regimens,Advanced,Peptide,Vaccine,Bladder,Cancer,DPP,Inhibitors,GLP,Modified,Reimbursement,LDP,JPMA,Collategene,AnGes,MG,Asahi,Kasei,Hisamitsu,Protein,Colon,Esophageal,Lixisenatide,sanofi,aventis,Merck,Serono,JMA,Suzuki,Chuikyo,Nocturnal,Respiratory,Symptoms,Mochizuki,ARB,CCB,Ogihara,HPV","No.2188 Contents")

st++; thePage[st]=new Array("2187_may_3.pdf","pdf/2010_5/","May 3 & 10","Bayer,Nexavar,Rivaroxaban,Fludara,Genzyme,Female,MRs,MSD,IMS,Health,MTPC,Wholesalers,MTPC,Administrative,Sanction,Gohara,Toho,Merge,Asucome,Shouei,Mochida,TRPV,Antagonists,Wyeth,AnGes,ILTS,MEDRx,GSK,Rare,Diseases,Medicine,Development,Center,Shionogi,Flomox,Patent,Litigation,BI,Fund,Biomedical,Cluster,Kansai,Symyx,ELE,Korosho,FPMAJ,Ethical,Compliance,Mitani,PMDA,NDA,Review,Pharmacies,Generic,Taiyo,Crecon,Osaka,Bio,Fund,IPV,Carna,Biosciences,NIBIO,CMIC,LFABP,Diagnostic,Technology,SSP,Kenko,com,Online,OTC,Kenporen,Deficit,Isentress,Lipids,Hanabusa,Elderly,neumococcal,Vaccines,Exam,Extended,Survival,Breast,Cancer","No.2187 Contents")

st++; thePage[st]=new Array("2186_apr_26.pdf","pdf/2010_4/","April 26","Bayer,Nexavar,Rivaroxaban,Fludara,Genzyme,Female,MRs,MSD,IMS,Health,MTPC,Wholesalers,MTPC,Administrative,Sanction,Gohara,Toho,Merge,Asucome,Shouei,Mochida,TRPV,Antagonists,Wyeth,AnGes,ILTS,MEDRx,GSK,Rare,Diseases,Medicine,Development,Center,Shionogi,Flomox,Patent,Litigation,BI,Fund,Biomedical,Cluster,Kansai,Symyx,ELE,Korosho,FPMAJ,Ethical,Compliance,Mitani,PMDA,NDA,Review,Pharmacies,Generic,Taiyo,Crecon,Osaka,Bio,Fund,IPV,Carna,Biosciences,NIBIO,CMIC,LFABP,Diagnostic,Technology,SSP,Kenko,com,Online,OTC,Kenporen,Deficit,Isentress,Lipids,Hanabusa,Elderly,neumococcal,Vaccines,Exam,Extended,Survival,Breast,Cancer","No.2186 Contents")

st++; thePage[st]=new Array("2185_apr_19.pdf","pdf/2010_4/","April 19","Ajinomoto,Southeast,Asian,Market,Daiichi,Sankyo,ARB,Mochida,Hisamitsu,Noven,Kyowa,Kirin,Antibody,Matsuda,Chofuku,Premium,Remicade,HP,Taizhou,China,Nippon,Shinyaku,Tramadol,Labopharm,Zeria,Hemostatic,Wound,Dressing,HemCon,Bayer,Intendis,CMIC,Propharma,Shizuoka,Plant,Alfresa,Wholesalers,MCI,PCs,Benesis,JCROA,Monitor,Certification,Test,Taiyo,Aratani,HPs,Generics,GPs,Korosho,GLs,BE,Dispensing,Pharmacies,JPA,Iwatsuki,Edoxaban,Medway,Data,Falsification,Committee,Lifting,Ban,Kongo,Shinryo,Nagatsuma,Arixtra,DVT,PE,GSK,Fulvestrant,AZ,Afinitor,Temodal,DPC,Payment,System,Regenerative,Biosimilars,Takeda,Executives,Gefitinib,EGFR,Positive,NSCLC,Cisplatin,Docetaxel,SGN,Lymphoma,AnGes,NFkB,Decoy,Shionogi,Sutent,OS,Japanese,mRCC,Avastin,Chemotherapy,PFS,Erbitux,Irinotecan,KRAS,Wild,CRC,Ticagrelor,Clopidogrel,Valsartan,Diabetes,CV,IGT,Switching,OTC,Status,JACDS,Online,Sale,JPA,Court,Decision,Idei,RDKK,Elecsys,RA,Kobayashi,Device,Medwatcher,Unapproved,David,Powell,AMDD,Chairman,Philip,Carrigan,JSIM,COI,GSK,Disclose,Payments,Physicians,Norvasc,Lipitor,DB,NIBIO","No.2185 Contents")

st++; thePage[st]=new Array("2184_apr_12.pdf","pdf/2010_4/","April 12","Exforge,Novartis,Takeda,Ferumoxytol,AMAG,Teijin,TMX67,Astellas,China,Hong,Kong,Colon,Cancer,Oncology,Gochenauer,Kantar,Health,IFN,Alfa,RCC,NSCLC,EGFR,Mutation,Iressa,Asahi,Kasei,AK138,Altheos,ASKA,Rifaximin,Alfa,Wassermann,Galantamine,Janssen,CDA,OSI,Eisai,Terumo,Diabetes,GSK,JCR,Shareholder,Kanda,JGA,Taiyo,JSGM,JPA,President,Aratani,FFP,Tokyo,District,Court,Teva,Lawsuit,Kyowa,Kirin,Toyama,Generic,APIs,Vildagliptin,NHI,Price,List,Exforge,Rezaltas,Victoza,Chuikyo,Limit,Prescriptions,Unapproved,Wolf,PhRMA,Eribulin,Banyu,Rotavirus,Vaccine,Revolade,Chronic,ITP,Ciprofloxacin,DPI,Orphan,Reed,Maurer,Prohibition,Online,Sale,OTC,Pharmacological,Society,GPR119,Daiichi,Sankyo,Acute,Cerebral,Infarction,TAK442,TAK700,Nissan,NIP151,AF,Adverse,Effects,Ventricle,US,Law,Disclose,Payments,Physicians,Denosumab,SRE,Breast,JAPhMed,Philip,Carrigan,Haranaka,JMA,President,Korosho,Flu,Diagnostic,JDS,NGSP,HbA1c,Seino,Datamonitor","No.2184 Contents")

st++; thePage[st]=new Array("2183_apr_5.pdf","pdf/2010_4/","April 5","Shionogi,NDA,HIV,Integrase,Inhibitor,Irbetan,Fluitran,Hisamitsu,Fentanyl,Transdermal,Funds,Imamura,Elimination,Bulk,Buying,Sucampo,Arbitration,Regarding,Amitiza,Takeda,Eisai,Oncology,Daiichi,Sankyo,Espha,Taiyo,Quality,Assurance,System,Yakuhin,Takayama,Plant,Hyogo,Generics,Bayer,Transfers,Imaging,Agent,Irom,Takeda,Rozerem,Korosho,Orphan,New,Pricing,System,Nagano,Premium,MRs,Education,Materials,JPMA,Eritoran,Alogliptin,SU,BU,Kondo,PMDA,Chief,Executive,NovoSeven,Bleeding,Congenial,FVII,Deficiency,Limit,Prescriptions,Thalidomide,Public,Hospital,Kitasato,Univ,Global,Clinical,Research,Center,Head,Club,Uyama,Keio,Core,Ono,BioSeek,Bioactive,Lipid,Discovery,RIKEN,Torii,Cedar,Pollinosis,Vaccine,Once,Monthly,Risedronate,Osteoporosis,Ajinomoto,Dabigatran,Strokes,Warfarin,AF,OTC,Drugs,Special,Nurses,Pharmacists,Combination,Eye,Drops,Compliance,Yamamoto,IFN,Beta,Ribavirin,First,Line,Hepatitis,XELOX,Erbitux","No.2183 Contents")

st++; thePage[st]=new Array("2182_mar_29.pdf","pdf/2010_3/","March 29","Olmesartan,Prasugrel,Daiichi,Sankyo,Rezaltas,Astellas,to,OSI,Stockholders,Erbitux,Bayer,Diagnostic,Imaging,Oncology,PET,Tracers,Molecular,GLs,JPMA,Funds,Eisai,Plant,Biologics,Febuxostat,Teijin,NBI,Quintiles,Tokyo,CMIC,Biomedical,Systems,Image,Analysis,Toho,Acquire,Dispensing,Pharmacy,Chains,Gifu,Taiyo,Yakuhin,Takayama,Plant,Stop,Operation,Recalls,JGA,Towa,MRs,Generics,Kyokai,Kenpo,Takata,Seiyaku,Shionogi,PMDA,Priority,PMDA,ADR,Pharmacists,Guidance,Isobe,Substitution,Takeda,Withdraws,MAA,Actos,Metformin,Chugai,Herceptin,Xeloda,Gastric,Actemra,Hizentra,PI,FDA,CSL,Behring,Lurasidone,Schizophrenia,DSP,NDA,Bendamustine,Taiwan,SymBio,Dry,AMD,ACU,Fast,Track,Otsuka,Acucela,New,Pricing,System,AD,Symptomatic,Causal,Therapy,Kyowa,Kirin,Antibodies,Cabazitaxel,OS,Hormone,Refractory,Prostate,Cancer,Sutent,Primary,Endpoint,Breast,Ghrelin,Protein,Mall,Kansai,JCS,Livalo,Lipitor,Crestor,ARB,CCB,Candesartan,Amlodipine,PAF,Coniel,Tenormin,Secondary,Prevention,IHD,Olmetc,CV,Events,Vaccination,Act,Amendment,Osaka,Pref,Korosho,Flu,Sapporo,Hib,Vaccines,Philip,Carrigan,Free,Coupons,Cervical,Checkups,Serious,Concern,Domestic,Counterfeit,Pfizer","No.2182 Contents")

st++; thePage[st]=new Array("2181_mar_22.pdf","pdf/2010_3/","March 22","Aricept,Patent,Expiration,China,Eli,Lilly,Teshirogi,Personalized,Mediceo,ALCs,Morimoto,Manufacturing,Site,Shanghai,DI,Pharmacists,Toshio,Asano,Asahi,Kasei,Wholesalers,Pharmacy,Chains,Symbicort,Booz,Company,Ajinomoto,Korosho,Hearings,Dispensing,Operators,Premium,Development,Poison,Bait,Santen,NDA,Higher,Concentration,Levofloxacin,CDFS,Rozerem,DE,Soliris,Dacogen,Eisai,Sato,OTC,Troxipide,Generics,Roche,Suspends,Ocrelizumab,Adverse,Reactions,JCLEAR,Data,Clinical,Studies,Merck,Early,Stage,Torii,Sublingual,Desensitization,Therapy,Pollinosis,Takara,Bio,Pennsylvania,HIV,Gene,Pfizer,Figitumumab,Advanced,NSCLC,VEGF,Trap,Eye,DME,Bayer,WG,Blood,Raw,Material,Plasma,JMA,Integrated,Medicine,Vaccine,High,Risk,Shionogi,Quick,Chaser,Mizuho,Medy","No.2181 Contents")

st++; thePage[st]=new Array("2180_mar_15.pdf","pdf/2010_3/","March 15","Schering,Plough,Merck,CV,Infectious,Diseases,Hepatitis,Cancer,Shionogi,Ospemifene,QuatRx,Astellas,Oncology,TOB,OSI,Lawsuit,Pfizer,Japan,Norvasc,Toyobo,Life,Science,Business,EFPIA,Drug,Lag,Teijin,SB,SanBio,IMS,Japan,Blopress,Diovan,Banyu,Santen,Cosopt,Kyowa,Kirin,Solasia,Sancuso,NanoCarrier,Process,Patent,NC,Tsumura,Raw,Materials,Kampo,Medicines,Laos,Quintiles,Tissue,Testing,China,Suzuken,Frontier,Dispensing,Pharmacy,CareNet,eDetailing,Matsumura,Terumo,Regulatory,Reform,Medical,Devices,NHI,Prices,Premium,Granted,Astellas,Price,Cut,Long,Listed,Original,Profitability,Price,Reduction,Rate,ARBs,Nagatsuma,Hearing,Major,Chain,Pharmacy,Operators,Astellas,Diabetic,Incipient,Nephropathy,Micardis,Korosho,GRU,Sanofi,aventis,Post,marketing,Apidra,Takeda,Lu,AA,Eli,Lilly,Merck,Pfizer,Cancer,DB,in,Asia,SymBio,Bendamustine,Aggressive,NHL,JCPM,Shiono,SSP,Switch,OTC,DrugsFuji,Keizai,Lanbaxy,I'rom,Amlodipine,Generics,Sawai,Generics,Originals,Schools,AJMC,JMA,Election,COPD","No.2180 Contents")

st++; thePage[st]=new Array("2179_mar_8.pdf","pdf/2010_3/","March 8","BMKK,Wright,Takeda,Lifestyle,Diseases,Pramlintide,Metreleptin,Davalintide,Biogen,Idec,MS,Ozaki,Astellas,Tender,Offer,OSI,Nippon,Shinyaku,PAH,Shionogi,Ospemifene,QuatRx,Koyama,New,NHI,Pricing,System,CROs,Nakamura,JCROA,Restriction,Prescription,Umeda,PhRMA,Daiichi,Sankyo,Eisai,Revovir,Philippines,AnGes,MG,Patent,eNOS,Angiogenesis,Paltac,TSE,OSE,Reed,Maurer,Pfizer,Lyrica,Distigmine,Dysuria,GRU,PMDA,JP,Preparations,Korosho,Hospitals,Settlement,Hotta,Public,Domain,NDA,Cancer,Pain,Killer,KW-2246,Kyowa,Kirin,Novartis,Ono,Rivastigmine,Patch,Janssen,Galantamine,AD,Regenerative,Cell,Therapy,Pneumococcal,Vaccine,Prevnar,WyethGenerics,Surgery,Societies,Database,Isavuconazole,Basilea,Innovation,Discovery,Sakata,South,Korea,Infrastructures,JPMA,Taniguchi,Clexane,Postoperative,VTE,sanofi,aventis,Switch,PPIs,OTC,Oxiconazole,Vaginal,Candidiasis,Legislation,Specific,Nurses,Pharmacists,Haranaka,Campaign,Office,JMA,Election,HIV,Humira,Psoriasis,Remicade,Nakagawa,GLP-1,Agonists,DPP-4,Kadowaki,UBC,Tokyo","No.2179 Contents")

st++; thePage[st]=new Array("2178_mar_1.pdf","pdf/2010_3/","March 1","RG3616,DSP,Overseas,Patent,Expirations,Sepracor,DSPA,Adachi,Eli,Lilly,Chugai,Roche,MTPC,Safety,Remicade,Psoriasis,UMN,Partner,Flu,Vaccines,Kissei,Marketing,Right,Cinalong,UCB,Maruho,Actosin,Medipal,Ikkou,Abbott,Acquisition,Solvay,Incretin,Related,Korosho,Hearings,SOP,Package,Inserts,CDFS,Vectibix,Takeda,Financial,Resources,Shionogi,Rapiacta,Pediatric,Olmetec,Children,Adolescents,FDA,Crestor,Preventive,AZ,Tykerb,Femara,GSK,ICH,Annexes,DPJ,Merci,Nihon,Medi,Physics,NMK36,NIMS,DES,Vascular,Endothelial,Formation,CMIC,Korean,Medical,Devices,Teva,Kowa,Taisho,Equivalence,Generics,Original,Distribution,Reform,Reed,Maurer,Eliminate,Clinical,Research,IND,System,Kawakami,Ethnic,Diversity,Early,Stage,Iwasaki,Takeda,Hematide,Toyama,Chemical,T705,Nippon,Shinyaku,Actelion,Macitentan,PAH,Hakui,President,Osaka,Medical,Association,Karasawa,Election,Governments,Stock,Relenza,Death,NewType,Vaccination,Takashi,Kodama,JPA","No.2178 Contents")

st++; thePage[st]=new Array("2177_feb_22.pdf","pdf/2010_2/","February 22","FUJIFILM,Generics,FFP,Toho,Chairman,Novartis,Diovan,Glivec,GSK,Rare,Diseases,JMHA,DB,METI,Ethical,ncretin,Related,Ranbaxy,Prasugrel,Mexico,Kyowa,Kirin,Research,Fellow,System,SRL,JCL,Medical,Brain,Korosho,Priced,Higher,Levels,Originals,JPA,Pricing,System,Miura,Premium,Antipsychotics,Exceptional,Basic,Dispensing,Fee,Medical,Fee,Nagatsuma,Kampo,Health,Insurance,Coverage,Edano,Hasegawa,JPA,Unapproved,Unmet,Medical,Needs,DPJ,Adachi,Advanced,Therapies,Daiichi,Sankyo,SUN,Gemzar,Breast,Cancer,Ely,Lilly,CDFS,Vectibix,Takeda,Mergers,Sawai,Taiyo,Recalls,Tetipline,BI,SSP,Switch,OTC,Konja,CHC,VTE,Anticoagulants,Sakon,Adcirca,PAH,ADRs,Sato,Vaccine,Policy,Wachi,MRs","No.2177 Contents")

st++; thePage[st]=new Array("2176_feb_15.pdf","pdf/2010_2/","February 15","Kowa,Livalo,Australia,New,Zealand,Takeda,Chugai,Nagayama,Tamiflu,Banyu,Schering,Plough,Novartis,Oncology,NBI,BI,Sifrol,Taiho,Aloxi,IHI,UMN,Pharma,Flu,Vaccines,QOL,Growell,Medipal,Toho,Itochu,China,Mepact,Osteosarcoma,EU,ASKA,Minclea,Nihon,Pharm,Kyowa,Kirin,KW,Hisamitsu,Wakunaga,California,Generics,Korosho,Daiichi,Sankyo,Laninamivir,Urief,Kissei,Bendamustine,Singapore,SymBio,Astellas,PII,Antibody,Ovarian,Cancer,Edoxaban,VTE,Eritoran,Eisai,BioNumerik,Tavocept,AnGes,Allovectin,FUJIFILM,Fuji,Pharma,Mochida,CSF,Biosimilar,Keiji,Nakamura,Peptide,Pharmaceuticals,Protein,Mall,Kansai,Abbott,DES,Market,XIENCE,V,RDKK,K,RAS,Gene,Mutation,Test,Kit,Insurance,Nipro,Home,Diagnostics,HSTTC,Mediates,NCC,MKI,JMA,President,JAID,C,Anti,Flu,Drugs,Smoking,Cessation,Aids,Prescribing,Rasilez,SSRI,MR,MS","No.2176 Contents")

st++; thePage[st]=new Array("2175_feb_8.pdf","pdf/2010_2/","February 8","JCR,EPO,Biosimilar,Ashida,GSK,DSP,Growth,Hormone,Animal,Health,Food,Speciality,Pregabalin,Pfizer,Primary,Harada,Wyeth,Kyowa,Kirin,Permax,Eli,Lilly,Zeria,Tillotts,Ibe,Price,Cuts,Long,Listed,Mochida,Januvia,Glactiv,Fuso,License,OTS,Otsuka,Kaken,Synphase,Tsumura,Tamiflu,Astellas,Choseido,NHI,Price,Revision,Chuikyo,Premium,Antipsychotics,Reimbursement,Anticancer,Providers,Shoda,Vaccine,Arepanrix,WHO,Actos,Glivec,Herceptin,Market,Expansion,RePricing,Tasigna,Sprycel,Isobe,Rozerem,PMDA,Kami,Medical,Fees,Combination,Gemzar,Breast,Cancer,FDA,PDUFA,Sepracor,STEDESA,NDA,Fluzone,Elderly,sanofi,aventis,Takara,Bio,Gene,Cell,Therapy,JSCTR,PGx,Evidence,Uyama,Bayer,Antsens,Horiba,Loxoprofen,Switch,OTC,SSP,Masami,Okubo,Asucome,Cancellation,Import,Shionogi,Rapiacta","No.2175 Contents")

st++; thePage[st]=new Array("2174_feb_1.pdf","pdf/2010_2/","February 1","Cymbalta,Shionogi,Sawada,PK,Study,S-2367,Takeda,Emerging,Markets,Hasegawa,Banyu,Schering,Plough,Januvia,Sakai,Credit,Suisse,Wholesalers,Margin,Kimura,JPMA,Teva,Kowa,Taisho,Pharm,Sciele,Kyowa,Kirin,Iwaki,eDetailing,GLP,Analogue,Victoza,Novo,Nordisk,ARB,Ca,Blocker,Rezaltas,Daiichi,Sankyo,Metformin,Metgluco,DSP,Xalacom,Glaucoma,Pfizer,Sugammadex,Neuromuscular,Blockade,Aloxi,Taiho,Arepanrix,GSK,BI,Sifrol,RLS,NBI,Remicade,Psoriasis,MTPC,Humira,Abbott,Eisai,DPC,Payment,Psoriasis,Anti,Flu,Agent,Rapiacta,NHI,Price,List,Post,Marketing,Korosho,Unapproved,Drugs,Premium,Tsutsumi,RePricing,Nishiyama,Advate,Hemophilia,Baxter,IP,Forum,Innovations,Severe,DM,NIHS,Generics,APIs,EPO,Biosimilar,JCR,Kissei,JGA,Households,Doctor,Ethical,Crecon,JSMI,Switching,OTC,Proper,Use,Afinitor,Bendamustine,NCCN,GLs,SymBio,Surgery,Insurance,Coverage","No.2174 Contents")

st++; thePage[st]=new Array("2173_jan_25.pdf","pdf/2010_1/","January 25","Crestor,Ticagrelor,AZ,Astellas,Symbicort,Merck,Serono,Gonalef,Saizen,Hisamitsu,Mohrus,Blopress,Ranking,Bayer,Shinbit,Hospira,Ranbaxy,Subsidiary,Mitsui,CRO,Asia,Premium,Wholesalers,Pricing,System,Panel,Unapproved,Nagatsuma,Eisai,Pediatric,Flecainide,Flu,Rapiacta,Shionogi,All,Patient,Survey,Vaccines,Novartis,Emergency,Subcommittee,NCs,Korosho,Preventive,Vaccination,Law,Safety,Actemra,Chugai,Roche,Pfizer,CRL,Lyrica,GAD,NichiIko,Biosimilars,Tamura,Latanoprost,Prevnar,Immunization,Wada,Eribulin,MK8669,Banyu,MBL,Osaka,Univ,Fully,Human,Flu,Virus,MAB,Tasigna,Glivec,CML,Abbott,Everolimus,Eluting,Stent,XIENCE,Seikagaku,Gel200,FDA,Kobayashi,OTC,Drugs,Hatori,GLs,Ads,Illegal,Internet,Informed,Consent,Albumin","No.2173 Contents")

st++; thePage[st]=new Array("2172_jan_18.pdf","pdf/2010_1/","January 18","Common,Approval,System,Asia,Shoda,Reform,Distribution,Drug,Pricing,Bessho,Wholesalers,Kohno,Matsutani,Eisai,Acquisition,AkaRx,Kyowa,Kirin,Bardoxolone,Reata,Meiji,Seika,Mochida,MTPC,Escitalopram,Daiichi,Sankyo,PharmaForce,Luitpold,Novartis,Diovan,Corthera,AnGes,NFkB,Elan,DDS,Hatoyama,Budget,Korosho,PFSB,HPB,Anticancer,DSP,Lurasidone,US,Teijin,Pharma,TMX,Herceptin,Advanced,Stomach,CHMP,Reorganization,Generics,Sawai,NJIHK,Hansha,MS,Certification,China,South,Korea,Ethnic,Differences,BI,Avastin,Chemotherapy,PFS,Breast,Tykerb,Herceptin,OS,Rivaroxaban,Symptomatic,VTE,Bayer,Kitasato,Keio,Biomarkers,KRAS,Gene,Test,GL,Hypoglycemic,Surrogate,Markers,Assess,CV,Yamanaka,Immunosuppressant,OB,GYN,Doctors,Transplacental,Antiarrhythmic,JMA,Consultation,Fee,Novartis,Flu,Vaccines,WHO,Ichiro,Umeda,Chairman,PhRMA,JBEC,Hiroshi,GSK","No.2172 Contents")

st++; thePage[st]=new Array("2171_jan_11.pdf","pdf/2010_1/","January 11","Pricing,System,Reform,Reorganization,Pfizer,Blockbusters,Umeda,Goettler,Nippon,Kayaku,Anticancer,Biosimilars,Januvia,Rep,Track,Janssen,AFM,Kowa,Livalo,Lilly,US,Ranbaxy,Olmesartan,Africa,Bayer,Intendis,Welfide,Korea,Mitsubishi,Tanabe,Toho,Acquire,Asucome,Investment,Examination,MR,Certification,FPMAJ,JPMA,Premium,Chuikyo,Interest,Refunds,ARB,Diuretic,Nagano,Kinoshita,NHI,Price,Cut,Rate,JSOM,Insurance,Coverage,Kampo,Flu,Vaccines,GSK,Novartis,Pregnant,Women,Rapiacta,Solvay,Pancreatic,Enzyme,Replacement,Fulvestrant,Postmenopausal,Breast,Cancer,Tamiflu,Prevention,Infants,Children,Bup4,OAB,FDA,Crestor,Generics,Substitution,Strengths,Teva,Kowa,Taisho,Subsidiary,Kyowa,Kirin,AD,Immunas,Sanofi,aventis,BSI,Switchover,Tamoxifen,Aromasin,AZ,Devices,Medical,Fees,OTC,Pharmacists,Aricept,Medicoeconomic,Female,Doctors,Surgery","No.2171 Contents")

st++; thePage[st]=new Array("2170_dec_28.pdf","pdf/2009_12/","2170 December 28 & January 4","Eisai,Aricept,Patent,Expiration,Naito,AkaRx,India,Mark,Timney,Schering,Plough,Takeda,Brentuximab,Vedotin,Seattle,Genetics,Astellas,FLT,Ambit,DSP,CNS,Actos,Pfizer,China,AZ,Asthma,Symbicort,COPD,Quintiles,Risk,Winstanly,Keidanren,NOF,Polymer,Micelle,Carrier,NanoCarrier,Kyowa,Hakko,Bio,Livestock,Aquaculture,ASKA,Fukai,Nihon,Chouzai,Teva,Kowa,JCR,GSK,Biosimilars,Bresch,Generics,Promotion,Chuikyo,Korosho,Premium,Inpatients,Dispensing,Rate,Chuikyo,Long,Listed,Medical,Fees,MOF,Double,Digit,Cut,Finance,Minister,Victoza,Bridion,Abraxan,Kinoshita,Unification,Revisit,Consultation,DPJ,Exclusion,Poultices,Multaq,EC,AF,sanofi,aventis,Vaccine,Arepanrix,WHO,Shionogi,Locusta,Hypercholesterolemia,Bendamustine,Low,Grade,NHL,SymBio,Payments,Institutions,TAK085,Hypertriglyceridemia,Novo,Nordisk,Insulin,Analogue,Riociguat,PH,ILD,Bayer,NIBIO,iPS,Cells,Carna,Biosciences,Colon,Cancer,JST,Reed,Maurer,Materials,CMIC,LFABP,Roche,IBL,Amyloid,Assay,Kit,NewType,Flu,Ethical,Crecon","No.2170 Contents")

st++; thePage[st]=new Array("2169_dec_21.pdf","pdf/2009_12/","2169 December 21","Hospital,Market,Prasugrel,Shoda,NDA,Edoxaban,Chugai,Diabetes,Banyu,DPP4,Inhibitor,Januvia,GSK,HPV,Vaccine,Cervarix,Nippon,Chemiphar,Ranbaxy,Alliance,Rep,Track,Wholesalers,Matsutani,Patent,Cliff,Datamonitor,Merck,Serono,hGH,Saizen,TMX67,Teijin,Ohyagi,Takara,Bio,Expansion,Culture,Lymphocytes,CMIC,DS,Propharma,Shizuoka,Plant,Price,Cut,Long,Listed,Chuikyo,FPMAJ,PhRMA,EFPIA,Korosho,Premium,JMA,Punishment,Calculation,Method,Average,Overseas,Biosimilars,Unapproved,Drugs,Medical,Fees,Revision,MOF,Shinyaku,Azacitidine,MDS,Onbrez,Breezhaler,COPD,EU,Novartis,Micardis,CV,Morbidity,Bayer,Schering,Florbetaben,Dabigatran,NonInferiority,Warfarin,BI,Sumitomo,Chemical,Kracie,Scabies,Treatment,BioComber,Protein,Synthesis,Technology,ED,Online,Counterfeits,OPINION,Philip,Carrigan,GLP,Niki,Taxotere,Prostate,Cancer,Akaza,Symbicort,Asthma,Adachi,OAB,Takahashi,RA,JCR,ACR,EULAR,NewType,Flu,Tamiflu,Abnormal,Behavior,DPC,Councillor,Karasawa","No.2169 Contents")

st++; thePage[st]=new Array("2168_dec_14.pdf","pdf/2009_12/","2168 December 14","Ichiro,Umeda,Pfizer,Generics,Wyeth,Gary,Winer,General,Manager,Abbott,Takeda,South,American,Bureaucrats,Subsidiary,Brazil,Otsuka,Collaboration,Galenea,Hisamitsu,Eisai,Oral,Jelly,Aricept,Sanofi,aventis,Chocat,DSP,Animal,Health,Food,EFPIA,Masuhiro,Kato,Chairman,Lantus,PMDA,Korosho,GRU,Price,Maintenance,System,Chuikyo,Drug,Pricing,Reform,Parliamentary,Secretary,Exclusion,Kampo,NHI,Coverage,MOF,Ordinary,Cut,Rate,Long,Listed,Medical,Fees,Sengoku,Sitagliptin,GSK,Rotavirus,Vaccine,Rotarix,FDA,Advisory,Committee,Prevnar,Hypoglycemic,Reed,Maurer,METI,Budgets,Tax,Merck,Serono,Cancer,Takara,Bio,Gene,Therapy,Relapsed,Leukemia,Crestor,CV,Events,Risk,Actemra,sJIA,Roche,Chugai,Protein,Mall,Kansai","No.2168 Contents")

st++; thePage[st]=new Array("2167_dec_7.pdf","pdf/2009_12/","2167 December 7","Astellas,Nogimori,Agensys,ADC,Seattle,Genetics,Citizen,Petition,Prograf,Price,Maintenance,System,Nagayama,National,Vaccine,Plan,Feliciano,Diovan,GP,Market,Rep,Track,Dutch,Innovation,Pfizer,Caduet,Abbott,Biologic,Pain,Killer,PanGenetics,Sanofi,aventis,Regeneron,Antibody,Alfresa,Contract,Manufacturing,Sakurai,DPJ,Yakkasa,GLP,Analogue,Victoza,ARB,Ca,Blockers,Afinitor,Abraxan,Chuikyo,Reform,Medical,Fees,MOF,Korosho,Legislators,Takeda,Ulcers,NSAIDs,Takepron,Glufast,China,Kissei,Abilify,Irritability,Autistic,Disorders,Eisai,Aricept,Extended,Release,Silodosin,AnGes,FDA,SPA,Collategene,Otsuka,Major,Depression,Tsumura,Daikenchuto,GLs,Effient,ACS,PCI,Biosimilar,EPO,Generics,Amgen,AMG531,Janssen,Keio,Ticagrelor,Clopidogrel,AZ,Roche,GLYT,Inhibitor,Schizophrenia,Nouvelle,Switch,OTC,Loxoprofen,Epinastine,Ketotifen,Nasal,Drops,OPINION,Philip,Carrigan,Blue,Letter,Nexavar,DB,Pharmacovigilance,Chan,Depression,Shimodera","No.2167 Contents")

st++; thePage[st]=new Array("2166_nov_30.pdf","pdf/2009_11/","2166 November 30","Dunoyer,FPIA,Masuhiro,Kato,Chairman,JPMA,Otsuka,Saxagliptin,Kaken,bFGF,Olympus,Zeria,Asacol,Ibe,Sciele,Pharma,Addrenex,Shionogi,Blopress,IMS,Nakamura,CRO,Toho,Meissa,Market,Eisai,Sedative,Hypnotic,Lusedra,Vibativ,Astellas,Alexion,MCCs,Strenger,TPG,CPP,Investment,Board,Daiichi,Sankyo,Levofloxacin,Patent,Lawsuit,Ventures,Kawakami,New,Type,Flu,Pfizer,Generics,Substitution,Isobe,Fuji,Keizai,Dispensing,Rate,NDA,Liraglutide,Vildagliptin,ARB,Ca,Blocker,Everolimus,Renal,Cell,Cancer,Price,Maintenance,System,FJPWA,GRU,WG,Wholesalers,Hasegawa,Nonclinical,Evaluation,Anticancer,ICH,Chugai,Epogin,Chemotherapy,Induced,Anemia,ASP,RLS,FDA,Omeprazole,Plavix,Pricing,Rule,Crecon,TAK,PII,Reflux,Esophagitis,Takeda,Liraglutide,Weight,Gain,CHO,BI,HEX,Miraka,Reed,Maurer,Designated,Disease,Taisho,BMS,OTC,Asia,Pacific,Sato,Switch,Vidarabine,Kobayashi,Rohto,Adverse,Reactions,GSK,Vaccine,Korosho,Canada,JDS,HbA1c,NGSP,Seino,JSA,Asthma,Hospitals,GPs,Pharmacies,Atopic,Xolair,JGL,Rasilez,Hypertension,ESH,GL,Novartis","No.2166 Contents")

st++; thePage[st]=new Array("2165_nov_23.pdf","pdf/2009_11/","2165 November 23","Plavix,sanofi,aventis,Chocat,Yakult,Elplat,Stomach,Cancer,Astellas,Prograf,Harnal,Patent,Expiration,Nogimori,Mirabegron,SGLT,Inhibitor,Santen,Kyorin,Kipres,Kissei,Urief,Shinyaku,Zeria,OTC,Drugs,Fuso,Seikagaku,Tsumura,Kampo,Meiji,Seika,Linaclotide,Ironwood,Nippon,Kayaku,Apaziquone,Spectrum,Wholesalers,Suzuken,Toho,SGA,Expense,Banyu,Januvia,First,Line,Haruo,Naito,President,IFPMA,Merck,Merger,Schering,Plough,Micromet,BiTE,Antibody,Daiichi,Sankyo,Levofloxacin,Litigation,Freund,NHI,Price,Listing,Sawai,Oral,Liquid,Levofloxacin,Generic,DPC,Hospitals,Towa,OD,Tablets,Amlodipine,Taiyo,Injectables,Univ,Isobe,GRU,WG,Reprice,Long,Listed,Osa,Price,Adjustment,Range,Exclusion,Insurance,Coverage,Korosho,NHI,Tsumura,Yoshii,Chuikyo,FPMAJ,Hasegawa,Miura,Novartis,New,Type,Influenza,Vaccine,Seibule,Biguanides,Avastin,NSCLC,Chugai,Fludara,Tablet,Injectable,Farletuzumab,Eisai,Subcutaneous,Velcade,Takeda,Nexavar,Responsive,Thyroid,Bayer,Onyx,Sancuso,Solasia","No.2165 Contents")

st++; thePage[st]=new Array("2164_nov_16.pdf","pdf/2009_11/","2164 November 16","Quintiles,Winstanly,AZ,Pharmacology,Eisai,Anticancer,Drugs,Business,Results,Astellas,Vesicare,Shionogi,Sciele,Ono,Kaken,Mochida,Torii,ASKA,Nippon,Chemiphar,JCR,Pharmaceuticals,Growject,Wakamoto,Asahi,Kasei,Teijin,Pharma,Osteoporosis,Olmetec,ARB,Market,DSP,Marketing,Lurasidone,Kyorin,Neramexane,Tinnitus,Merz,Banyu,vaccine,Pneumovax,Gardasil,Pneumococcal,Pneumovax,GSK,Cervarixd,MRs,Medipal,Alfresa,China,Chuikyo,Pricing,Rule,Products,Existing,API,Chuikyo,Original,Korosho,Fees,Prescribe,Antipsychotics,Healthcare,Hodanren,Proposal,Peramivir,Celgene,Lenalidomide,Arzerra,GSK,Genmab,Micardis,CHMP,BI,Healthcare,Insight,Reed,Maurer,Takeda,Amylin,Obesity,Daiichi,Sankyo,CS,Epadel,Coronary,Events,Sugar,Metabolism,Disorders,SC,Administration,Orencia,BMS,Tasigna,Gilvec,CML,Novartis,Pfizer,Norvasc,OD,Tablets,InCROM,PI,Off,Patent,TMA,Premium,Prices,Biosimilars,Nagano,Asahi,Kasei,Kuraray,Korean,Subsidiary,Hospira,Japan,GemStar,PCA,Pump","No.2164 Contents")

st++; thePage[st]=new Array("2163_nov_9.pdf","pdf/2009_11/","2163 November 9","Medipal,China,Takeda,Hasegawa,Barr,Covance,Astellas,MDV3100,Prostate,Cancer,Medivation,Eisai,Bahrain,Ludwig,BD,Terumo,Relief,Pain,Eiken,Chemical,Influenza,Virus,Osteoporosis,Glycemic,Sugimoto,Amlodipine,NPO,Generics,Cravit,Patent,Extension,IP,High,Court,Daiichi,Sankyo,Injectable,Levofloxacin,Chuikyo,Market,Price,Adachi,Suzuki,Korosho,Tax,Break,PMDA,Simultaneous,EU,Kondo,Societies,Cervarix,SymBio,NDA,SyBL0501,Abbott,Eisai,Humira,Telavancin,Theravance,Herceptin,Roche,Cervical,Cervarix,GSK,Gardasil,Condyloma,Acuminatum,Votrient,RCC,Micardis,CV,Risk,BI,Cimzia,RA,Pramipexole,EU,Quintiles,Anticancer,AZ,Vandetanib,JAPhMed,Korosho,Toyama,Chemical,Antiviral,T705,Celsion,Yakult,Honsha,ThermoDox,Sanofi,aventis,ALOHA,Sosei,SD281,Biocopea,Actemra,MTX,NovoMix,HbA1c,Insulin,Glargine,Taxotere,Cisplatin,OS,HNC,Erbitux,mCRC,Merck,NIBO,LRG,Biomarker,MORE,Medical,CROs,Kenkocom,OTC,Singapore,Yano,Research,Nissui,Epadel,Stroke","No.2163 Contents")

st++; thePage[st]=new Array("2162_nov_2.pdf","pdf/2009_11/","2162 November 2","Roche,artnering,McCracken,TMX-67,T-DM1,Pfizer,Wyeth,DSP,Sepracor,Teijin,Menarini,Eisai,Denileukin,Diftitox,TSD,Japan,wholesaler,Hasegawa,MLIT,Growth,Strategy,Council,Medipal,China,Kyowa,Kirin,NeuUp,Yakult,BioWa,POTELLIGENT,NKTT,Sanofi,aventis,Diabetic,Wellstat,Pharmaceuticals,EP,Mint,Sogo,SMO,EPS,Generics,okinawa,Products,Januvia,Glactiv,Banyu,Ono,Prevenar,Pneumococcal,Vaccine,Wyeth,HPV,Cervarix,GSK,Rasuritek,Chemotherapy,Associated,Hyperuricemia,Erizas,Allergic,Rhinitis,Nippon,Shinyaku,Emend,CINV,Miripla,Hepatocellular,Carcinoma,Symbicort,Turbuhaler,Bronchial,Asthma,AZ,Asacol,Ulcerative,Colitis,Zeria,Ozex,Fine,Granules,Children,Toyama,Chemical,Factor,IX,BeneFix,Adcirca,PAH,Eli,Lilly,Basen,IGT,Takeda,Paxil,SAD,GSK,Feron,Chronic,Hepatitis,C,ribavirin,Toray,Prograf,Myasthenia,Gravis,Bridion,BISifrol,RLS,Korosho,Hatoyama,Medical,Expenditure,JMA,Chuikyo,Members,Price,Maintenance,System,Kinosita,Naito,Transmission,Safety,Information,Fentanyl,Transdermal,System,Pain,US,Hisamitsu,Chugai,Avastin,Breast,Cancer,Eldecalcitol,Osteoporosis,Taisho,Reorganization,Pharmacology,Aging,Longevity,Therapeutics,Keiji,Nakamura,Kyowa,Kirin,to,r,KW,Astellas,IBL,ASK,RA,Sekiguchi,Global,Trials,EFPIA,Evotec,Ion,Channel,BSP,AC,Immune,AD,NanoCarrier,IFN,Therapy,LDP,Ibaraki,Presidency,Terumo,Saving,FN,Syringe","No.2162 Contents")

st++; thePage[st]=new Array("2161_oct_26.pdf","pdf/2009_10/","2161 October 26","Biogen,Idec,IFN,Rasilez,Rosenberg,Novartis,Datamonitor,Solvay,Abbott,Hospitals,Joint,Purchasing,Hokkaido,Cravit,HP,GP,Markets,Rep,Track,Survey,Otsuka,Investor,France,Award,Kringle,Grand,Prix,Japan,BioVenture,Global,IMS,Health,MTPC,Mediscience,MRs,Astellas,BI,Flomax,Patent,Impax,Korosho,Supplementary,Budget,NHI,Price,Revision,Minister,JMA,Medical,Fees,Dispensing,Development,Temodal,Onglyza,Diabetes,Europe,sNDA,FDA,Clonicel,ADHD,Shionogi,Sciele,Restrictions,Isentress,HIV,Naive,Banyu,Shionogi,UK,Life,Science,Oncolys,Astellas,BioWa,Lonza,Cell,Line,Antibody,Production,ePRO,Raymond,Lantus,Detemir,sanofi,aventis,Reed,Maurer,Premium,Generics,Isobe,Biosimilars,OTC,Crecon,Yakuban,JSH,ARB,CCB,Ishimitsu,Diuretic,Abnormalities,Hypertension,DM,Blood,Pressure,Shimada,Evista,Sugar,Liraglutide,Novo,Nordisk,Incretin,Seino","No.2161 Contents")

st++; thePage[st]=new Array("2160_oct_19.pdf","pdf/2009_10/","2160 October 19","Takeda,Kowa,Livalo,Algorithm,Middle,East,Africa,Sanwa,Kagaku,FYX,Fuji,Yakuhin,Meiji,Seika,CNS,Daiichi,Sankyo,Novartis,Sales,Force,Effectiveness,Summit,Takada,Cost,Effectiveness,Paterson,NBI,Hayakawa,Ajinomoto,Shinji,Takema,Schering,Plough,Nasonex,Ranbaxy,Mexico,BioWa,POTELLIGENT,Otsuka,Kureha,MTPC,Kremezin,Alfresa,Tampei,Nakata,Hans,Dieter,Hausner,Bayer,Holding,Medical,Fees,Price,JMARI,Budget,Unapproved,Maintenance,FPMAJ,Kinoshita,JPMA,Korosho,CDFS,Committees,Obescare,Astellas,IBS,Women,Irribow,Multaq,sanofi,aventis,BioJapan,Merck,Wiederrecht,JJ,LaPolla,Mylan,Cysteamine,Zeria,Phosphate,Quality,Payment,Method,Sosei,Transfers,AD,Pharmasol,Oncolys,NRTI,Regorafenib,RCC,Taxol,JGOG,Nexavar,Xeloda,PFS,Onyx,Tamoxifen,Aromasin,DFS,Pfizer,Sandoz,Somatropin,Nakamichi,JSGM,Prescription,Form,Pharmacists,Generics,Muto,IGPA,HSTTC,Tumor,TransGenic,Terumo,Left,Ventricular,Assist,System,Work,at,Home,Scheme,Banyu,Erbitux,KRAS,Gene,Mutation,GSK,Novartis,Flu,Vaccines,Relief","No.2160 Contents")

st++; thePage[st]=new Array("2159_oct_12.pdf","pdf/2009_10/","2159 October 12","Mediceo,Distribution,Costs,Novartis,Rasilez,Antihypertensive,Eli,Lilly,Alimta,Ajinomoto,Abbott,Solvay,Teijin,Homecare,Kyorin,Uritos,Eisai,China,Takeda,Bayer,Genzyme,Fludara,Hisamitsu,Mohrus,Astellas,Lawsuit,Teva,Customs,Ban,Import,Counterfeit,Botox,CMIC,Medidata,EDC,Quintiles,MTPC,Recalls,Arofuto,Taiyo,Famotidine,Generic,DPP4,Inhibitor,Sitagliptin,GERD,Pariet,Humira,Crohn,Disease,Shinya,Adachi,Chuikyo,HP,Eradication,Seikagaku,Supartz,Shoulder,Osteoarthritis,Roche,Joint,Damage,Actemra,RA,Xeloda,XELOX,Chugai,FDA,Pancreatitis,Januvia,Gardasil,Merck,Cervarix,GSK,Tsukuba,DNDi,Chagas,Antibody,Cancer,JCA,Korosho,Unapproved,BI,Linagliptin,QAB,Lung,Function,Spiriva,Switch,OTC,SSP,Hayakawa,Guidance,Biosimilars,Mylan,Merckmezin,Post,Marketing,Taiyo,Ophthalmic,Solution,Philip,Carrigan,Scheme,Vaccines,Flu,NewType,RA,Yamamoto,Abolition,Later,Stage,Elderly,Minister,Impairments,JOA,HCV,Reagent,Anti,HCV,Roche,Diagnostics,Endeavor,Stent,Paclitaxel,Eluting,Stent,Medtronic,Siemens,Mochida,Medical,System,Frank,Florio,BD","No.2159 Contents")

st++; thePage[st]=new Array("2158_oct_5.pdf","pdf/2009_10/","2158 October 5","Bayer,Schering,VEGF,TrapEye,Eisai,Pfizer,Aricept,Quintiles,COPD,Disease,Management,DSP,Amlodin,OD,Tab,SUITAB,NEX,Novo,Nordisk,Insulin,Analogues,Otsuka,Meptin,Air,Nagatsuma,Shinya,Adachi,NHI,Drug,Pricing,System,Reform,Chuikyo,Price,Gaps,Similar,Efficacy,Comparison,Method,Fixed,Dose,Korosho,Unapproved,S/GSK1265744,NovoRapid,Mix,Elplat,Chugai,Tarceva,Pancreatic,Cancer,Market,Exclusivity,FLOMAX,US,DPJ,LDP,Maurer,Reed,Abbott,BusinessWeek,Biomarker,Science,Heart,Transplantation,JPMA,Clinical,Studies,Bioventures,GSK,Kaketsuken,Flu,Vaccines,HIV,Viral,Load,Shionogi,Spiriva,Lung,Function,Lag,PK,PD,Kumagai,Kihito,Takahashi,President,LOTUS,Nihon,Chouzai,Matsumotokiyoshi,Hoyu,Kracie,Recognition,Criteria,Mirtazapine,Kinoshita,PMS,Kenporen,Karasawa,JMA","No.2158 Contents")

st++; thePage[st]=new Array("2157_sept_28.pdf","pdf/2009_9/","2157 September 28","Akira,Nagatsuma,Health,Minister,Budget,Formation,Hatoyama,METI,JPMA,Biosimilars,Easypod,Growth,Hormone,Merck,Serono,Intuniv,FDA,ADHD,Children,Shire,Galderma,Dermatology,Taisho,BMS,Indonesian,Subsidiary,Caduet,Japanese,Bioventures,Yoshida,Sepracor,DSP,Mediceo,Paltac,Wholesalers,Kinoshita,Cravit,HP,GP,Markets,Rep,Track,Nippon,Kayaku,Transfers,ImmuCyst,sanofi,aventis,Sanus,Omwell,Toho,Ethical,Crecon,Novo,Nordisk,GLP,Analogue,Insulin,Liraglutide,Sitagliptin,WG,Ethnic,Differences,Asians,Kitasato,Harvard,Symposium,Research,Funds,JAPhMed,Narukawa,Drug,Lag,DPJ,Furukawa,LDP,Bayer,Algeta,Bone,Metastases,Aflibercept,Pancreatic,Cancer,JCR,Korosho,Flu,Vaccine,Novartis,Extended,Release,Fluvastatin,Operative,Cardiac,Outcomes,JMA,Periodical,Hib,HPV,Antipsychotics,Pariet,Prescription,Diovan,Vascular,Protective,Matsubara,Rasilez,Hypertension,Kushiro,Schering,Plough,Asmanex,Twisthaler,Asthma,Janssen,Prezista,HIV,Infection,Shionogi,OxiNorm","No.2157 Contents")

st++; thePage[st]=new Array("2156_sept_21.pdf","pdf/2009_9/","2156 September 21","Eli,Lilly,Alzheimer,Disease,GSK,Urology,Avolve,Asahi,Kasei,Silodosin,South,Korea,Choongwae,Kissei,Taiyo,Ophthalmic,Nidek,Olmetec,ARB,MR,Sonet,Micombi,Fukuoka,Generics,Schering,Plough,Meiji,Seika,Remeron,Reflex,Depression,Prostatic,Hypertrophy,Novartis,Flu,Vaccine,ESC,Barcelona,Diovan,Plavix,PCI,Ticagrelor,Dabigatran,Warfarin,BI,Crestor,AZ,Bayer,Rivaroxaban,TAK,Prostate,Cancer,Takeda,MF,Adjuvanted,Spiriva,COPD,Otsuka,NDA,Korosho,All,Patient,Surveys,EPPV,DPJ,Vibativ,Astellas,PMDA,Bristol,Myers,Website,da,Vinci,FDG,PET,Tumors,Advanced,Vaccination,New,Type,Acceptable,ACIP,Providers,Import,JPA,Pharmacists,Chugai,Tamiflu,Pregnant,Women,JAOG,Relenza,NHO,Avonex,Kobayashi,OC,France,Schering,Plough,TFR,Norvasc,Nextit,Research","No.2156 Contents")

st++; thePage[st]=new Array("2155_sept_14.pdf","pdf/2009_9/","2155 September 14","DSP,Sepracor,Lurasidone,Hisamitsu,Acquisition,Noven,Janssen,CNS,China,Essential,Drug,List,Yano,Research,NHI,Price,Cuts,Blopress,IMS,RA,Fuji,Keizai,Ethical,Kadonaga,Terumo,Narcotics,Takeda,Teikoku,Seiyaku,Ranbaxy,Daiichi,Sankyo,Evista,Romania,Merck,IML,CAPLAN,CSO,Kureha,Kremezin,Patent,Infringement,Lawsuit,Novartis,Oncology,Cancer,Patient,Survey,Idebenone,DMD,NewType,Flu,Vaccine,Adjuvant,Ono,Asimadoline,Tioga,Genzyme,Alemtuzumab,Mochida,Hokkaido,Joint,Schizophrenia,Panitumumab,PFS,KRAS,Wild,mCRC,GenomIdea,METI,JAPhMed,IITs,Abbott,Pfizer,Molecular,Diagnostic,Test,Eluting,Catheter,NEDO,Alogliptin,Actos,FDC,Valcyte,CMV,Children,Roche,Saphris,Schering,Plough,Vimovo,AZ,Reed,Maurer,Unike,Houken,Generics,Promotion,Specifications,Dosage,OTC,Phone,Kenkocom,Switching,Multiple,Antipsychotics,National,Healthcare,Expenditure,Regional,Gaps,Respiratory,Medical,Services,Respiratory,Red,Social,Security,JMA,JPA,DPJ,LDP,Upper,House,Election,Avastin,Chemotherapy,OC,RSV,Infections,Kusuda,Facilities,Bankrupt","No.2155 Contents")

st++; thePage[st]=new Array("2154_sept_7.pdf","pdf/2009_9/","2154 September 7","DPJ,LDP,Biotechnology,Hatoyama,FPMAJ,JPMA,Korosho,JPA,NHI,Price,Listing,Caduet,Mirtazapine,Paxil,Toledomin,Chuikyo,Basen,Diabetes,Asacol,Symbicort,Cervarix,Schering,Plough,Asthma,Xolair,Asthmatic,Xyzal,FDA,Multaq,Canada,sanofi,aventis,Biogen,Idec,Avonex,PMS,Banyu,Januvia,Pfizer,Astellas,SymBio,Bendamustine,Settlement,Rate,MediciNova,Avigen,Merger,J&J,Antipsychotics,Datamonitor,MTPC,Orapenem,Meiji,Seika,Takeda,Alogliptin,Discovery,Research,Lilly,Arzoxifene,Hisamitsu,HTU520,Tinea,Unguium,Merck,Serono,Ovitrelle,NT702,Intermittent,Claudication,Spinal,Canal,Stenosis,OTC,Switch,Troxipide,Generics,Same,Original,Hiroshima,JSGM,OPINION,Philip,Carrigan,JTEC,JACC,NewType,Flu,Vaccination,Outbreak,JPS,Vaccines,Simple,Test,METI,Healthcare,Tourism,Sentinel,Initiative,Olmetec,Brand,Value,ARBs,Nielsen,SoNet,M3","No.2154 Contents")

st++; thePage[st]=new Array("2153_aug_31.pdf","pdf/2009_8/","2153 August 31","CS-8958,SyB-0702,WAP-8294A2,DSP,Tada,MRs,Certification,CV,Field,Kowa,Livalo,MTPC,Taiwan,Indonesia,Cravit,Rep,Track,Survey,Hisamitsu,Tender,Offer,Noven,Schering,Plough,Remeron,Chugai,Cancer,Daiichi,Sankyo,Vaccine,Site,Support,Institute,Contract,Mediscience,CPOC,Patent,Litigation,Olmesartan,Mylan,Shionogi,Sawai,Infringement,Flomox,Crystal,Levemir,Risk,Novo,Nordisk,Sampling,Tests,Approval,Conditions,Korosho,Generics,Japan,China,South,Korea,Regulatory,Consultations,Everolimus,EU,Novartis,FDA,Review,Prevnar,NovoRapid,Elplat,Avastin,Docetaxel,Breast,Advisory,Committee,Prolia,Amgen,Pediatric,TNF,Blockers,JPMA,Tamiflu,MRSA,NEDO,aRigen,SymBio,p53,iPS,Cell,SSP,GG,Rohto,JPA,OTC,Fuji,Keizai,Crecon,GSK,Adjusting,Shipments,Relenza,Minister,Flu,NIID,GL,Antidepressants,Sentinel,Initiative,Databases,Allopurinol,Uralyt,MetS,Adiponectin,Morbidity,Champix,Gene,KCNQ,Diabetes,Kadowaki,CSL,Behring,HAE","No.2153 Contents")

st++; thePage[st]=new Array("2152_aug_24.pdf","pdf/2009_8/","2152 August 24","HOB294,Zeria,Acquire,Tillotts,DSP,NDA,Lurasidone,Daiichi,Sankyo,Eli,Lilly,Effient,AZ,Astellas,Symbicort,Wholesaler,Gross,Profit,MSs,Bessho,CMIC,CMO,Shizuoka,Plant,Zogenix,Sumavel,DosePro,Taiho,Tsukuba,Research,Institute,Banyu,Zenotech,ACRONET,BELLSYSTEM,CRO,Hisamitsu,Noven,NHI,Pricing,System,Chuikyo,Isobe,Combination,Hasegawa,Kowa,Livalo,Otsuka,Samsca,Cardiac,Edema,Exenatide,Bipolar,Disorder,Zyprexa,Vandetanib,FDA,EMEA,Roche,BLA,Actemra,Citizen,Petition,Prograf,Complaint,JMA,Exceptional,Maintenance,System,HPB,Generics,Asonuma,Cravit,Resistant,Organisms,ASP,Shionogi,Diabetic,Neuropathic,Pain,Duloxetine,Blopress,Actos,Ono,BI,BIBW,NSCLC,Fuso,OTS,Biliary,Cancer,Nasal,Granisetron,SNBL,OAB,Takara,Bio,RetroNectin,MSKCC,Emergency,Delivery,Reed,Maurer,JACDS,OTC,Mochida,Switch,Epadel,Risk,Magnesium,Oxide,GE,Healthcare,Terumo,Hospitals,Xarelto,Enoxaparin,Bayer,Nexavar,Capecitabine,Breast,Cancer,Onyx,Xeloda,Elplat,DFS,Colon","No.2152 Contents")

st++; thePage[st]=new Array("2151_aug_10.pdf","pdf/2009_8/","2151 August 10 & 17","Hisamitsu,Daiichi,Sankyo,Effient,Zeria,Tillotts,Erbitux,Stimuvax,Cilengitide,Takeda,Wyeth,Seltouch,CSOs,Merge,Ajinomoto,Risedronate,P&G,Kyorin,Gatifloxacin,Senju,China,MTPC,MP424,Vertex,AnGes,MG,NFkB,Decoy,Oligo,Nesp,Espo,Kyowa,Kirin,Yakult,Patent,Expiration,Campto,Adoair,GSK,sanofi,aventis,NIDEK,Eisai,Eluting,Bead,Biocompatibles,Artificial,Ventilator,Clozaril,Schizophrenia,Novartis,Kowa,Livalo,Onglyza,DPP4,Inhibitor,Miripla,Hepatic,Cancer,Price,Maintenance,System,Nishijima,LDP,DPJ,Generics,Adachi,JPA,Kinoshita,Raw,Materials,Inspections,NDAs,Antidiabetics,FDA,GIO,Teriparatide,NDA,Actos,SU,Shire,Intuniv,Prevenar,Chile,Prescribing,Advice,Lantus,EMEA,OMT,Immunoglobulin,Knockout,Rats,Sawai,JGAJSHP,Premium,Lists,JPMA,ThermoDox,BSI201,mTNBC,Kringle,HGF,ARF,Tarceva,OS,Chemotherapy,Roche,Exenatide,Glucose,Edoxaban,Bleeding,OTC,Tokita,SSP,BRONJ,Bisphosphonates,SMUD,Thalidomide,Diabetes,Osteoporosis,Okazaki,Renal,Failure,Serious,Adverse,Reaction,Visiclear,JSGE,GL","No.2151 Contents")

st++; thePage[st]=new Array("2150_aug_3.pdf","pdf/2009_8/","2150 August 3","Bayer,Schering,Oncology,Rosen,PMS,Kogenate,Chugai,NBI,Spiriva,Recomodulin,Asahi,Kasei,Kyowa,Kirin,Matsuda,Nippon,Chemiphar,Ranbaxy,BMS,Medarex,Astellas,REGiMMUNE,Vaccine,Brazil,BioWa,POTELLIGENT,Merck,ARBs,Sonet,M3,MS,MR,Exam,Wholesalers,Eisai,Switzerland,FDA,NDA,Alogliptin,ACTOS,Sitagliptin,Sibutramine,Exceptional,NHI,Price,Maintenance,System,Nagano,Generics,DPJ,Manifesto,Renal,Anemia,Cancer,Pain,Oral,Jelly,Aricept,TS,Singapore,Label,Erbitux,mCRC,Kras,Mutations,Korosho,QA,Biosimilars,Kure,City,Generics,Image,of,Kinoshita,Hodanren,JLHWO,Rosai,Hospitals,NS,Nippon,Shinyaku,Shionogi,HIV,Integrase,Inhibitor,MediciNova,MN,COPD,Peramivir,Takara,Bio,Gene,Therapy,Mie,NIBIO,Osaka,Annexin,Malfunctions,Fuso,Surgical,Hemostatic,Material,3DM,Toyobo,FADGDH,Blood,Glucose,Regenerative,Philip,Carrigan,Expenditures,Pharmacies,JPA,Isentress,Hanabusa,Tamiflu,Resistant,Fractures,Arimidex,AZ,Cervarix,HPV,WHO,Prequalification,HPB","No.2150 Contents")

st++; thePage[st]=new Array("2149_jul_27.pdf","pdf/2009_7/","2149 July 27","Immunology,Inflammation,MTPC,Nephrology,Generic,Hisamitsu,Acquire,Noven,Peter,Brandt,Merck,Serono,Reproductive,Metabolic,Oncology,Cravit,Rep,Track,Survey,EASD,Lantus,sanofi,aventis,Celgene,Revlimid,Betrixaban,Portola,Bristol,Myers,Kenacort,Elmed,Eisai,Sanwa,Kagaku,Tella,Imax,Ehime,EPS,EDC,NS,ELEX,Acre,Exceptional,Price,Maintenance,System,DPO,Combination,Korosho,NHI,NDA,Sitagliptin,Iressa,Alimta,Maintenance,Therapy,NSCLC,Pediatric,Flomax,Contract,Manufacturers,Counterfeit,Drugs,Restrictions,Cow,Derived,Materials,Canada,PMDA,PhRMA,Market,Expansion,Repricing,Maurer,Crecon,Sarpogrelate,NichiIko,Teikoku,Medix,Global,Research,Centers,Takeda,Everolimus,Pancreatic,NET,Novartis,Gaster,GI,Ulcers,Aspirin,Champix,YAKUGAI,Ombudsperson,Schizophrenia,Association,Kyoto,DPC,Hospitals,Zeria,OTC,Acinon","No.2149 Contents")

st++; thePage[st]=new Array("2147_jul_20.pdf","pdf/2009_7/","2147 July 20","Sprycel,Bristol,Myers,Micombi,Imahori,Astellas,Higher,Dosage,Cravit,Daiichi,Sankyo,JCR,Bio,Matrix,Antibody,Sciele,Merger,Victory,Pharma,Kringle,Pharma,Takara,Bio,Gene,Therapy,Omiya,RetirementMediceo,Paltac,Prasugrel,Effient,Efient,Ube,Industries,Enbrel,JIA,Caduet,Pfizer,Avolve,Prostatic,Hyperplasia,GSK,Prograf,Refractory,Ulcerative,Colitis,Astellas,Mirtazapine,Schering,Plough,Meiji,Seika,N,Remicade,MTPC,Rasilez,Novartis,Gonalef,Infertility,Women,Merck,Serono,Celgene,Revlimid,MM,Liraglutide,Diabetes,Novo,Multaq,Arrhythmia,FDA,sanofi,aventis,Cimzia,EU,RA,UCB,Anplag,Generic,NHI,Price,Listing,Anticancer,Mylan,Indian,Biotech,Biosimilars,JPA,MED,Ryotan,Kisoku,Hitech,Sugio,Seko,Pfizer,Sutent,Metastatic,CRC,ASCO,Matson,Jack,Direct,RCC,Biotechnology,Eisai,Dacogen,AML,CanBas,CBP,NSCLC,Takeda,Pancreatic,Islet,Epadel,Coronary,Epogin,Chemotherapy,Induced,Anemia,CEP,Lantus,NPH,Alnylam,RNAi,NTD,DNDi,OTC,Taisho,Fuji,Keizai,Obesity,Flat,Sum,System,Adoair,COPD,Konishi,Cervical,Cancer,Vaccines,MRs","No.2148 Contents")

st++; thePage[st]=new Array("2147_jul_13.pdf","pdf/2009_7/","2147 July 13","GSK,Oncology,Tykerb,Otsuka,Bayer,Blopress,IMS,Diovan,BAY73-4506,KW-0761,TAK-5361,Astellas,Qutenza,NeurogesX,Takeda,Tender,Offer,IDM,Pharma,Toa,Eiyo,Medet,Alogliptin,Actos,Korosho,Plerixafor,Rasilez,Avolve,Saxagliptin,MAA,Positive,Opinion,Review,PMDA,Sandoz,Growth,Hormone,Biosimilar,Somatropin,JSGM,Free,Pricing,Generics,MEXT,JJ,CorTyzine,Allergy,JSMI,OTC,Kyowa,Kirin,BI,Vitae,BACE,Inhibitors,AD,ASCO,Enbrel,MTX,Joint,Damage,RA,Replagal,Fabry,Disease,Women,DSP,Tasigna,CML,Novartis,Actemra,Remission,Extended,Release,BISifrol,Immediate,NBI,ARB,HCTZ,Micombi,Eli,Lilly,Strattera,ADHD,Breast,Allermist,Nasal,Spray,Allergic,Rhinitis,Janssen,Risperdal,Consta,IM,Injection,ExAblate,Uterine,Myoma,JIMRO,Blood,Cell,Remover,Orphan,ArBlast,Cultured,Corneal,Epithelial,Sheet,CDFS,Insurance,Coverage,IP,Paclitaxel,COPD,Stimulant,Inhaled,Steroid,JSA,Stroke","No.2147 Contents")

st++; thePage[st]=new Array("2146_jul_6.pdf","pdf/2009_7/","2146 July 6","GSK,Oncology,Tykerb,Otsuka,Bayer,Blopress,Ethical,IMS,Diovan,Astellas,Qutenza,NeurogesX,Takeda,Tender,Offer,IDM,Pharma,Toa,Eiyo,Medet,DSP,Alogliptin,Alogliptin,Actos,Korosho,Plerixafor,Rasilez,Avolve,Saxagliptin,MAA,Positive,Opinion,Review,Period,PMDA,Sandoz,Growth,Hormone,Biosimilar,Somatropin,JSGM,Generics,MEXT,Hospitals,J&J,CorTyzine,Nasal,Allergy,JSMI,OTC,Kyowa,Kirin,KW0761,TAK536,BI,Vitae,BACE,Inhibitors,AD,BAY73-4506,ASCO,Enbrel,MTX,Joint,Damage,RA,Replagal,Fabry,Women,Tasigna,CML,Novartis,Actemra,Remission,Extended,Release,BISifrol,NBI,ARB,HCTZ,Micombi,Eli,Lilly,Strattera,AD/HD,Allermist,Rhinitis,Janssen,Risperdal,Consta,IM,Injection,ExAblate,Uterine,Myoma,JIMRO,Blood,Orphan,ArBlast,Corneal,Epithelial,Cell,Sheet,CDFS,Insurance,Coverage,IP,Paclitaxel,COPD,Stimulant,Steroid,JSA,Stroke","No.2146 Contents")

st++; thePage[st]=new Array("2145_jun_29.pdf","pdf/2009_6/","2145 June 29","Glufast,Urief,Z-338,Kissei,Ajisawa,Biosimilars,Eli,Lilly,Anticancer,Injectable,Risperdal,Schizophrenia,Janssen,Matsutani,Zithromac,Rep,Track,Sekiguchi,Baxter,Ethical,Corporate,Citizens,Sanofi,aventis,Diabetes,Apidra,ASKA,Wyeth,Toyobo,Antibody,Takeda,Blopress,Ono,Eisai,Marketing,Subsidiary,Austria,MSs,MR,Certification,Exam,Price,Protection,FPMAJ,Market,Expansion,Long,Listed,Original,Dosage,Treatment,Patentable,DDS,Formulations,API,Patent,Period,Restoration,Yamana,DSUR,Yokohama,ICH,Astellas,Pfizer,Celecox,Medet,Monotherapy,Diabetes,Asahi,Kasei,Planova,BioEX,TopQuark,Asian,JAK,Pfizer,ZERIA,FD,KW-6602,PD,Kyowa,Kirin,Novartis,ASCO,BSI,TNBC,Linagliptin,FPG,ADCs,JACDS,Tadayuki,Teranishi,OTC,PAL,In,House,Minoxidil,OPINION,Philip,Carrigan,Joint,Purchases,Generics,Imaging,Antibacterials,Koyama,Kudo,Nexavarr,HCC,Sorafenib,Tamiflu,New,Type,Flu,Infections,Oshitani,Titration,Renal,HbA1C","No.2145 Contents")

st++; thePage[st]=new Array("2144_jun_22.pdf","pdf/2009_6/","2144 June 22","Teijin,Asia,Generics,Bonalon,TMX64,Wyeth,RA,Biologics,YANO,Research,Mediceo,Paltac,Wholesaler,China,Bessho,Ultmarc,Sanofi,Pasteur,Flu,Vaccine,HSTTC,NIHS,Technology,COSMO,BIO,Taiyo,Kinoshita,MSs,Eguchi,Hansha,Patents,Mylan,NCVC,NHI,Price,Listing,APIs,Chuikyo,Combination,Drugs,High,Dose,Cravit,Health,Minister,Social,Security,Spending,Prograf,MMF,Astellas,Pfizer,Smoking,Allowance,Eli,Lilly,Solanezumab,Tadalafil,PAH,Exercise,Capacity,United,Therapeutics,Treatment,Regimens,ANTCliPh,PK,Acronet,Oncology,Kyushu,Medarex,Ono,Fully,Human,PD,Antibody,Xarelto,VTE,Enoxaparin,Gaster,Peptic,Ulcers,Aspirin,Herceptin,Median,Survival,Stomach,Cancer,Roche,Mediscience,CPOC,Reed,Maurer,RLS,JDS,HbA1C,DPP,Inhibitors,Liraglutide,Exenatide,Voglibose,IGT,Olmesartan,Nephropathy,Anticoagulants,Gibson,Rivaroxaban,Antithrombotic,Thrombotic,Events,Hemorrhagic,Goto","No.2144 Contents")

st++; thePage[st]=new Array("2143_jun_15.pdf","pdf/2009_6/","2143 June 15","Asahi,Kasei,Meiji,ME3301,Amalyte,JCR,EPO,Biosimilar,GSK,Pola,Topical,JPMA,Seikagaku,Zimmer,Gel200,Botox,Wakamoto,Bayer,Genzyme,Quintiles,Tsumura,Kampo,Takeda,OTC,GI,Price,Cut,Exemption,Innovative,Chuikyo,ARBs,Unapproved,Yamamoto,Dunoyer,FJPWA,Bessho,Isobe,FPMAJ,Cost,Calculation,Method,Nakagaki,Sandoz,Somatropin,Caduet,Ca,Blocker,Statin,Aliskiren,Mirtazapine,Bimatoprost,MAA,Alogliptin,NAD,AuAA21004,AstraZeneca,Anticancer,Merck,Serono,Erbitux,Gastric,Cancer,Solasia,CTA,SP01,China,Lurasidone,DSP,Schering,Riociguat,PAH,QAB149,COPD,Novartis,Hokunalin,Tape,Abbott,Maruho,Kaletra,Raltegravir,Viral,Load,Actemra,Joint,Structural,Damage,RA,Chugai,Vero,Cell,derived,Japanese,Encephalitis,Vaccine,Philip,Carrigan,JMA,Tamiflu,Relenza,Kyokaikenpo,Generics,Sanko,Junyaku,NANOPIA,KL6,Eisai,Wako,Pure,Chemical,TASWako,i30,Hepatocellular,Yamasa,Dako,Flow,Cytometry,Antibodies","No.2143 Contents")

st++; thePage[st]=new Array("2142_jun_8.pdf","pdf/2009_6/","2142 June 8","NBI,Heil,Micombi,Spiriva,Dabigatran,Takeda,Hib,Vaccine,Novartis,Daiichi,Sankyo,CoDIO,Ecard,Yoshiki,Bessho,Suzuken,FJPWA,President,CMIC,CRO,Normosang,PHT,ePRO,EPS,Hong,Kong,NanoCarrier,Nucleic,Acid,Technology,Todai,Sanofi,aventis,MABs,Takara,Bio,PhRMA,Brennan,Chuikyo,Price,Gaps,Generics,Endo,Ryukaikon,Distribution,Settlement,Rates,Hospitals,Wholesalers,Matsutani,Negi,Koyama,Otsuka,Hyponatremia,HCC,Nexavar,Cimzia,UCB,Metformin,First,Line,Therapy,Controlled,Release,Carmustine,Orphan,Drug,Sawai,Towa,Rosai,Yamagata,NichiIko,Venture,Mitani,Sangyo,Raw,Materials,Korosho,Ryotan,kisoku,JSHP,Rohto,Yoshino,Taisho,RiUP,Hair,Stimulator,Switch,OTC,Vidarabine,Online,Sale,Kenko,com,Wellnet,Medical,System,Reform,Lurasidone,DSP,GLP,DPP,Japanese,Bayer,VEGF,TrapEye,Atul,Sobti,CEO,Ranbaxy,Sleep,Disorders,GYN,RLS,Essential,Fax,Anti,viral,New,Type,Flu,Virus,Infections,Blood,Tamiflu,Internet","No.2142 Contents")

st++; thePage[st]=new Array("2141_jun_1.pdf","pdf/2009_6/","2141 June 1","Reform,Structure,Kumakura,Operating,Profit,Wholesalers,Suzuken,Pharmacy,Chains,Ota,Toho,Obtain,Invoice,Prices,Matsutani,Allowance,Rebate,Omwell,Subsidiary,Overseas,Taisho,Addition,Biofermin,Kyorin,Kipres,Pentasa,Kaken,KP103,Inui,Mochida,Epadel,Atelec,Kissei,Urief,Glufast,KPS0373,Spino,Cerebellar,Nippon,Shinyaku,Eviprostat,Urology,Hematology,Otsuka,Zeria,ASKA,Seikagaku,Artz,Nippon,Chemiphar,Wakamoto,Teijin,HHC,Meiji,Asahi,Kasei,Famvir,Yakult,Honsha,Elplat,SymBio,Bendamustine,Eisai,Korea,Singapore,Flu,Infections,Takeda,Ireland,Sanofi,Pasteur,Plant,GTC,ATryn,Lundbeck,Combination,Injury,SSRIs,SNRI,Alimta,NSCLC,Eli,Lilly,Promac,SK,Chemical,Amitiza,CIC,Sucampo,Abbott,UMN,UMN0501,BI,Sifrol,RLS,Pfizer,DPC,Hospitals,Hiroyuki,Sawai,JGA,President,Quintiles,CRO,InHouse,Sanjou,Pharmacies,JPA,Iressa,Fertilized,Human,Embryos,Champix,JSMI,OTC,Gargles,Masks","No.2141 Contents")

st++; thePage[st]=new Array("2140_may_25.pdf","pdf/2009_5/","2140 May 25","Novartis,Everolimus,Epstein,ASA404,Takeda,TAK,491,Chlorthalidone,Astellas,YM150,Daiichi,Sankyo,Ranbaxy,Acquisition,Cravit,ARB,Ca,Blocker,Diuretic,Shoda,Eisai,NDA,Filing,MORAb003,Aricept,DSP,Amlodin,Lurasidone,Amlodipine,Irbesartan,MTPC,Remicade,Talion,Medway,Argatroban,Europe,Shionogi,Crestor,Ono,Patch,AD,Santen,IDM,Pain,Kyowa,Kirin,Licenses,Anti,LIGHT,Antibody,sanofi,aventis,IMS,Health,Mediceo,Paltac,Retirement,Alfresa,Ishiguro,Teijin,TMX67,Taiwan,Teikoku,Seiyaku,DDS,AZ,Nesp,Injection,Plastic,Syringe,Sawai,ACTOplus,met,XR,Liraglutide,Novo,Nordisk,Iressa,Positive,Opinion,NSCLC,CHMP,JCR,Rheumatology,Tanaka,Blood,IL6,Tocilizumab,Nishimoto,Humira,ADR,Infliximab,Etanercept,JCR,MTX,Public,Comments,Transient,Marketing,System,JPA,CS,Yakuhin,OTC,Drugs,Wholesale,Tomita","No.2140 Contents")

st++; thePage[st]=new Array("2139_may_18.pdf","pdf/2009_5/","2139 May 18","BI,Barner,Cancer,Diabetes,DPP4,Inhibitor,NSCLC,Dabigatran,Stroke,AF,Spiriva,Micardis,Flomax,Sifrol,Michihiro,Tsuchiya,MTPC,Hayama,Kunio,Takeda,Bipha,Kyowa,Kirin,Teijin,Home,Healthcare,Torii,Stronger,Neo,Minophagen,Price,Settlement,Rate,Alfresa,SGA,Cost,Ratio,IMS,Emerging,Markets,Chugai,Portugal,Eisai,Aricept,Pfizer,Caduet,CDFS,GSK,Dutasteride,Nexabar,Valixa,Alimta,UCB,Japan,Pediatric,Zyrtec,Dry,Syrup,Janssen,Long,acting,Parenteral,Risperidone,Eli,Lilly,Teriparatide,Osteoporosis,epileptic,Zebinix,Eisai,FDA,ONGLYZA,Patent,Kinoshita,Generics,Nichiiko,JPMA,Unapproved,Drugs,Multinational,Trials,Sato,JPharma,Hyperphosphatemia,AnGes,Peptide,Morishita,Jintan,Bayer,Ardea,Biosciences,MEK,Avastin,Early,stage,Colon,Roche,Basen,Lancet,Reed,Maurer,APIs,Switch,OTC,Novartis,Voltaren,Taisho,Topical,OTC,NSAIDs,Diclotect,Mochida,Epadel,Online,Applied,Therapeutics,Society,JUA,Annual,Meeting,Asian,Suitable,Iwasaki,PSA,Test,Gemzar,Urothelial,Sunitinib,Precautions,TKIs,Application,NCCN,Hospitals,Prescriptions,Yakkasa","No.2139 Contents")

st++; thePage[st]=new Array("2138_may_4.pdf","pdf/2009_5/","2138 May 4 & 11","Sanofi,aventis,Chocat,Apidra,Rapid,Acting,Insulin,Analogue,Medley,Brazil,Shionogi,Sugar,Chain,Analysis,Molecular,Imaging,Kyowa,Kirin,POTELLIGENT,GSK,Respiratory,Adoair,Toyota,Tsusho,ChemRoutes,Hyperlipidemia,Fuji,Keizai,Nippon,Kayaku,Tykerb,Pfizer,HIV,Specialist,Stiefel,Tsumura,Yubari,Quintiles,EDC,Female,MRs,Obstetricians,Astellas,Novartis,PhRMA,NHI,Price,Maintenance,System,Sekiguchi,Korosho,Anticancer,Pediatric,Supplementary,Budget,Collaborative,Multinational,Trials,Nakagaki,NBI,Telmisartan,HCT,Eli,Lilly,AD,HD,Strattera,Allermist,Nasal,Spray,Clozaril,Resistant,Schizophrenia,Cravit,Recurrent,Ovarian,Cancer,Doxil,DPC,Payment,Everolimus,Fast,Track,Takeda,NEDO,Large,Scale,Clinical,Trial,AD,Bone,Fractures,TZD,Earmark,Banyu,MK0683,Takara,Bio,Gene,Therapy,Leukemia,TAK379,SCH530348,Schering,Plough,Plavix,Aspirin,Stroke,hsCRP,y,Crestor,JUPITER,Generics,JSHP,Patient,Education,Clearer,Criteria,Patent,Period,Restoration,SSP,Switch,OTC,Version,Diclofenac,Magnesium,Oxide,Taisho,Tiquizium,Bromide,Philip,Carrigan,Bonoteo,Severe,Osteoporosis,Steroids,Overcome,Anxieties,Opinion","No.2138 Contents")

st++; thePage[st]=new Array("2137_apr_27.pdf","pdf/2009_4/","2137 April 27","AC-3933,Janssen,Sekiguchi,Overstijns,Shire,Orphan,Santen,Tapros,Merck,Otsuka,Oncology,CNS,Asahi,Kasei,Flivas,DongA,China,Hiring,Graduates,Bayer,Mylan,Copromote,Renivace,Lipovas,Banyu,Toyama,Roche,T-5224,Sanofi,aventis,BiPar,Sciences,Mediscience,HCRC,Hawaii,Astellas,Fermentation,Building,Substance,Patent,AnGes,MG,NFkB,Decoy,Oligo,MTPC,Executives,Compensation,Medway,Wakunaga,Court,Quinolone,DSP,Seiwa,Sangyo,PMDA,Review,Anticancer,Generics,DPC,Hospitals,Peginterferon,Combination,Hepatitis,Schering,Plough,FDA,Advisory,Liraglutide,Biomarker,Oxaliplatin,Tanigawara,CoreMed,Dementia,CROee,JPMA,Unapproved,Reed,Maurer,EMTs,Epipen,Korosho,Taiyo,Kasukabe,Plant,Generics,Online,Sales,OTC,Nippon,Kayaku,Vascular,Embolization,BioSphere,Medical,Sepacell,MBL,Gene,Function,Analysis,Kit,Health,Insurance,Societies,Yokohama,Clinic,Cancer,Therapy,Dendritic,Cells","No.2137 Contents")

st++; thePage[st]=new Array("2136_apr_20.pdf","pdf/2009_4/","2136 April 20","KYORIN,Kissei,Urief,Daiichi,Sankyo,Eli,Lilly,Prasugrel,Cialis,Nippon,Shinyaku,Otsuka,BMS,Abilify,Plavix,Pfizer,Macrolides,Zithromac,Hisamitsu,HFT-290,Merck,Serono,Gonalef,Subcutaneous,Injection,Pen,SymBio,Bendamustine,Cephalon,China,BioWa,POTELLIGENT,sanofi,aventis,Eisai,E7389,Shiro,Kondo,Teijin,Febuxostat,Medway,Data,Falsification,OHARA,NichiIko,Taiyo,Cravit,Laboratorios,Kendrick,Mexico,Nihon,Chouzai,Shiga,CDFS,Ca,Blocker,ARB,Combination,Unapproved,Medical,Expenses,Nakagawa,Wyeth,BLA,Prevnar,JPDSC,PGx,Sutent,Advanced,Breast,BI,Pradaxa,Nobilon,Intranasal,Influenza,Vaccine,Seattle,Genetics,Millennium,ADCs,Takara,Bio,RetroNectin,Cell,Immunotherapy,Erbitux,FOLFIRI,mCRC,NAE,Inhibitor,Asahi,Kasei,Evaheart,Gliadel,Wafer,Nobelpharma,Agilent,SurePrint,G3,Microarray,Olympus,Biliary,Stent,Medinol,GE,Intel,Ally,Kyoto,AMDD,Wang,Alpha,MOS,Kowa,Apo,Plus,Station,OTC,Online,Sale,Lifestyle,Diabetes,DIANA,KRAS,Gene,Test,Medical,Bills,Zyprexa,MINIREN,MTPC,Sonet,M3","No.2136 Contents")

st++; thePage[st]=new Array("2135_apr_13.pdf","pdf/2009_4/","2135 April 13","Bayer,iPS,Cells,Genzyme,Agreement,Takeda,Canada,Europe,Chugai,Genentech,Roche,MediciNova,MN-166,MS,Taiho,Yondelis,PharmaMar,Eisai,Urief,Kissei,ASEAN,India,Mochida,Co-DIO,Ecard,Rep,Track,Survey,Toray,JT,Torii,Remitch,Hemodialysis,Patients,Fosrenol,Hyperphosphatemia,MTPC,Dementia,EnVivo,Tella,Cancer,Antigen,Nitten,AzaSite,InSite,Vision,Quintiles,CAP-Accredited,Central,Lab,Network,Ranbaxy,Olmesartan,Actavis,ASKA,NHI,Price,Listing,Generics,Cravit,Isobe,Amlodipine,Hansha,Mylan,Seiyaku,Society,Applied,Therapeutics,Daiichi,Sankyo,DU-176b,Oral,Anti-Xa,Agent,Prasugrel,Biologics,InCROMy,MHRA,Enrollment,PREDICTIVE,Levemir,Novo,Nordisk,Medinet,Malignant,Glioma,FDA,Advisory,Committee,ONGLYZA,Celgene,NDA,Lenalidomide,Takeda,Combination,Blopress,Amlodipine,Takepron,Prevent,Aspirin,Ulcers,Alexion,Eculizumab,Problems,Data,Everolimus,Online,Sale,Drugs,Taisho,Switch,OTC,Diclofenac,OTC,Version,Voltaren,Novartis,JKMA,English,Terminology,Kampo,Medicines,Prices,of,Medical,Devices,Japan,Abroad,Medtronic,Japan,Endeavor,Coronary,Stent,System,FUJIREBIO,ESPLINE,HIV,Ag,Ab,for,Quick,HIV,Detection,JCS,Japanese,Circulation,Society,Ethnic,Factors,Lucentise,Mainstay,AMD,Optimal,Antiviral,Prevent,Liver,Cancer,Izumi,Synergistic,Adoair,UFT,CMF,Postoperative,Breast,Supportive,Care,Perspectives,SCP,Synix","No.2135 Contents")

st++; thePage[st]=new Array("2134_apr_6.pdf","pdf/2009_4/","2134 April 6","Millennium,Takeda,Oncology,Dunsire,Vectibix,Meiji,Seika,Schizophrenia,ACADIA,Eli,Lilly,Matsutani,FJPWA,President,Pfizer,Zithromac,SR,Dry,Syrup,Otsuka,Abilify,Oral,Solution,Bristol,Myers,Sprycel,CML,ALL,Marketing,Right,Prostap,Wyeth,UK,Alfresa,Forecasts,Downward,Growth,Generics,Price,Rule,Promote,Korosho,Substitution,Rate,NHI,Patent,Dispensing,DPC,Daiichi,Sankyo,Levofloxacin,Violation,Amlodipine,Sugio,Seko,Falsification,Data,Recombinant,Human,Albumin,Coadministration,Actos,Insulin,FDA,Advisory,Committee,Rivaroxaban,LDP,Bendamustine,SymBio,Herceptin,Roche,Arimidex,Postoperative,Breast,Cancer,AZ,Oncolys,BioPharma,Telomelysin,Okayama,JSMO,Lenalidomide,NSCLC,Iressa,Velcade,Palonosetron,CINV,Aggregates,Kenacort,EPPV,Sutent,Hypotensive,CoDIO,Ogihara,Selective,Inhibitors,MS,Dysuria,Horie,AD/HD,Tanaka,JSHP,Exposure,Anticancer,Financial,Burden,MOF,CKD,Healthclick,CareNet,JSMO,KRAS,Gene,UGT1A1,Polymorphism,Sekisui","No.2134 Contents")

st++; thePage[st]=new Array("2133_mar_30.pdf","pdf/2009_3/","2133 March 30","RDKK,Anticancer,Colon,Cancer,Takara,Bio,LA,PCR,Biotools,Spain,Tanaka,Kikinzoku,Flu,Virus,Detection,Reagent,Gold,Asubio,Pharma,NBI,Tokyo,CRO,Seoul,Price,Maintenance,Chuikyo,Kawabe,JPMA,Isobe,FPMAJ,Nagano,Unapproved,Adjust,GSK,MAA,Pazopanib,RCC,Toyama,Eisai,to,Withdraw,T-614,Dispensing,Generics,Urushibata,Takata,NCCHD,Reed,Maurer,Amlodipine,Sugio,Seko,Astellas,Shionogi,Academia,Molecular,Imaging,Center,Osaka,Univ,Physicians,Takara,Bio,RetroNectin,JAPhMed,LDP,Diet,Members,Safety,Online,Sale,Ishii,JPA,Mikitani,Schizophrenia,Recovery,Fixed,Dose,Adherence,AntiAging,Botox,Stomach","No.2133 Contents")

st++; thePage[st]=new Array("2132_mar_23.pdf","pdf/2009_3/","2132 March 23","Covance,Barr,TPNA,Febuxostat,Janssen,Ono,Xention,Gilead,Sciences,CVT,Astellas,Novartis,DSP,Trerief,Parkinson,Seikagaku,Roche,Genentech,Forest,Holdings,JCROA,Wholesalers,Biosimilars,JGA,Generics,JSGM,Tsushima,NHI,Price,Maintenance,System,Canada,Originated,Cow,Nesp,Clevudine,Hepatitis,Philippines,Eisai,Botox,Talipes,Equinus,Children,Cerebral,Palsy,JPMA,PhRMA,EFPIA,Sekiguchi,SymBio,Bendamustine,Pfizer,Stops,PIII,Sutent,Early,Solasia,Toray,Taiho,OAB,Zonisamide,Neuroprotective,LDP,Diet,Members,Online,JODA,Counterfeit,Drugs,Tokashiki,Medwatcher,Japan,Deaths,Evaheart,EIKEN,Carrigan,Chemotherapy,Asthma,Steroids,Rx,DPC,Hospitals","No.2132 Contents")

st++; thePage[st]=new Array("2131_mar_16.pdf","pdf/2009_3/","2131 March 16","NTC8011,Wyeth,Pfizer,Iwasaki,Nippon,Shinyaku,Prulifloxacin,Lee's,China,Teijin,Nissan,Chemical,BMS,Bristol,Myers,Sprycel,Tasigna,IMS,Antineoplastics,Astellas,CVT,Olmetec,RepTrack,Hospital,Bausch,Lomb,Ophthalmic,Aurobindo,Generics,Sanofi,aventis,Czech,QOL,FDA,Alogliptin,Takeda,Clozaril,Micombi,Teva,Glatiramer,Orphan,Toda,Counterfeit,Shasun,Tokyo,Guidance,Biosimilars,Chuikyo,Lists,Unapproved,Ethnic,Japan,South,Korea,Cancer,Peptide,Vaccine,Applied,Endpoints,Allergic,Rhinitis,MLN8237,Collategene,AnGes,MG,Zeria,EMEA,Z338,ASP8825,XP13512,ASP2314,ACR16,JCROA,LDP,ActHIB,OrthoK,Endeavor,Coronary,Stent,Terumos,Artificial,Heart,Takara,Bio,Reagent,Human,iPS,Cells,Yamada,Rohto,OTC,JODA,Hypertension,GL,JHF","No.2131 Contents")

st++; thePage[st]=new Array("2130_mar_9.pdf","pdf/2009_3/","2130 March 9","Eisai,Adhesive,Aricept,Teikoku,Seiyaku,Daiichi,Sankyo,Teva,Kowa,Shire,Abbott,Amitiza,Kyorin,Uritos,Saudi,Arabian,Takeda,KAPIDEX,Maruho,Astat,Tsumura,Shionogi,Sugar,Chain,Analysis,Contract,Bristol,Myers,Recalls,Kenacort,Tap,Water,APIs,Lucentis,Xolair,Cell,Cultured,Vaccine,Japanese,Encephalitis,BIKEN,Prasugrel,GSK,Tykerb,ARB,Diuretic,Data,Ranbaxy,FDA,Amlodipine,Pfizer,EDC,Astellas,PMDA,Multinational,Nippon,Kayaku,Hycamtin,Sanofi,Pasteur,Difficile,Sandostatin,LAR,NETs,Novartis,Zometa,RDKK,Lag,ACCJ,Deliberating,Online,Sale,OTC,JODA,Korosho,Public,Comments,Goto,Wholesaler,FJPWA,NCVC,Generics,Sanjou,Hospital,Inhouse,Prescriptions,Reappointment,Maeda,Chuikyo,Masuzoe,Tasigna,Ohyashiki,Chugai,Avastin,Stomach,Constipation,Hongo","No.2130 Contents")

st++; thePage[st]=new Array("2129_mar_2.pdf","pdf/2009_3/","2129 March 2","Sanofi,aventis,Diabetes,Eisai,Zebinix,Epilepsy,Bial,Portela,Chugai,Nitazoxanide,Romark,Lurasidone,US,DSP,GSK,Nippon,Kayaku,Lapatinib,Shoda,Crisis,Shionogi,Itochu,Chemical,Frontier,Flomox,Patent,MTPC,PharmaDesign,PharmaAccess,CMIC,SMO,SSI,Sonet,M3,CareNet,HEREON,IFPMA,Pfizer,Korosho,RePricing,JPA,JMA,Invoice,Prices,PMDA,NICE,Sutent,First,Line,mRCC,Flu,Pandemic,Relenza,Bayer,Yakuhin,Wellnara,Postmenopausal,Osteoporosis,MD,Velneperit,Takeda,TAK242,Sepsis,Schering,Riociguat,Allovectin,AnGes,MG,National,Cancer,Center,Generics,Website,JGA,Reed,Maurer,CO2,FPMAJ,Online,Sale,LDP,Lawmakers,OTC,GL,Influenza,Tamiflu,Resistant,Tamiflu,Abnormal,Behavior,HPV,Vaccination,Training,CKD,Asahi,Kasei,TechniKrom,RDKK,KRAS,Gene,Mutation,Test,Kit","No.2129 Contents")

st++; thePage[st]=new Array("2128_feb_23.pdf","pdf/2009_2/","2128 February 23","Novartis,Multinational,Clinical,Oncology,Drug,Lag,Sekiguchi,Astellas,MTPC,Meiji,Seika,Antibody,Infectious,Meiact,Depromel,Olmetec,Rep,Track,Adoair,GSK,Eisai,LIVACT,Ajinomoto,Asia,Relenza,Clio,Science,Shanghai,UPSHE,Yakugaku,FALCO,Shimeno,Yakkyoku,Nippon,Shinyaku,Zeria,ASKA,JT,Torii,Rohto,Taiyo,Sawai,Towa,Investments,FDA,Gout,Teijin,Takeda,PMDA,Chugai,Cancer,Anemia,Epogin,UCB,Cimzia,BLA,PFSB,Orphan,Bayer,Schering,iPS,Cell,iZumi,Bio,Motesanib,Squamous,Carcinoma,Oncolys,Festinavir,Takeda,XOMA,Otsuka,Erbitux,KRAS,Wild,Merck,Serono,Pharmacists,JPA,Salespersons,SSP,HythiolC,Direct,Switch,OTC,JODA,Online,Sale,JACDS,Rakuten,Mikitani,Philip,Carrigan,Device,Deposit,Teijin,Homecare,Spain,Suzuken,Medifacts,QT,Interval,SMU,IBL,Diagnosis,GVHD,Asahi,Kasei,Planova,Teva,Kowa,Recalls,Generic,Fosfomycin,JSHP","No.2128 Contents")

st++; thePage[st]=new Array("2127_feb_16.pdf","pdf/2009_2/","2127 February 16","Eli,Lilly,Chugai,Anticancer,Oncology,Price,Settlement,Rate,Wholesalers,Shionogi,Vaccines,OTS,GSK,Kaketsuken,Pandemic,Urief,AnGes,MG,HGF,Daiichi,Sankyo,GenomIdea,HVJ,Envelope,TSD,Denroku,Ishiguro,Alfresa,Ono,Santen,Kyorin,Kipres,Pentasa,Kaken,Artz,Mochida,Atelec,Kissei,Fuso,Lixelle,Torii,Minophagen,Seikagaku,Tsumura,Nippon,Chemiphar,Wakamoto,Asahi,Kasei,Famvir,Yakult,Elplat,Mediceo,Paltac,Suzuken,Toho,Fuji,Biomedix,Reed,Maurer,AMD,Novartis,RLS,Takeda,Lansoprazole,Successor,FDA,Prasugrel,Astellas,Controlled,Release,Tacrolimus,Strattera,AD,HD,Biosimilars,PMDA,PE,Post,Marketing,Safety,Insurance,Coverage,KRAS,Gene,Mutation,Tests,NPhA,DPP4,Inhibitor,Actos,Pfizer,Axitinib,Advanced,Pancreatic,Oncolys,Festinavir,HIV,Infection,Pancreatic,Ordinance,Online,Sale,OTC,Paltac,BD,Uterocervical,Cytodiagnosis,Baxter,Bone,Marrow,Collection,Kit,Medtronic,Attain,CRT,Arkray,Desktop,Automatic,SNPs,Hp,JSHR,Eradication,Hokkaido,Sanofi,aventis,Bungyo,JSHP,JPA","No.2127 Contents")

st++; thePage[st]=new Array("2126_feb_16.pdf","pdf/2009_2/","2126 February 9","OTS102,Taisho,Toyama,infection,Pfizer,Biopharma,Jeff,Kindler,OTC,Wyeth,Datamonitor,Astellas,CV,Therapeutics,Rejection,Proposal,aRigen,Peptic,Ulcer,Taiho,Novartis,Lucentis,Alcon,GSK,Adoair,COPD,Takeda,Daiichi,Sankyo,Ranbaxy,Eisai,MTPC,Remicade,Dainippon,Sumitomo,Shionogi,Sciele,Taisho,Teijin,Bonalon,Alvesco,Kyowa,Hakko,Kirin,Kringle,Maruho,Relenza,JPMA,Tax,NHI,Health,Insurance,Generics,Lansoprazole,Carbapenem,Everolimus,RCC,Patent,Expiration,Blockbuster,Keiji,Nakamura,Antibacterials,Pancreatic,Cancer,ChronSeal,Sweden,DPC,Muto,PICCs,Complications,BioAccess,Baxter,Bone,Marrow,Collection,Kit,Evaheart,Fancy,Color,Contact,Lenses,Mochida,Epadel,LDP,Diet,Online,Sale,Restrict,Masuzoe,Coolingoff,Haichiyaku,GL,Colon,Bevacizumab,Cetuximab,Risperidone,Olanzapine,Quetiapine,Diabetes,AERS,DB,ADRs,Tamiflu,Resistant,Strains,Abnormal,Behavior,smoking,COPD,Primary,Care,Pollinosis,NBI","No.2126 Contents")

st++; thePage[st]=new Array("2125_feb_2.pdf","pdf/2009_2/","2125 February 2","Takeda,Hasegawa,Millennium,Vedolizumab,Pfizer,Celsentri,CCR,HIV,Infection,Schering,Plough,Ganirest,Premature,LH,Acquire,Wyeth,Obama,Astellas,CV,Therapeutics,Financial,Crisis,BCG,Hisamitsu,Fosamac,Banyu,Wholesalers,Kimura,Minakem,Contract,FALCO,Biosystems,Pharmacies,Lantus,Insulin,sanofi,aventis,JMHA,MRkun,QOLkun,Sonet,M3,Paltac,Alfresa,Novartis,ARB,Diuretic,Unapproved,API,SAE,Kinoshita,Biomarkers,Molecular,Minodronic,Acid,Ono,DSP,Trerief,Parkinson,GSK,Botox,Vista,Bristol,Myers,sprycel,Remitch,Pruritus,Hemodialysis,Zithromac,RoACTEMRA,RA,Chugai,Roche,Cows,Daiichi,Sankyo,Flu,Bayer,Micromet,Solid,Tumor,Antibody,JHSF,Kitasato,Yamanaka,iPS,Cell,JGA,Generics,Takenaka,Oncolys,Sysmex,Diagnostic,FUJIFILM,Given,Imaging,PillCam,SB,Endoscope,JIRA,Digital,XRay,Imaging,Fee,Korosho,Kit,Bone,Marrow,Grafting,Online,Sales,OTC,JMC,JACDS,JPA,Yakkasa,Bungyo,Mortality","No.2125 Contents")

st++; thePage[st]=new Array("2124_jan_26.pdf","pdf/2009_1/","2124 January 26","Ranbaxy,Daiichi,Sankyo,Olmesartan,India,NDA,Prasugrel,FDA,Singh,Taisho,GSK,Xenical,Korosho,Pricing,System,Kinoshita,Generics,Diovan,RepTrack,Survey,Mochida,Lialda,Shire,Torii,Serotone,Stefan,Ziegler,TPAsia,JPMA,NichiIko,Tamura,JGA,Cravit,NHI,Yokohama,Hospital,Febuxostat,Anti,HIV,Novoseven,Unapproved,JPO,Patent,DDS,Formulations,Nulotan,Doxil,Kyowa,Kirin,KW6002,Novartis,Everolimus,Stomach,Cancer,POC,Biosimilars,Ihoken,BDNF,Hormones,NCNP,NIN,MediciNova,MN221,GSK,Kaketsuken,UMN,Immunogenicity,UMN0501,Pandemic,Flu,Vaccine,Reed,Maurer,Jansen,Intelence,Infection,Sato,Diagnostic,Malfunctions,Kaken,Seprafilm,Endometrial,Ablation,Microwaves,Kobayashi,Obesity,Iwaki,Chuo,Bussan,JSMI,Online,Sales,Hypertension,GL,ARBs,Peritoneal,Dialysis,JSDT,Tamiflu,Resistant,Viruses,fee,Thalidomide,Diabetes","No.2124 Contents")

st++; thePage[st]=new Array("2123_jan_19.pdf","pdf/2009_1/","2123 January 19","JPMA,NHI,Drug,Pricing,System,Reform,Shoda,Bayer,Schering,PET,Tracers,Hamamatsu,Photonics,Meiji,Seika,CMIC,Human,Hemin,Micellar,Anticancer,Nippon,Kayaku,Merger,Mediceo,Paltac,Alfresa,FTC,Hamada,Toho,Takeda,Toho,Omwell,ASUCOME,Matsutani,Zensharen,Hospitals,JPA,Niigata,Iwai,OPIR,Suit,Abbott,Humira,Patent,Daiichi,Sankyo,Subsidiary,Puerto,Rico,UPS,Merck,Sanjou,General,InHouse,Prescriptions,Vaccine,Administration,Silodosin,China,Seibule,Insulin,SKK,FDA,Cimzia,UCB,Eli,Lilly,Complete,Response,Letter,Olanzapine,LAI,Eculizumab,Orphan,SymBio,PI,Bendamustine,Exjade,Iron,Overload,Novartis,Zometa,Breast,Tumors,Femara,Tamoxifen,Fulvestrant,AZ,GenomIdea,GEN,TSD,JTEC,Jace,MHIR,RNA,Structures,Korosho,NCVC,Evaheart,Investigation,Committee,Artificial,Joints,Sato,Thyrogen,Thyroid,Cancer,Diagnosis,OTC,Cream,Vaginal,Candidiasis,Amended,PAL,Philip,Carrigan,Biologics,RA,DRG,PPS,Tamiflu,Medwatcher","No.2123 Contents")

st++; thePage[st]=new Array("2122_jan_12.pdf","pdf/2009_1/","2122 January 12","FPMAJ,President,Takenaka,Aricept,Domestic,Drugs,Ranking,Olmetec,ARBs,Daiichi,Sankyo,Loss,Indirect,MRs,Novo,Nordisk,Kyowa,Kirin,Transfer,NeuUp,AML,MediciNova,Avigen,MN166,MTPC,API,MCC,Chosei,Yakuhin,Generics,Novartis,Mochida,Copromotion,Diovan,Kringle,Subsidiary,Stockholm,Hokuyaku,Takeyama,Manabe,Prasugrel,Omalizumab,Maraviroc,Nalfurafine,Korosho,Budget,METI,Regenerative,Medicine,Pfizer,Anti,HIV,Celsentri,Nateglinide,Combination,TZD,Combination,Actos,Biguanides,GSK,Levocetirizine,Wyeth,MAA,13Valent,Vaccine,EU,Takeda,Alogliptin,NDA,Intanza,IDflu,Sanofi,Pasteur,Baxter,EMEA,CELVAPAN,Nexavar,JSGO,HPV,ATL962,Obesity,Alizyme,Kitasato,Institute,PSJ,Symposium,Ohkawa,Vesicare,Astellas,Meiji,Seika,Carbapenem,Tetrabenazine,Huntington,Chorea,Losartan,Uric,Acid,Glivec,Ranbaxy,Agilent,Technologies,RDKK,Titanium,Reagent,Kits,Genome,Sequencer,FLX,GEYMS,Signa,MRI,Acquisition,Ventana,NCVC,Death,Implantation,LVAS,Online,Sales,Medwatcher,Rakuten,Ain,Seven,Hib,Prevenar,Pediatric,Bacterial,Meningitis,Asthma,Omalizumab","No.2122 Contents")

st++; thePage[st]=new Array("2121_dec_29.pdf","pdf/2008_12/","2121 December 29","Reed,Maurer,EVEC,Antibodies,Yakult,ThermoDox,Celsion,Diovan,Rep,Track,JMHA,Hypertension,JPMA,Unapproved,Korosho,JHIA,Global,Sales,Generics,Dissolution,Original,UDCA,NIHS,Prasugrel,Positive,Opinion,CHMP,FDA,Eisai,Sedative,Hypnotic,LUSEDRA,Injection,CDFS,Committee,LEEM,PMDA,OTC,NHI,Price,List,Pegasys,Copegus,Roche,Test,EGFR,Bungyo,GSK,Pazopanib,Sunitinib,RCC,Eldecalcitol,Vertebral,Fractures,Chugai,Taisho,JSCPT,Symposium,Adaptive,Design,Clinical,Trials,Ohashi,Assumption,Ethnic,Differences,Novartis,Everolimus,Breast,Cancer,OTS,Pancreatic,Baxter,rVWF,CMIC,Normosang,Acute,Porphyria,Aromasin,DFS,Event,Risk,Tamoxifen,Pfizer,Lapatinib,Letrozole,PFS,ErbB,Metastatic,Etanercept,MTX,Joint,Destruction,RA,JPhA,Etizolam,Loxoprofen,Ciclosporin,Steroids,Igarashi,Infliximab,Tanaka,Tokai,Univ,Therapy,Pirespa,IPF,JPA,Online,Sales,Ishii,Victims,ADRs,DPJ,Devices","No.2121 Contents")

st++; thePage[st]=new Array("2120_dec_22.pdf","pdf/2008_12/","2120 December 22","Galderma,Dermatology,Differin,Acne,Kawashima,Astellas,GSK,CNS,Lamictal,Teijin,TMX67,AZ,BMS,Dapagliflozin,BioWa,POTELLIGENT,DSP,Chinese,Business,Suzhou,Cytotoxic,Emerging,Countries,Mitsubishi,Chemical,Medience,SMO,Neues,Quintiles,Targeted,Molecular,Diagnostics,Takeda,ACTOS,Patent,Litigation,NichiIko,Breast,Cancer,Daiichi,Sankyo,Olmesartan,Ca,Blocker,Combination,DB,Aspirin,Arteriosclerotic,FDA,Advisory,Committee,Dronedarone,Cervarix,Dutch,NIP,Package,Inserts,DU176b,CanBas,CBP501,Malignant,Pleural,Mesothelioma,Multinational,Clinical,Okayama,REIC,ICH,GL,ZD4054,OS,Metastatic,HRPC,SD118,Sosei,AnGes,MG,Hybrid,Decoy,Gene,Design,Erbitux,Merck,Avastin,PFS,Chugai,PrePandemic,Vaccines,Online,Sales,Crestor,CV,Risk,High,Sensitive,CRP,Levels,JUPITER,Postprandial,Hyperglycemia,Tajima,GLP1,Analogues,DPP4,Inhibitors,Kobayashi,HbA1c,Relenza,Tamiflu,Matsumoto,Janssen,AD/HD,HPV,Fertility,Preservation,Urination,Kuroda,Cerebral,Hemorrhage,Oxytocin,YAKUGAI,Ombudsperson,DPC,ED,Levitra,Bayer,Schering","No.2120 Contents")

st++; thePage[st]=new Array("2119_dec_15.pdf","pdf/2008_12/","2119 December 15","Pfizer,Iwasaki,Chugai,Chiome,Monoclonal,Antibody,Nippon,Shinyaku,Trisenox,BLH,South,Korea,Mediscience,PTA,Taiwan,LSK,Maruho,Farom,Mediceo,Alfresa,Suzuken,Negi,Generic,NHI,Pricing,Thalidomide,ARB,Diuretic,Lucentis,AMD,Eculizumab,Sulfonated,Human,Ig,Orphan,Drugs,Ethnic,Differences,Precautions,RA,Actemra,PMS,Fiscal,Policy,LDP,Shionogi,FDA,Ceftibuten,Nonclinical,Roche,Eli,Lilly,Withdraws,sNDA,Cymbalta,Chronic,Pain,Eltrombopag,GSK,Biomarkers,Anticancer,Inoue,Kyowa,Hakko,Kirin,Tripartite,iPS,Cells,Yamanaka,OAB,Diabetes,Genes,PMDA,Kringle,ChronSeal,Norway,Yakult,Irinotecan,Pancreatic,NSL,SD,Neuropathic,Sosei,Kidney,Lipitor,CV,Events,GARDASIL,External,Genital,Lesions,Banyu,HUMIRA,Joint,Damage,MTX,Abbott,Takara,Bio,RetroNectin,UCLA,Philip,Carrigan,Korosho,Medical,Devices,PDA,Closure,Online,Sales,OTC,ADRs,JSMO,GL,KRAS,Mutation,Sleep,Disorders,NBI,Tobacco,Tax","No.2119 Contents")

st++; thePage[st]=new Array("2118_dec_8.pdf","pdf/2008_12/","2118 December 8","VITAL,KSK,HEREON,Hospitals,Wholesalers,Yakult,Honsha,Elplat,Colon,TOPQUARK,MS,MediciNova,DSP,Kyowa,Hakko,Kirin,China,Pemilaston,Alfresa,Daiichi,Sankyo,Ireland,MOF,Generics,CML,HIV,Biological,Gemzar,Urothelial,Cancer,Chugai,NSCLC,Avastin,JCR,Kissei,EPO,Biosimilar,Takeda,MAA,Pioglitazone,Metformin,Silodosin,BANZEL,Adjunctive,LGS,Eisai,Tocilizumab,RA,CHMP,Roche,Teijin,Febuxostat,JPA,Topical,Permethrin,LDP,Tobacco,Tax,Toyota,NEC,Payment,Bills,Sanofi,aventis,JMA,HRD,Excellence,Award,Otsuka,Sedation,Reed,Maurer,NBI,Kobe,JPMA,iPS,Cell,IP,Transplantation,Heart,Failure,Nexavar,EPPV,Vandetanib,Survival,Gefitinib,Docetaxel,HUMIRA,Fistula,Crohn,Abbott,Pradaxa,BI,BARACLUDE,Liver,Damage,Hepatitis,ORENCIA,MTX,Bristol,Myers,Squibb,Multaq,AF,Aliskiren,Blood,Pressure,Ramipril,Novartis,ISENTRESS,Merck,Wyeth,Vaccine,Prevnar,Immune,Responses,Pasteur,Online,JACDS,JODA,DPJ,Sales,Creams,Vaginal,Switch,OTC,Magnesium,Oxide,Breast,Examination,HRT,SGA,Short,Stature,Pfizer,Hypermagnesemia","No.2118 Contents")

st++; thePage[st]=new Array("2117_dec_1.pdf","pdf/2008_12/","2117 December 1","CMIC,CRO,MR,TSE,Chocat,EFPIA,Japan,VITALNET,KSK,Merge,Wholesaler,Korosho,Settle,Prices,Matsumotokiyoshi,Asahi,Kasei,Naftopidil,Roche,Diagnostics,EPS,Astellas,Subsidiary,India,NichiIko,Sawai,Taiyo,Yakuhin,Towa,Actavis,ASKA,Promote,Generics,Chuikyo,Irbesartan,Heart,Failure,Preserved,LVEF,Enrollment,AMG706,Daiichi,Sankyo,Influenza,Eisai,Genetic,Research,Data,LOAD,TorreyPines,Ribbon,type,NFkB,Ets,decoy,Aortic,Aneurism,Reed,Maurer,DPP4,Inhibitors,SUs,NHI,Pricing,System,Kinoshita,Telavancin,Favorable,Recommendation,FDA,Advisory,Committee,JODA,GL,Online,Sales,OTC,Rohto,Kampo,Metabolic,Syndrome,HRT,Pfizer,Japanese,Evidence,Selara,Medical,Fee,System,High,Cost,Ishikawa,Proper,Psychotropics,Elderly,Website,Program,Bristol,Myers,Standard,Regimens,Colon,Cancer,Miraca,HD","No.2117 Contents")

st++; thePage[st]=new Array("2116_nov_24.pdf","pdf/2008_11/","2116 November 24","Bayer,Wenning,Rivaroxaban,ACS,Wholesalers,Mediceo,Paltac,FTC,Alfresa,Suzuken,Ota,Toho,Fuji,Biomedix,Matsutani,Nihon,Chouzai,Generics,GSK,Mitsuhara,QOL,Management,Seminar,Kinoshita,Mimura,FPMAJ,NHI,Pricing,System,Yamamoto,Santen,Tafluprost,Kaken,Artz,Kyorin,Gatifloxacin,Mochida,Kissei,Cabaser,EPO,Biosimilar,Nippon,Shinyaku,NS304,Seikagaku,Supartz,Zeria,JCR,Asahi,Kasei,Famvir,Teijin,Bonalon,Home,Care,Meiji,Seika,Ajinomoto,Daiichi,Sankyo,TOB,Ranbaxy,Dissolve,Subsidiaries,sanofi,aventis,DSP,Replagal,Pola,Pierre,Fabre,ADerma,ASKA,Actavis,DPC,JHA,ArQule,Oncology,Ys,Therapeutics,YSCMA,France,AnGes,Atopic,Dermatitis,Actemra,Structural,Joint,Damage,RA,Chugai,Roche,ADVATE,Bleeding,Episodes,Hemophilia,Baxter,Chuikyo,Nagano,Kenporen,Olmesartan,Amlodipine,Combination,Germany,Apidra,Diabetes,Children,SelfMed,NRK,Sekisui,Medical,Invader,UGTA,ADRs,Irinotecan","No.2116 Contents")

st++; thePage[st]=new Array("2115_nov_17.pdf","pdf/2008_11/","2115 November 17","Merck,Serono,Erbitux,Colon,Cancer,Wild,type,KRAS,Genes,Gonal-F,Hasegawa,Mediceo,Alfresa,Takeda,Astellas,Prograf,MTPC,Amlodipine,DSP,Shionogi,Rosuvastatin,Doripenem,Sciele,Ono,Kowa,Livalo,Import,Permission,China,Diovan,RepTrack,Adapalene,Kawashima,Irbesartan,Price,Settlement,Rate,Bulk,Buying,Practice,Generics,NHI,Listing,Cefdinir,Kyowa,Kirin,Small,Molecules,Antibodies,Bikaken,Lilly,TB,Drug,Discovery,Initiative,CPZEN,XDR,TB,JSCO,Cetuximab,Avastin,JCA,Mauvernay,Award,Ichijo,Mano,Sanofi,aventis,MOF,Consumption,Tax,Aso,Mundipharma,Transdermal,Buprenorphine,Wyeth,Nonacog,Bendamustine,Relapsed,Indolent,NHL,FDA,Home,Monitoring,QOL,CRD,Device,Recipients,Self,Blood,Glucose,Cold,Remedies,Korosho,Public,Education,Diabetic,Nephropathy,COPD,UPLIFT,Spiriva","No.2115 Contents")

st++; thePage[st]=new Array("2114_nov_10.pdf","pdf/2008_11/","2114 November 10","AVT-02,GEN0101,Roche,Zabrowski,Genentech,Takeda,Semiannual,Daiichi,Sankyo,Eisai,Aricept,MGI,Pharma,MTPC,Remicade,Mearubik,DSP,Amlodin,Kyowa,Hakko,Kirin,JT,Torii,Futhan,TSD,COLAL,PRED,HVJE,FUJIFILM,Taisho,Toyama,Chemical,Alfresa,Toho,Nippon,Chemiphar,PMDA,NMEs,Actos,Metformin,Bayer,Kogenate,FS,Routine,Prophylaxis,Children,Hemophilia,House,Lords,Refuses,NICE,Alzheimer,Disease,Notification,Pirespa,Pulmonary,Fibrosis,Generic,Sekiguchi,Lenalidomide,Teratogenicity,Celgene,Kringle,PI,HGF,Protein,UE,Ointment,Psoriasis,Hormone,resistant,Prostate,Cancer,AnGes,MG,Pfizer,UCB,Novartis,Vasella,JSMI,Switch,OTC,Taisho,SSP,Nihon,Chouzai,Matsumotokiyoshi,Intracranial,Stent,Artificial,Jaw,Joint,Eiken,Chemical,Nipro,Colorectal,GL,HRT,IFN,Hepatitis,Revatio,PAH,GS1","No.2114 Contents")

st++; thePage[st]=new Array("2113_nov_3.pdf","pdf/2008_11/","2113 November 3","BI,Antidiabetics,BI1356,Barner,DPP4,SLGT-2,Market,Wholesalers,Ono,SC,MNTX,Progenics,Daiichi,Sankyo,Ranbaxy,Shares,FPMAJ,NHI,Nagano,Premium,Innovativeness,Ryukaikon,AnGes,Meyer,NFkB,Decoy,Oligo,Levofloxacin,Patent,Infringement,Lawsuit,Mediscience,Planning,ARBs,Rep,Track,Survey,Kowa,Pitavastatin,ASKA,Menoaid,Combipatch,Prasugrel,NDA,PMDA,Reviewers,Nakagaki,Shionogi,Pirfenidone,Idiopathic,Pulmonary,Fibrosis,Santen,Tapros,Glaucoma,GSK,Lamotrigine,Epilepsy,Bayer,Wellnara,Julina,Postmenopausal,Osteoporosis,Pfizer,Genotropin,SGA,DSP,Sumiferon,Novartis,Atopic,Dermatitis,Neoral,Schering,Plough,Bepridil,Persistent,Atrial,Fibrillation,Eisai,ONTAK,FDA,TAK390MR,Astellas,MAA,Telavancin,JPRN,WHO,JLCS,AZ,Osaka,Univ,Neuropsychiatry,Tohyama,Takeda,Prostate,Vaccine,GVAX,Banyu,Tsukuba,Research,Institute,DIA,Workshop,Kitasato,Uterocervical,Asia,Biosimilars,Korosho,Bioventures,JBA,Survey,JGA,Generics,Chuikyo,MRs,Masuhara,Japan,India,EPA,OPINION,Philip,Carrigan,Online,Sale,OTC,Liberalization,Olympus,Endo,Capsule,Optimize,Thiazide,Diuretics,Irribow,Diarrhea,Predominant,IBS,JSHP,JPA","No.2113 Contents")

st++; thePage[st]=new Array("2112_oct_27.pdf","pdf/2008_10/","2112 October 27","SOH075,AZ,Biopharmaceuticals,Brennan,Kato,Merck,Serono,Bristol,Myers,Erbitux,Kowa,DPP4,Sanwa,Kagaku,Meiji,Seika,Biocodex,Stiripentol,SMEI,Ajinomoto,MoviPrep,Norgine,Fuji,Biomedix,Toho,VITALNET,Heidrick,Struggles,GenomIdea,Prostate,Cancer,TSD,Tsumura,Topical,Antifungal,Maruho,Hisamitsu,Mohrus,Tape,QPI,CSO,Generics,Sawai,India,EPA,Korosho,Criterion,Payment,Premium,Bohsei,Pharmacy,Original,Makers,Mylan,Pfizer,Macugen,AMD,BioJapan,Hayashi,Takeda,Araki,Daiichi,Sankyo,Kitasato,Harvard,Symposium,Sawada,Bayer,Schering,Riociguat,Baxter,Alzheimer,Disease,Wyeth,Vaccine,Pneumonia,Prevention,Sosei,KRAS,Wild,Type,mCRC,Tiotropium,UPLIFT,Betaferon,MS,Progression,Tella,Shinshu,Immunotherapy,Lag,SJP,Seminar,Pharmacovigilance,FDA,Review,NDA,Alogliptin,PDUFA,Gardasil,Vulvar,Vaginal,Reed,Maurer,OTC,Kishida,Terbinafine,Pranoprofen,JACDS,GL,Hypertension,JSH,Diabetes,CKD,ACCORD,Personalized,Blood,Glucose,Ishii,AD,Amyloid,Thiazide,Diuretics,Kishida,Donations,Cognitive,Disorders,BP,Levels,Hypotensive,CareNet,Sports,Schizophrenia","No.2112 Contents")

st++; thePage[st]=new Array("2111_oct_20.pdf","pdf/2008_10/","2111 October 20","Mediceo,Paltac,Alfresa,Merge,Wholesaler,Takeda,Nihon,Chouzai,Suzuken,Antimonopoly,Act,Astellas,Tsukuba,Daiichi,Sankyo,CV,Shoda,Shionogi,TOB,Sciele,AnGes,MG,Influenza,DNA,Vaccine,Vical,Eli,Lilly,ImClone,Novartis,Mediscience,Thalidomide,Multiple,Myeloma,Fujimoto,Prifenidone,Kinoshita,GMP,Kissei,Silodosin,Generics,Kato,Koga,FPMAJ,Fujii,Pfizer,Mycobutin,Capsule,Mycobacteriosis,Irribow,Diarrhea,IBS,Otsuka,Galenea,Genentech,GlycArt,Roche,Takara,Bio,HSV,TK,Leukemia,NVA,Sosei,Liraglutide,Glimepiride,Novo,Nordisk,Yamanaka,iPS,Cells,Virus,Vector,Teijin,FALCO,Gene,Patent,LGC,Diagnostics,Amplicor,HPV,Kyowa,Medex,Coagtron,Sekisui,Diabetes,Boston,Scientific,Korosho,Ureteral,Stents,OTC,Kenkocom,Draft,Peptic,Ulcer,Quinolones,PCV,Wyeth,ACS,PACIFIC,FlexPen","No.2111 Contents")

st++; thePage[st]=new Array("2110_oct_13.pdf","pdf/2008_10/","2110 October 13","Kyowa,Hakko,Kirin,Antibody,Solid,Cancer,Matsuda,Bayer,Women,ActHIB,Kamiya,Sales,Force,Effectiveness,eyeforpharma,Arnaud,sanofi,aventis,QOL,Bioequivalence,Kowa,Biosimilars,Costs,BI,Humanized,EVEC,Nippon,Shinyaku,Antipruritic,Taiho,Tazobactam,Sato,Aspirin,Gatiflo,Daiichi,Sankyo,DSPP,Osaka,Plant,ASTEM,KSK,Takeda,Alogliptin,Korosho,Code,Labeling,Lag,Sato,OPIR,Astellas,Myasthenia,Gravis,Tacrolimus,Xarelto,Erbitux,NSCLC,Kringle,IND,HGF,FDA,Singulair,Fine,Granules,Coartem,Priority,Review,Melamine,Taisho,Toyama,Lactamase,Penicillin,Zosyn,Terumo,Neostigmine,Atropine,GENERICS,NCVC,Meiji,Seika,Amlodipine,Physicians,Taiyo,RAD001,PFS,RCC,Novartis,Pancreatic,NET,Growth,Lantus,Apidra,Diabetics,AnGes,MG,Nucleotide,Hybrid,Decoys,Inflammatory,NFkB,Decoy,Oligo,HGF,ONO2506,TS003,Takara,Bio,RetroNectin,Seikagaku,Glycoscience,JBCS,TN,Subtype,Dasatinib,Etoposide,Breast,Vaccines,DDS,AMD,HbA1C,Heart,Failure,BP,Komuro,Telmisartan,Alzheimer,Horiuchi,Locomotor,JOA,ED,Lilly,Insurance,Societies,Deficits,tPA,Carmona,Nicotinell,Gum,Zeria,IONA","No.2110 Contents")

st++; thePage[st]=new Array("2109_oct_6.pdf","pdf/2008_10/","2109 October 6","Teva,Kowa,Generics,Yanai,Ethical,OTC,Miwa,JGPMA,Sawai,JT,Oral,Osteoporosis,Merck,ARBs,RepTrack,Alfresa,Medical,System,Network,Pharmacy,MSNW,Expiration,Patents,Bayer,Onyx,Liver,Cancer,Educational,Program,TOB,Ranbaxy,Daiichi,Sankyo,Takeda,Singapore,Genzyme,Blood,Sonet,M3,SSRI,FDA,NDA,Prasugrel,Chuikyo,NHI,Pricing,Reform,FPMAJ,Taro,Aso,Yoichi,Masuzoe,JMA,Alogliptin,ACTOS,Monotherapy,Adefovir,GSK,Withdraw,MAA,Ramelteon,Xarelto,Canada,PMDA,Spiriva,BI,Pfizer,Boceprevir,Treatment,Naive,Hepatitis,Schering,Plough,Korosho,Vision,Devices,NHO,Reagents,PAL,Argatroban,DPC,Payment,Erythropoietin,Levemir,Nocturnal,Hypoglycemia,Novo,Nordisk,Tamiflu,Teenagers,Medwatcher,Pylori,Eradication,Bungyo,Toyota,NEC","No.2109 Contents")

st++; thePage[st]=new Array("2108_sept_29.pdf","pdf/2008_9/","2108 September 29","Meiji,NanoCarrier,Taiwan,Nanoplatin,Kirin,Erbitux,Merck,Serono,Bristol,Myers,Astellas,Maxygen,Autoimmune,Transplant,Rejection,Quintiles,Masuzoe,IFPW,Kumakura,Iwasaki,Matsutani,Banyu,Marketing,Asmanex,Twisthaler,Schering,Plough,Takeda,Taiyo,Contract,Manufacturing,Defective,Toho,Ethos,Kyowa,Medex,HDLC,Abatacept,Biosimilars,PhRMA,Korosho,Hire,Ex,Employees,Roche,Complete,Response,Letter,Actemra,GSK1557484A,Sodium,Phenylbutyrate,Orphan,Ishii,Centenarians,Pfizer,Fibromyalgia,Blopress,Diabetic,Retinopathy,Vildagliptin,TZDs,Novartis,Aliskiren,Blood,Pressure,Obese,Multaq,Stroke,sanofi,aventis,Liraglutide,Glucose,Iressa,YSPSL,Graft,Function,IRI,Y's,Therapeutics,Yamanaka,iPS,Cell,Patented,Julina,Estradiol,Maurer,Reed,Mylan,Merckmezin,PMS,Generics,Urushibata,Draft,Ordinance,Enforcement,Amended,PAL,JPA,JODA,JACDS,Avastin,Kras,Gene,Mutation,Narcotics,Schizophrenia,IADL,Measles,Vaccination,Lifestyle,Donations,Gardasil,Burden,Social,Security","No.2108 Contents")

st++; thePage[st]=new Array("2107_sept_22.pdf","pdf/2008_9/","2107 September 22","Eli,Lilly,Zulueta,Monoclonal,Antibodies,Datamonitor,Kissei,Y's,Therapeutics,NovoRapid,Novo,Nordisk,Chris,Viehbacher,sanofi,aventis,Brunn,Takeda,Europe,Meiji,Seika,Dairy,UCB,Maruishi,Yoshida,Astellas,Grand,Island,Plant,APP,Mylan,Razadyne,Lawsuit,Yamato,Generics,Distribution,Kokan,Chugai,Post,Marketing,Safety,Measures,Avastin,PMDA,Yakult,Oxaliplatin,RAD001,Taxotere,Prostate,Cancer,Bayer,Rivaroxaban,Saxagliptin,Antidiabetic,DPP4,Inhibitors,HbA1c,Diabetic,Nephropathy,Needed,JHSF,Schering,Nagasaki,Univ,Alzheimer,Takara,Bio,Liver,MediciNova,DU-176b,VTE,Dalteparin,Daiichi,Sankyo,Telmisartan,ACE,Intolerant,Micardis,OPINION,Philip,Carrigan,Growell,HD,Taisho,OTC,Miconazole,Recurrent,Candidiasis,Kakonal,Kakkonto,JPA,Store,Managers,MN-221","No.2107 Contents")

st++; thePage[st]=new Array("2106_sept_15.pdf","pdf/2008_9/","2106 September 15","Shionogi,Sciele,Acquisition,Teshirogi,DSP,Kowa,Livalo,Novartis,NDAs,Jiho,Tour,Group,Leiden,Bio,Science,Park,Loxonin,Tape,Rep,Track,Yamato,Kumakura,Suzuken,Settlement,Rate,Idiopathic,Pulmonary,Fibrosis,Sumiferon,Viremia,Hepatic,Cirrhosis,Pediatric,Methotrexate,Dose,Cavergoline,PMDA,Post,Marketing,Safety,Sodium,Phenylbutyrate,Orphan,NICE,Lucentis,Macugen,Wet,AMD,Otsuka,Acucela,Dry,Eye,VEGF,TrapEye,Bayer,Regeneron,Pramipexole,RLS,BI,PD,Generics,Muto,Mitsuhara,Korosho,Quality,Angina,Diagnosis,CAG,AIDS,Resistant,Virus,Antidiabetic,Tokyo,Migraine,GSK,Seminar,Glaucoma","No.2106 Contents")

st++; thePage[st]=new Array("2105_sept_8.pdf","pdf/2008_9/","2105 September 8","Astellas,Prograf,Advagraf,Shionogi,Sciele,Pharma,Sanwa,Kagaku,SK-0403,ChoongWae,Korea,Yamato,Otsuka,Acquires,IPP,Czech,Sanofi,aventis,Thymoglobulin,Genzyme,IPEC,UMN,Influenza,Vaccine,Baxter,Granisetron,IV,NHI,Price,Listing,DPC,Payment,System,CDFS,Thalidomide,Vancomycin,Mylan,Korosho,PFSB,Budget,HPB,Dementia,METI,MEXT,Yasuo,Fukuda,CGI,Prostate,Takeda,Hematide,Chemotherapy,Cancerous,Anemia,Hp,Eradication,JSHR,Asaka,Clusters,Nexavar,Liver,Bayer,Onyx,JPharma,Agrex,Cronova,CRO,Epadel,Mochida,Vascular,Embolization,AVM,BD,Cytodiagnostic,Cervical,Terumo,DuraHeart,CyberKnife,Accuray,Switching,OTC,RiUP,Minoxidil,Angina,Prologue,JMA,JPA,Takara,Bio,Immunotherapy,Kyoto,Clinic,Hasegawa,Society,Uterocervical","No.2105 Contents")

st++; thePage[st]=new Array("2104_sept_1.pdf","pdf/2008_9/","2104 September 1","MCHC,Kobayashi,MTPC,Shares,Choseido,Takeda,Oncology,Hasegawa,Nisshin,Seifun,Withdraws,Ethical,Kyorin,Nippon,Kayaku,Micellar,Yakult,Celsion,Thermally,Sensitive,Doxorubicin,PI,Forum,Oracle,Software,Tokai,Univ,Crecon,Yamato,HD,Direct,Delivery,System,Generics,Masuhara,Toho,Korosho,Budget,PMDA,Criteria,Thalidomide,OPIR,JSMO,KRas,Gene,Aloxi,Capsules,Eisai,Multaq,FDA,Priority,Review,AF,sanofi,aventis,Prasugrel,Recurrence,CV,Clopidogrel,AZ,SCC,KRP104,Seikagaku,Israel,Diabetes,opinion,Philip,Carrigan,Switch,OTC,Drug,Flavoxate,Kowa,Artificial,Ventilation,Given,Imaging,Iressa,CDFS,Biologics,RA,JCR,Higher,Doses,MTX,Surgeon,Guilty,Court,SAS,Depression,Cerebral,Blood,Flow","No.2104 Contents")

st++; thePage[st]=new Array("2103_aug_25.pdf","pdf/2008_8/","2103 August 25","DSP,Lurasidone,Tada,Metformin,OD,Amlodin,Eisai,Bendamustine,SymBio,Ono,Pfizer,Macugen,AMD,Bayer,FUJIFILM,RI,Zevalin,Price,Settlement,Rates,Mediceo,Paltac,Matsutani,Wholesalers,Kowa,DPP,Sanwa,Kagaku,Alfresa,Nobelpharma,Daiichi,Sankyo,TOB,Ranbaxy,Yakult,Elplat,Hiroyuki,Saeki,Hospira,Masuzoe,Minister,EAD,Kinoshita,Raw,Materials,Basiliximab,Alteplase,Korosho,Reference,System,Rivaroxaban,Nexavar,HCC,China,Onyx,Apidra,sanofi,aventis,Astellas,Vernakalant,Schering,Plough,Letter,Sugammadex,NICE,Insurance,Molecular,Targeted,Renal,OPIR,Preclinical,Oncology,Nycomed,Alnylam,Takeda,RNAi,AZ,Shizuoka,Cancer,Center,Proteus,Sciences,Kyoto,Brain,Isentress,Naive,HIV,Merck,GSK,HSCI,Johns,Hopkins,Asthma,COPD,Reed,Maurer,Generics,ACCJ,Sakurai,MDCT,Hayashi,PCI,IHD,Nakamura,Seven,Ain,JPA,Online,OTC,Ishii,SSP,Hatori,JODA,GL,Remicade,Uterocervical,Vaccination,Parkinson,Gene,Testing,IFN,Hepatitis","No.2103 Contents")

st++; thePage[st]=new Array("2102_aug_11.pdf","pdf/2008_8/","2102 August 11 & 18","Nippon,Chemiphar,Ranbaxy,Kowa,ProEthic,MTPC,Hyperparathyroidism,Cytochroma,Avastin,Herceptin,Chugai,Roche,Subsidiary,Kodama,Tocilizumab,Genentech,Bayer,GSK,Suzuken,Matsumotokiyoshi,Mogi,Avapro,Rep,Track,NPhA,Wholesalers,Mediceo,Paltac,Price,Settlement,Rate,JPMA,Negi,MSNW,Tokushukai,Eisai,Lipon,STADA,Health,Vision,Enterprise,China,Astellas,Mycamine,Otsuka,HD,Taiho,Lamotrigine,Neoral,Atopic,Dermatitis,Rhabdomyolysis,PMS,Lipovas,Taxotere,Prostate,Cancer,Social,Security,Spending,Masuzoe,Seikagaku,Gel,Erbitux,First,Line,mCRC,Merck,Rivaroxaban,FDA,Actemra,RA,Not,Approvable,Letter,Fospropofol,Takeda,Candesartan,Amlodipine,Amgen,Fractures,Denosumab,siRNA,GeneCare,Super,Tokku,Korosho,Iressa,Superiority,Asians,AZ,JRCS,Joint,Purchase,Increases,Generics,NHI,Pricing,Isobe,Isentress,HIV,Banyu,Vaccines,Bacterial,Meningitis,Wyeth,stroke,Depression,Subarachnoid,Hemorrhage,Deficit,Ridden,FALCO,Biosystems,Gene,Testing,Familial,Breast,Ovarian","No.2102 Contents")

st++; thePage[st]=new Array("2101_aug_4.pdf","pdf/2008_8/","2101 August 4","Erbitux,Merck,Serono,Rebif,Roche,Genentech,Shareholders,Mirus,RNAi,Delivery,Arius,Nippon,Zoki,NZ419,Hyundai,Korea,Alizyme,COLAL,PRED,Norgine,Tsumura,Kampo,Chugai,Toyobo,Eisai,Aciphex,Patent,Infringement,Lawsuit,Astellas,Flomax,JADEC,sanofi,aventis,HbA1c,Aroglycem,Hypoglycemia,Hyperinsulinemia,Schering,Plough,Irinotecan,Sawai,MRETC,Fuji,Yakuhin,Gout,Novartis,Everolimus,RCC,Gene,Therapy,Zetia,Comtan,EPPV,ADR,Korosho,Risedronate,Consumption,Tax,Social,Security,Cervarix,UK,National,Immunization,GSK,BMS,AZ,Saxagliptin,Primovist,Bayer,PMDA,Victims,OPINION,Philip,Carrigan,Kobayashi,Paltac,KS,Miconazole,Emedastine,Fumarate,OTC,Registered,Seller,SSP,JMA,Performance,Oriented,Morphine,Quality,Expenditures,Nicotine,Dependency,Management,Admission,Fees","No.2101 Contents")

st++; thePage[st]=new Array("2100_jul_28.pdf","pdf/2008_7/","2100 July 28","NichiIko,Kyowa,Hakko,Lonza,Eisai,Aricept,Controlled,Release,Pfizer,Sutent,First,Line,RCC,Wage,JPLA,RaQualia,Korosho,GPOs,France,UK,TOB,Ranbaxy,Daiichi,Sankyo,MTX,Overdosing,Nucleic,Acid,Macugen,MAD,Mycobutin,Mycobacteriosis,Argatroban,HIT,Type,II,MTPC,Erbitux,Colorectal,Merck,Serono,Bristol,Myers,Nasonex,Allergic,Rhinitis,Schering,Plough,Differin,Acne,Vulgaris,Galderma,Biopten,Asubio,Lactamase,Inhibitor,Antibiotic,Zosyn,Taiho,Toyama,Diarrhea,Predominant,IBS,Irribow,Astellas,Tacrolimus,Novo,Liraglutide,Risedronate,Paget,Pediatric,Vaccine,Pentacel,Sanofi,Pasteur,PhRMA,Market,Expansion,Repricing,Maurer,Reed,Vildagliptin,Voglibose,Sosei,SOH075,SymBio,Granisetron,Patch,ALS,Tokai,Prepandemic,Influenza,Baxter,Scientia,Asia,Pacific,Sawai,Generic,Substitution,Nihon,Chouzai,NPhA,Asahi,Kasei,Medical,Devices,Clopidogrel,Gefitinib,Adenocarcinoma,Smoking,History,Gefitinib,adenocarcinoma,Salagen,Dry,Eyes,Kissei,STD,HIV,Avastin,FOLFOX,FOLFIRI","No.2100 Contents")

st++; thePage[st]=new Array("2099_jul_21.pdf","pdf/2008_7/","2099 July 21","Ferring,OD,Tablet,Desmopressin,Daiichi,Sankyo,NSAID,Nippon,Kayaku,Macromolecular,Anticancer,Ranbaxy,Allegations,Korosho,Price,Agreement,Rate,Ain,Pharmaciez,Takeda,Taxation,Eisai,ALOXI,PONV,Lead,Chemical,Loxonin,Tape,Venofer,Fresenius,FPAMJ,Chuikyo,Revision,US,Safety,Measures,Influenza,NHI,Reform,Shionogi,Allerport,TARC,Kyowa,Hakko,siRNA,Seattle,Genetics,ADC,Alzheimer,Unapproved,Glycomedics,Flu,Inhibitor,Fuso,Oncotherapy,OTS102,Takara,Bio,Roche,CD20,Antibody,GA101,Tests,Purity,APIs,OHARA,Amlodipine,Tanabe,Seiyaku,Hanbai,KYORIN,Rimedio,OTC,NMRA,JPA,Label,Switch,Tamiflu,Abnormal,Behavior,QOL,Antihypertensive,Prostate,Antigen,Insulin,Pancreas","No.2099 Contents")

st++; thePage[st]=new Array("2098_jul_14.pdf","pdf/2008_7/","2098 July 14","Pfizer,Research,Center,RaQualia,Prefilled,Syringes,Enbrel,Takeda,TAP,Chugai,Actemra,Shionogi,DSP,Irbesartan,Ferring,Desmopressin,Kyowa,Hakko,INTERPHEX,Novartis,Mitani,Shoda,Nagai,OD,Tablets,Nishiura,Makov,Nihon,Chouzai,Wholesalers,Taisho,Biofermin,AnGes,MG,Patent,HGF,Lymph,Edema,Qualicaps,PEG,Gelatin,Capsules,Avapro,RepTrack,Amlodipine,Ebastine,Meloxicam,Sawai,JGPMA,FPMAJ,Armala,Sutent,ASCO,Everolimus,Wagner,DDS,RNA,Nippon,Shinyaku,Nakamura,Antibody,Rivaroxaban,Enoxaparin,Bayer,Aliskiren,Ambien,Insomnia,MDD,sanofi,aventis,Lantus,Retinopathy,Progression,NPH,Levemir,Insulin,Glargine,Novo,Nordisk,NDA,Panitumumab,Bio,Development,Amgen,SCJ,Medical,Expenditure,Reference,Price,System,Hisamitsu,Fentanyl,Tape,Merck,Erbitux,Head,Neck,Aciphex,ShortTerm,GERD,Adolescents,Eisai,Alfresa,Catheter,Access,Port,Toray,Roche,Diagnostics,Ventana,Philip,Carrigan,KRAS,Gene,Predict,Biologics,RA,Hormonet,Localized,Prostate,Cancer,JMA","No.2098 Contents")

st++; thePage[st]=new Array("2097_jul_7.pdf","pdf/2008_7/","2097 July 7","Bayer,Yakuhin,Multinational,MN221,MRs,English,Daiichi,Sankyo,Shoda,Otsuka,Reorganized,Holding,shareholders,Meetings,Blopress,Olmetec,ARBs,Enbrel,Ethical,IMS,Japan,Astellas,Lexiscan,Nippon,Kayaku,Roche,Chugai,DSP,Japanese,Executives,Survey,Reference,Price,System,Late,Stage,Rehabilitation,FPMAJ,Chuikyo,FDA,Review,Period,Prasugrel,Eli,Lilly,Raltegravir,Velcade,MM,Takeda,TRILOGY,ACS,Tyverb,GSK,Ulcerative,Colitis,Tacrolimus,SymBio,Bendamustine,Relationship,Tamiflu,Abnormal,Behavior,Erbitux,CHMP,First,Line,mCRC,PMDA,Diabetes,Physician,Talc,Hepatitis,MediciNova,Protosera,Systemic,Scleroderma,Benesis,Actemra,RA,Benicar,Arterial,Narrowing,Hypertension,Sawai,Anticancer,MedicalPharmacy,Amlodipine,Zetia,Statins,Yamada,HbA1c,Nexavar,PPIs,Dyspepsia,Symptoms,JFOCUSF,VTE,Steroids,Hinders,Atopic,smoking,Tax,Cigarettes,SCJ,Doctors","No.2097 Contents")

st++; thePage[st]=new Array("2096_jun_30.pdf","pdf/2008_6/","2096 June 30","Abbott,Japan,Bohuon,Humira,Kyowa,Hakko,RNAi,RSV,Alnylam,Banyu,Stocrin,HIV,Sanofi,aventis,Lantus,SoloSTAR,Eli,Lilly,Humalog,MTPC,Zione,Korea,Yuhan,Asahi,Kasei,Recomodulin,Hisamitsu,Transdermal,Cancer,Pain,Killer,Maruho,Famvir,Schering,Plough,Merge,Nippon,Organon,Daiichi,Sankyo,Acquisition,Ranbaxy,Adapalene,FPMAJ,Tsushima,Nagano,EMEA,Negative,Opinion,Ramelteon,Nippon,Kayaku,MAA,Spanidin,Tamiflu,Abnormal,Behavior,Chemotherapy,Okayama,Univ,Gene,Therapy,Prostate,Glycomedics,GM04001,Alogliptin,HbA1c,Takeda,Sugammadex,Muscle,Relaxation,UMN,UMN0501,Roche,Taspoglutide,Novo,Nordisk,Neose,NN7128,Carna,Biosciences,Kinase,Inhibitors,NCC,PharmaDesign,AZ,Vascular,XIENCE,Terumo,Eisai,Doug,Berger,Taiyo,Capacity,Aratani,Prescriptions,Nihon,Chouzai,Urushibata,Generics,Delivery,Service,Yamato,Wholesaler,License,Norvasc,IHEP,Tobacco,Tax,Smoking,Cessation,Aids,Steroids,Hokunalin,Tape,Elderly,Asthma,Multiple,Sclerosis,Bayer,Yakuhin,ED,Cerebrovascular,Horie,GSK,Taisho,Ciganon,CQ,OTC,JJ,Nicorette,Patch,Society,Obesity","No.2096 Contents")

st++; thePage[st]=new Array("2095_jun_23.pdf","pdf/2008_6/","2095 June 23","Daiichi,Sankyo,Ranbaxy,Singh,Asahi,Kasei,Osteoarthritis,Pfizer,Norvasc,PMS,Exjade,Diovan,RepTrack,Otsuka,UCB,Keppra,Cimzia,Sonet,M3,MRkun,Yamato,Direct,Deal,Taiyo,NHI,Price,FPMAJ,Revision,Repricing,Premium,Usefulness,PMDA,Orphan,FDA,Promacta,ITP,Nippon,Shinyaku,RNA,AnGes,MG,Gene,Mucopolysaccharidosis,VI,Guidance,MD,OPIR,Ohita,Pluripotent,Stem,Blood,Korosho,Lipitor,CV,Bypass,Surgery,Amikacin,Inhale,IV,Amikacin,Bayer,HealthCare,Rivaroxaban,VTE,Enoxaparin,Alimta,NSCLC,Eli,Lilly,Aliskiren,Kidney,Protection,Novartis,LDP,Kawasumi,Shimadzu,Techno,Reed,Maurer,Rohto,Fuji,Humira,RA,QOL,Iron,Overload,Ambulatory,Chemotherapy,Cialis,Vascular,Endothelial,Arteriosclerosis,LDL,HDL,Nohara,Nobelzin,Refractory,Wilson,Diarrhea,Predominant,IBS,Cell,Vaccines,Influenza,Advanced,Medical,JMA,Tax,Rate,Voglibose,Ophthalmologists,Glaucoma,Physical,RLS","No.2095 Contents")

st++; thePage[st]=new Array("2094_jun_16.pdf","pdf/2008_6/","2094 June 16","Banyu,Vaccines,Timney,Daiichi,Sankyo,Acquire,Ranbaxy,Lurasidone,DSP,Tada,Kissei,Selective,SGLT2,Inhibitors,GSK,Antihypertensives,MOA,EPS,Chinese,CRO,CMIC,CMO,Nippon,Shinyaku,NS126,Yoo,Young,Kowa,Livalo,Solvay,Santen,Sirolimus,MacuSight,RTech,Ueno,Human,Serum,Albumin,MTPC,Kyowa,Hakko,Kyorin,Allelock,VITALNET,Litigation,AZOR,Mylan,Generics,Amlodipine,Raw,Materials,JMA,List,Isentress,Sutent,Zevalin,DPC,Lunabell,Humira,Follistim,Shoda,DE089,Dry,Eye,Alfresa,Modiodal,H5N1,Prepandemic,Prepandrix,Gardasil,Precancerous,Vaginal,Lesions,Nature,Relenza,Gracevit,Granules,Sugio,Seko,Oncology,U3Pharma,MORAb003,Ovarian,Eisai,Incretin,Diabetes,Society,ASCO,Everolimus,Zometa,Novartis,Telomelysin,Oncolys,BioPharma,Taxotere,DFS,sanofi,aventis,TroVax,Metastatic,Renal,Erbitux,KRAS,Wild,Type,Merck,ONO4538,MDX1106,Medarex,Activus,TA270,Shionogi,Hokkaido,BioMedCore,Sapporo,Thorough,Dronedarone,CV,Death,Epadel,Recurrence,Stroke,Korosho,Officials,OTC,Nicotinell,Patch","No.2094 Contents")

st++; thePage[st]=new Array("2093_jun_9.pdf","pdf/2008_6/","2093 June 9","Takenaka,Morita,Shoda,JPMA,NHI,Pricing,Sales,TSE,Kise,ATOL,Wholesalers,Fair,Trade,Council,Tsumura,Kampo,Meiji,Seika,Meiact,Yakult,Honsha,Elplat,JCR,Growject,Wakamoto,Nipradilol,Nippon,Chemiphar,Teijin,Osteoporosis,Nishikawa,Marketing,Excellence,AZ,Keohane,IMS,FJPWA,Agreement,Rate,NPhA,Santen,Takeda,Alnylam,RNAi,Eisai,Bufferin,Japan,Bridge,Granisetron,Patch,ProStrakan,Abilify,MBS,AnGes,Patent,HGF,Gene,Sawai,Towa,Orodispersible,Taiyo,Yakuhin,Nichiiko,Medisa,Shinyaku,Erbitux,Thymoglobulin,Mycobutin,UMN,Forodesine,Orphan,Galderma,Adapalene,INO,Therapeutics,Inoflow,Controlled,Release,Prograf,Botulinum,Toxin,Tacrolimus,Infliximab,OTC,Version,Miconazole,Vaginal,Candidiasis,DVx,Excimer,Laser,Lead,Withdrawal,Departure,Yagi,Guidelines,HRT,Sutent,Progressive,RCC,Korosho,Antihepatitis,LDP,Social,Security,Spending,HIV,Positive,Blood,Sample","No.2093 Contents")

st++; thePage[st]=new Array("2092_jun_2.pdf","pdf/2008_6/","2092 June 2","Daiichi,Sankyo,Turkish,Subsidiary,India,U3,Pharma,Germany,Takashi,Shoda,JPMA,Toichi,Takenaka,FPMAJ,President,Otsuka,Ono,Opalmon,Daikichi,Fukushima,Korekane,Kyorin,Kipres,Kaken,Artz,Mochida,Epadel,Atelec,Kissei,Cabaser,Nippon,Shinyaku,Hypen,Zeria,Torii,ASKA,Toyama,Chemical,Geninax,FUJIFILM,Agreement,Rate,Invoice,Hearings,Wholesalers,Hamada,Roche,Stake,Chugai,Pharmacy,Takumiya,Morita,Hiroko,Ogihara,Hidefumi,Hagiwara,Nisshin,Bungyo,Mitsuhara,Niwa,Fujiwara,JMA,SSRI,Package,Inserts,Medwatcher,Japan,NHI,Pricing,System,Chuikyo,Isobe,OTC,Drugs,SymBio,NDA,Bendamustine,Korosho,E7389,Breast,Cancer,Eisai,Takeda,Xa,Inhibitor,GAMMAGARD,Alzheimer,Baxter,Philip,Carrigan,CV,Market,Protosera,Biomarkers,Bayer,Yakuhin,Blood,Glucose,Meter,Intravascular,Image,Wire,Insurance,Kainos,Immucor,Immucor,JSMI,Switch,Kobayashi","No.2092 Contents")

st++; thePage[st]=new Array("2091_may_26.pdf","pdf/2008_5/","2091 May 26","Kyowa,Hakko,Kirin,Biotechnology,ARQ,Nesp,Espo,Takeda,Acquisition,Millennium,Astellas,Prograf,Patent,Daiichi,Sankyo,Eisai,MGI,Subsidiary,China,Machinery,MTPC,Remicade,Avapro,Strategic,DSP,Lurasidone,Taisho,Shoji,Uehara,Shionogi,Crestor,Irbetan,Arteriosclerosis,Janssen,Preminent,Banyu,Mediceo,Paltac,Alfresa,Suzuken,Yakkasa,Toho,Court,Appeal,NICE,Cost,Effectiveness,Model,Forest,Terminate,AZOR,Copromotion,Kissei,Salagen,Wakamoto,Wakunaga,California,UMN,Flu,Vaccine,Irom,Ranbaxy,Amlodipine,Korosho,Notification,Welfare,Beneficiaries,Multinational,PIII,VEGF,TrapEye,iPS,NDA,BIBF,OS,PFS,NSCLC,BI,Lipitor,CKD,Pfizer,Actemra,Joint,Damage,RA,Roche,JHSF,Industry,Academia,DDS,Formulations,KCRC,Cimzia,Crohn,UCB,RAPS,dementia,ARTCEREB,Irrigation,Perfusion,Solution,Otsuka,Factory,Actos,CV,Events,Diabetics,Enbrel,Beers,Criteria,Vaccination,Children,WHO,Fracture,Risk,Assessment,Tool,FRAX,Cervical,Cancer,Resistant,TB,Kenporen,Terumo","No.2091 Contents")

st++; thePage[st]=new Array("2090_may_19.pdf","pdf/2008_5/","2090 May 19","Bayer,Lowinski,Pletaal,Sweden,Otsuka,Takeda,Millennium,DSP,Remicade,Santen,Kyowa,Hakko,Bonalon,Teijin,Asahi,Kasei,Sanofi,aventis,Clexane,SC,Women,Lunabell,Nippon,Shinyaku,Sugi,Pharmacy,Fuso,Heparin,Ito,Ham,Sciences,LMW,Eisai,Appeal,Antidementia,UK,Korosho,Wholesalers,Abbott,Pfizer,Macugen,Astellas,Ramosetron,Terumo,Antagonist,Muscle,Relaxant,Petitioned,Natalizumab,Orphan,Banyu,Isentress,Daiichi,Sankyo,Olmetec,Calblock,Japanese,Version,FDA,LDP,Life,Science,Summit,NIH,OSCHR,FPMAJ,Pricing,System,Reform,Takeshima,Endo,Chuikyo,AMITIZA,IBSC,Mycamine,Taflotan,Glaucoma,Denmark,FK506,Modified,Release,Formulation,Liver,Transplants,Advisory,Committee,Fospropofol,Eisai,AstraZeneca,Iressa,Agranulocytosis,ADR,Carbapenem,Zulueta,Eli,Lilly,Ikuo,Ogihara,Itaru,Kojo,Kyorin,Reed,Maurer,Obituary,Yutaka,Mizushima,LTT,Bio,Nihon,Chouzai,Mylan,JPMA,MTPC,Choseido,Towa,JMA,Immunomodulator,AZ,Olympus,MediPhysics,Tohoku","No.2090 Contents")

st++; thePage[st]=new Array("2089_may_5.pdf","pdf/2008_5/","2089 May 5 & 12","BI,Banchi,Micardis,Barner,Contract,Leuchs,Eisai,MGI,Naito,Aoki,Ishii,Executive,President,Astellas,OB,GYN,Lunabell,Nippon,Shinyaku,PAH,Actelion,BACE,CoMentis,Kyorin,Flutiform,SkyePharma,Kyowa,Hakko,Antibody,Cancer,Arana,Australia,DSP,Lonasen,Yoshitomi,Chugai,NHI,Revisions,JPMA,Daiichi,Sankyo,Nexavar,DPC,Price,cutting,CDFS,Heparin,Korosho,Quality,Control,Tokku,PMDA,Hyperinsulinemic,Hypoglycemia,Schering,Plough,Novartis,DPP,Inhibitor,Vildagliptin,Rotarix,GSK,Pegintron,Rebetol,Validity,Tamiflu,iPS,Cells,Yamanaka,Nakahata,Kyoto,NIBIO,Kitasato,KCRC,Emergency,Budgets,Pramipexole,Sleep,Disturbance,RLS,Pulmicort,Infants,Saiseikai,NHO,Yazaki,Hatori,SSP,Patch,OTC,Smoking,Cessation,Ciganon,CQ,Registered,Carotid,Artery,QOL,J&J,Iressa,Japanese,Lung,ONTARGET,Concern,CV,CKD,Diabetes,Palliative,JMA,Diet,JJ,Conor,Stent,Pfizer,Champix,Depression","No.2089 Contents")

st++; thePage[st]=new Array("2088_apr_28.pdf","pdf/2008_4/","2088 April 28","Janssen,Remicade,Takeda,Bio,Development,Center,Panitumumab,Sanofi,aventis,Patrick,Chocat,Plavix,Kawagoe,Bayer,Yakuhin,Nexavar,RCC,GSK,Amerge,Migraines,Pfizer,Revatio,Pulmonary,Arterial,Hypertension,Banyu,Singulair,Asthma,Allergic,Rhinitis,Asahi,Kasei,Recomodulin,DIC,Syndrome,Ain,Pharmaciez,Eisai,Acquisition,MGI,Feiba,Korosho,Irbesartan,ARB,Chugai,Actemra,RA,Novartis,Exjade,Iron,Overload,Julina,Hormone,Replacement,Humira,Abbott,Famvir,Herpes,Zoster,Sutent,GIST,RCC,Wholesalers,Korea,China,Ethnic,Tominaga,Tohkin,Mori,Nagata,EFPIA,Astellas,Asia,Pharmacovigilance,PDUFA,IV,EPPV,Kishida,JMA,Pandemic,Vaccine,GL,Biosimilars,Forsteo,GIOP,Eli,Lilly,MORAb003,MORAb009,Orphan,Welchol,ACE,AACE,Daiichi,Sankyo,ADR,Data,Vitamins,NichiIko,GDAJ,Multinational,Ono,AZ,JUPITER,Yamanaka,Human,iPS,Cells,Lipitor,Angina,Attack,Limaprost,Alfadex,Cervical,Spondylosis,Device,Lag,LDP,DS,Biomedical,Serum,Free,Medium,JAN,Codes,Material,Sanko,Junyaku,CoaguChek,XS,FALCO,Biosystems,Oncomics,Gene,Testing,Schizophrenia,Elderly,Asthma,Hepatitis,IFN,Treatment,Tokyo,Medical,Institutions,Dementia","No.2088 Contents")

st++; thePage[st]=new Array("2087_apr_21.pdf","pdf/2008_4/","2087 April 21","Takeda,Millennium,Oncology,IBD,Inflammation,Shionogi,Teshirogi,Diovan,Rep,Track,JHSF,Alzheimer,Disease,Datamonitor,Mohrus,Tape,Hisamitsu,Akiyama,Jozai,Personnel,Orchid,India,Rao,Sawai,Nihon,Chouzai,Muto,Ogata,Korosho,Nakagaki,Kameda,Medical,Center,PMDA,Chief,Executive,Autologous,Cells,LDP,FDA,Eisai,E2007,Parkinson,Kobayashi,PhRMA,iPS,Yamanaka,JSRM,Human,ES,JPMA,MediciNova,MN166,Multiple,Sclerosis,UMN,Vaccine,Flu,Nano,Carrier,Micelles,Nucleic,Acid,TOUDAI,TLC,Kringle,AnGes,MG,NFkB,Decoy,Oligo,Actos,Progression,Atherosclerosis,IVUS,Prasugrel,ST,PCI,Daiichi,Sankyo,Regression,Crestor,QCA,AZ,Levitra,Hypercholesterolemia,Bayer,Livalo,Lipitor,Coronary,Arterial,Plaque,Pharmacists,JACDS,Rohto,Switch,OTC,Recurrent,Vaginal,Candidiasis,Philip,Carrigan,NCC,Advanced,Hepatitis,Viral,Infections,Chugai,JAOG,Uterocervical,Cancer,Body,Turning,Point,Novo,Nordisk","No.2087 Contents")

st++; thePage[st]=new Array("2086_apr_14.pdf","pdf/2008_4/","2086 April 14","DSP,Teijin,Osteoporosis,Dong,Wha,Korea,Takeda,Prostate,Cancer,Cell,Genesys,JPRI,Sabin,Inactivated,Poliovirus,Vaccine,Asahi,Kasei,Chugai,Sales,Structure,Mochida,Mediceo,Paltac,Korosho,Public,Hospital,Idaikyo,Kyowa,Hakko,Coversyl,Daiichi,Sankyo,GSK,Zantac,Bio,Development,Center,Hitachi,Inspharma,Shares,Patent,Infringement,Litigation,Actos,Quintiles,Mizushima,LTT,Bio,Mitsuo,Sawai,GEDA,NPhA,Ushimaru,Tsuchida,Chuikyo,ADRs,Heparin,PSJ,Symposium,Ajinomoto,Gasmotin,Niflec,Anticoagulant,Pradaxa,Boehringer,Ingelheim,Alimta,CHMP,NSCLC,First,Line,Eli,Lilly,Naglazyme,FDA,FG2216,FG4592,Astellas,Eisai,E2012,Alzheimer,JIA,MTX,Acute,Piroxicam,Ampiroxicam,Interferon,Hepatitis,Traffic,Accidents,Parkinson,Olopatadine,Award,Kirin,Toxicity,Screening,iPS,Cells,JCLIPNET,KoNECT,MediciNova,MN221,Asthmaticus,LY450139,Biopharmaceutical,PhRMA,Actemra,RA,Roche,JACRI,Reagents,LDP,Devices,Counterfeit,Cialis,Website,JPMA,Yamane,Karasawa,JMA,Family,Physicians,Depression,Diagnosis,Smokers,Exam,Peripheral,Arterial,J&J,Antidepressants,OffLabel,Chronic,Pain,Relief,Consortium,Advanced,Baby,Delivery","No.2086 Contents")

st++; thePage[st]=new Array("2085_apr_7.pdf","pdf/2008_4/","2085 April 7","Isao,Teshirogi,Shionogi,President,DSP,Masayo,Tada,Toyama,Chemical,FJPWA,Matsutani,Ono,Evotec,Pfizer,Nagoya,Laboratories,Teikoku,Medix,Nichiiko,Sawai,Nippon,Chemiphar,Sandoz,Medisa,Shinyaku,JGPMA,PSJ,Symposium,Sakaeda,Generics,PMDA,Chief,Executive,Chuikyo,NHI,AnGes,MG,NDA,HGF,Gene,Trianda,SymBio,HUMIRA,Polyarticular,JIA,Abbott,DAPTACEL,Sanofi,Pasteur,Merck,GARDASIL,Priority,Review,Campaign,Multinational,Asian,Mori,Takeda,Discontinues,TAK475,Daiichi,Sankyo,MorphoSys,Alexion,Eculizumab,Human,Hemin,Anticoagulants,Pathological,Thrombosis,Hemorrhage,Mevalotin,CAD,Migraines,QT,Proarrhythmia,OTC,Isoconazole,Nicotinell,TTS","No.2085 Contents")

st++; thePage[st]=new Array("2084_mar_31.pdf","pdf/2008_3/","2084 March 31","Takeda,Astellas,Kissei,Kanzawa,GSK,Adoair,NBI,Pfizer,eDetailing,Spiriva,Korosho,FJPWA,FPMAJ,EDC,Quintiles,FUJIFILM,TOB,Toyama,Chemical,NHI,Revision,APIs,Generics,Amlodipine,Sawai,Quality,Chemiphar,TV,Commercial,Architecture,Synix,Tavocept,ASKA,JCROA,CRO,JAPhMed,FDA,EMEA,EDC,Oncolys,IND,HIV,Festinavir,Femara,Breast,Cancer,Tamoxifen,Novartis,GSK,HPV,Vaccine,Cervarix,QT,Syndrome,JPS,Philip,Carrigan,PET,Facility,Bankrupt,PMDA,Review,Division,Pentasa,Nisshin,Kyorin,Blopress,Diuretic,Regenerative,Allogenic,Cells,Standard,Chemotherapy,April,DPC,Kodama,JPA,Chronic,Kidney","No.2084 Contents")

st++; thePage[st]=new Array("2083_mar_24.pdf","pdf/2008_3/","2083 March 24","Sanofi,aventis,Fauchet,Plavix,Allegra,Tawara,Alfuzosin,Rimonabant,Trovax,M'sScience,SA4503,Takeda,Novo,Nordisk,Liraglutide,Eilersen,Insulin,Analogs,Suzuki,Pfizer,Korosho,Vaccine,Gap,EFPIA,Recall,Heparin,Baxter,Fuso,Graduates,MTPC,MRs,Daiichi,Sankyo,Evista,Janssen,Durotep,Patch,Taisho,Biofermin,TOB,JCR,TPG,Biotech,Hokkaido,Biopharmaceuticals,NichiIko,Teikoku,Medix,Suzuken,Torrent,CareNet,Towa,NichiIko,NBI,Nishikawa,Zeria,FD,Astellas,Lilly,Inhaled,Oncolys,TT033,Tacere,Reyataz,HIV,Loxonin,Tape,Lead,Chemical,Drugstores,JACDS,Doug,Berger,Galvus,Metformin,Novartis,Positive,Opinion,CHMP,FK506,Modified,Release,Kidney,Recipients,Prepandrix,GSK,FDA,Cimzia,RA,UCB,Accelerated,Avastin,Roche,Injectafer,Jelly,Aricept,US,Embassy,ACCJ,Herceptin,KL6,Diagnosis,ILD,Eisai,Sanko,Junyaku,Fujirebio,Asahi,Kasei","No.2083 Contents")

st++; thePage[st]=new Array("2082_mar_17.pdf","pdf/2008_3/","2082 March 17","Eisai,Kyowa,Hakko,KW8761,Amgen,Nippon,Shinyaku,NS304,Actelion,Bendamustine,SymBio,Herceptin,Chugai,NPhA,Korosho,Pharmacy,Quintiles,HMS,Claritin,Rep,Track,NHI,Prices,ARBs,SSRIs,Reduction,Rates,Vasolan,Tachyarrhythmia,Aloxi,Prevention,PONV,MTPC,Hebsbulin,IH,Pentasa,Pediatric,Nisshin,Kyorin,GSK,Adefovir,Novartis,Aliskiren,Mylan,Coury,Marianna,JPA,Cravit,Generics,Collaborative,Multinational,Iressa,AstraZeneca,Oncolys,BioPharma,Medigen,Biotech,Telomelysin,Takara,Bio,Immunity,Reconstruction,SNBL,Granisetron,Everolimus,PFS,Renal,Patients,Novartis,MEXT,iPS,Cell,Nicotinell,TTS,OTC,Salonpas,Hisamitsu,Pompe,Kawai,Molecular,targeted,Renal,Carcinoma,Akaza,Clexane,VTE,sanofi,aventis,Karasawa,Candidacy,Daiichi,Sankyo,Public,Awareness,TV,Commercial,Female,MR,Society","No.2082 Contents")

st++; thePage[st]=new Array("2081_mar_10.pdf","pdf/2008_3/","2081 March 10","Pfizer,Norvasc,Sunitinib,OD,Tablet,IMS,Blopress,Nippon,Shinyaku,OB,GYN,IKH-01,Alfresa,Tanpei,Nakata,Schering,Plough,Organon,Imigran,Headaches,GSK,Humira,Irbesartan,Methotrexate,Sutent,Famvir,Chugai,Capecitabine,Bevacizumab,Oxaliplatin,Takeda,Ramelteon,Insomnia,Teijin,Gout,TMX-67,Kyowa,Hakko,Istradefylline,Piroxicam,Korosho,Toledomin,PMDA,Herceptin,Adjuvant,Breast,Cancer,Cephalon,Treanda,Sanofi,Pasteur,ID,Influenza,Vaccine,Plaque,Psoriasis,Abbott,Asmanex,Twisthaler,Asthma,BIBW2992,Boehringer,Ingelheim,Reed,Maurer,Kitasato,Harvard,Symposium,Mori,PMDA,Harada,Antibody,Nucleic,Acid,Morishita,iPS,Cells,Avastin,Metastatic,Seikagaku,Gel-200,SSI,Tuberculosis,NIBIO,GCP,Gore,TAG,Thoracic,Aorta,Graft,Dornier,Epos,Ultra,Shionogi,Allerport,TARC,EVAR,AAA,Cook,Medical,Terumo,Eluting,Stent,DPC,Hospitals,Muto,Takashi,Kodama,JPA,President,Karasawa,JMA","No.2081 Contents")

st++; thePage[st]=new Array("2080_mar_3.pdf","pdf/2008_3/","2080 March 3","Daiichi,Sankyo,Prasugrel,DU176b,VTE,Rivoglitazone,HbA1c,Pioglitazone,First,Track,Toyobo,Plavix,sanofi,aventis,Statins,Invoice,Prices,Hamada,Toho,Iberica,Halved,Urushibata,Pasteur,ActHIB,IBL,Water,Soluble,Creatine,Muto,Wholesalers,Hansha,Compensation,Stock,Option,Japan,Reed,Maurer,FUJIFILM,Toyama,Nexavar,NSCLC,Bayer,Onyx,Takeda,Merck,Serono,Matuzumab,CMIC,Antibody,Dyax,NCCHD,Unapproved,GCP,Horie,Korosho,iPS,Eli,Lilly,Autologous,Cells,Liver,Cancer,Medicoeconomic,Assessment,Kamae,JPMA,NHI,Pricing,Reform,OPC67683,CC5013,Lenalidomide,Orphan,Drugs,Celgene,OTC,NPhA,Diabetic,Progression,CV,Surgery,Facilities,Bankruptcy,Pfizer,Supports,NGOs,Tobacco,Breast,Blood,Pressure,Antihistamines,Inadequate,Pollinosis","No.2080 Contents")

st++; thePage[st]=new Array("2079_feb_25.pdf","pdf/2008_2/","2079 February 25","FUJIFILM,Toyama,Chemical,Taisho,DSP,Lurasidone,Amlodin,OD,TOB,Biofermin,Mochida,Baxter,Kawabata,Korosho,SSP,Drewell,AZ,Novartis,Galvus,Eisai,India,Accenture,GSK,Revision,Medical,Fees,Chuikyo,Prescription,Alteplase,Dementia,Depression,Tsuchida,NHI,JPA,MTX,JIA,Heparin,Adverse,Reactions,Watson,NDA,Silodosin,Kissei,Avastin,Roche,Dabigatran,Boehringer,Ingelheim,Noxafil,Antifungal,Prophylaxis,Schering,Plough,EMEA,Tamiflu,Relenza,JPMA,Novo,Nordisk,Transpulmonary,Insulin,AERx,Lipitor,Simvastatin,Pfizer,Mevalotin,NFkB,Decoy,Oligo,Atopic,Dermatitis,Sosei,Myozyme,Pompe,Genzyme,Shionogi,Philip,Carrigan,LDP,Mediceo,Paltac,Hansha,Eguchi,Seibu,Sawai,Poster,Piecework,IFN,Narcotics,MRI,EOB,Primovist,Databases,ADR,Karasawa,JMA,Hakui,Diovan,Advertisements,","No.2079 Contents")

st++; thePage[st]=new Array("2078_feb_18.pdf","pdf/2008_2/","2078 February 18","Takeda,Amgen,Stock,Aricept,Pariet,AcipHex,Eisai,Nobelpharma,Takara,Bio,Protein,Regulation,Astellas,Choseido,Shionogi,ASKA,Colorcon,Dow,Cellulose,Korosho,France,JPMA,Reduction,CO2,Herceptin,Postoperative,Adjuvant,Chemotherapy,EPPV,Velcade,Alimta,MRs,Daiichi,Sankyo,Injectafar,Pregabalin,FMS,E7389,Otsuka,OPC67683,Celgene,CC5013,Ienalidomide,Orphan,Arixtra,Fast,Track,Actos,DPP4,Inhibitor,Prograf,ASP9813,TMDU,Nippon,Chemiphar,NC2300,Autoimmune,CDK,RA,Denosumab,BMD,Alendronate,AZ,Crestor,Lipitor,PhRMA,GLIT,Glycotechnology,Taiyo,Towa,Overnight,Delivery,Hansha,Novartis,Sandoz,Maurer,Reed,COPD,NBI,Pfizer,Switch,OTC,Flavoxate,Paltac,JACDS,JSMI,PAL,Amendment,JPA,IFN,Etanercept,Kyushu,Medical,Association,Karasawa,Osaka,LDLC,HDLC,Arteriosclerosis,PSA","No.2078 Contents")

st++; thePage[st]=new Array("2077_feb_11.pdf","pdf/2008_2/","2077 February 11","Chugai,Takeda,Amgen,Bayer,EOB,Primovist,MRI,Liver,Mediceo,Paltac,Pharmacies,Shigeo,Oyagi,Teijin,Osamu,Nishikawa,Eisai,Acquisition,MGI,Abbott,Scheme,Adalimumab,ARBs,SSRIs,Repriced,Consultation,Chuikyo,NHI,Pricing,Revision,Stroke,Mental,Illnesses,Actemra,RA,Daiichi,Sankyo,Gracevit,DSP,Lonasen,Schizophrenia,Nexavar,Zevalin,Singulair,Kipres,Allergic,Rhinitis,Asahi,Kasei,Licomodulin,Pfizer,Revatio,Champix,Sanofi,aventis,Clexane,Amerge,GSK,Migraines,Keiji,Nakamura,Multinational,JMACCT,Mori,PMDA,Live,Vaccine,Influenza,Otsuka,Peptide,OTS,Kyorin,Merck,ClioScience,CRO,China,Adoair,Zyrtec,Flunase,Pollinosis,Burden,Mylan,Seiyaku","No.2077 Contents")

st++; thePage[st]=new Array("2076_feb_4.pdf","pdf/2008_2/","2076 February 4","Nihon,Chouzai,Mitsuhara,Medical,Pharmacy,Kashiwagi,CFS,Ain,Pharmaciez,AEON,Okada,Mochida,Yakkasa,FPMAJ,Morita,Wholesalers,FJPWA,Matsutani,Preminent,Rep,Track,Nissin,Yamagata,Solvay,Kawagoe,Teva,CoGenesys,Regpara,Hyperparathyroidism,Kirin,Claritin,Dry,Syrup,Schering,Plough,Shionogi,Eli,Lilly,Humatropen,Film,Metformin,Nippon,Shinyaku,Sonet,M3,SSRI,SPONSOR,FEATURE,Revision,Fees,Chuikyo,Pricing,PhRMA,APIs,Nexavar,Champix,Insurance,COI,GL,Avamys,GSK,FDA,Mycamine,Astellas,Welchol,Diabetes,Daiichi,Sankyo,Pfizer,Chantix,Labeling,Stelic,STNM,Stenosis,Crohn,MolMed,HSV,TK,Gene,Italy,Takara,Bio,RetroNectin,Kyoto,iPS,Cell,Aoki,Korosho,MD,Patent,Law,Akimoto,JPMA,Takeda,Hematide,Boehringer,Ingelheim,Enrollment,RELY,Kringle,Tripep,ChronSeal,Sosei,COPD,Novartis,Cardiac,Reagent,NTproBNP,RDKK,Scorba,EX,Athlete,Antipruritic,Pabron,Ace,AX,Ambroxol,Taisho,Cholesterol,Hamazaki,Antihistaminics,sanofi,aventis,Debt","No.2076 Contents")

st++; thePage[st]=new Array("2075_jan_28.pdf","pdf/2008_1/","2075 January 28","Mundipharma,Takeda,SYR322,TAK390MR,Hasegawa,Kissei,ALI,ARDS,Pneuma,Merger,Ain,Pharmaciez,CFS,Ishida,Pharmacy,JJ,Nicorette,Nippon,Shinyaku,Baynas,Novartis,Lochol,Sanofi,Pasteur,Crucell,Biologicals,Rabies,Chugai,Murray,Merz,Mediceo,Kobayashi,Stock,Swap,Kobashou,eDetails,Sonet,M3,Aggregate,Market,Value,Bioventures,Ihoken,Baxter,Yoshiki,Kawabata,Sawai,NichiIko,Kayaku,JGPMA,MEXT,iPS,METI,EDC,JPMA,Vildagliptin,COI,Organon,NDA,Sugammadex,PrePandemic,Vaccines,Life,Expectancy,Nagano,Okinawa,OTC,Miwa,JPA,JSMI,FPMAJ,Morita,Switch,Terbinafine,Zeria,Dooley,Chairman,Japan,Intraocular,Lens,Association,Pfizer,Auctions,Internet,Sekisui,Medical,Asahi,Leukocyte,Depletion,Filters,Fujirebio,Rebio,Gen,Philip,Carrigan,Advanced,Insurance,Coverage,Chuikyo,Fees,Hepatitis,Victim,Relief,Act,Diet,Drug,Related,Tragedies,JPMA,Aoki,OB,GYN,JMA,Nakanishi,Kodama,Election,PMDA,Chief,Executive,Akira,Miyajima","No.2075 Contents")

st++; thePage[st]=new Array("2074_jan_21.pdf","pdf/2008_1/","2074 January 21","Yakkasa,SYR322,TAK390,Takeda,LCM,Prograf,Vesicare,Astellas,Olmesartan,Prasugrel,Daiichi,Sankyo,Eisai,MTPC,Amlodipine,DSP,NDAs,Blockbusters,Meiji,Seika,Taisho,TS032,Pfizer,Mochida,Analgesic,Wyeth,Novartis,Tsukuba,Research,Institute,Ihoken,Matsutani,PMDA,Review,OTC,Miyajima,Korosho,NichiIko,Overnight,Fuji,Keizai,Nippon,Chemiphar,MSS,Konoike,Transport,Repricing,Isobe,FPMAJ,EAD,Aoki,Cephalon,NHL,Bendamustine,SymBio,Local,Data,Precaution,Abnormal,Behavior,Relenza,Symmetrel,Package,Inserts,Dinagest,Endometriosis,Tacere,RNAi,Hepatitis,Toyama,T705,China,Anticancer,Consultation,Antibody,Taxotere,Overall,Survival,Breast,Cancer,sanofi,aventis,thrombotic,AVE5026,Glivec,Leukemia,Novartis,Maurer,Downsizing,Smoking,Teijin,Home,Equipment,HealthNet,MedSolution,Imaging,Protosera,Biomarkers,Scleroderma,Malfunction,Reimbursement,Chemotherapy,DPC,Counterfeit,Kimura,Salagen,JMA,Karasawa,Hospitalized,Albumin,Air,Borne,Pollen","No.2074 Contents")

st++; thePage[st]=new Array("2073_jan_14.pdf","pdf/2008_1/","2073 January 14","JPMA,Aoki,AstraZeneca,Breast,Cancer,Blopress,Aricept,Severe,Alzheimer,Eisai,JCR,JR,Mochida,Ono,Thrombopenia,Nissan,Novartis,Asahi,Kasei,Voltaren,Preminent,NBI,Daiichi,Sankyo,Asian,Business,Singapore,Nippon,Kayaku,GSK,China,CMIC,Brazil,Astellas,Cefzon,Aricept,Novartis,Sugio,Seko,Teva,Generics,Urushibata,Welfare,Recipients,Korosho,Budget,Social,Security,Nexavar,Licomodulin,Zevalin,Abnormal,Behavior,Tamiflu,Teens,Errors,NDA,Data,Chugai,FPMAJ,Yakkasa,GMP,Standard,Clinical,Trial,Documents,Pfizer,Glaucoma,NicOx,AIST,JBA,Glycotechnology,METI,Innovative,BCS,Autologous,Skin,CDFS,CARTO,XP,JJ,powell,Kongyo,Shinryo,JAPhMed,ED,Arteriosclerosis,Eli,Lilly,Abuse,Headaches","No.2073 Contents")

st++; thePage[st]=new Array("2072_jan_7.pdf","pdf/2008_1/","2072 December 31 & January 7","Ira,Wolf,AstraZeneca,Brennan,Kato,aRigen,ARB,CF,Axentis,Otsuka,Busulfex,PDL,BioPharma,Eisai,Neo,Minophagen,GSK,Anticancer,Arranon,G,for,TALL,LBL,Tarceva,NSCLC,Chugai,Beraprost,PAH,Toray,Kaken,Astellas,Asubio,Biopten,Shionogi,Lawsuit,Crestor,ANDAs,Toho,Korosho,MOF,NHI,PMDA,Xeloda,Postoperative,Adjuvant,Colorectal,Taxol,Breast,Banyu,Quadrivalent,HPV,Vaccine,Wyeth,Viviant,Takeda,Basen,NBI,Tax,Break,Reform,JPMA,Takeda,Lu,AA,Ms,Science,SA,Cerebral,Infarction,Erbitux,Metastatic,Liver,mCRC,Pramipexole,Dyskinesia,Parkinson,Arimidex,ABCSG,Tamoxifen,ATAC,MR,Certification,Isoconazole,Emedastine,OTC,Matsumoto,JACDS,Taisho,RiUP,Plus,SSP,Kyowa,Banyu,Preminent,Losartan,Serum,Uric,Acid,Kyowa,Medex,Trinity,Biotech","No.2072 Contents")

st++; thePage[st]=new Array("2071_dec_24.pdf","pdf/2007_12/","2071 December 24","Eisai,Oncology,MGI,Pharma,Downgrade,Plavix,Antithrombotics,IMS,Pfizer,Novo,Nordisk,Revemir,Geninax,ASKA,MPS,JCR,Alfresa,Nobelpharma,Nobelzin,AnGes,Dermatological,Maruishi,DSP,Suzuka,Kirin,TOB,Kyowa,Hakko,CMIC,VPS,Amgen,Mark,Timney,Banyu,RePricing,Revision,Long,Listed,Morita,Bargaining,Kenporen,JMA,Fees,APIs,NHI,Listing,Deaths,Enbrel,Wyeth,Ono,NDA,Sitagliptin,Roche,MAA,Actemra,RA,Donations,CDFS,IFN,Reed,Maurer,Takeda,Pharmacists,Nextit,Astellas,Oral,Xa,Inhibitor,Controlled,Release,Prograf,Appearance,IBD,JHSF,SymBio,Bendamustine,Rivaroxaban,Enoxaparin,Bayer,Zevalin,PFS,FL,BI,Dabigatran,ACS,Philip,Carrigan,Nasal,Mucus,Influenza,Diagnostic,Kit,Migraines,Home,Imigran,GSK,Insurance,Coverage,TWMU,Prostate","No.2071 Contents")

st++; thePage[st]=new Array("2070_dec_17.pdf","pdf/2007_12/","2070 December 17","NBI,PSP,Alesion,Livalo,Female,MRs,Retention,Rates,CMIC,PVC,HVC,Site,Support,Institute,EPS,Yan,Hao,JapanBridge,Anticancer,Stock,Exchange,NEO,Bioventures,Court,NICE,Verdict,Alzheimer,BMS,Novartis,Ritalin,Eisai,Manufacturing,India,Sanofi,aventis,Vaccine,China,Plant,BI,Kringle,Tokyo,Science,Tsukuba,Hospital,RePricing,Adjustment,FJPWA,FPMAJ,Long,Listed,Original,Morita,Pediatric,CDFS,Chugai,PMS,Tarceva,NHI,Reform,Eli,Lilly,Platelet,Peanut,Skins,BioArctic,Neuroscience,BAN,TSD,COLAL,PRED,Alizyme,Regeneron,Fully,human,Therapeutic,Antibodies,SCH,Aggregation,PCI,Schering,Plough,TEMODAR,Survival,GBM,FORTEO,Spine,BMD,Enbrel,Methotrexate,RA,Wyeth,Amgen,CORONA,Crestor,Heart,Failure,Yamazaki,UPLIFT,Spiriva,COPD,Oya,Sutent,Renal,Cancer,CRC,Training,Course,Generics,Dispensing,Fee,Prescription,Form,Kurabo,Contract,HPV,Genotyping,METIS,Medtronic,Keio,eTraining,Kawasumi,Korosho,Withdraw,Appeal,Blood,Concentrations,Budesonide,Detection,Breast,Fed,Babies","No.2070 Contents")

st++; thePage[st]=new Array("2069_dec_10.pdf","pdf/2007_12/","2069 December 10","Astellas,Fujisawa,sanofi,aventis,Agensys,Geninax,Ethical,Aricept,Takepron,Gaster,Ulcers,DSP,Gasmotin,China,Baxter,Dissolve,Advate,Sonet,M3,Nielsen,Market,Survey,MRs,Banyu,Retirement,Mochida,Beselna,ACCJ,Informatization,Chuikyo,JMA,Market,Price,Gap,Wholesalers,Janssen,Prezista,NHI,List,Partial,Xeloda,Taxol,Recommended,Eisai,NDA,KES,Obesity,Wyeth,Mircera,Roche,Tasigna,Novartis,PEGINTRON,REBETOL,Hepatitis,Schering,Plough,BLA,Actemra,RA,Raltegravir,Orphan,LDP,Consumption,Tax,FDA,Abnormal,Behavior,Varenicline,Reliefn,Hospital,Korea,Network,Universities,Sosei,PI,SD,AD,Seikagaku,SI,NichiIko,Reliability,Generics,JMA,Prescription,JGPMA,IGPA,Kobashou,Mediceo,Merger,Taisho,Switch,OTC,Ambroxol,SSP,STAC,EVE,FINE,NIPRO,Manufacturing,Eiken,Influenza,Virus,Detection,Kit,Korosho,Council,Kongo,Shinryo,Deregulations,Ban,Shimada,Osteoporosis,GL,JOS,Once,Weekly,Bisphosphonates,OB,GYN,Estrogens,Physicians,Bone,Mass,Evening,Dialysis,Services,Pharmacists,Cancer","No.2069 Contents")

st++; thePage[st]=new Array("2068_dec_3.pdf","pdf/2007_12/","2068 December 3","Kyowa,Hakko,Kirin,Matsuda,Antibody,Takeda,ASKA,ZERIA,Fuso,Wakamoto,Rysmon,CMIC,SS,CMO,EPS,Diovan,Rep,Track,Revision,Premium,NHI,ARBs,Niwa,Prescription,Aoki,Rocephin,Once,Daily,Children,Nexavar,Liver,Cancer,Bayer,Onyx,Korosho,Psychotropic,AstraZeneca,JOINT,Risedronate,Vitamin,IMMD,Shionogi,Seikagaku,SI,Novartis,QVA,Sanofi,Pasteur,Influenza,Vaccine,Merck,Serono,AS,Rigel,PhARMA,Ono,Nisshin,Carcinogenicity,Insulin,Glargine,MI,aventis,Kobayashi,Paltac,Kobashou,Merger,Suzuken,Household,Rohto,OPINION,Philip,Carrigan,CareNet,Recruit,Olympus,Nipro,Eiken,Chemical,Miraca,Holdings,Takara,Bio,JGPMA,Kongo,Shinryo,Pneumococcal,Vaccination,Banyu,Adoair,GL,Medicinal,Narcotics,Pain,Relief,Dependence,Self,injection,Enbrel","No.2068 Contents")

st++; thePage[st]=new Array("2067_nov_26.pdf","pdf/2007_11/","2067 November 26","Genzyme,Ono,Santen,DE,Kaken,KCB,Regeneration,Periodontal,Tissue,Artz,Seprafilm,Kyorin,Mochida,Epadel,Atelec,Kissei,Urief,Glufast,Bezatol,Cabaser,Nippon,Shinyaku,Maekawa,Toyama,Chemical,Yakult,Honsha,Elplat,Seikagaku,Nissan,Wholesalers,Mediceo,Paltac,Alfresa,Tanpei,Nakata,CS,Yakuhin,Suzuken,Toho,AnGes,MG,NFkB,Decoy,Oligo,Meyer,Meiji,Seika,Meiact,Depromel,Avonex,Biogen,Idec,Astellas,BI,Settlement,Ranbaxy,Flomax,Patent,FJPWA,Jasdaq,Bioventures,NEO,Taiyo,Sawai,Towa,Yoshida,Chemiphar,Uralyt,Prescription,NPhA,JPA,Korosho,Sharma,Chairman,Kyowa,Blopress,Onset,Diabetes,Takeda,Actemra,RA,DMARDs,Fenofibrate,Retinopathy,FIELD,GARDASIL,HPV,Infection,Banyu,Zevalin,Progression,Free,Survival,Lymphoma,Bayer,Exenatide,TRA,Schering,Plough,IBL,Osteopontin,Antibodies,Nateglinide,Biguanides,Remicade,Maintenance,Therapy,Crohn,Tebipenem,Crestor,Inverness,Aska,Diagnostics,Iwaki,POLA,Estradiol,Gel,Kongo,Shinryo,JMA,Comtan,Parkinson,Pediatric,Otitis,Media,Salaries,Eli,Lilly,Mentor,System,Female,MR","No.2067 Contents")

st++; thePage[st]=new Array("2066_nov_19.pdf","pdf/2007_11/","2066 November 19","Daiichi,Sankyo,Prasugrel,Olmesartan,Shoda,Takeda,Actos,FDA,TAK,RA,Depressants,Astellas,Lipitor,Crestor,DSP,Amlodin,Gasmotin,Blonanserin,YOSHITOMI,Taisho,MTPC,Shionogi,Crestor,Doripenem,IMS,Ono,Kinase,Inhibitor,Locus,KAKETSUKEN,Baxter,Sanwa,Kagaku,Kolon,South,Korea,Bayer,Trasylol,Yakuhin,Pfizer,Exubera,Nektar,Tamiflu,Chugai,Selara,Hypertension,NHI,Prices,PMDA,NDA,Review,Abilify,Rivaroxaban,VTE,EU,Sanofi,aventis,NV,FGF,Korosho,Serious,CV,Events,AHA,Alexander,Hematide,Takeda,CORONA,Betaferon,Disability,MS,Imatinib,Dasatinib,CML,Boceprevir,Virologic,Response,Schering,Plough,Pegasys,Copegus,PegIntron,Roche,GNI,Patents,Hepatic,Fibrosis,China,Dispensed,Prescriptions,Substitution,Pharmacies,Urushibata,OTC,IDF,DM,Postprandial,Glucose,Vaccination,Uterine,Cervical,Cancer,Dyslipidemia,Metastron,JPA","No.2066 Contents")

st++; thePage[st]=new Array("2065_nov_12.pdf","pdf/2007_11/","2065 November 12","Pfizer,Simultaneous,Prasugrel,Clopidogrel,Taisho,LOI,Debiopharm,DACH,platin,MediCelle,NanoCarrier,Eisai,Aricept,Tanabe,Remicade,MPC,Kyowa,Hakko,Kogyo,Kirin,Matsuda,HIV,Teijin,Pharma,Osteoporosis,Asahi,Kasei,SSP,Spiriva,NBI,PCPs,COPD,Janssen,Concerta,ADHD,Merck,Serono,Banyu,Degussa,Evonik,Dovonex,Teikoku,Medix,Torii,Meiji,Seika,Ciproxan,Novartis,Patent,Infringement,Neoral,Astellas,India,Kimura,Mundipharma,NHI,Biannual,Sawai,Shortfall,JMA,Depression,Ritalin,Antidepressants,Suicide,FDA,TAK,Takeda,Korosho,Kissei,Salagen,Dryness,Sjφgren,Syndrome,Nexavar,HCC,Bayer,Tasigna,Menactra,Pasteur,Taxotere,CHMP,sanofi,aventis,ACCJ,Parkinson,Ono,Medarex,MDX,Hepatitis,AMG,AnGes,TS,Taiho,CRESTOR,AstraZeneca,Shionogi,Female,MRs,Films,Imaging,Wako,Pure,Chemical,Micro,RNA,Cloning,JJ,Mebix,Blood,Glucose,Otsuka,WT,mRNA,Terumo,Denka,Seiken,Flu,Vaccines,Mammography,Interferon,Intestinal,Flora,Species","No.2065 Contents")

st++; thePage[st]=new Array("2064_nov_5.pdf","pdf/2007_11/","2064 November 5","JTEC,Autologous,Epidermis,Chugai,Tarceva,EPS,CCPIE,Travatanz,Ophthalmic,Alcon,Ventures,India,Kurogi,Eli,Lilly,GSK,Novartis,Sekiguchi,PhRMA,NHI,Pricing,Kirin,Kyowa,Hakko,DIR,Freund,Adenoscan,Patent,Lawsuits,Astellas,JPMA,Promotion,Code,Lonasen,Clexane,Amage,Nexavar,Zevalin,Gracevit,Prezista,Telavancin,Korosho,Package,Insert,Antidepressants,Mental,Tamiflu,Abnormal,Behavior,PGI,Mochida,Dinagest,Levemir,Novo,Nordisk,Regpara,Hyperparathyroidism,Arranon,Leukemia,Nicorandil,Acute,Heart,Failure,Plavix,Coronary,sanofi,aventis,Maurer,Janssen,LuAA24530,Takeda,GNI,Prasugrel,Daiichi,Sankyo,Pasteur,Malaria,Vaccine,Miraca,Merge,SRL,Kansai,Nipro,BBraun,Eluting,Balloon,Catheter,Olympus,Chiome,JFMDA,Wachi,Endoscopic,Gastric,Cancer,TS1,Inoperable,Radiotherapy,Liver,Hepatitis,MTPC,Varicella","No.2064 Contents")

st++; thePage[st]=new Array("2063_oct_29.pdf","pdf/2007_10/","2063 October 29","Kirin,Merge,Kyowa,Hakko,Eiki,Shionogi,Doripenem,Merck,ImClone,BMS,Erbitux,EPO,Revisions,Forecasts,MR,Education,AstraZeneca,Pfizer,Antibacterials,Datamonitor,Molecuence,Protosera,Haupt,CMIC,Bayer,Patent,Infringement,Lawsuit,Taiyo,Yakuhin,Genzyme,Elaprase,Recombinant,Human,Serum,Albumin,Concerta,Depression,Ritalin,Korosho,Ambulatory,Chemotherapy,Radiotherapy,Imigran,GSK,Claritin,Schering,Plough,ISENTRESS,HIV,Infection,Novartis,Lucentis,PEGINTRON,Positive,Opinion,Hepatitis,Chuikyo,Generics,JGPMA,OHARA,Information,Daiichi,Sankyo,Corning,Epic,Cancer,Pain,Hisamitsu,Sutent,Advanced,Gastric,Glycemic,Macrovascular,sanofi,aventis,Visceral,Fat,Seretide,Advair,COPD,Bazedoxifene,Vertebral,Fractures,Wyeth,Oncolys,Bioventure,Paltac,OTC,Kobashou,Suzuken,Kobayashi,Switch,Philip,Carrigan,Paxil,Suicides,Uterine,Cervical,Paclitaxel,Cialis,ED,Hokunalin,Smoking,Cessation,Fuji,Keizai,JPA,Monitoring,Channel,Blockers","No.2063 Contents")

st++; thePage[st]=new Array("2062_oct_22.pdf","pdf/2007_10/","2062 October 22","Alcon,Rayment,Sanofi,aventis,Teijin,Osteoporosis,Eli,Lilly,Cialis,MEDRx,DDS,Technology,Nipro,Double,Bag,Kit,CWP,Korea,CFS,Ain,Pharmaciez,Merge,Diovan,Kyorin,Bayer,Comarketing,Baynas,Suzuken,Kobashou,Paltac,Taisho,Upward,Early,Retirement,Astellas,Lupin,India,Kyowa,Industry,JPA,Korosho,FDA,PMDA,MediciNova,Asthmaticus,SymBio,SyB,Hematide,Takeda,Atomoxetine,ADHD,Adults,Takara,Bio,Cancer,China,DIA,Collaborative,Hara,Transactions,NovoRapid,Elderly,Novo,Nordisk,Taxotere,SCCHN,Tasigna,Novartis,Medtronic,Implantable,Holter,ECG,Fast,Track,Olympus,Terumo,Liaison,Johannesburg,Insulin,Analogues,JMA,Local,Hepatitis","No.2062 Contents")

st++; thePage[st]=new Array("2061_oct_15.pdf","pdf/2007_10/","2061 October 15","Merck,Serono,Mylan,Mitsubishi,Tanabe,Taisho,Psychiatric,Brain,Cells,EPS,Medidata,Solutions,EDC,Software,VITAL,NET,KSK,Banyu,Singulair,Meiji,Seika,Panaldine,Daiichi,Sankyo,sanofi,aventis,Korosho,Pediatric,Orphan,Chuikyo,Recombinant,Serum,Albumin,Genzyme,Elaprase,Concerta,ADHD,Argatroban,HIT,Physician,Clavamox,GSK,Valtrex,Varicella,Adults,Bayer,Hepatocellular,Carcinoma,Nexavar,Bepricor,Atrial,Fibrillation,Nippon,Organon,Novartis,Patch,Alzheimer,Galvus,PFSB,Package,Insert,Ancaron,FPMAJ,Documents,Kaken,KCB,Regenerate,Periodontal,Tissue,Silodosin,Tamsulosin,Kissei,First,Gene,Therapeutic,Vessels,JMACCT,Multinational,ZD,OS,Prostate,AstraZeneca,Vildagliptin,Blood,Sugar,Influenza,Vaccine,pasteur,Neuropsychopharmacology,Keio,JCA,Mauvernay,Awards,Given,Imaging,Capsule,Endoscope,Takara,LA,PCR,Kapa,Biosystems,Siemens,Mochida,Laryngeal,Fiberscope,Medtronic,LDL,Schering,Plough,Synagis,RSV,Kidney,Transplants,Bernard,Poussot,CEO,Wyeth,Osawa,NBI,Takeda,Oral,OTC,Neck,Shoulder,Kyorin,Kipres,Granules,Toyama,Astellas,Geninax,Eslax,Intravenous","No.2061 Contents")

st++; thePage[st]=new Array("2060_oct_8.pdf","pdf/2007_10/","2060 October 8","Roche,Nagoya,Pfizer,Sekiguchi,JBEC,Chairman,PhRMA,Tanabe,Bepotastine,Besilate,ISTA,JT,Torii,Hyperphosphatemia,Keryx,Kyorin,Nisshin,Prevenar,Larsen,Wyeth,DBV,Viaskiny,Banyu,Fosamac,Paltac,Kobashou,Suzuken,Korosho,Takeda,Kamiya,Bristol,Myers,Squibb,Adnexus,Eisai,Kissei,Glufast,China,Subsidiary,Belgium,Bridge,Kyowa,Hakko,Taiho,TS1,Nippon,Kayaku,CareNet,Plasma,Pheresis,Topina,Partial,Seizures,GSK,Taisho,Labial,Herpes,Yasuo,Fukuda,Yoichi,Masuzoe,LDP,Komeito,Cervical,Cancer,Vaccine,JMA,NHI,Pricing,System,AZOR,Daiichi,Sankyo,Abbott,Adalimumab,Psoriasis,Chugai,Epogin,LTT,Bio,PC,SOD,IL,PE,QQR,Sitagliptin,Hb1A,Exubera,Dabigatran,VTE,Boehringer,Ingelheim,Ihoken,Reed,Maurer,JSGM,NPhA,GUNZE,Biodegradable,Dura,Microscope,Olympus,Alimta,SSRIs,Kenporen","No.2060 Contents")

st++; thePage[st]=new Array("2059_oct_1.pdf","pdf/2007_10/","2059 October 1","Oncodesign,Cancer,Pharmacology,ASKA,LINTEC,MTPC,Computer,Systems,Anstice,Banyu,Hirate,BioJapan,Takeda,Antibody,Nucleic,Acid,Hasegawa,Daiichi,Sankyo,Biopharmaceuticals,Wyeth,Bioventures,JGPMA,JGA,Korosho,Chuikyo,NHI,Price,Listing,Novartis,Withdrawal,Depression,Ritalin,GSK,SAD,Paxil,Arixtra,Coronary,Syndrome,Astellas,FDA,Action,Letter,FK,Modified,Exjade,Fast,Track,PMDA,Asia,CMIC,Epadel,Coronary,Glucose,Metabolism,Abnormalities,Aliskiren,Heart,Failure,Taxotere,NSCLC,sanofi,aventis,ALIMTA,NSCLC,Eli,Lilly,MPM,Zoladex,Prostate,AstraZeneca,Australia,QCTN,Queensland,Olympus,Capsule,Endoscope,Tokyo,Boeki,Machinery,BIOLIS,mini,DSM,Orthopedic,Surgery,Upper,GI,Endoscopy,Auto,LIA,FM,RDK,Patients,JMA,IBS,Pharmacoeconomics,Pharmacogenomics,Araki,Interferon,Irritable,Bowel,Replacement,Hemophiliacs,Bayer,Yakuhin,JSMD,Suicide,Antidepressants,Lung,Androgen,Blockade,Environment,MRs","No.2059 Contents")

st++; thePage[st]=new Array("2058_sept_24.pdf","pdf/2007_9/","2058 September 24","Kashiwagi,sanofi,aventis,AltaCare,Eli,Lilly,GP,Cialis,Taiyo,Yakuhin,Boehringer,Ingelheim,Ablynx,Nanobody,Nihon,MediPhysics,Nippon,Kayaku,Metastron,GE,NBI,Innovex,Sonet,M3,MR,Kyowa,Hakko,Coniel,IPHC,Astellas,Patent,Cefdinir,Chugai,Hepatology,Banyu,Female,Nextit,Korosho,Surveillance,Generics,Towa,Abe,Aoki,Financial,Erikawa,Toguchi,Breast,Cancer,Nishiyama,FTY,Sapropterin,Orphan,Glycerin,OTC,BIBW,Takara,Bio,Anticancer,Immunotherapy,Korean,Chemotherapy,PPAR,Agonists,Obayashi,Legalize,Pfizer,Sunitinib,Erlotinib,NSCLC,Astellas,Alefacept,Fuso,OTS,Colon,ONTARGET,ARB,ACE,Inhibitor,OPINION,Philip,Carrigan,Influenza,Vaccines,European,Coronary,Artery,SDS,CJD,Siemens,Mochida,Kyowa,Medex,Mizuho,Medy,Daiichi,Pure,Chemicals,Sekisui","No.2058 Contents")

st++; thePage[st]=new Array("2057_sept_17.pdf","pdf/2007_9/","2057 September 17","eDetails,Takuma,CareNet,Lundbeck,Takeda,Mood,Anxiety,CSL,Behring,Turner,SymBio,PEG,ZnPP,Eisai,Salix,COLAZAL,GSK,Zantac,Toho,Wholesaler,China,Leuplin,Takeda,Diovan,Blopress,IMS,Female,Taiyo,Tablet,Production,Capacity,Subsidy,Takayama,JA,Zenkouren,ASKA,Retirement,MPC,Tanabe,DDD,Technical,Minister,Nursing,Korosho,Social,Security,Spending,ADRs,Influenza,Vaccines,EFPIA,Arixtra,Takara,Gene,Therapy,Nelarabine,Avastin,Roche,sNDA,MYCAMINE,Astellas,POTELLIGENT,Kyowa,Hakko,Shitara,Bayer,Kobe,Research,Aspirin,Heart,Attack,Stroke,JMACCT,Iressa,Docetaxel,AstraZeneca,GenomIdea,HVJ,Vectors,NEDO,AnGes,NCC,Chiba,Enoxaparin,Acute,Coronary,sanofi,aventis,Switch,OTC,Urinary,Frequency,LCitrulline,Rapid,PT,INF,JExcel,DNA,Polymerase,JPA,Pharmacists,Ishii,JADEC,HbAc,Antirheumatic,Fuji,Keizai,JMA,Generics","No.2057 Contents")

st++; thePage[st]=new Array("2056_sept_10.pdf","pdf/2007_9/","2056 September 10","Korosho,FPMAJ,RENGO,Takeshi,Erikawa,PFSB,HPB,LDP,Readjustment,ADHD,Acetaminophen,Pain,Fever,Clusters,JMA,Original,Generics,Aliskiren,Novartis,NBI,ARBs,Leiden,Netherlands,ASAP,Toho,TII,Eli,Lilly,Takeda,Ruboxistaurin,Daiichi,Sankyo,Yakult,Irinotecan,AnGes,Naglazyme,Hamari,Oncolys,Tokyo,CRO,JGC,CMO,Zeria,TM,TMRC,Hypertension,JCL,Bioassay,RIKEN,Kobe,PET,CRCs,IRB,Forms,Documents,IBL,Kirin,Antibody,HGF,Gene,Patent,Korea,AnGes,Nexavar,Overall,Survival,Asia,Pacific,Liver,Cancer,Bayer,Onyx,Gakkai,Mark,Colby,Taiyo,Yakuhin,JGPRG,DPC,Muto,NHO,JGPMA,Reimbursement,Lab,Tests,Tazawa,Roche,Diagnostics,Olympus,Microimaging,India,Expenditures,NHO,Psychoneurotics,Respiratory,Uematsu,Karasawa,Election,JMA,President,Physicians,Mastectomy,Bristol,Myers,Myocardial,Infarction,Metabolic,Syndrome,Pharma,Delegates,Fentanyl,Infants,Teikoku,Indomethacin,Plaster","No.2056 Contents")

st++; thePage[st]=new Array("2055_sept_3.pdf","pdf/2007_9/","2055 September 3","Personalized,PGx,Third,Wave,Daiichi,Sankyo,Forest,AZOR,Teijin,Ipsen,ITM,Chugai,Peptisyntha,Peptide,Manufacturing,DSP,Wholesalers,Operating,Profit,Ratio,Matsutani,Ota,MCH,LTT,Bio,PC,SOD,Chinese,Toho,Fuji,Biomedix,HSTTC,Leishmaniasis,Matsuura,Yakugyo,DTC,GSK,HHS,Antigen,Korosho,CU,Asian,GRP,Metronidazole,Eradicate,Pylori,Aricept,Alzheimer,Taiho,Biliary,Tract,Cancer,Tsushima,Social,Security,Spending,BASF,Kollicoat,IR,China,Korea,Codeine,Morphine,FDA,Nexavar,Priority,Review,Liver,Bayer,Onyx,JMA,GL,CCT,Asahi,Kasei,Artisan,Tissue,Engineering,Autologous,Epidermis,Stryker,CentPillar,TMZF,Sankyo,Junyaku,PicolumiucOC,Suzuken,Sleep,Recorder,Apnea,Protosera,Sysmex,Abbott,Vascular,Training,Center,ACCJ,IMCJ,Hyperuricemia,Hypertensive,Psychiatrists,Suicide,Pfizer,Avastin,FOLFOX,Advanced,Colorectal,Enuresis,Stress,Healthcare,Chloasma,Kobashou,Rejection","No.2055 Contents")

st++; thePage[st]=new Array("2054_aug_27.pdf","pdf/2007_8/","2054 August 27","DSP,Lurasidone,Ono,Anesthetic,CeNeS,Hisamitsu,Percutaneous,Mundipharma,Toho,Ohki,Kokubu,Fuji,Biomedix,Korosho,Copyright,Astellas,Taiyo,Cefdinir,Patents,Innovex,CMIC,Kine,Amgen,Chuikyo,Korea,China,Indonesia,Supply,Influenza,Virus,WHO,Takeda,Avandia,Actos,UK,High,Court,NICE,Guidance,Alzheimer,Novartis,Glivec,Idebenone,HPB,HSB,Mircera,Anemia,Roche,Selzentry,HIV,Pfizer,Tasigna,Switzerland,Avastin,AnGes,Naglazyme,JGPMA,AstraZeneca,ZD,Prostate,Regeneron,Bayer,VEGF,Trap,Eye,Sosei,Contraceptive,Baxter,Seasonal,Vaccine,Rectal,Vitamin,Philip,Carrigan,Terumo,DuraHeart,LVAS,Fujirebio,CLEIA,JRCS,Phadia,Iwai,President,MOF,LDP,Insurance,JSHP,Anesthesia,Janssen,Comtan,Parkinson,ADRs,PMS,Antidepressant,GSK,Banyu","No.2054 Contents")

st++; thePage[st]=new Array("2053_aug_13.pdf","pdf/2007_8/","2053 August 13 & 20","Bayer,Yakuhin,Merger,lestrogel,Takeda,CCR,Antagonists,Tobira,Therapeutics,Santhera,SNT,MC,Astellas,Chugai,VAL,GM,Taiyo,Pansporin,Sanofi,aventis,Marketing,Collaboration,Vaccine,Kitasato,jforceNET,Vesanoid,Canada,Cows,Pasteur,ACTOS,Avandia,GSK,Bisphosphonate,JGPMA,Sawai,JMA,Chuikyo,PhRMA,EFPIA,Matsutani,FPMAJ,ADR,NHI,Drug,Pricing,System,IRBs,Banyu,Kyorin,Montelukast,Fine,Granules,Infants,Alcon,BAC,Travoprost,Eye,Drop,Toyama,Chemical,Geninax,Pfizer,Selective,Aldosterone,Blocker,Selara,Topiramate,Partial,Seizures,Eli,Lilly,Cialis,ED,Coadministration,Levitra,Blockers,POLA,Divigel,Hormone,Replacement,Ajinomoto,Paget,Risedronate,Baraclude,Nippon,Shinyaku,Alternatives,Animals,POTELLIGENT,Kyowa,Hakko,Clexane,Lovenox,VTE,Stiripentol,Korosho,Eisai,Sanko,Junyaku,PyloriTek,Test,Kit,GE,Healthcare,PSS,Purelumn,Nipro,French,Dialysis,Related,Devices,Candidates,JMA,JPA,Upper,House,LDP,Amiodarone,Arrhythmia,Diabetes,NAG,Containing,Ketotifen,OTC,Metabolic,Syndrome,JSMI,miwa","No.2053 Contents")

st++; thePage[st]=new Array("2052_aug_6.pdf","pdf/2007_8/","2052 August 6","Nycomed,Pantoprazole,Alvesco,Roflumilast,Surfactant,Nasal,Fentanyl,Merck,NovaCardia,Eisai,Eszopiclone,Sepracor,Kissei,Nuon,Therapeutics,Rizaben,Nippon,Kayaku,Mitsubishi,Tanabe,TCC,Urothelial,Tract,Astellas,Pfizer,Arteriosclerosis,Korosho,Wholesalers,Otsuka,Racol,CPC,South,Korea,Nippon,Shinyaku,Nobelpharma,Dysmenorrhea,Schering,Plough,T3811,Toyama,Chemical,AstraZeneca,Tempstaff,Flivas,OD,Asahi,Kasei,Makers,JPMA,FPMAJ,Exelon,Skin,Patch,Novartis,Metronidazole,Eradication,Tarceva,Albumin,Aricept,Alzheimer,Dementia,Fentanyl,IIT,Galvus,SPIRIVA,Respimat,Boehringer,Ingelheim,Ryukaikon,JKMA,Kampo,Vaccine,IP,Report,Maurer,Kyowa,Hakko,Antibody,BioWa,STELIC,Niigata,London,InCROM,SMO,Smoking,Cessation,Elmed,PMS,GEDA,Transnasal,Endoscopy,JGES,Knife,Body,Mega,Power,Alfresa,Takara,LA,PCR,Kemp,Cook,Medicos,Hirata,Medtronic,Contegra,Kato,DTC,Glaucoma,JHM,Critical,Path,Viagra","No.2052 Contents")

st++; thePage[st]=new Array("2051_jul_30.pdf","pdf/2007_7/","2051 July 30","Eisai,Naito,Cancer,Long,Listed,Ohyagi,Kyowa,Hakko,Matsuda,Pfizer,JZOLOFT,Janssen,Risperdal,Alfresa,SGA,Kirin,Terumo,Banyu,Merck,NPhA,MD,Ohno,Histopathological,eIND,RIKEN,Harvard,Protein,Structure,LTC4,Synthase,NanoCarrier,Patent,Macromolecular,Micelles,Adiponectin,Kadowaki,Thrifty,SCCRE,Takeda,TAK491,Sosei,NVA237,Lantus,sanofi,aventis,Apidra,JANUVIA,Metformin,Rivaroxaban,HUMIRA,Abbott,Dabigatran,Etexilate,Boehringer,Ingelheim,Synagis,Novo,Nordisk,Kringle,Osaka,Korosho,Korea,China,Kitasato,Bayer,Levitra,EFPIA,Sucampo,Lubiprostone,Mammography,MRI,Pacemakers,VK2,ucOC,XRay,OTC,Aciclovir,SSP,Drewell,JACDS,Philip,Carrigan,Mebix,Home,Blood,Pressure,Nutrition,Ohyanagi,Schizophrenia,Frye,Breast,Herceptin","No.2051 Contents")

st++; thePage[st]=new Array("2050_jul_23.pdf","pdf/2007_7/","2050 July 23","Wyeth,Daiichi,Sankyo,Denosumab,Amgen,MTPC,Hayama,Evista,Package,Pharmacy,Chains,Verification,Vaccines,GSK,Gallery,Prizes,Novo,Nordisk,Takeda,Patent,Infringement,Litigation,ACTOS,Nippon,Chemiphar,DPC,NichiIko,Taiyo,Yakuhin,NHI,JPMA,Yamabe,Exelon,Patch,Alzheimer,Novartis,Arixtra,Taxotere,FDA,Priority,Review,sanofi,aventis,Inserts,Cabaser,Permax,Risperdal,Otsuka,GW,NSCLC,Pfizer,Comtan,Levodopa,Cerebral,Infarction,Biomarkers,Kyushu,Univ,NFkB,Decoy,Oligo,Atopic,Dermatitis,AnGes,MG,HVJE,Vectors,Sitagliptin,Metformin,Blood,Sugar,Control,Merck,Micardis,Proteinuria,NBI,Astellas,CIMZIA,RA,UCB,Liraglutide,Watada,Phenobarbital,IV,Neonatal,Convulsions,Eisai,Nitrol,Tanabe,Orodispersible,Talion,Kirin,Nesp,Renal,Anemia,Hemodialysis,Bayer,Yakuhin,Fludara,Lymphoma,CRTD,Concerto,Medtronic,EnRhythm,Cook,Zilver,PTX,Stent,Asahi,Kasei,Kuraray,Merge,Dialysis,Roche,Diagnostics,PCR,Govidien,Tyco,FALCO,Biosystems,InSite,BB,GEYMS,Chuikyo,Radio,Implanted,Avastin,PMS,DPC,Readmission,Korosho,Anticancer,Chemotherapy","No.2050 Contents")

st++; thePage[st]=new Array("2049_jul_16.pdf","pdf/2007_7/","2049 July 16","Nippon,Shinyaku,Niche,Maekawa,Orodispersible,Gaslon,Takeda,Yamanaka,Wholesalers,Kayaku,Nexavar,Standard,Hepatocellular,Carcinoma,Avastin,Wagner,Blopress,ARB,Orthopedic,Eyeforpharma,Shigihara,SFE,Okada,IMS,Daiichi,Sankyo,Takada,MPC,Takahashi,Kowa,Feldman,Banyu,Armstrong,Novartis,Hirai,GSK,FLMs,Nishitani,Schering,Plough,Nozaki,Banyu,Preminent,Diovan,Rep,Track,Kaken,Exclusive,Rights,Integrin,Antibody,Generics,NHI,Price,Listing,Risperidone,Cetirizine,Sawai,Tanabe,Elmed,Kyorin,Fluorouracil,Booster,Teva,Baxter,Granisetron,aRigens,CDFS,Ryukaikon,Makers,Price,Agreement,Organon,Meiji,Seika,Mirtazapine,Plavix,AntiCancer,Bioimaging,Osaka,Astellas,Kyoto,Collaborative,Guidance,Microdose,Micardis,Morning,BP,Astellas,NBI,Expenditures,Progression,CKD,Dialysis,DPC,Review,Advanced,Medical,Technologies,Korosho,Pharmacist,Bungyo,Adhesives,Narcotics,Smoke,Sonet,M3,SSRI","No.2049 Contents")

st++; thePage[st]=new Array("2048_jul_9.pdf","pdf/2007_7/","2048 July 9","Philips,Medical,Systems,Smit,Eisai,Actonel,Once,Weekly,Osteoporosis,Yakult,Anticancer,Satraplatin,GPC,Biotech,GSK,Adoair,MediBIC,PGx,Merger,MPC,Tanabe,Ajinomoto,Acetate,Carbostar,Dialysate,Sanofi,aventis,Ancaron,Life,Threatening,Arrhythmia,Nippon,Kayaku,Maruishi,Sevoflurane,Smith,Nephew,Cadex,Janssen,Ono,Daiichi,Sankyo,Patent,Litigation,Mylan,Biopharmaceutical,Fuji,Keizai,Pricing,Reform,Premiums,DPO,NHI,Revision,Chuikyo,Eli,Lilly,NDA,AD,HD,Atomoxetine,Exforge,Novartis,Nilotinib,Tambocor,Antiarrhythmic,Takeda,Actos,Insulin,Bayer,Onyx,sNDA,Nexavar,HCC,Aspirin,JGPMA,IGPA,JMA,MasuharaLong,Kikuchi,Ohara,MRs,Kyowa,Pharm,Ind,Risperidone,DPC,Cephalon,Bendamustine,SymBio,NITE,Chugai,Microorganisms,Mongolia,PC,SOD,Interstitial,Lung,LTT,Bio,BYETTA,Blood,Glucose,Galvus,Sugar,Diabetes,NAG,Water,Skin,Tsubouchi,BMS,Bufferin,Lion,Tranexamic,Acid,Liver,Transino,Roche,TOB,Acquire,Ventana,Given,Imaging,Capsule,Endoscope,Torii,Toray,TorayMixin,Shionogi,SRL,JACR,Korosho,Transplantation,Hemorrhoids,Hokunalin,Elderly,Abbott","No.2048 Contents")

st++; thePage[st]=new Array("2047_jul_2.pdf","pdf/2007_7/","2047 July 2","Iwatani,Kringle,HGF,Astellas,Advagraf,T-5224,Eisai,Inovelon,Toyama,Roche,Takeda,Once,Weekly,Risedronate,Banyu,Fosamac,Teijin,Bone,Treatment,Otsuka,Pletaal,Powder,Sato,Otorhinology,Ophthalmology,Oncolys,Tacere,HCV,Kaneka,Antibody,Evec,Kaken,Sunstar,bFGF,Dental,Intage,TM,Marketing,MCHC,MPC,Bioventures,Aoki,AnGes,MG,License,Naglazyme,Ain,Pharmaciez,Sanofi,Pasteur,Retrofit,Influenza,Vaccine,Quintiles,Monitors,FPMAJ,Reform,Premiums,APIs,Budgeting,Araki,Chugai,Tamiflu,Abnormal,Behavior,Crohn,Abbott,PhRMA,Review,Miyajima,FDA,Propofol,JGPMA,Healthcare,Nishimura,Korosho,Sutent,PFS,Advanced,RCC,Pfizer,Pazopanib,GSK,Actemra,RA,Hospitalization,Rasilez,Novartis,Pramipexole,RLS,NBI,Betaferon,Multiple,Sclerosis,aventis,Visceral,Fat,Cardiometabolic,Diagnostics,Cobas,Myocardial,Infarction,ECLusys,proBNP,NT,proBNP,NimbleGen,Nippon,Shinyaku,Reagent,RNA,Daiichi,Pure,Chemicals,Determine,Oxidized,LDL,DNA,Chip,HPV,Wachi,Lendormin,Insomniacs,Cervical,Cancer,JPMA,JMA,Bankruptcies,Teikoku,Data,Bank,Tom,Dooley,Alcon,JHSF,Fuji,Keizai,OTC","No.2047 Contents")

st++; thePage[st]=new Array("2046_jun_25.pdf","pdf/2007_6/","2046 June 25","Teijin,Ohyagi,Rental,Oxygen,Condenser,Zetia,Dyslipidemia,Schering,Plough,Bayer,Eisai,Kissei,Glufast,ASEAN,Kirin,Nesp,Yakult,Oxaliplatin,Pfizer,JPMA,Aoki,MOSS,Chugai,Herceptin,Canadian,Court,Daiichi,Sankyo,Levofloxacin,Patent,Astellas,COX,Inhibitor,Celecox,Abilify,Otsuka,Benet,Actonel,Takeda,Ajinomoto,Kyorin,Ono,Imidafenacin,Overactive,Bladder,Nihon,Shiseido,lestrogel,Genzyme,Myozyme,Glycogenosis,Maruho,Oxarol,Lotion,Psoriasis,Kit,JPMA,Original,Mukai,MOF,Korosho,Methotrexate,JIA,Iressa,Sudden,Deat,Tamiflu,Philip,Carrigan,ASCO,Sorafenib,PFS,Advanced,Renal,Cell,Carcinoma,Temsirolimus,INF,MabThera,Aggressive,NHL,Roche,Tykerb,Paclitaxel,HER,Positive,Breast,GSK,GEMZAR,Early,Stage,Eli,Lilly,Erbitux,Colorectal,Merck,Aromasin,Endometrial,Thickening,Femara,PgR,Cisplatin,Casodex,eIND,Symposium,POC,Torii,Janssen,Mori,PMDA,AMG0001,CLI,AnGes,MG,Archemix,Aptamer,DMARDs,Actemra,RA,Avastin,NSCLC,JGPMA,Nippon,Kayaku,Kytril,Chiba,DPC,Koyama,Supply,Asahi,Kasei,Hitachi,NCC,Blood,Diagnosis,Method,Hemorrhoid,Zione,smokers,Smoking,Novartis,TS-1","No.2046 Contents")

st++; thePage[st]=new Array("2045_jun_18.pdf","pdf/2007_6/","2045 June 18","Takeda,Hasegawa,Tsuji,Medical,Fees,Clinical,NHI,Hosoda,Sales,TSE,Bulk,Buying,Sum,Value,FJPWA,OPIR,Reimbursement,Ethical,IMS,Daiwa,Chugai,Share,Avastin,Epogin,Nesp,Nikko,DIR,DIR,Pay,Diovan,Site,Support,Institute,Irom,Granisetron,SNBL,Sawai,Criticisms,NichiIko,OTC,Maruko,Mitsuhara,Bioequivalency,Intage,PMDA,Insurance,TORISEL,RCC,Wyeth,Taxotere,Priority,Prostate,Cancer,SGLT,Inhibitor,Tanabe,Frequent,Yamamoto,BioMedCore,Anticancer,DDS,LTT,Bio,PC,SOD,Seikagaku,CIMZIA,Crohn,UCB,Dipyridamole,Aspirin,Recurrent,Stroke,BI,Eiken,bioMerieux,AMO,Recalls,Contact,Lens,Solution,Korosho,Salespersons,JACDS,Matsumoto,Taisho,Ads,Janssen,Velcade,Responsive,Acute,Rehabilitation,Arixtra,VTE,GSK,JPA,Pharmacists,Metabolic,Syndrome,Cerebral,Infarction,Recurrence,COPD,Asymptomatic,NBI,Pfizer","No.2045 Contents")

st++; thePage[st]=new Array("2044_jun_11.pdf","pdf/2007_6/","2044 June 11","Hirate,PhRMA,Multinational,Trials,Aoki,CRAs,CRO,Nakamura,CMIC,EPS,Graduates,SMO,Wholesalers,Korosho,Allowances,HPB,Pharmacy,Kashiwagi,Matsutani,FJPWA,President,Mitsubishi,Chemical,Merge,Quintiles,TMO,Joint,Venture,IRT,Takara,Bio,Gene,Engineering,Synergism,Clontech,Patent,Litigation,Hiroyuki,Mitani,CEO,Novartis,Wright,Bloom,Bristol,Myers,Nakamura,General,Manager,Genzyme,NHI,Price,Listing,APIs,Chuikyo,Bill,Cialis,TRAVATANZ,Reexamination,Imigran,AnGes,MG,Galsulfase,Orphan,Imiquimod,Garenoxacin,Chugai,Tamiflu,Omeprazole,NERD,ASTERAZENECA,MPC,Lovenox,STEMI,sanofi,aventis,Cervical,Cancer,Vaccine,Cervarix,Australia,GSK,Abbott,HUMIRA,JRA,Roche,Positive,Opinion,Mircera,PI,Chile,BSE,Sawai,Taiyo,Yakuhin,Towa,Suzuken,Given,Imaging,Capsule,Endoscope,JGES,Monitoring,Intestinal,Lesions,Fujimori,Mochida,Gonastick,Pregnancy,Diagnosis,Higher,Dose,Magnevist,Nihon,Schering,Wakamoto,Nipro,Eye,Drops,Filtered,Containers,Terumo,Vietnam,Insurance,Coverage,Protocol,GCP,SJP,BioWa,POTELLIGENT,Sosei,SD,Takeda,Actos,TAK,NSAID,Induced,Ulcers,Anticancer,Arrhythmia,Heart","No.2044 Contents")

st++; thePage[st]=new Array("2043_jun_4.pdf","pdf/2007_6/","2043 June 4","JGPMA,Sawai,Generics,Korosho,Switching,Uchida,JMA,Tsushima,Wholesalers,Mediceo,Paltac,Price,Agreement,Rate,Alfresa,CS,Yakuhin,Ryuyaku,Suzuken,Toho,VITAL,NET,Hokuyaku,Takeyama,Ohki,Otsuka,Meiji,Seika,Kaisha,Tsumura,Ethical,Kampo,TU,Nippon,Shinyaku,Urology,Zeria,Fuso,NHI,ASKA,Yakult,Honsha,Elplat,Toyama,Chemical,Seikagaku,JCR,Sosei,UK,Nissan,Livalo,Kaigen,NanoCarrier,Protein,Nanoencapsulation,Technology,ShinEtsu,Chemical,Cellulose,Sanofi,aventis,Ampule,Sonet,M3,MRkun,Reed,Maurer,Philip,Carrigan,NEJM,Avandia,Incomplete,Evidence,GSK,GNI,Human,PFTK,Amlodipine,Olmesartan,Hypertension,Daiichi,Sankyo,Takara,Bio,Mie,Cancer,Immunity,Reconstruction,Requirement,IRB,FPMAJ,Kissei,Glufast,GI,Bayer,Yakuhin,Levitra,Initial,Repeat,Consultation,Breast,Treatment,PPI,blockers,Esophagitis,DPC,Hospitals,Kobayashi,Household,Product,Rohto,SSP,Nissui,TOX,A/B,QUIK,CHEK,Kyowa,Medex,DiaSorin,Sekisui,Pure,Miraca,Kawasumi,Kawamoto,ADHD,Eli,Lilly","No.2043 Contents")

st++; thePage[st]=new Array("2042_may_28.pdf","pdf/2007_5/","2042 May 28","Baxter,BioScience,Delivery,Renal,Lema,CD,Stem,Cell,CMI,Adjuvant,Free,Pandemic,Flu,Vaccine,PD,Female,Daiichi,Sankyo,Olmesartan,Pravastatin,ARB,Ca,Antagonist,Iron,Deficiency,US,Astellas,Vesicare,Eisai,Commercialize,NeuroBloc,Europe,Gasmotin,Thailand,Lawsuit,Aciphex,Generic,Taisho,Shionogi,Royalty,Crestor,Ono,Kyorin,Tequin,Mochida,Epadel,Atelec,Kissei,Mitsubishi,Tanabe,Wyeth,Takeda,Enbrel,Wakunaga,India,Revision,Prescription,Chuikyo,Korosho,GMP,Compliance,Investigations,Reed,Maurer,Diovan,CV,Novartis,CU,Tamiflu,Sleep,Abnormal,Behavior,Relenza,Symmetrel,MOF,Nippon,Kayaku,Ovarian,Cancer,Hycamtin,Risperdal,Omniscan,Ambrisentan,Orphan,PAH,Edwards,Lifesciences,Carpentier,PERIMOUNT,Plus,Mitral,Heart,Valve,Wako,Pure,Chemical,Microfluidic,Asahi,Kasei,Polysulfone,Membrane,Artificial,Kidneys,JAS,Dyslipidemia,LDL,Dialysis,Erythropoietin,Anemia,Joint,Destruction,JCR,JSMI,OTC,Drugs,Kowa,Miwa,President,OTC","No.2042 Contents")

st++; thePage[st]=new Array("2041_may_21.pdf","pdf/2007_5/","2041 May 21","Wyeth,Lag,Takeda,Patent,Hasegawa,Simultaneous,Applications,DSP,Miyatake,MPC,Chronic,Nephritis,MCH,Tanabe,Seiyaku,Remicade,Santen,Teijin,Kaken,Torii,JT,Asahi,Kasei,Fasudil,Nissan,Chemical,Taisho,License,Milford,GSK,Relenza,Quintiles,ECG,Analysis,Korosho,Agreement,Rates,Tamiflu,RepTrack,Chugai,Roche,Actemra,Spiriva,Innovative,Discovery,JPMA,Yamabe,FRAGMIN,Recurrent,VTE,Cancer,Eisai,Vaccine,Humans,Avian,Flu,pasteur,Advagraf,Astellas,REQUIP,LP,Release,Taiho,Toyama,Antibiotic,Telavancin,MAA,Keppra,Epilepsy,Children,UCB,Enbrel,Surveillance,Nippon,Shinyaku,RNA,Oligomers,Chukaku,Kyoten,Hospitals,Schering,Plough,SCH,Seikagaku,Supartz,Osteoarthritis,Clexane,Lovenox,UFH,VTE,JHSF,Natsuki,Hayama,Mitsubishi,Denroku,Ishiguro,Alfresa,Olympus,Capsule,Endoscope,VisEn,NIR,Fluorescent,Reagents,HuBit,Genomix,deCODE,Boston,Scientific,TAXUS,Stent,Alcon,AcrySof,IQ,Kawasumi,Terumo,Blood,Bag,China,Nissui,Immunoserological,Reagents,Denka,Seiken,Kawasumi,Lab,Upward,ACCJ,Huimin,Wang,JSC,Antibacterial,Chemotherapy,Specialist,Certification,FEM,Bone,Strength,Advanced,Therapy,Unused,Dry,Eyes,Healthclick","No.2041 Contents")

st++; thePage[st]=new Array("2040_may_14.pdf","pdf/2007_5/","2040 May 14","Banyu,Tsukuba,Research,Institute,DSP,MR,Kyowa,Hakko,NDA,KW-6002,KW-2478,Parkinson,Disease,US,Tumor,ArQuLe,Nicotinell,Novartis,Amgen,Tokyo,Prefectural,Local,Purchasing,Tanabe,MPC,Merger,Kissei,Glufast,Actos,Kissei,MAB,BioMedics,LTT,Bio,Pharma,PC,SOD,ILD,Daiichi,Sankyo,Quintiles,Kansas,VITAL,NET,Inoue,Seishodo,Cancer,Pain,Killer,Metastron,Eplerenone,Topiramate,Rocuronium,Ambrisentan,Orphan,CDFS,Donations,Vorinostat,CTCL,Package,Inserts,Shionogi,Obesity,Crestor,AstraZeneca,Shionogi,Erbitux,PFS,Metastatic,Colorectal,Merck,Mochida,Epadel,Coronary,JELIS,Lancet,Death,FG-2216,Astellas,Nippon,Shinyaku,NS-9,JSMI,Switch,OTC,Nihon,Medi,Physics,Distribution,FDG,Given,Imaging,Capsule,Endoscope,Suzuken,FUJINON,Olympus,Vital,Observation,Shimadzu,Full,Digital,Mammograph,FPD,J&J,Seikagaku,MucoUp,Eisai,Sanko,Junyaku,Kyorin,Transfers,Plasma,Expander,Fresenius,Kabi,Showa,Yakuhinkako,Dentsply,Sankin,Defibrillation,Medtronic,Teramoto,Municipal,Towa,Generics,Korosho,JMA,JGPMA","No.2040 Contents")

st++; thePage[st]=new Array("2039_apr_30.pdf","pdf/2007_4/","2038 April 30 & May 7","Plavixf,sanofi,aventis,Fauchet,India,CPhi,Garg,Eisai,Noji,Mizuho,SymBio,Bendamustine,Asia,Pacific,Rim,Acquisition,Morphotek,Morimoto,Iyaku,CRO,China,Mebix,PHT,ePRO,Tanimura,Sonet,M3,eDetails,Mirena,Contraception,Nihon,Schering,Comtan,Parkinson,Novartis,Explosion,ShinEtsu,Chemical,Zydus,Nippon,Universal,NHI,Generic,Substitution,Prescription,Chuikyo,ADRs,Intellectual,Property,PMDA,Kishida,Ingredients,JGPMA,Actonel,Benet,Ajinomoto,Takeda,Avastin,Colorectal,Cancer,Chugai,Imidafenacin,OAB,Kyorin,Ono,Varicella,Valtrex,GSK,Arixtra,SC,Injection,Thromboembolism,Adoair,Diskus,ZETIA,Hypercholesterolemia,Plough,Alvesco,Asthma,Adults,Teijin,Nesp,Syringe,Kirin,Brewery,Expert,Unapproved,CU,Harsh,Delay,Korosho,Kurokawa,Kamoshita,Budgets,Life,Science,Nishiyama,Smoking,Alcohol,Tanabe,JPMA,Pricing,System,FDA,EMEA,Nakagaki,Xeloda,Advanced,Stomach,Avastin,Metastatic,Breast,Roche,Januvia,Diabetes,Merck,Keppra,PGTC,Seizure,UCB,Abbott,Humira,Psoriasis,Package,Insert,Tamiflu,Abnormal,Behavior,GeneFrontier,Hepatocyte,Preservation,MPC,Transgene,HPV,MediBIC,Glufosfamide,JACIC,JASMO,Enrollment,Multiple,Trials,BioVeris,Asahi,Kasei,Reagent,Determine,Myo,inositol,Crustacean,Protein,Kit,Nissui,WT,Ovation,FFPE,RNA,Amplification,MediBIC,AMO,IntraLase,Philip,Carrigan,Critical,Path,Kakizoe,Salaries,JHSF,Alzheimer,OPIR,Harsh,Thalidomide,ISHIZUE","No.2039 Contents")

st++; thePage[st]=new Array("2038_apr_23.pdf","pdf/2007_4/","2038 April 23","Bayer,Yakuhin,Integrate,Schering,Portoff,Follistim,Nippon,Organon,Shionogi,Crestor,Irbesartan,Asahi,Kasei,Explosion,ShinEtsu,Chemical,Cellulose,Korosho,Choufuku,Mediceo,Paltac,Wholesalers,Hospitals,Pharmacies,Agreements,InCROM,Facility,Clinical,Trials,London,Wyeth,Wholly,Owned,Subsidiary,Fujifilm,Anticancer,Cangen,DDS,Hisamitsu,General,Assembly,Medical,Congress,Aoki,Bioventures,Hasegawa,Critical,Path,TR,Tamura,Zoonotic,Infections,Kida,China,South,Korea,Cooperate,Yanagisawa,Molecular,Imaging,PET,Nakamura,Iguratimod,Cancer,Cachexia,Toyoma,Chemical,Positive,Interim,VEGF,Trap,Eye,HealthCare,Regeneron,Multiple,CV,sanofi,aventis,Everolimus,PTLD,Aliskiren,Diovan,MDRP,GSK,Lapatinib,BLA,Cervarix,Eisai,MAA,Aricept,Severe,Alzheimer,Package,Inserts,Permax,Cabaser,Affiliation,PICS,GE,Healthcare,Bio,Science,Bioprocess,Medium,Capto,Adhere,Hemocytometer,Otsuka,Eiken,Rapirun,H,Pylori,Antibody,Detection,Kit,Notification,Sawai,DPC,Allopurinol,Nihon,Taiyo,Yakuhin,FOYA,Toa,Pharm,Plant,DPI,Medical,SpendingJMA,Hyperlipidemia,Diabetes,Early,Prevent,Liver,Cancer,Low,Arteriosclerosis,METEOR,NOXAFIL,Antifungal,Prophylaxis,Plough","No.2038 Contents")

st++; thePage[st]=new Array("2037_apr_16.pdf","pdf/2007_4/","2037 April 16","Daiichi,Sankyo,Hire,Contract,MR,Panaldine,Transferred,sanofi,aventis,Mochida,NBI,Neoangiogenesis,Inhibitor,Janssen,NHI,Price,Cuts,Santen,DE-085,Europe,TroVax,Oxford,BioMedica,BML,Dispensing,Pharmacy,JCROA,Monitor,Training,Program,Ethical,IMS,Hideyuki,Ashikaga,President,BD,India,Abnormal,Behaviors,Tamiflu,Korosho,Lawmaker,Stockpiling,Chugai,Institutions,Minister,Permax,Data,Protection,Period,Precautions,Employment,Rule,PMDA,Novartis,Zelnorm,Enzastaurin,Orphan,Eli,Lilly,Wyeth,WHO,Pneumococcal,EFPIA,EC,Joint,Discovery,Project,Vice,President,Dehecq,Multinational,FDA,EMEA,Kawaoto,Single,Tox,MD,AstraZeneca,Baxter,H5N1,Influenza,Vaccine,VEGF,Trap,Eye,Bayer,HealthCare,Regeneron,Asian,Uechi,Licensing,Patented,Tools,Abilify,PSJ,Award,Otsuka,Updating,Numbers,Reed,Maurer,Reagents,Pancreatic,Islet,Transplantations,ARKRAY,GEYMS,Voluson,IMJ,POCT,Nihon,Schering,Lab,Test,METIS,Relaxation,GCP,Supply,Generics,Quality,PSJ,Luncheon,Seminar,Sakaeda,MasadaCerebro,Cardiovascular,Teramoto,Symptoms,Consultation,NTG,Pfizer,Switch,OTC,ACNielsen,Sonet,M3,Radar,Track","No.2037 Contents")

st++; thePage[st]=new Array("2036_apr_9.pdf","pdf/2007_4/","2036 April 9","BI,Banchi,Contract,Manufacturing,Biopharmaceuticals,Eisai,Mochida,Remodulin,Asahi,Kasei,Eril,South,Korea,Kissei,MRs,Safety,Data,Alfresa,Narcolepsy,Modafinil,Rep,Track,Allergy,Pollinosis,Korosho,Price,Agreements,Chain,Pharmacies,Takeda,Graduates,Pfizer,Gerald,Lema,Baxter,Masamichi,Koike,BioWa,LTT,Bio,PC,SOD,Asahi,Glass,JCR,Infertility,ASKA,Serono,CellFree,Science,Taiho,Inhibitor,Screening,Shionogi,Cancer,ZLB,CSL,Behring,Zetia,Avastin,Adoair,Nilotinib,Dasatinib,Orphan,Tamiflu,Avian,Flu,Grants,Chugai,Excluded,Medwatcher,Ban,Novartis,Patients,Promotion,Takeda,CanBas,Anticancer,LGLS,Obesitys,M3,R-851,SB-497115-GR,hMAbs,Kringle,HGF,Rogosin,Merck,Lundbeck,Gaboxadol,OTC,President,Watanabe,Cook,Zenith,AAA,Endovascular,Graft,Roche,Diagnostics,Coaguchek,XS,Ultra,Gene,Sequencing,Edwards,Lifesciences,PreSep,CV,Oximetry,Catheter,Medical,Devices,Lag,Guide,Wire,Recall,Kobayashi,Kako,Asian,Generics,Masuhara,Cost,Sexual,Harassment,Measures,Law,Amendment,Quintiles,Contender,Fortune,Admired,Pediatric,ACT,Understand,Asthma,GSK,JSMO,Specialists,Chemotherapy,diabetic,Domestic,Production","No.2036 Contents")

st++; thePage[st]=new Array("2035_apr_2.pdf","pdf/2007_4/","2035 April 2","Eli,Lilly,GP,Market,Crenshaw,Duloxetine,Specific,Pain,Emotional,Depression,Eisai,Antibody,Morphotek,Kissei,Urief,Oncology,Marketing,Suzuken,Ota,Ethical,IMS,Blopress,Pfizer,Distribution,Wholesalers,Takara,Bio,Thermotolerant,RT,Sigma,Aska,Yakult,Honsha,Banyu,Lipopeptide,Antibiotic,Cubist,Schering,Plough,Antifungal,Anacor,Bayer,Yakuhin,Intendis,Bayer,Dow,Colorcon,Excipients,Orodispersible,Risperidone,Janssen,Nippon,Shinyaku,Teva,HMN214,TZT1027,EPS,CRO,Asia,Toyama,DSP,Wakunaga,Alfresa,Access,CS,Susumu,Kurata,Wyeth,Masuji,Sugata,President,Hirate,Chairman,PhRMA,JBEC,Biopharmaceuticals,Korosho,Chugai,Dear,Doctor,Letter,Tamiflu,CDFS,ADR,Health,Minister,Relenza,Supply,Tykerb,Xeloda,Breast,GSK,Takeda,MAA,Ramelteon,Astellas,FDA,Action,Prograf,sNDA,Vaccine,JMA,Symposium,Clinical,Trials,Hire,Capable,Human,Resources,JPMA,Essential,Documents,ANTCliPh,PK,Renal,Disorders,Regenerative,Medicine,Spinal,Injuries,TTI,Iontophoretic,DDS,SCH530348,Switch,OTC,Aciclovir,JSMI,Western,Herbal,Herb,Extracts,Aging,ARKRAY,Foreign,JPA,Category,Philip,Carrigan,Gallen,Consensus,Oncologists,Breast,Cancer,Irinotecan,Colorectal,Localized,Prostate,Soy,Products,Entecavir,Chronic,Hepatitis,Kumada,Copegus,Pegasys ","No.2035 Contents")

st++; thePage[st]=new Array("2034_mar_26.pdf","pdf/2007_3/","2034 March 26","Philips,Simplicity,Event,Hong,Kong,Sense,Simplicity,AED,MRXO,Tokai,Univ,Hospital,Cardiac,MRI,Education,Center,Mie,Medical,Systems,Asia,Pacific,Takeda,Paradigm,UK,Nippon,Chemiphar,Chinese,Generic,SymBio,Abeille,Wholesalers,Kimura,Schering,Plough,Organon,BioSciences,IMS,ZoeGene,Molecuence,MCM,MediWith,Astellas,Lawsuit,Cefzon,Motohiro,Yamasaki,Reed,Maurer,NHI,Price,Kawashima,Santen,Novartis,Immunosuppressant,Certican,Kyorin,Korosho,China,Niwa,Toyama,Chemical,IMMD,Success,Fee,Shionogi,Hamajima,AstraZeneca,CIMZIA,Joint,Damage,RA,UCB,PrePandemic,Vaccine,GSK,FPMAJ,Mori,PMDA,Urso,Improvement,Hepatic,Chronic,Hepatitis,Lipitor,Avastin,Positive,Opinion,Metastatic,Breast,Cancer,Roche,Xeloda,Advanced,Gastric,Cancer,Orphan,Influenza,Operating,Profit,FJPWA,OTC,Steroids,Asthma,Resistant,Aeruginosa,MIC,White,Paper,JLIT,Subanalysis,Banyu","No.2034 Contents")

st++; thePage[st]=new Array("2033_mar_19.pdf","pdf/2007_3/","2033 March 19","Eisai,Naito,Private,Univ,Hospitals,Wholesalers,Novo,Nordisk,Eilersen,Nippon,Shinyaku,NBI,MR,Ain,Pharmaciez,Sonet,M3,Pfizer,Kyowa,Hakko,Melanoma,LSP,Shionogi,Flu,BioCryst,APIs,Celecoxib,NHI,Price,List,Private,Sector,Hepatitis,Package,Insert,Rituximab,CymbaltaEli,Lilly,HUMIRA,Crohn,Disease,Abbott,Aliskiren,Novartis,PMDA,Lactoferrin,Dyslipidemia,Lion,Seretide,COPD,GSK,China,Anticancer,SymBio,Enrollment,Bendamustine,MediBIC,Glufosfamide,Sosei,STELIC,Niigata,Inflammatory,Colon,Avastin,NSCLC,Roche,Korosho,Antibiotics,Otitis,Media,Elderly,JPA,Symptoms,Adverse,Reactions,Strengths,Generics,Given,Imaging,Capsule,Type,Endoscope,Terumo,Heart,Valve,Kφhler,Citrullinated,Peptide,Antibody,Efficacy,Narcotic,Analgesics,Gene,Polymorphisms,Bio,Business,Market,Life,Expectancy,Licensing,Seko,PAL,JACDS,Pharmacy,Matsumoto","No.2033 Contents")

st++; thePage[st]=new Array("2032_mar_12.pdf","pdf/2007_3/","2032 March 12","Pfizer,Iwasaki,Personnel,Cut,DSP,Miyatake,Lurasidone,Nippon,Organon,van,Eerd,DSM,Preminent,Rep,Track,Ono,Strategic,Alliance,HQs,Eisai,Abbott,Humira,Astellas,Tsukuba,Daiichi,Sankyo,sanofi,aventis,Plavix,China,Chugai,Lawsuit,Epogin,APDD,KickOff,Symposium,Microdosing,Korosho,MD,Kurokawa,Mori,PMDA,Sugiyama,Tozuka,Human,Subjects,Arjomand,Marketing,JCROA,JMA,Takeda,Antibody,XOMA,Interprotein,Evotec,IL,Inhibitors,Mebix,Sonet,M3,Recruitment,Femara,Tamoxifen,Glufosfamide,Fail,Primary,Endpoint,PIII,MediBIC,CERA,Roche,Admired,Pharma,Reed,Maurer,Prefectural,Conference,Market,Prices,EAD,PFSB,OTC,Lag,NME,Novartis,Offlabel,Femara,Children,Tamiflu,Minister,Thai,Compulsory,License,Vaprisol,Hypervolemic,Hyponatremia,Taxotere,Sildenafil,Orphan,PAH,ADR,Nipro,Surelyzer,PES,NeuroStimulator,Medtronic,Abe,GSK,Sleep,Inducer,Fuji,Biomedix,ITOCHU,Segami,Seijo,Merger,Kanebo,Kracie,Drugstores,JACDS,PMDA,Package,Inserts,Website,JPHC,Breast,Cancer,Taller,Women,Physical,Activity,Colon,VitaminC,Cataracts,Colorectal,Peptide","No.2032 Contents")

st++; thePage[st]=new Array("2031_mar_5.pdf","pdf/2007_3/","2031 March 5","Brennan,AstraZeneca,Otsuka,Abilify,Mochida,Novartis,Diovan,Vesicare,Pollakisuria,Urinary,Incontinence,Sanofi,pasteur,Encephalitis,Vaccine,Acambis,Hubit,Genomix,NJC,Astellas,BM,Lawsuit,Flomax,Generic,Kowa,Potelligent,Technology,BioWa,Adiponectin,Etiological,Diabetes,Kadowaki,Kringle,Skin,Ulcer,Tripep,Sosei,SD118,Biopharmaceutical,Pfizer,Sutent,RCC,IPASS,CDFS,HYLENEX,Trial,Baxter,Halozyme,Therapeutics,HUMIRA,Psoriasis,Abbott,Intensive,Lipitor,Hospitalizations,NOXAFIL,IFIs,Schering,Plough,Nexavar,Advanced,Liver,Cancer,Bayer,NME,Avastin,Nilotinib,Dasatinib,Orphan,PMDA,Nephritis,Lansoprazole,Government,Pharmacists,Ohara,Pharm,Western,Herbs,OTC,Drugs,JSMI,Risk,Classification,PMDA,Package,Inserts,OPINION,Philip,Carrigan,Expenditure,OECD,JMA,IT,Korosho,Radiologists,Radiotherapy,Equipment,Nakagawa,Pramipexole,Depressive,Symptoms,PD,Boehringer,Ingelheim,Pharmacist,Antimonopoly,Law,Administration,Nakagawa,Naito,Prize,Kinoshita,Molecule,Physiology,Sonet,M3,Sanko,Junyaku,Patent,PALSAR,In,Vitro,Diagnostics,Recall,Filters,Cardioplegic,Solution,Norvasc,EPOCA,Marketing,Strokes,Bayer,Epilepsy,Phrma","No.2031 Contents")

st++; thePage[st]=new Array("2030_feb_26.pdf","pdf/2007_2/","2030 February 26","Daiichi,Sankyo,Making,Shoda,Prasugrel,US,Europe,DSP,Miyatake,Replagal,IV,Drip,Infusion,Fabry,Disease,Kyowa,Hakko,Personnel,Cost,Intage,MR,Preminent,Otsuka,Cannabinoid,Cancer,Pain,Killer,GW,Pharm,MCHC,Healthcare,Toyobo,Sell,GenomIdea,Master,Cell,Bank,Nihon,Chouzai,Mitsuhara,Lifecycle,Hatanaka,Regulatory,Systems,Dunoyer,EFPIA,China,Korea,Biomedical,Consultation,Fees,Toxicogenomics,DB,Compounds,GL,Toyoshima,CMIC,Clinical,Trials,Lecithin,Bound,SOD,Cerebral,Infarction,LTT,Bio,Pharma,ES,Cell,Ikegaya,JHSF,JPMA,Teijin,Viramune,HIV,Boehringer,Ingelheim,Roche,Diagnostics,Bearish,Market,JMCoE,Project,Medical,Devices,Vitatron,Recalls,Pacemakers,Korosho,Early,Price,Settlement,Continuous,Infusion,KOGENATE,Bayer,EU,Lovenox,sNDA,FDA,Priority,sanofi,aventis,Relenza,Prevention,Fractionated,Plasma,English,Translation,Residue,Ignition,Test,Method,Kurokawa,Switch,OTC,METI,Health,Information,Platform,Initiative,JPA,GE,Toyama,Generics,Control,Roger,Moore,Order,Knight,Dannebrog,Novo,Nordisk,Pfizer,JGAP,Hypertensive,Ca,Blockers,Hypertension,Kurata,Fast,dissolving,Tablets,Preferential,Pediatricians,Continue,JPA,SOPs,Pharmacies,Influenza,Epidemic","No.2030 Contents")

st++; thePage[st]=new Array("2029_feb_19.pdf","pdf/2007_2/","2029 February 19","Mitsubishi,Tanabe,MRs,Generic,CS9803,OTC,Kirin,KRN321,Eli,Lilly,Shionogi,Duloxetine,Chugai,AnGes,MG,Patent,HGF,Gene,Daiichi,Sankyo,KAI,Modified,Regimen,pylori,Eradication,Nippon,Shinyaku,RNA,MCH,ZoeGene,Roche,Licensing,Mucosal,Vaccines,Kiyono,Prostanoid,Kyoto,Threshold,PII,Glufosfamide,MediBIC,Dipyridamole,Aspirin,Recurrent,Stroke,SRL,Nakahata,Arteriosclerotic,Reed,Maurer,Merck,Bristol,Myers,Erbitux,Vaccine,Prepandemic,Flu,Confidentiality,Tarceva,Pancreatic,Category,Change,NovoRapid,Pregnant,Women,FDA,Novo,Nordisk,ADR,Tsuji,Korosho,Narcotics,Private,Sector,Dialogue,Sawai,Supply,Nihon,Chouzai,Prescriptions,NichiIko,DPC,Kit,Adverse,Reaction,Irinotecan,Otsuka,Eiken,Uropaper,Test,Strip,Olympus,Abbott,Vascular,Devices,Discomfort,TS-1,Adjuvant,Therapy,Gastric,Stomach,Screening,nonsedative,Antihistaminics,Kaken,Metabolic,Syndrome,Website,Teijin,Sleep,Apnea,JMA,Female,Doctor,Bank,Personal,Physicians,Healthcare,Awareness,AMD,Novartis,Contact,Lens,Pollinosis,JJ,Urological,National,Burden,Rate,Bilingual,Glossary,GMP,ICH,Terminologies","No.2029 Contents")

st++; thePage[st]=new Array("2028_feb_12.pdf","pdf/2007_2/","2028 February 12","PREMINENT,Combination,ARB,Thiazide,Tanabe,Seiyaku,Mitsubishi,Merge,AstraZeneca,Takeda,Centralize,Fund,Zeria,Kyowa,Hakko,Asacol,CLEA,In,Vivo,Science,Artemis,Nitto,Denko,Adhesive,Anesthetic,Astellas,Pfizer,Settlement,Lipitor,Retirement,Hatanaka,Brest,Cancer,Sunitinib,Internet,Toyo,Pharmar,KYORIN,Rimedio,Kyorin,Intersite,Nanoscience,Interprotein,Merck,Seiyaku,Somavert,SC,Injection,Nihon,Schering,Fludara,Mirena,Iressa,Docetaxel,Fukuoka,CDFS,Abe,Yanagisawa,EAD,Korosho,Wholesalers,APIs,RAC,pylori,Eradication,Glivec,Novartis,GSK,pandemic,Influenza,Vaccine,Viagra,Orphan,Drug,PAH,Pipelines,Keiji,Nakamura,Takeda,Research,Fujisawa,Molecular,Symposium,GL,PET,MD,Korea,DNA,Resistance,Diabetes,T-0047,Threshold,Glufosfamide,MediBIC,Sawai,Capital,Participation,Summit,Glycoresearch,Taiyo,Yakuhin,Ohara,Pharmaplan,Sankyo,Yell,Mizuguchi,Olympus,AFT,Videoscopes,Swallowable,Imaging,Capsule,Tohoku,Endoscopic,Laser,Sysmex,Automated,Hematology,Analyzer","No.2028 Contents")

st++; thePage[st]=new Array("2027_feb_5.pdf","pdf/2007_2/","2027 February 5","Mochida,Copromote,Novartis,Diovan,Pfizer,Restructuring,Nagoya,Iwasaki,Alimta,Eli,Lilly,Cisplatin,Chemotherapy,MPM,Janssen,Pharm,Ultiva,METI,Transfer,Pricing,Taxation,System,NPhA,Astellas,Kirin,Fully,Human,Monoclonal,Antibody,Otsuka,Marketing,Sonet,M3,jforce,Dendrite,Synix,Database,Reexamination,PFSB,Government,private,Sector,Abe,Policy,Speech,Cabinet,Health,Minister,Yanagisawa,Sankyo,Headquarters,EAD,Celecox,Funguard,Prograf,Valtrex,Glivec,Darunavir,Orphan,Alemtuzumab,Talc,Vorinostat,Telbivudine,Alfresa,Narcolepsy,Copegus,Pegasys,Retinal,Uveitis,Remicade,Prophylactic,Relenza,Inovelon,LGS,Eisai,Sutent,MRCC,Exforge,Action,Letter,FDA,FK506,Package,Insert,Tocilizumab,Korosho,Nicotine,Dependence,Management,Fee,CDFS,Kansai,BioCluster,Morishita,Ajinomoto,Diabetes,BI,Toyama,Anti,Flu,T-705,AnGes,MG,Naglazyme,BioMarin,Sanofi,aventis,CREDIT,Bezatol,Actemra,RA,Roche,Akimoto,Generics,DPC,Chikamori,Taiyo,Yakuhin,GE,Healthcare,BioSciences,Effector,Cell,Institute,Defect,Leukocyte,depletion,Filters,Saiseikai,Joint,Purchasing,MEXT,Anticancer,Dialysis,Patients,Pill,Fertility,Juvenile,Organ,Donation,Yoshimitsu,Kobayashi,MCHC,MREAC,Ministry,Environment,Pollen","No.2027 Contents")

st++; thePage[st]=new Array("2026_jan_29.pdf","pdf/2007_1/","2026 January 29","MPC,Tanabe,Merger,M&A,Yamaguchi,Nikko,Citigroup,Bioventures,Yamazaki,Life,Science,Toyobo,MediBIC,PGx,Affymetrix,JRCS,WBC,Blood,Transfusion,Nippon,Kayaku,End,Tieup,Quintiles,eDetails,Sonet,M3,Market,ARBs,Tsuji,PFSB,APIs,Bungyo,Matsutani,Checkup,FDA,Metabolites,JPMA,Dropped,Compounds,Metabolites,NMEs,PMDA,Chuikyo,NHI,Price,Alimta,Doxil,Mukai,MOF,Tandemact,Europe,Takeda,Combination,ACTOS,Biguanides,Wyeth,Torisel,Priority,NDA,Review,JCQHC,Methotrexate,Amlodipine,Atorvastatin,Pfizer,Ankhs,Metastatic,Cancer,NR,Ligands,Kissei,Positive,Results,PIII,Silodosin,Enrollment,Prasugrel,Daiichi,Sankyo,Molecular,Imaging,ICR,Imura,PET,Dose,Suhara,Kobe,Japan,Multinational,Sato,Early,Microdosing,GCP,BI,Ablynx,Alzheimer,PI,Glufosfamide,Shinyaku,Discontinue,NS-8,OAB,Akimoto,Novartis,Independent,OTC,PAL,Ibe,JACDS,NichiIko,Maruko,Seiyaku,Sawai,Wholesalers,GE,Korosho,Pharmacists,Miura,Medical,Device,MR,Sysmex,in,Vitro,Diagnostic,Technology,Cancers,AMO,IntraLase,Retirement,Baby,Boomers,Social,Security,Kawasaki,Keidanren,Insurance,Mixed,Care,Gastric,Ulcers,JSA,Allergic,Diseases,JPA,JMA,Expenditure,DTC,Education,Obesity","No.2026 Contents")

st++; thePage[st]=new Array("2025_jan_22.pdf","pdf/2007_1/","2025 January 22","PMDA,PFSB,Takahashi,Regenerative,Medicine,JPMA,NHI,Pricing,Innovation,Private,JPA,Flat,Sum,System,Dispensing,Pediatric,Pharmacotherapy,Janssen,Kaposi,Sarcoma,Doxil,Parkinson,Ulcerative,Colitis,Population,Korosho,Meiji,Seika,Infectious,Diseases,CNS,Generics,Nippon,Kayaku,Micelle,Kirin,Brewery,Bayer,Yakuhin,Absorb,Diabetes,Care,Astellas,Terminates,Carperitide,DTC,Education,Wholesalers,Nakagawa,ARBs,Takeda,CASEJ,Novartis,Banyu,Nulotan,Diabetic,Nephropathy,NBI,PPARg,Micardis,Sankyo,Olmetec,Sugio,Seko,Early,Clinical,Trials,Vaccine,NIBIO,Toyama,Flu,Tamiflu,Relenza,Kashiwagi,Clarithromycin,Influenz,AD,Intellect,Neurosciences,Nexavar,Kidney,Cancer,Onyx,Education,Kajimoto,JGPMA,Matsutani,Taiyo,Kodak,Health,Onex,Sonazoid,Ultrasound,Contrast,J&J,DePuy,Spine,Daiichi,Radioisotope,Fuji,Film,RI,Pharma,METI,Invasive,Devices,Cancer,Surgery,JSA,Anti,stroke,JMA,DRG,PPS,Nakagawa,Online,Medical,Billing,Pollinosis","No.2025 Contents")

st++; thePage[st]=new Array("2024_jan_15.pdf","pdf/2007_1/","2024 January 15","Ira,Wolf,PhRMA,JT,Antibody,Candidate,MedImmune,Blopress,Statins,Otsuka,Pletal,Germany,BMS,Diabetes,CMIC,Korea,Subsidiary,Pfizer,Recall,Halcion,ARB,Korosho,Innovation,FPMAJ,Morita,HPB,Budget,CRCs,flu,PMDA,Price,Agreement,Rates,Celecox,Copegus,Alimta,Doxil,Eli,Lilly,Alimta,Pleural,Mesothelioma,Cisplatin,Pleural,Mesothelioma,Sunitinib,Renal,Cell,Carcinoma,GIST,Novartis,Tentative,Exforge,FDA,Astellas,sNDA,MYCAMINE,Daiichi,Sankyo,Additional,WelChol,Nippon,Kayaku,Spanidin,Takeda,Actos,Insulin,CHMP,Tarceva,EU,Opinion,Roche,Reference,Price,System,Councilor,Diet,Copyright,Law,Life,Science,MEXT,CRCs,UK,DOH,High,risk,Agents,Baxter,Blood,Free,Recombinant,VWF,Preclinical,Hemophilia,Xeloda,Endpoint,PIII,Hisamitsu,Mohrus,Tape,Vical,Allovectin,AnGes,MG,Glufosfamide,Partial,Responses,Threshold,Aromasin,Enoxaparin,VTE,Taxotere,Herceptin,Death,sanofi,aventis,Deferasirox,Body,Iron,Cetrorelix,JABEX,Hepatitis,Neoral,Patent,Dispute,Prescriptions,JammNet,Philip,Carrigan,Constipation,Colorectal,Cancer,Bile,Acid,Reflux,Gastric,Ulcers,Haruma,NPhA","No.2024 Contents")

st++; thePage[st]=new Array("2023_jan_1.pdf","pdf/2007_1/","2023 January 1 & 8","Hatsuo,Aoki,JPMA,Reed,Maurer,Shionogi,DSP,ARB,Irbesartan,Schering,Plough,Teijin,Kirin,Dong,A,Elaspol,South,Korea,Ono,Astellas,European,Plants,Temmler,Pfizer,Female,MRs,MediBIC,PGx,Paltac,Kobashou,Daiichi,Sankyo,Jean,Luc,Lowinski,Bayer,Yakuhin,Glenn,Warner,Zahir,Lavji,Abbott,EFPIA,Yamaguchi,J&J,Matsubara,MediSearch,NHI,Price,Revision,Budget,Korosho,JMA,Licensing,Research,LDP,Komeito,DPJ,hepatitis,Measures,PMDA,Kibanken,Fosrenol,Hyperphosphatemia,NOXAFIL,Blue,Letter,Regarding,Rituxan,Package,Inserts,Tacrolimus,Gefitinib,Lifestyle,Related,Uchida,ABMJ,Vaccine,IBRI,Pharmacology,Trials,IPF,PIII,Levemir,Blood,Glucose,Diabetics,Novo,Nordisk,Arimidex,Tamoxifen,Early,Breast,Cancer,AstraZeneca,Galvus,Novartis,Dabigatran,VTE,BI,Zevalin,Elderly,Aggressive,NHL,Nihon,Flecainide,JACDS,JPA,Generics,Original,Products,Ihoken,ADRs,Patients,Sawai,Cook,Zenith,Endovascular,Graft,Insurance,Coverage,Smoking,Cessation,Metabolic,Syndrome,Alcohol,Consumption,Contributes,ALT,OECD,Health,JPC,SED,Medical,Institutions","No.2023 Contents")

st++; thePage[st]=new Array("2022_dec_25.pdf","pdf/2006_12/","2022 December 25","Pfizer,Iwasaki,New,Marketing,Structure,December,Torcetrapib,Chugai,Copromote,Otsuka,Antiplatelet,Pletaal,Pazufloxacin,Toyama,MPC,SMO,CRC,Training,LTT,Bio,Pharma,Cipla,Nano,Steroids,Fuji,Biomedix,Stake,Biotoxtech,Korea,Nippon,Shinyaku,Roche,Arimidex,Tamoxifen,Early,Breast,Cancer,Yamato,Logistics,Distribution,Nippon,Organon,Marvelon,Low,dose,Oral,Contraceptive,Banyu,Antihypertensive,PREMINENT,Abilify,Biopharmaceuticals,JHSF,DTC,Ads,EBMs,China,Following,Accidents,JGPMA,Benefit,Standard,Price,System,Korosho,NPhA,Hansha,Eguchi,Taxation,Innovation,Nippon,Keidanren,PMDA,ADR,Abe,Blair,Declaration,Wyeth,Kyushu,Univ,Alliance,Andersen,Neuroscience,Pangalos,Takata,Sanofi,aventis,Large,Epidemiological,Cerebral,Infarction,Clopidogrel,Ticlopidine,Suzuki,AstraZeneca,Novartis,Meiji,Seika,Antibody,Symphogen,TS,Death,Gastric,Cancer,Surgery,Taiho,Algorithm,Predict,Hepatitis,Nexavar,Bayer,Onyx,DSP,Lurasidone,PharmaDesign,CASP,OTC,PFSB,Asahi,Kasei,Medical,Kuraray,Olympus,VisEn,Molecular,Imaging,Asia,Terumo,Joint,Venture,Biomaterials,Financial,Support,Ulcerative,Colitis,Parkinson,Disease,Cancer,Refugees,Resistance,Tamiflu,Allergic,Rhinitis,Productivity,Okamoto,Influenza,Preventive,Catechin,Gargle,Hire,Income,Nichibyokyo,Young,Doctors","No.2022 Contents")

st++; thePage[st]=new Array("2021_dec_18.pdf","pdf/2006_12/","2021 December 18","AstraZeneca,Astellas,VISION,ADVATE,Hemophiliacs,Baxter,Hemophiliacs,Pathogens,Hanabusa,Pipe,Michigan,Synix,Treatment,Database,Parexel,CROs,VITALNET,HANSHIN,Amgen,Yuji,Orihara,President,Takeda,Giacomo,Di,Nepi,CEO,Takeda,Pharm,Europe,NichiIko,Prime,Minister,FDA,Approval,OPIR,Council,Korosho,Earlier,Medwatcher,Gefitinib,Tax,System,Package,Insert,Tocilizumab,Safety,Tokai,Symposium,Transfer,Technology,Aoki,Doi,Patent,Yamada,Consortium,Uchida,NIBIO,Yamanishi,Osaka,NIBIO,Toxicity,Screening,Sorivudine,Cream,aRigen,Fuso,OTS,Bayer,Ortho,McNeil,Rivaroxaban,Takara,Bio,RetroNectin,Australian,Stem,Cells,Scientists,Nakahata,OAB,Vesicare,Detrusitol,Harnal,Pfizer,Imigran,PMS,GSK,Genzyme,Japan,Aldurazyme,IV,Drip,Infusion,GSK,Requip,Parkinson,Terumo,MicroPlex,Coil,System,Cerebral,Aneurysms,Miraca,Holdings,PMDA,Contact,Lens,HSTTC,NCC,MBC,Banyu,Leukotriene,Antagonists,Asthma,GINA,JPA,Keidanren","No.2021 Contents")

st++; thePage[st]=new Array("2020_dec_11.pdf","pdf/2006_12/","2020 December 11","Guidant,Abbott,Vascular,Bryant,Xience,DES,Nakamura,Chugai,Banyu,Preminent,Hypertension,Blopress,IMS,Nippon,Shinyaku,EuroTIDES,SMO,Site,Support,Institute,Daiichi,Sankyo,Fuso,Zeria,SNBL,Wakamoto,Nissan,Chemical,JCR,Kaigen,CMIC,Singapore,EPS,Data,Management,ADM,Korea,Jinjiro,Kanada,InCROM,Institute,PhRMA,Patient,Centered,Healthcare,Reform,Access,Ihoken,Forum,Takeda,Henmi,JPMA,LEEM,Meeting,Tax,Commission,Depreciation,System,Ajinomoto,Astellas,Fastic,Starsis,Toray,JT,Torii,NDA,Pruritus,Treatment,Herceptin,Exenatide,Diabetes,Eli,Lilly,Amylin,Zometa,Relief,Bone,Pain,Novartis,Pramipexole,Moderate,Severe,Primary,RLS,BI,FDA,Combination,Idursulfase,Orphan,COPD,Price,System,Keio,Kyoritsu,Pharmacy,Merge,Teijin,Yamagishi,Database,Protein,Interactions,GSK,Tanaka,QVA,Sosei,DSP,Anxiety,Depression,Hisamitsu,Nippon,Shinyaku,Cancel,Actos,Recurrence,Proven,Crestor,Arteries,AstraZeneca,Lipitor,Heart,Attack,Stroke,Chronic,Kidney,Disease,Pfizer,Polymorphisms,Orencia,RA,BMS,MEXT,Budget,Accident,UK,Kenporen,Generic,Supply,Ability,DDS,Suzuki,Sawai,Kaken,Shoyaku,Terumo,Triplex,Artificial,Blood,Vessel,Criteria,Established,Observation,Services,Eiken,Chemical,RS,Virus,Kit,BinaxNOW,RSV,Test,LDP,Depreciation,Systems,Banyu,Pneumococcal,Vaccine,Pneumovax,NP,Janssen,Pharma,Velcade,SSP,OTC,Western,HerbsProduction,Korosho","No.2020 Contents")

st++; thePage[st]=new Array("2019_dec_4.pdf","pdf/2006_12/","2019 December 4","Mediceo,Paltac,Holdings,SGA,Kumakura,Yakkasa,Chinese,Alfresa,HD,Suzuken,Toho,Wholesalers,Nippon,Shinyaku,Pharmion,Vidaza,Hatsuyama,Spiriva,NBI,COPD,Chugai,GSK,flu,Tamiflu,Eisai,Portugal,Seikagaku,Liver,Hydrolysate,Nissui,Nipro,EPO,Toyobo,Taiyo,Yakuhin,Chuikyo,NHI,Prices,PREMINENT,Requip,Advate,Gaps,Original,Aoki,FJPWA,Seminar,Kawasaki,Matsutani,JMA,NHI,Price,Revision,Karasawa,Eisai,Positive,Inovelon,CHMP,GSK,COPD,Package,Amantadine,Ceftriaxone,Anticancer,Candidates,PIIb,BI,Araki,SymBio,Bendamustine,PI,Sosei,Avontec,PIIa,STAT,Asthma,AnGes,MG,Epadel,Coronary,Disease,Mochida,Strokes,Mucodyne,Alleviates,Acute,Exacerbation,Kyorin,LTT,Bio,Pharma,PC,SOD,Ulcerative,Colitis,Anastrozole,Breast,Cancer,Recurrence,AstraZeneca,PEGINTRON,REBETOL,HCV,Schering,Plough,HUMIRA,Moderately,Severely,Active,Crohn,Abbott,Diovan,Urinary,Protein,Hypertensive,Diabetes,Novartis,VIRxSYS,RetroNectin,Takara,Bio,Abatacept,Moderate,Severe,RA,BMS,Duties,Raises,Japan,Umehara,MEDINET,Oncotherapy,Stelic,Institute,Kummoto,Anticholinergic,OAB,Pfizer,BML,Gene,Testing,Hosokawa,Micron,Kyushu,Stent,MIC,Medical,Consultation,Services,Nissho,Kirindo,Kawamoto,MBL,OPINION,Philip,Carrigan,JMA,Insurance,Elderly,Tax,Takemi,Prevention,Economy,Syndrome,Japan,PharmaCyclopedic,Naishitoru,OTC,Kobayashi,Rohto","No.2019 Contents")

st++; thePage[st]=new Array("2018_nov_27.pdf","pdf/2006_11/","2018 November 27","Kowa,Tamura,Overseas,MPC,Infrastructure,US,China,Wholesalers,Ono,Korekane,Mochida,Epadel,Atelec,Antidepressant,MLD,Toyama,Chemical,Yakult,Oncology,Centered,Specialty,Oxaliplatin,Teijin,Bonalon,Meiji,Seika,Kaken,Kyorin,Generics,Kissei,Urief,Nippon,Shinyaku,ASKA,Seikagaku,SSP,Sawai,Management,Towa,Yoshida,Nippon,Chemiphar,JMA,Covance,CRU,Honolulu,Bridging,Studies,MD,Studies,Ruckle,JSNM,BBI,Contract,Preliminary,Torcetrapib,Atorvastatin,Varenicline,Smokers,Pfizer,Macugen,CIMZIA,Crohn,UCB,Stalevo,Parkinson,Novartis,Secondary,Stroke,Prevention,Recruitment,BI,Sanofi,aventis,RIO,Diabetes,STELIC,NJIT,Wyeth,Prevenar,Council,Reference,Price,System,FTC,Joint,Purchases,Ryukaikon,JPMA,China,Taiwan,FPMAJ,Korosho,Mukaida,PMDA,Anticancer,Chemotherapy,Network,NOXAFIL,OPC,Schering,Plough,BD,Recall,Pen,Type,Insulin,Injector,Miraka,Kawasumi,A&T,Global,Drug,Market,IMS,Health,Ulcerative,Colitis,Patients,Defensive,Cautious,Takeda,duetact,Zepharma,OTC,Version,Lanoconazole,Steroids,Atopic,Dermatitis,Astellas","No.2018 Contents")

st++; thePage[st]=new Array("2017_nov_20.pdf","pdf/2006_11/","2017 November 20","CMIC,Value,Creator,Takeda,Inappropriate,Vendor,Selection,Process,Astellas,Asian,Studies,Atorvastatin,Nogimori,Licensing,Costs,Daiichi,Sankyo,Olmetec,Benicar,Dainippon,Sumitomo,Overseas,Taisho,OTC,Shionogi,Antibiotics,Crestor,Tanabe,Seiyaku,Generic,Ono,Santen,Meiji,Seika,Penem,Antithrombotic,Agents,MPC,Kremezin,Kureha,Kobayashi,Banyu,Merck,Yasuchika,Hasegawa,OPMA,Henry,McKinnell,Grand,Cordon,Pfizer,Disclosure,Kitasato,University,Harvard,Critical,Path,Woodcock,Imura,Nakagaki,Shimatani,Harada,AnGes,MG,PII,NFkB,Decoy,Oligo,Atopic,Dermatitis,Ischemic,Heart,Disease,Korea,Takara,Bio,VM202RY,Oncolys,BioPharma,PI,Telomelysin,TU025,Tsumura,Maurer,Alcon,Vegamox,Ophthalmic,Solution,Biogen,Idec,Avonex,Syringe,IM,Injection,Medtronic,MBL,CCP,MESACUP,BP180,Test,eVent,Ireland,Olympus","No.2017 Contents")

st++; thePage[st]=new Array("2016_nov_13.pdf","pdf/2006_11/","2016 November 13","Guerbet,Baxter,Plasma,Albumin,Factor,VIII,Hemophilia,Eisai,Kyowa,Hakko,Torii,Asahi,Kasei,CMIC,Contract,Genetic,Polymorphism,Analysis,Ono,Sapphire,Therapeutics,Choongwae,Kissei,Glufast,South,Korea,Takeda,XOMA,Antibody,ASKA,Terminate,Tavocept,Teijin,Subsidiaries,China,Mediceo,Paltac,Veterinary,Wholesaler,Women,MRs,MR,GENERICS,Nihon,Chouzai,HPV,Vaccine,PMDA,Global,Groundbreaking,Mori,FPMAJ,JPMA,Taxation,JCROA,Wyeth,Torisel,RCC,Lag,PFSB,Packages,Inserts,Tacrolimus,Gefitinib,Korosho,Device,Terumo,DPC,Terumo,Moscow,Reagent,Eiken,Chemical,Kizai,Flu,Vaccine,Denka,Seiken,Flu,Test,Kit,Sanko,Junyaku,PALSAR,Gene,Amplification,Freund,Nipro,Warsaw,Roche,Diagnostics,Accuchek,Aviva,Good,Design,Prize,Sato,Shionogi,NBI,Pramipexole,RLS,paxil,Symptoms,GSK,Antiviral,Peptide,Ashitaba,Takara,Bio,JACDS,Rohto,Kampo,Alfresa,OTC,CS,Medicines,Social,Security,Alteplase,DTC,Marketing,Diet,iNPH,J&J","No.2016 Contents")

st++; thePage[st]=new Array("2015_nov_6.pdf","pdf/2006_11/","2015 November 6","JPA,JACDS,JPA,CMIC,Brazil,Merger,Schering,Eiki,Bayer,Eisai,Oncology,Ligand,Takeda,BioNumerik,Tavocept,Court,Daiichi,Levofloxacin,Patent,Otsuka,KMP,Hokkaido,Sogo,Medical,NHI,Price,Revision,Frequency,Price,Agreement,Rate,Institutions,MucoUp,Seikagaku,Corporation,Pediatric,Allegra,sanofi,aventis,Itrizole,Velcade,Janssen,Ultiva,IV,Injection,OXINROM,Powder,Shionogi,Requip,Tablet,Parkinson,GSK,Takepron,Preminent,Banyu,Fludara,Leukodepleted,JPMA,FTC,DPP-4,Inhibitor,JANUVIA,Merck,Tandemact,Takara,Bio,FDA,Large,scale,Iressa,CDFS,PMDA,Proteins,Lung,Cancer,Adjuvant,Genes,Osteoporosis,Society,Interim,Analysis,JOINT,Bisphosphonates,Fracture,Risk,Nakayama,bisphosphonate,LocomoGene,Kyushu,obesity,Prasugrel,Platelet,Aggregation,Daiichi,Sankyo,Lilly,Panitumumab,Colorectal,Cancer,Wyeth,Tygacil,CAP,TS-1,Interim,Analysis,Taiho,JASMO,Entecavir,Hepatitis,Philip,Carrigan,Chuikyo,Insurance,InVitro,Diagnostics,Simultaneous,Test,Gonorrhea,Chlamydia,Trachomatis,Signa,HDx,Signa,HDx,GE,Yokogawa,Eiken,Meridian,Bioscience,Sanko,Junyaku,Fujirebio,Signa,HDe,BrightSpeed,Good,Design,Awards,Novartis,Global,BP,GOAL,Initiative,Korosho","No.2015 Contents")

st++; thePage[st]=new Array("2014_oct_30.pdf","pdf/2006_10/","2014 Octomber 30","Aoki,Korosho,Lilly,Acquire,ICOS,Corporation,BML,HPB,Sankyo,Lifetech,Transfer,Animal,Novartis,Animal,Health,CMIC,Accium,BioSciences,Microdose,S-Medisa,Software,IRBs,Kyowa,Hakko,Nippon,Shinyaku,Wakamoto,Promotion,Code,Pharmacy,Chains,HIB,Taiyo,Yakuhin,Symposium,APEC,Multinational,Asia,Mori,Harrison,Toyoshima,JPMA,Abe,Cabinet,Yamabe,Drug,Lag,Celecoxib,Reexamination,Propofol,Methotrexate,pandemic,Flu,Vaccine,Aricept,Severe,Alzheimer,Eisai,Avastin,NSCLC,Roche,GMP,QMS,International,Society,Hypertension,Candesartan,Amlodipine,CV,Events,CASEJ,CASE-J,Amlodipine,Pfizer,Candesartan,Diabetes,Takeda,SBP,JATOS,Valsartan,JIKEI,HEART,Telmisartan,Nephropathy,INNOVATION,Caduet,Halves,GEMINI,AALA,METI,Taxation,Sosei,FMS,GALIANT,Galvus,OCCI,Patent,Online,Marketplace,Agilent,Market,LUMINOVIEW,MIC,Medical,Image,Analysis,AdvaMed,Chairman,Ludwig,Video,Scope,Upper,GI,Tract,Olympus,Kobayashi,Corin,Design,Awards,Health,Economics,Insurance,Indemnity,Yoshikawa,Innovative,Lawmaker,Kamoshita,Family,Lung,Cancer,Prescriptions,JMA,Acute,Otitis,Media,Children,GSK,Valaciclovir,Genital,Herpes,Survival,AstraZeneca","No.2014 Contents")

st++; thePage[st]=new Array("2013_oct_23.pdf","pdf/2006_10/","2013 Octomber 23","Shionogi,Hokkaido,Governor,Takahashi,Taiho,Hisamitsu,Nichiiko,Pulmicort,Respules,AstraZeneca,BI,Seiyaku,Haupt,Court,Aciphex,Patent,Eisai,Miyoshi,Daiichi,Subsidiary,Kyorin,Ketas,License,South,Korea,Taisho,UCB,sanofi,aventis,Xyzal,TPNA,Takeda,Otsuka,Physuline,Kirin,Busulfex,IV,Drip,Infusion,Conference,Tokyo,Symposium,APEC,PFSB,PMDA,HIB,Flu,Anti,Smoking,Pill,Champix,Pfizer,Novartis,Aliskiren,MRP,Symbicort,SMART,Precaution,Ciproxan,Injection,Bayer,Yakuhin,Kurokawa,Kiyoshi,Kurokawa,Baxter,Cell,Based,Vaccine,Mechanism,Anticancer,AIST,PGx,Tsuya,Oncolys,BioPharma,Kyoto,Mortality,CV,Events,REACH,Registry,Femara,Cancer,Recurrence,Novartis,Liraglutide,Diabetes,Novo,Nordisk,NovoMix,Basal,Bolus,HUMIRA,Methotrexate,Psoriasis,Abbott,Xeloda,Avastin,Colorectal,Cancer,Roche,Maurer,Stryker,Tohoku,Univ,Vascular,Function,Monitoring,System,MC3,Annuloplasty,System,Edwards,Lifesciences,DSP,JCR,Growjector,Human,Growth,Hormone,Society,Hypertension,Iressa,JACDS,Prescription,Psychotics,JMA,Herceptin,Arimidex,Postmenopausal,Breast,Tourette,Syndrome,SAD,Inhalant,Steroid,Asthma,Control,Urinary,Frequency,Fuji,Keizai,OTC,Book,Tokuho,Foods,JPA,Data,Sheet,Database,ADRs,Statins","No.2013 Contents")

st++; thePage[st]=new Array("2012_oct_16.pdf","pdf/2006_10/","2012 Octomber 16","Debiopharm,Astellas,Management,Plan,Nogimori,Vesicare,YM150,Pfizer,IFPW,General,Membership,Meeting,Lung,Specific,DNA,Marker,RFID,Counterfeit,Parallel,Import,FFS,Wholesalers,Biopharmaceuticals,Frictions,JPA,NPhA,Yakkasa,Kashiwagi,Maruho,Amorolfine,Nail,Lacquer Innovation,Takaichi,VITAL,NET,Acquire,Stake,Inoue,Seisho,Dou,Yusaku,Yamaguchi,Genzyme,Alcon,PATANOL,Ophthalmic,Solution,Special,Pediatricians,Abe,PMDA,Priority,EAD,ADR,SD,Director,Basic,Law,Cancer,Measures,Okabe,Lag,Korosho,Nakagaki,Daiichi,Sankyo,Pediatric,Indication,Fentanyl,Kyowa,Hakko,Anticancer,Keryx,Animal,YM155,Takeda,Analgesic,XEN401,Japanese,Association,Anticancer,DDS,Nanotechnology,Nippon,Kayaku,TWMU,Operative,Wounds,Esophagus,Vitamin,Epidemiological,Sunlight,Bovine,Lactoferin,HuBit,Genomics,Causative,Gene,Parkinson,Tanabe,Seiyaku,Candidates,Vietnam,Cell,Membrane,Structure,MS,ILD,Iressa,Vildagliptin,Blood,Glucose,Novartis,Nipro,Avandia,Progression,Diabetes,GSK,JMA,FTC,GENERICS,Central,Glass,Abbott,Laboratories,Patent,Infringement,Case,Daiichi,Pure,Chemicals,LAMP,Method,Eiken,PALSAR,Europe,Sanko,Junyaku,AstraZeneca,Shanghai,Genomics,Artificial,Bone,China,GNI,Cathex,Recalls,Wires,Angiography,Kainos,ADAMTS,Reagent,Bungyo,Detection,Prostate,Ishii,JPA,Deregulation,Narcotics,Pharmacies,Expenditure","No.2012 Contents")

st++; thePage[st]=new Array("2011_oct_9.pdf","pdf/2006_10/","2011 Octomber 9","Hakuo,Yanagisawa,Health,METI,MOF,CDFS,Velcade,OTC,HSB,PFSB,PAL,Lag,Glivec,EU,Novartis,Lyrica,Difficult,nerve,Pain,Pfizer,Tykerb,Advanced,Breast,US,GSK,GCP,Guidelines,Package,Inserts,Amantadine,Ceftriaxone,CMIC,CRF,Checking,FTC,Generics,Joint,Purchasing,Wholesalers,Manufacturers,PMS,SJP,Seikagaku,inflammatory,CanFite,Israel,Novo,Nordisk,Insulin,Statistics,JGPMA,IPHC,Lawsuit,Selbex,Mutoh,Isobe,Society,Generic,NHO,Sanshodoh,Cancer,Association,Genes,Anticancer,Resistance,Hormones,Adipocytes,Progression,Correlation,Colorectal,Precancerous,Lesions,Visceral,Fat,ICH,GCP,PMDA,Miyajima,Sanofi,Pasteur,PI,Trial,Vaccine,Kyowa,Hakko,animal,L,Tyrosine,Mizushima,China,South,Korea,Steroid,Administration,Neoral,MBC,PCR,Gene,Testing,InVivoScribe,Daiichi,Pure,Chemicals,Shanghai,Meiji,Dairies,BOTHDEL,Oral,Solution,Philip,Carrigan,Optia,Partners,Stomach,Tsubono,Ulcerative,Colitis,Parkinson,Takeyama,OAB,Expenditure,Diabetics,Lifestyle,Pfizer,African,Children,Malaria","No.2011 Contents")

st++; thePage[st]=new Array("2010_oct_2.pdf","pdf/2006_10/","2010 Octomber 2","Zydus,Generics,India,JPMA,Cabinet,Naito,UK,DOH,MPI,Harvey,Blair,EAD,Korosho,METI,MRs,MREAC,Certification,PMDA,Daiichi,Sankyo,Downsizing,Kevin,Sharer,PhRMA,Nipro,Nichiiko,Ethical,Wholesalers,Tsuji,J&T,Institute,GSK,Blepharospasms,Hemifacial,Spasms,Spasmodic,Torticollis,Applications,Align,Original,Taiyo,Pharm,Seamless,Prefilled,Syringes,Grounded,Barcode,Labering,Requirements,PFSB,PLAVIX,STEMI,EU,sanofi,aventis,BMS,Valtrex,Recurrent,Genital,Herpes,JPA,Pharmacists,IMMD,PI,IMD0354,IIT,Leuprorelin,SBMA,ACTOS,Cardiovascular,Risk,Diabetics,Takeda,Lipitor,CV,Eventsn,Heart,Metabolic,Syndrome,Enoxaparin,Repeat,Attacks,Stroke,Gabapen,Shionogi,Cetrotide,Injection,Bristol,Myers,Baraclude,Schering,Plough,Temodal,Teijin,Pharma,Bonalon,Banyu,Fosamac,Sanyo,Chemical,Lauromacrogol,LDP,President,Agilent,Technology,Compact,LC/MS,System,TOF,Medtronic,Micro,Driver,Stent,System,Color,Fluorescent,Observation,Advanced,Therapy,Gold,Colloid,Insurance,General,Assembly,DPC,Referral,Centers,Nicotine,Dependence,Hospital,JNA,Philippine,Nurses,AMD,Macugen,Pfizer,JCQHC,Chronic,Headache,Glaucoma,Novartis,Terminate,Lamisil,AT,Nicotinel,TTS,SSP,CholesteGuard,Cholesterol,Johnson,Tough,Guard,Band,Aid,CSO,Matsumotokiyoshi,Franchise,Sugiura,BestDenki,Nihon,Chouzai","No.2010 Contents")

st++; thePage[st]=new Array("2009_sept_25.pdf","pdf/2006_9/","2009 September 25","Crestor,AstraZeneca,Shionogi,Kato,LDL,Teramoto,Roche,Partnerships,Noguchi,Kowa,Bale,IFPMA,BT,Mimura,Jetro,Biolink,Forum,Taisho,Osteoporosis,Treatment,IBL,Taconic,Sankyo,Shares,DRL,Fuji,Film,CMIC,License,Tokyo,Sonet,M3,British,Embassy,UK,Trade,Janssen,Cilag,Ortho,Biotech,Prix,Galien,Velcade,Nichia,Sawai,Daiko,JMA,Toa,NTT,TMRC,Ekimoto,SRI,Bio,Wyeth,Symposium,RA,BBC,IHEP,Aoki,Lawmaker,Fujii,NIBIO,Grants,MEXT,METI,XLP,GNI,ACTOS,Secondary,Stroke,Diabetes,Takeda,Spraying,DSP,Aliskiren,Blood,Pressure,Novartis,COPD,Respimat,SMI,NBI,Spiriva,Lung,Mild,NBI,Pfizer,Flutide,Serevent,Pediatric,Asthma,Seretide,Diagnosis,Asbestos,Mesothelioma,Vaccine,Blood,Donation,Online,Processing,Medical,Bills,ELD,Roche,EMEA,Tarceva,Pancreatic,Cancer,Paxil,Manual,Narcotics,Maurer,Pneumococcal,Vaccination,Elderly,Osteoporosis,Aging,Vitamin,COPD,Nosocomial,Infection,Statin,Monotherapy,Schering,Plough,SKYRON,Nasal,Drops,Chugai,Invirase,Pulmicort,Inhaled,Janssen,Itrizole,Oral,Solution,Sekisui,Daiichi,Pure,Sanko,Junyaku,Glucose,Monitoring,System,Beckman,Coulter,Morphology,AEDs,Kobayashi,PFSB,Registered,Drug,Sellers,Council,Zaditen,Capsules,Switch,OTC,Dysuria,Survey,Stomach,pylori,Positive","No.2009 Contents")

st++; thePage[st]=new Array("2008_sept_18.pdf","pdf/2006_9/","2008 September 18","Taurel,Eli,Lilly,Investment,Reduce,Eisai,Oncology,Ligand,Takara,Bio,Retronectin,MSKCC,Janssen,MRs,CNS,JRCS,Joint,Purchase,GSK,Online,Learning,Program,Daiichi,Sankyo,Invest,Healthcare,Venture,Fund,IMS,IntrinsiQ,Database,Cancer,Commentary,Direct,Makers,JPA,Korosho,NHI,Pricing,Revision,Frequency,Chuikyo,Kaletra,Tablets,Abbott,Japan,Anti,HIV,Asahi,Kasei,ART123,Artisan,Pharma,Tax,Unapproved,Bio,hazard,ICH,Q8,Q9,E14,Guideline,MEXT,Security,Manual,Spending,LDP,Dispute,Resolution,Once,daily,Allergic,Rhinitis,JCA,Meeting,Novartis,Pharma,Voltaren,Tape,L,Bayer,Rivaroxaban,PII,Toray,JT,Torii,Codevelop,Antipruritic,TRK820,TMRC,Drug,Development,System,FDA,Informed,Consent,Glutamic,Bone,Degradation,Moriyama,AnGes,MG,NFkB,Decoy,Oligo,Atopic,Dermatitis,GNI,Uniservice,Gene,Networks,Takeda,Discontinue,TAK654,Pramipexole,Mood,Disturbance,RLS,NBI,Tissue,Sections,Kurabo,Contact,Lens,Wearable,Roche,Diagnostics,Nihon,Kohden,Cardiac,Reader,Nipro,Filter,Catheter,FILTRAP,Japan,Lifeline,Otsuka,Eiken,AEDs,Kyorin,DPC,Flu,Test,Kit,J&J,AEDs,Wako,Pure,Chemical,SphereLight,Brahms,PCT,Chemicals,Nordia,HbA1c,Towa,Suzuken,Nationwide,Errorneous,Bills,ECLusys,proBNP,HPB,Pediatric,OB,GYN,Hospitals,Core,Endoscopic,Surgical,Therapeutic,Colorectal,HIV2,Infection,Taisho,Tokuhon,Tie,Up,Flurbiprofen,Plaster","No.2008 Contents")

st++; thePage[st]=new Array("2007_sept_11.pdf","pdf/2006_9/","2007 September 11","Healthcare,Philip,Remote,MRXO,Diagnostic,Imaging,Taisho,Toyama,Super,MRs,Infectious,Ajinomoto,Sankyo,Agreement,Novel,Diabetes,Korosho,Pharmaceutical,Industry,Norvasc,IMS,Merck,KGaA,Darmstadt,SSP,Former,Toyama,CMIC,Novartis,Administrative,Guidance,Lamisil,Meiji,Seika,Habekacin,MRKun,Furukawa,EBMs,Urges,DTC,Unike,Software,CUBE,Pharmacy,Support,NHO,Reduction,Products,Affiliated,BI,Pharmaton,IdeaSphere,JACDS,Prescription,Budget,PFSB,Core,Tamiflu,Relenza,METI,CDFS,Velcade,Victims,Tainted,Blood,Products,Interim,Acetaminophen,Pediatric,Wholesalers,Switchover,PLAVIX,Severe,Heart,Attack,US,Keppra,Juvenile,Myoclonic,Epilepsy,UCB,Deferasirox,Transfusional,Iron,Overload,EU,Novartis,Relenza,Prevention,Influenza,GSK,Fukui,Dissolution,Test,Methods,APIs,Reevaluation,JPMA,Takara,Bio,Antitumor,Kelp,derived,Fucoidan,Oncolys,Biopharma,IND,Telomelysin,DNA,Chip,Research,Prediction,Prognosis,Preoperative,Diagnosis,Unapproved,GE,Yokogawa,Medical,Systems,Lunar,iDXA,Nipro,Blood,Glucose,Self,tester,Oriental,Yeast,SDI,DNA,Analysis,Bio,Rad,Life,Science,Research,Ciphergen,Biosystems,Mebix,Shares,JMS,Subsidiary,Clinography,JPA,Impact,TV,Commercials,Generics,Medical,Expenditure,Original,Generic,Cooperate,Stable,Supply,Esophageal,Varix,Endoscopy,Kyowa,Hakko,PhRMA,Gene,Manipulated,Destroys,Mesothelioma,Asbestos","No.2007 Contents")

st++; thePage[st]=new Array("2006_sept_4.pdf","pdf/2006_9/","2006 September 4","IMD-1041,FPMAJ,NHI,Prices,Existing,Nagano,APIs,Paxil,Tablet,Orphan,RAPS,Nichiiren,Takemi,Upper,House,Stromectol,Scabies,UCB,Keppra,Approval,Package,Inserts,Gemcitabine,Adsorbed,Tetanus,Toxoid,Picosulfate,Blood,Donations,Placenta,JP,Blopress,IMS,Japan,Direct,Deal,Katagiri,FTC,Wholesalers,FJPWA,DSP,Sumitomo,Chemical,Pfizer,Amlodin,Lawsuit,FALCO,Exclusive,Rights,Pharmacogenomics,Gentris,Red,Cross,Sanofi,aventis,Astellas,Terminate,Marketing,Alliance,Ketek,EPS,TSE,Suzuken,Novartis,Voltaren,Lotion,Nikken,Chemical,Renal,Function,Test,Inulead,IMMD,IkB,Kinase,IMD,Bribery,Ihoken,Seminar,Government,Tanabe,Janssen,Anti,TNFa,Monoclonal,Antibody,Hisamitsu,HKT,MediBic,Micron,PET,ACT,ES,Cells,Destroying,Embryos,Commentary,GCP,JSQA,Nippon,Chemiphar,Pamphlet,Rx,Korosho,Budget,Accidents,Dosage,JCQHC,JPA,Nishimura,Irom,LTT,Bio,Pharma,UDX,EBS,NovusGene,Gene,Analysis,Preventing,Lifestyle,Diseases,Victims,Health,Minister,Breast,Cancer,Shimadzu,Olympus,Cytori,Therapeutics,SSP,OTC,Hatori,Matsumotokiyoshi,Izumi,Organ,Transplantation,Coordinators,Salaries,JST,Organ,Donor,Cards,Genital,Herpes","No.2006 Contents")

st++; thePage[st]=new Array("2005_aug_28.pdf","pdf/2006_8/","2005 August 28","MPC,Muscular,Komine,Beijing,Hepatitis,PI,Forum,Ohyagi,BI,Sales,Profits,Kirin,Pharma,Division,Taisho,Lilly,Toho,Merge,Transfers,Fisher,Scientific,Meissa,MS,Korosho,Matsubara,Outsourcing,India,MediBic,Schering,Plough,Withdraws,NDA,Garenoxacin,FDA,Wholesalers,NHI,Price,Revision,FJPWA,Matsutani,Urushibata,NPhA,Pancreatic,Cancer,Taiho,Thalidomide,Multiple,Myeloma,UCB,Keppra,IV,Injection,Pulmicort,QOL,Families,Nishima,NovoRapid,Pregnancy,EU,Novo,Nordisk,Baxter,Factor,VIII,Hemophilia,Canada,Avastin,NSCLC,Roche,CHMP,Positive,Opinion,CHAMPIX,AMG,Tolvaptan,Orphan,Drugs,Barcode,JPMA,Taiwan,Government,Sleep,Medication,Depression,GSK,PFSB,Benzene,Drink,Insight,Reed,Maurer,JJ,Heart,AstraZeneca,Employees,Quintiles,Consulting,Olympus,Bacus,Advanced,Virtual,Slide,Immunologic,Testing,VisEn,FMT,FV,MPE,Complete,AminoMoist,Lens,AMO,Cook,Endograft,Nipro,Cardiopulmonary,Brazil,Eiken,Test,Kits,Binax,China,Tokyo,Municipal,ADEPT,Adhesion,Reduction,Solution,Innovata,Reimbursement,Chuikyo,Stem,ES,Cells,Mouse,Skin,Cells,PI,Integrase,Inhibitor,Shionogi,Software,Protein,Lipitor,Crestor,Japanese,Famotidine,NSAID,Gastric,Mucosal,Lesions,Astellas,Global,Cooperative,Smoking,Cessation,Taiyo,Supply,Discontinuation,JPA,Pulmicort,QOL,Nishima","No.2005 Contents")

st++; thePage[st]=new Array("2004_aug_14.pdf","pdf/2006_8/","2004 August 14 & 21","DSP,Dops,Torii,Dialysis,Abbott,JMIRI,Prescription,Data,Analysis,Service,Takeda,Daiichi,Sankyo,Olmetec,China,Eisai,Prialt,Severe,Chronic,Pain,MPC,LHRH,Antagonist,Ozarelix,Carna,Biosciences,Agreements,BASF,Disintegrants,Prevails,Patent,Ofloxacin,Ear,Drop,Epogin,Recall,Chugai,Kobashou,Taisho,Shares,Mikasa,Seiyaku,Influenza,Vaccines,GSK,Wholly,Owned,Subsidiary,Arm,Systex,CAC,Corporation,Tanabe,Proscope,Patent,Infringement,Mylan,Eisai,Aricept,ODT,ANDA,India,Partnership,Summit,Korosho,Budget,Translational,Council,Miyauchi,JMA,Elimination,Losses,Consumption,Tax,SJP,Busulfan,IV,Infusion,Kirin,Avonex,Syringe,IM,Injection,Genzyme,Santen,Glaucoma,Ocular,Hypertension,Competact,Diabetes,Ono,IND,Antibody,Sutent,mRCC,Pfizer,Glivec,DFSP,Ph+,ALL,Tarceva,Negative,Opinion,pancreatic,Cancer,Roche,Dissolve,Drink,Subsidiary,Australia,Keiji,Nakamura,Chiome,Bioscience,SymBio,Bendamustine,Reduction,Rate,JPMA,Micardis,Insulin,Resistant,Hypertension,Ono,Banyu,Sitagliptin,Anti,EGFr,Nimotuzumab,Avastin,Xeloda,Primary,Endpoints,Tavocept,BioNumerik,RetroNectin,Cytotoxicity,Immunotherapy,Takara,Bio,JHSF,GL,Human,Stem,Cells,MEXT,OPINION,Philip,Carrigan,Nippon,Kayaku,Gelpart,Hepatic,Arterial,Plugging,Material,Kyphon,IBT,ASKA,Transfer,Kyowa,Medex,J&J,SV,Wire,Diagnostics,Position,Technology,reactions,Health,Insurance,Deficit,Kenporen,Gastric,Detection,Replacement,Tamoxifen,AIs,Metabolic,Syndrome,Uric,Acid,Oncology","No.2004 Contents")

st++; thePage[st]=new Array("2003_aug_7.pdf","pdf/2006_8/","2003 August 7","eTrial,Multinational,Trials,china,EDC,Santen,Management,Meiji,Seika,Nonsteroidal,Eisai,Solvay,SA001,Kosaku,CMIC,Wholesalers,JPA,Vice,President,NPhA,Suzuken,Nippon,Chemiphar,Report,Uralyt,Zyloric,ASTEM,Taisho,Pharm,Capsule,Production,Facility,Sandoz,Momenta,Olympus,Biomaterial,Artificial,Bone,Replacement,Astellas,Gelpart,Chuikyo,Mobile,Phones,Pacemakers,PATANOL,VEGAMOX,Ophthalmic,Solutions,Alcon,Japan,Genotropin,Hormone,Deficiency,Pfizer,Gabapen,Itrizole,Oral,Solution,Janssen,Fosamac,Bonalon,Teijin,Pulmicort,Respules,AstraZeneca,Hepatitis,Treatment,Baraclude,Bristol,OPIR,Unapproved,FPMAJ,PhRMA,EFPIA,FPMAJ,Patent,Crenshaw,Ohhashi,Predicting,Bulk,Ryukaikon,PMDA,Registration,Fulminant,Hepatitis,ADR,Atorvastatin,Nexavar,Advanced,Kidney,Cancer,Bayer,SYMBICORT,Asthma,Xeloda,Stomach,Roche,JMA,NHI,Antibody,Formation,Factor,VIII,Preparations,DSP,BMKK,Hypertension,Treatments,GSK,Wyeth,Pneumococcal,Vaccine,Banyu,Nulotan,Participating,Shizuoka,Compounds,Long,term,Paxil,Osaka,Cambridge,MOTI,Pharmacotherapy,Bronchial,JMA,Nipro,Transfer,Shares,Nissho,Kirindo,Tonic,Drink,Fuji,Keizai,Insomnia,SSP","No.2003 Contents")

st++; thePage[st]=new Array("2002_jul_31.pdf","pdf/2006_7/","2002 July 31","Covance,Preclinical,Phase,IV,Coordinator,Honolulu,Bridging,Parkinson,KW-6002,Product,Kyowa,Hakko,Chugai,Tamiflu,Epogin,Novo,Nordisk,GP,Acquisition,Schering,AG,Bayer,Yakuhin,Nexavar,Clarithromycin,Taisho,Toyama,Ohira,Asahi,Kasei,Wholesalers,NPhA,Novartis,Flu,Vaccine,CV,Lansoprazole,DTC,Marketing,Furukawa,EBMs,Korosho,Social,Security,Spending,Orphan,Budget,Anact,Purpura,Fulminans,JPMA,PMDA,Kamoshita,Keppra,Positive,Opinion,Monotherapy,Partial,Onset,Seizures,English,JP,Japanese,Version,OTC,JPA,Teikoku,Databank,Transdermal,Agent,AD,Imura,ADR,Eiken,Chemical,Critical,Path,Opportunity,Report,JPMA,Astellas,Telavancin,Seikagaku,PIII,Gel-200,Osteoarthritis,Actos,TAK-536,Takeda,AS04,Adjuvant,Immune,Response,Cervical,GSK,NERD,IBD,Bezatol,Lipid,Levels,Glucose,Metabolism,Kissei,Livact,Liver,Cancer,Cirrhosis,Ajinomoto,FK962,Global,Cooperative,Pfizer,Affected,Generics,Ranbaxy,Acquires,GSK,Spain,Tanabe,Seiyaku,Methotrexate,Nikken,Selenica,Maruishi,Mepivacaine,Flumazenil,Injections,Clinical,Pharmacy,Symposium,Package,Inserts,Leukemia,Advances,Glivec,Arteriosclerosis,Breast","No.2002 Contents")

st++; thePage[st]=new Array("2001_jul_24.pdf","pdf/2006_7/","2001 July 24","Torrent,Teijin,Pharma,Vesicare,OAB,Bushu,Contract,InCROM,Ryukaikon,JPMA,Meiji,Dairies,Taiho,Takeda,Antibodies,Galaxy,Evista,Daiichi,Sankyo,Takara,Bio,China,Eisai,Teva,Rasagiline,Sandoz,Nichiiko,Meiji,Seika,Generic,Kotobuki,Pharm,Towa,Taiyo,Chuikyo,Nippon,Kayaku,Paclitaxel,Injection,NK,Basic,Policies,Chuikyo,NHI,Drug,Price,Revisions,Tsuchida,Henmi,Nichibyokyo,Osteoporosis,Ono,Astellas,Avastin,Advanced,Breast,GMP,JPEC,Sengoku,Tamiflu,PFSB,Notification,CV,Anticancer,Neuropsychiatric,Fuji,Keizai,Implanted,Cardiac,Device,ARKRAY,AUTION,MAX,Automated,Urine,Test,System,Daiichi,Pure,Chemicals,Toshiba,Diagnostics,HPV,Olympus,Sysmex,America,Premier,Pinnacle,Award,NordiFlex,Injection,Zeria,Promac,Reed,Maurer,Efficacy,obesity,Shionogi,Banyu,HPV,Vaccine,GARDASIL,Matsumotokiyoshi,OTC,Kita,Baxter,Pandemic,Vaccine,Smoking,Cessation,Varenicline,Pfizer,Candesartan,Nippon,Zoki,Neurotropin,NIBIO,DSP,Amlodin,JZOLOFT,Novo,Nordisk,Norditropin,GSK,Flunase,Nasal,Solution,Puffs,Nippon,Organon,Avishot,DTC,Marketing,EBMs,Bone,Aromatase,Inhibitors","No.2001 Contents")

st++; thePage[st]=new Array("2000_jul_17.pdf","pdf/2006_7/","2000 July 17","Alfresa,HD,Watanabe,NHO,Amlodin,Norvasc,Novartis,Pharma,Diovan,Taiho,sanofi,aventis,Takara,Bio,AML,Testing,Method,InVivo,Scribe,Nihon,Schering,Daiichi,Radioisotope,ADR,Solving,Patent,Disputes,Ono,Locus,Pharmaceuticals,Nippon,Kayaku,Anticancer,Eisai,Singapore,ETP,Pfizer,Japan,Viagra,Call,Centers,APO,PLUS,STATION,Ingredients,Drug,Listing,Specifications,Taiyo,Original,Preparing,Eguchi,Kyushu,Ain,Pharmaciez,Wholesaler,Biliary,Tract,Cancer,Gemzar,PhRMA,Japan,Chinese,NBI,A,Diabetic,Neuropathy,Micardis,Bristol,Applies,Pleural,Mesothelioma,Briplatin,Entecavir,EC,Hepatitis,Dasatinib,Indications,BMS,ICH,Events,Tipranavir,ADR,Recalls,Blood,Donation,Korosho,Demographic,Prediction,PFSB,Reexamination,Minoxidil,Promotion,Anti,cancer,Measures,PFSB,Advertising,Nationwide,APIs,JPA,GE,OPINION,Philip,Carrigan,Astellas,Pharma,TeGenero,Bankruptcy,Ashitaba,Bone,Mass,Osteoporotic,Takara,Global,Cooperative,Clinical,Trials,Commentary,Kobayashi,CHC,Family,Planning,Association,Campaign,Novartis,Breast,Cancer,Screening","No.2000 Contents")

st++; thePage[st]=new Array("1999_jul_10.pdf","pdf/2006_7/","1999 July 10","Eisai,Simultaneous,SERM,Radius,Asahi,Kasei,Fasudil,CoTherix,Oncology,Nexavar,Yakuhin,Takeda,Taxes,Shareholders,Tanabe,Seiyaku,Takeda,Global,Rights,Hematide,Pfizer,Acquires,Schwarz,OAB,Oncolys,HIV,Yale,Alcon,Kyowa,Hakko,Comarket,Olapatadine,Eye,Drops,Nippon,Shinyaku,Baynas,Nippon,Kayaku,AstraZeneca,Inquiries,Mebix,Sonet,M3,Blood,Collection,Needl,Merck,Cervical,Cancer,Vaccine,Gardasil,Nikken,Chemicals,Kowa,Hoei,Teijin,Sato,Bonalfa,High,Lotion,ARKRAY,Naturalet,Puncture,Original,Generics,Ogata,Matsuyama,Marketing,Cooperate,Market,Price,MR,Certification,System,Reform,METI,Proposes,Economic,Framework,Korosho,METI,Ministers,Otsuka,Mozavaptan,Social,Security,Spending,Vaccine,Flu,Orphan,HPB,HPB,JMA,Ishii,JPA,Opposition,NHI,Price,Ingredients,OAB,Levitra,Diabetics,Viagra,Ely,Lilly,Japan,NDA,Mesothelioma,Treatment,Pemetrexed,Nippon,Kayaku,Cisplatin,Acomplia,sanofi,aventis,Novartis,NDA,Xolair,Severe,Asthma,Saiseikai,Central,Hospital,Prescribing,Information,Ketek,Cholesterol,Strokes,RTech,Ueno,Shuji,Inoue,Chairman,CHC,OTC,Aftach,Precautions,Cold,Patches,Amended,PAL,Retail,Industry,ASCO,Matson,Jack,Pancreatic,JACCRO,BI,Sifrol,RLS,LTT,Bio,Steroid,Asthma,Diabetes,CHD,Insulin,Detemir,Blood,Glucose,weight,Astellas,Discontinues,Immunosuppressant,Roche,Avastin,Advanced,Pancreatic,Bioventures,Bayer,Diagnostics,Siemens,Allergy,Symptoms,Testing,Phadia,Depression,Parkinson","No.1999 Contents")

st++; thePage[st]=new Array("1998_jul_3.pdf","pdf/2006_7/","1998 July 3","Shionogi,Teshirogi,Crestor,Irbesartan,Epadel,Atelec,Mochida,Blopress,S-2367,T-5524,Hypotensives,ARBs,Industry,Direct,Bargaining,Sankyo,Shanghai,Subsidiary,Average,Wage,Hike,Bayer,Taking,Over,Schering,AG,Kyowa,Hakko,Antibody,Teijin,India,Russia,Chugai,Recall,Recombinant,UK,Court,Pfizer,Dispute,DSP,Sumitomo,Chemical,Income,Outlay,Health,Insurance,Benefits,Aoki,Korosho,Market,Price,HIB,Official,Ryukaikon,PMDA,JPMA,WGs,ICH,Yokohama,Classification,NHI,Pricing,Neoral,Systemic,Myasthenia,Gravis,Lipitor,European,Countries,Cautions,Oxytocics,Precautions,Azithromycin,Smoking,PFSB,Clinical,Trial,Management,Guidance,Office,Indications,Original,Products,PromoteGenerics,Complaints,Supply,EAD,OriginalO,JFTC,Katagiri,Extension,Protection,Period,IGPA,American,Diabetes,Association,PIII,Sitagliptin,Presented,ADA,Vildagliptin,PIII,Novartis,Actos,Cardiovascular,Takeda,Pediatric,Ketek,Temporarily,Discontinued,sanofi,aventis,Toyama,Chemical,Trial,RA,Bayer,Antithrombosis,Rivaroxaban,Selectivity,Urief,Receptors,Viagra,Pulmonary,Artery,Hypertension,Atherosclerosis,Rasilez,Diabetes,High,Blood,Pressure,Wyeth,Vaccine,Leadership,Chuikyo,Coverage,Materials,Sellers,OTC,Smoking,Cessation,Aids,Fuji,Keizai,Mugitani,GE,ACNielsen,Japan,MREAC,Detection,Glaucoma,Japan,Launching,Speed,Eli,Lilly,Japan,Equal,Employer,FPMAJ,CFC,Committee,EPA,Ozone,Protection","No.1998 Contents")

st++; thePage[st]=new Array("1997_jun_26.pdf","pdf/2006_6/","1997 June 26","PMDA,Miyajima,Diet,JPA,Medical,Service,Law,LDP,MOF,Korosho,Cost,LDP,Industry,FPMAJ,JPMA,Protection,PFSB,Price,Study,Committee,Mukaida,Once,yearly,NHI,Price,Revision,Kimura,Iinuma,JMA,FDA,Merck,Cervical,Cancer,Vaccine,GARDASIL,Banyu,Imuran,Crohn,Disease,Ulcerative,Colitis,Takeda,Takepron,Nonerosive,GERD,Ryukaikon,EFPIA,PhRMA,ADR,Seminar,Yazaki,NHO,Tanaka,Public,Affairs,Committee,Teijin,Medical,Takeda,Ties,Up,Cephalon,promote,Provigil,US,Mediceo,Paltac,Stake,Nihon,DSP,Ambisome,IV,Infusion,Shionogi,Finibax,Drip,Infusion,Beckman,Coulter,GenomeLab,GeXP,Maurer,Cervarix,Women,Roppongi,Cleanup,Maurer,Lilly,PIII,Enzastaurin,HMW,Fucoidan,Inhibits,Clot,Formation,Takara,Bio,JSCPS,Criteria,Hepatic,Functions,Gleevec,CML,Patients,American,Society,Clinical,Oncology,ASCO,Sunitinib,Advanced,Lung,Raloxifene,Tamoxifen,Breast,Lapatinib,Survival,Renal,Cancer,Patients,EGFR,Gefitinib,EGFR,Gene,Mutant,Carboplatin,Paclitaxel,Ovarian,Letrozole,Zometa,Multiple,Myeloma,Novartis,Lapatinib,Cerebra,Metastasis,GSK,Increases,Osteoporosis,Smoking,Cessation,Center,Otsuka,Abilify,Receives,Prix,Galien,GENERICS,Pharmacists,ADRs,GE,Dispensing,Pharmacies,Medical,Institutions,Elmed,Eisai,Drugmaker,Astellas,Pfizer,Large,scale,Epidemiological,OA,Chuikyo,Correlation,Surgeries,Drugstore,Matsumoto,Taisho,Abbott,Clarith,Klaricid,Dry,Syrup,Children","No.1997 Contents")

st++; thePage[st]=new Array("1996_jun_19.pdf","pdf/2006_6/","1996 June 19","Abilify,Otsuka,Higuchi,Side,Effects,Mechanism,Action,MIYARISAN,MIYA,BM,Svizera,India,Fuji,Keizai,Tanabe,Seiyaku,Maruho,PDE,Inhibitor,Torrent,India,JGPMA,GE,Inserts,Forms,Generics,Yoshida,FPMAJ,JPA,JMA,Listing,Hisamitsu,Meiji,Seika,Comarket,Tulobuterol,Tape,Korosho,EFPIA,PhRMA,Foreign,Crenshaw,Kenporen,OTC,Drugs,JSMI,Diet,PAL,NHI,Price,Listing,PMDA,Clinical,Trial,Consultation,Services,ACE,Inhibitors,Teratogenicity,Precautionary,Statements,Lipitor,Nicotine,Dependence,Management,Pfizer,OAB,Detrusitol,Capsule,Sugio,Seko,MBC,American,Society,Clinical,Oncology,ASCO,Sunitinib,Temsirolimus,Thalidomide,Multiple,Myelomas,Lapatinib,Exemestane,Nexavar,Renal,Cancer,Bayer,Taxotere,NSCLC,sanofi,aventis,Herceptin,Chugai,Arimidex,AstraZeneca,CHMP,Takeda,Diabetes,Domestic,AMG,AnGes,MG,Threshold,Glufosfamide,Propecia,Inhibits,Entecavir,Bristol,Myers,Drug,Eluting,Stents,J&J,Seminar,Takashi,Wachi,JMDMA,Olympus,EVIS,LUCERA,Bronchial,Video,Scope,Chuikyo,Asia,Switch,Rohto,Dynamis,Anti,aging,Employees,Retirement,SSP","No.1996 Contents")

st++; thePage[st]=new Array("1995_jun_12.pdf","pdf/2006_6/","1995 June 12","Morita,FPMAJ,Detrusitol,Pfizer,Layoffs,Iwasaki,Citizenship,Report,Fake,Viagra,Yoh,Narimatsu,Quintiles,Transnational,Wakunaga,Quinolone,Rib-X,Dainippon,Sumitomo,Dops,Aoki,FJPWA,Contract,Amamoto,NEUES,JASMO,Vesicare,NHI,Astellas,osteoporosis,Servier,Importance,Continues,Nishi,So-net,M3,JCR,Erythropoietin,Nissui,Oki,Irom,SSI,Taiyo,Sawai,Tanabe,Sawai,Towa,Towa,Nichi-iko,Formulation,MRs,MREAC,Wakomoto,GE,Ophthalmology,Novartis,moking,Cessation,Aid,JAPIC,GMP,Inspections,Korosho,GL,MS,Astellas,Modified,Release,Formulation,Tacrolimus,Toyama,Chemical,NDA,Quinolone,Antibacterial,T-3811,Pediatric,AstraZeneca,Pulmicort,Nihon,Medi,Physics,Avastin,Breast,Cancer,Roche,Wholesalers,Yakkasa,Niwa,Simultaneous,Wyeth,AnGes,Vical,Gene,Therapy,Activate,Iwasa,Reexamination,Patent,NFkB,Decoy,Oligo,TeGenero,TGN1412,MHRA,Tsuji,IRBs,J&T,Institute,Aliskiren,Antihypertensive,Novartis,Aggrenox,Recurrent,Stroke,NBI,Spiriva,Acute,Exacerbation,COPD,PET,Tohoku,MBL,Baraclude,Lamivudine,Resistant,Hepatitis,B,BrainLAB,Radiotherapy,Alcon,AcrySof,Natural,Single,Piece,Takara,Bio,PrimeSTAR,Max,DNA,polymerase,PrimeScript,Wako,Junyaku,Amyloid,Measurement,Kit,Asahi,Kasei,Kuraray,Manufacture,Hollow,Fiber,Membranes,OPINION,Philip,Carrigan,OTC,Segments,Fuji,Keizai,Yakuhin,Functions,Drewel,SSP,Social,Security,NHO,Hospitals,ADR,Statins,JPA","No.1995 Contents")

st++; thePage[st]=new Array("1994_jun_5.pdf","pdf/2006_6/","1994 June 5","Aoki,JPMA,Astellas,Pipeline,Global,Nogimori,Chuikyo,NHI,Price,List,Ambisome,Nicotine,Patch,Commentary,Smoking,Cessation,Aids,OTC,Products,Itraconazole,Moxifloxacin,Avonex,Baraclude,Niwa,Social,Security,Reform,Pricing,Innovative,Baxter,FEIBA,Huntingdon,Life,Sciences,Japanese,Business,Cass,KineMed,Aborted,Compounds,CMIC,Rx,License,SSP,Toyama,Plant,Sales,Force,Effectiveness,Japan,Encouragement,Aoki,Nagayama,Wholesalers,Buyers,Matsutani,Toho,MRs,Takeda,Pfizer,Takada,Daiichi,INTERPHEX,JAPAN,Fauchet,sanofi,aventis,Okamoto,DSP,India,IPA,President,Taisho,Health,Food,LTT,Bio,Pharma,Mikasa,Zepolas,China,Nikken,Chemicals,Subsidiary,Kowa,Otsuka,Hisamitsu,Midterm,Mediceo,Paltac,Suzuken,Astis,Alfresa,DKSH,Switzerland,Asia,Toho,Tokai,Integrated,Toho,Pharmaceutical,Hokuyaku,Takeyama,TGN1412,Korosho,Esophageal,Cancer,IRBs,Factor,VIII,Bayer,NanoCarrier,PI,NC6004,UK,LTT,Bio,Pharma,Sustained,release,IF,Nasal,Spray,emetic,Granisetron,CytoPathfinder,Qiagen,RNAi,Screening,Oxygenix,Nipro,Betaferon,Clinically,Definite,MS,Vesicare,OAB,Yamaguchi,Anticoagulants,Cerebral,Infarction,Generic,Drugs,Sawai,Generics,Prescriptions,Dermatology","No.1994 Contents")

st++; thePage[st]=new Array("1993_may_29.pdf","pdf/2006_5/","1993 May 29","Shoda,Daiichi,Sankyo,Pfizer,Detrusitol,OAB,Comparative,Korea,Nishizawa,Banyu,Nulotan,Astellas,Takenaka,Eisai,Dissolve,Subsidiary,Taisho,Shionogi,Royalties,Crestor,Korekane,Ono,Santen,Ethical,Meiji,Seika,Kaken,Kyorin,Mochida,Epadel,Atelec,Kissei,Nippon,Shinyaku,Torii,ASKA,Toyama,Chemical,Seikagaku,Kirin,JT,FPMAJ,So-net,M3,Doctors,Blog,Morita,FPMAJ,Aoki,JPMA,Nakamura,JCROA,Baxter,John,Greisch,President,International,Maurer,Healthcare,Insight,Expenditure,Korosho,JMA,Terumo,Yakult,Honsha,Codevelop,Irinotecan,DDS,MD,Studies,Mass,Spectrometry,Conference,Invest,Glivec,CML,Novartis,Carna,Biosciences,Enamine,Animal,Studies,Severe,Alzheimer,Alicept,JGPMA,Yoshida,JGPMA,DB,Ishii,JPA,Benefit,Standard,Prices,System,Advertising,GE,taiyo,Metabolic,Syndrome,Lifestyle,Policies,Uterine,Corpus,Cancer,COPD,NBI,Internet,LCA","No.1993 Contents")

st++; thePage[st]=new Array("1992_may_22.pdf","pdf/2006_5/","1992 May 22","Nogimori,Astellas,Takeda,Hasegawa,Tanabe,Seiyaku,GE,Business,Daiichi,Sankyo,Olmesartan,Expiry,Mevalotin,Patent,DSP,Merger,MPC,Development,Subsidiary,Beijing,Teijin,Medical,Asahi,Kasei,NDAs,President,Oe,Kaken,Licenses,Antifungal,KP-103,Dow,SymBio,Bendamustine,Kissei,Daiichi,Urief,Area,based,MR,System,Pfizer,MOSS,Institute,Eisai,Nitto,Denko,TD,Aricept,NBI,Pfizer,Spiriva,LTT,Bio,Pharma,Pediatric,Society,Korosho,Pediatric,Use,Sato,ELD,Yamaguchi,Epogin,Anemia,Premature,Infants,Actemra,RA,Keppra,IV,Administration,EU,UCB,European,MAA,Novel,Anemia,CERA,Herceptin,Roche,IgM,Antibody,Organ,Transplant,Donors,Definition,Influenza,Novartis,Chugai,Femara,Sanofi,aventis,Antiplatelet,Plavix,Otsuka,Quinolone,Eye,Adults,Children,Alzheimer,Disease,CPhI,Clinical,Trials,Doi,Alliance,Strategies,Essential,Tsuchiya,Tanabe,Global,Clinical,Davenport,Eli,Lilly,Mega,Pharma,Paradigm,Blockbusters,Niche,Haydock,SCRIP,Kawahara,PFSB,Generics,Patents,Crystal,Umimoto,Towa,Kissei,Codevelop,CD,MAB,BioMedics,Santen,Ube,Glaucoma,Peptide,Inflammation,Bone,Resorption,Tokumasu,METI,Projections,Expenditure,JMA,Gap,Novartis,Mammographic,Examination,Project,Influenza,Vaccine,Expected,Denka,Seikan,Roche,Diagnostic,AmpliChip,CYP,Olympus,Segment,Posts,Strong,JPMA,Evaluation,PMDA,Regulatory,Affairs,GMP,Quality,ICH,Antibacterials,Instructed,BP,Control,Inadequate,Patients","No.1992 Contents")

st++; thePage[st]=new Array("1991_may_15.pdf","pdf/2006_5/","1991 May 15","Banyu,Hirate,NBI,Astellas,Anemia,FibroGen,Hyperphosphatemia,Ilypsa,Novartis,Takeda,Sucampo,AMITIZA,Chronic,Constipation,Vaprisol,Euvolemic,Hyponatremia,Daiichi,Sankyo,Wakodo,Asahi,Breweries,BMS,Gatifloxacin,Suzuken,Shoyaku,Wholly,Owned,Subsidiary,Sonet,M3,Kyowa,Hakko,Torii,TachoComb,Masafumi,Nogimori,FPMAJ,President,Schering,Plough,Temodar,Unapproved,Draft,Vision,Vaccine,Flu,Orphan,Status,PMDA,JZOLOFT,Detrusitol,Zyvox,MRSA,Infection,Pfizer,Roche,BLA,CKD,CERA,Chugai,Bevacizumab,Janssen,Doxorubicin,Iressa,PFSB,Omori,hRMA,World,Pharmaceutical,Organization,Asia,Pacific,Krivi,Lilly,Research,Strategy,Commercialize,Corr,Cooperative,Clinical,Trials,LDP,Clinical,Research,Life,Science,Summit,TeGenero,Incident,Victims,Compensated,Chugai,Actemra,RA,DSP,Mosapride,JMMS,Trial,Bezatol,Insulin,Resistance,Kissei,AstraZeneca,Patients,IPASS,Trial,Abbott,Guidant,Vascular,Morimoto,Iyaku,Consulting,Beijing,Alfresa,Pharma,Asahi,Kasei,Medical,Polysulfone,Dialyzers,china,Terumo,Freund,JMA,Prescriptions,Generic,Substitution,NPhA,Hospitals,Insurance,Hospitals,Avian,Influenza,GE,Houses,List,Generic,Clarithromycin,Among,NSAIDS,Loxonin,Prescribed,Kyowa,Hakko,Meiji,Dairies,Oral,GI,Contrast,Medium,Improves,Quality,Sleep,Rohto","No.1991 Contents")

st++; thePage[st]=new Array("1990_may_1.pdf","pdf/2006_5/","1990 May 1 & 8","aventis,Vaccine,Hib,Sanofi,Pasteur,SanofiPasteur,IPV,Bayer,Schering,GCP,South,Korea,CMIC,Brazil,Epidemiological,Marketing,Robinson,Mattson,Jack,Eisai,Gasmotin,Asian,Takeda,ACTOS,Lilly,US,Baynas,Nippon,Shinyaku,Daiichi,Sankyo,Astellas,Zepharma,Kyorin,IMS,BI,Heil,NBI,Takara,Bio,JPMA,Aoki,Reappointed,DSP,Ambisome,IV,Infusion,Cetrotide,Prevention,Ovulation,Nippon,Kayaku,Vesicare,Overactive,Bladder,Astellas,Funguard,Pediatric,Humatrope,Growth,Hormone,Replacement,Adults,Nu-lotan,Diabetic,Nephropathy,Feron,Compensatory,Type,Liver,Cirrhosis,Chuikyo,Prices,NHI,Prices,Gabapentin,Mozavaptan,JPMA,Korosho,Burden,Population,Decline,Chugai,NSCLC,Treatment,Erlotinib,Prograf,Heart,Transplants,NDA,Bevacizumab,US,Non,Squamous,NSCLC,Bayer,Nexavar,Orphan,EU,JT,Licenses,GSK,DIA,Workshop,AE,UK,PMDA,Policies,PGx,PI,Keppra,inferior,Carbamazepine,UCB,Long,term,Betaferon,Reduces,Recurrence,MS,JHSF,Pharmacogenomics,JMA,Expand,NW,Tsuji,Endo,Awarded,Discovery,Statins,Silodosin,Prostatic,Hypertrophy,OAB,Behavioral,OPINION,Philip,Carrigan,MR,System,SSP,Retirement,Program,Long,Transferred,Eliminated,AIDS,Fuji,Biomedix,Seishin,Works,Medtronic,InSync,ICD,Alfresa,ISO,Dispensing,Fee,Pharmacies,Kubo,RDKK,Female,Children,SSP,Eve,Series,Headache,Strong,Wakamoto,GI,Disorders,Methotrexate,hadia,IUS,Levonorgestrel,Nihon,Schering,PollinosisAllergy,Symptoms","No.1990 Contents")

st++; thePage[st]=new Array("1989_apr_24.pdf","pdf/2006_4/","1989 April 24","Acquisition,Schering,Specialty,Care,Bayer,HealthCare,Portoff,Bayer,Yakuhin,Adalat,Chugai,Takeda,Eisai,Hire,Mediceo,Paltac,JT,Hiroshi,Kimura,Hisamitsu,Wyeth,CriAtive,CRA,Dispatch,Contract,Clinical,Research,Carna,Biosciences,ChemDiv,Edetails,So,net,M3,Industry,Exemption,Supply,Original,Full,Range,Strengths,Pasta,Femara,Postoperative,Breast,Cancer,Novartis,BiSifrol,RLS,Astellas,Candin,Antifungal,Micafungin,EU,Korosho,Smith,Nephew,Philips,Electronics,Cardiac,MRI,Education,Center,Medtronic,Japan,Implanted,Spinal,Cord,Stimulator,Flo,Track,Sensor,Edwards,Lifesciences,Blood,Glucose,Tester,Receives,Commendation,Compliance,Confirmed,Terumo,Skeletal,Myoblasts,Stryker,Japan,Obtains,ISO,JPMA,Aoki,Likely,Reappointed,President,JPMA,Huma,Expand,Clinical,Trial,Volunteer,Recruitment,Business,Pre,screening,Medical,Charts,CRCs,Illegal,CRCs,Xeloda,Roche,Seretide,COPD,Patients,Provides,Zyprexa,Antipsychotics,CATIE,Lilly,Prevnar,Antibiotic,Resistant,IPD,Quintiles,EDC,Trial,GNI,Beijing,Continent,Sanofi,aventis,Rights,Rimonabant,Takeda,PACIF,Capsule,Anthrobin,Injection,ZLB,Behring,Kogenate,FS,BIO,SET,Hemophilia,JPA,Database,Comparing,Original,Prescription,Shaking,Pharmacies,Breast,Patients,Unsatisfied,Explanations,Stroke,Undergoing,Pfizer,Awareness,Normal,Tension,Glaucoma,Increasing,Specialists,Kawasaki,Glossary,Terms,Licensing","No.1989 Contents")

st++; thePage[st]=new Array("1988_apr_17.pdf","pdf/2006_4/","1988 April 17","Boehringer,Ingelheim,Banchi,Mochida,Kissei,Novel,Diabetes,Astellas,Amevive,Sankyo,Daiichi,Kirin,Intercell,Antibodies,Pneumonia,Iwasaki,Pfizer,Kowa,Nikken,Integration,Takeda,Arius,Canada,Asahi,Kasei,Eisai,China,Eril,DSP,US,Alfresa,Tanabe,Modafinil,Ensure,Liquid,TULC,Cans,Asahi Kasei,Teikoku,Seiyaku,Torii,Dovonex,Abbott,MTCI,Mitsui,Chemicals,API,Yokohama,City,University,Korean,Version,MRKun,Sonet,M3,R-Tech,Ueno,Yukiko,Hashitera,CEO,Evidence,Pediatric,Designation,Vaccines,Orphan,Teikoku Seiyaku,Novo,Nordisk,Insulin,Detemir,TPNA,ACTOplus,UCB,Zyrtec,Dry,Syrup,Prograf,Bayer,Nexavar,Kidney,Cancer,Switzerland,PFSB,ADRs,Ethical,OTC,Quasi,Pharmacopoeia CHC,Zepharma,EPS,Subsidiary,Asia,Seretide,Mortality,COPD,GSK,Influenza,Vaccines,MediciNova,PI,MN-246,MN246,Urinary,Incontinence,Pramipexole,QOL,RLS,BI,PharmaDesign,PharmaGCHEM,CKII,Library,Child,rearing,Support,Seikagaku,Corp,Encourage,Childbearing,Nihon,Medi,Physics,PET,CT,Intrathecal,Gagalon,Synchromed,Siemens,Asahi,TechMatrix,SDS,Methods,Reservation,JMA,LDP,Karasawa,Uematsu,JMARI,Radiotherapy,Molecular,Sawai,Wholesalers,Dispensing,Pharmacies,Original,Collaborate,Nipro,Zensei,Nihon Medi Physics","No.1988 Contents")

st++; thePage[st]=new Array("1987_apr_10.pdf","pdf/2006_4/","1987 April 10","Wolf,PhRMA,Mixed,Care,Astellas,Toyama,Quinolone,T-3811,Deloitte,Touche,Tohmatsu,Life,Science,Janssen,Yoh,Narimatsu,President,CEO,Quintiles,Japan,Kissei,Glufast,o,Elixir,Terumo,Contrast,Medium,Imagenil,Tsumura,NIPRO,Tanabe,Seiyaku,Abbott,DSP,Opocrin,Ito,Life,Science,Fuso,Nippon,Kayaku,NBI,MediBIC,Budget,Korosho,Provisional,Delivery,Economist,Conferences,Roundtable,Asian,Aoki,Innovative,Generics,Yoshida,JGPMA,Eisai,Indication,Non,erosive,GERD,Pariet,Yakult,Pancreatic,Irinotecan,Daiichi,Sankyo,Ono,Medarex,Antibody,Therapeutics,Santen,Oakwood,Lab,DME,Eisai,DNAVEC,Vaccine,Therapy,AD,OTS,Fuso,Pharmaceutical,Norvasc,Statins,CV,Taxotere,Adjuvant,Breast,JBCRG,IFPMA,Report,Reexamination,Restoration,Reed,Maurer,Irinotecan,Rate,IRIS,Daiichi,Sankyo,Zepharma,Market,Bio,derived,Materials,Fuji,Keizai,Nippon,Shinyaku,Enter,OPINION,Pilip,Carrigan,Examination,Medical,Practitioners,FALCO,Genetic,Screening,Colorectal,Cancer,Takara,Bio,China,Nipro,Paris,Osaka,Nihon,Medrad,Sheeman,JMA,Yoshihito,Karasawa,Ueno,Nihon,Medi,Physics,Nobuyoshi,Mikami,Takao,Ohmura,President,Oxygenix","No.1987 Contents")

st++; thePage[st]=new Array("1986_apr_3.pdf","pdf/2006_4/","1986 April 3","Eli,Lilly,Tadalafil,Crenshaw,NDA,US,Subsidiaries,Daiichi,Sankyo,Exelixis,CV,Tamiflu,Chugai,Outsource,MP,Technopharma,Patent,Infringement,Ajinomoto,Ono,Santen,PDE,Inhibitor,Novartis,Asahi,Kasei,Copromotion,Voltaren,Nippon,Chemiphar,Torii,Discontinue,Uralyt,Arm,Systex,EXSAS,Nippon,Chemiphar,Deloitte,Touche,Tohmatsu,Campina,Fonterra,Excipients,Dispensing,Fee,JPA,Medical,JPA,Outlined,Ishii,Hodanren,PFSB,Quicker,Quality,Products,ELD,NHI,Price,Revision,HPB,Deloitte Touche Tohmatsu,ELD,Information,Pediatric,Use,GLs,ICH,OTC,Categories,WHO,IFPMA,Counterfeit,Novo,Nordisk,Norditropin,NordiFlex,Selegiline,Infectious,Mortality,Northern,Prefectures,Takeda,Astellas,Anti,Human,Osteopontin,Antibodies,IBL,Nippon Chemiphar,Toyama,Avian,Flu,Toyama,Chemical,Schering Ploughn,Janus,Initiates,Topical,Herpes,Zoster,CytoPathfinder,Santen,Ophthalmic,PMDA,Regarding,Participate,Global,Trials,Mori,JCROA,Global,Studies,Statins,Inhibit,Strokes,s,Pfizer,TeGenero,Investigational,Antibody,Disaster,PI,AE,T-075,T075,Becton Dickinson,Korosho,Package,Inserts,Generics,Wholesalers,FJPWA,Novo Nordisk,Kobayashi,Toyo Shinyaku,Toyo,Health,Food,JV,Taisho,Yomeishu,Pfizer,Yamanashi,MR,So-net,M3,Sonet,On-line,Bill,Infertility,JSSR,Hitachi High Technologies,Nippon,Becton,Dickinson,Hitachi,High,Technologies,Contract,Analysis,Schering,Ploughn,Claritin,Ready","No.1986 Contents")

st++; thePage[st]=new Array("1985_mar_27.pdf","pdf/2006_3/","1985 March 27","Diabetes,Novo,Nordisk,Takeda,Tavocept,NPhA,Chain,Pharmacies,Hokuyaku,Takeyama,Hokuyaku,Kissei,ASKA,Prescription,IMS,Health,NHI,Price,Revision,Korosho,Generics,Towa,Sawai,Nichiiko,Taiyo,JGPMA,GSK,Cervarix,Cervarix,EU,Vaccine,FPMAJ,Aricept,Cognitive,Function,Vascular,Dementia,Eisai,Blopress,Hypertension,Crestor,Plaque,Coronary,Artery,Disease,Baraclude,Lamivudine,CHB,US,Against,ASO,Anticancer,GL,Animal,GNI,Fukuoka,ActivX,Pfizer,Kyorin,Novo Nordisk,JST,Zeria,Rhinitis,Statins,REACH,Registry,JPMA,Aoki,Shiozaki,Seminar,Schizophrenia,Otsuka,Kobayashi,Dentsu,Reform,Dainippon,Sumitomo,Orodispersible,Amlodipine,Ranibizumab,Orphan,NIBIO,JMA,Takemi,Nishijima,Kodama,JPA,Banyu,SSP,Retirement,Kyowa,Hakko,Terumo,Reemployment,Female,MR,Society,Forum,Healthcare,Taisho,Mediceo,Paltac,Selmesta,Sysmex,Roche,Diagnostics,Beckman,Coulter,DHEA,Kit,Kyowa Hakko","No.1985 Contents")

st++; thePage[st]=new Array("1984_mar_20.pdf","pdf/2006_3/","1984 March 20","Sanofi,aventis,Plavix,Sanofi-aventis,Myslee,Astellas,NHI,Price,Revision,JPMA,Aoki,Yoshida,JGPMA,Asahi Kasei,Takeda,Wholesalers,Bundling,Pharmacy,Chains,Yamamoto,ERBITUX,SCCHN,Selenica-R,UCB,BLA,Crohn,FDA,Selenica,Isobide,DS,Nikken,Chemicals,FDA,Bristol,Myers,Dasatinib,Quality,Reevaluation,HPB,Kowa,Nikken,Chemicals,Integrate,Shionogi,Galderma,Acne,Kyorin,Asahi,Kasei,Pharma,CTCLS,Software,INSTEM,LSS,KyowaHakko,Kyowa Hakko,Dendrite,Hitachi,Engineering,TrackWise,AsahiKasei,Morishita,Jintan,Kobayashi,Pharm,Irom,Banyu,Site,Support,Institute,ARC,Bankruptcy,Civil,Rehabilitation,Law,Kyowa,Hakko,PIII,Trials,Parkinson,Treatment,KW-6002,PI,Diabetes,OPIR,PMDA,Consultations,Symposium,Cancer,Diagnosis,NBI,Promote,COPD,Benefits,Pravastatin,MRGA,Nakamura,Human,Resource,Job,Wage,System,DSP,JPA,PAL,Create,SD,Micrus,Obtains,Endovascular,Imatron,Japan,Heart,Laser,Sweden,Diagnostics,Phadia,Generics,Yanagawa,JammNet,Generic,Market,Share,Report,JMA,General,Assembly,Osaka,allergy,GPs,JMDC,Cardiac,Cerebrovascular","No.1984 Contents")

st++; thePage[st]=new Array("1983_mar_13.pdf","pdf/2006_3/","1983 March 13","Eisai,Pfizer,Takeda,Basen,OD,Norvasc,IMS,Bushu,Biotech,Lexicon,Genetics,Abbot,House,Zeria,Promac,SK,Chemicals,Korea,SK Chemicals,Daiichi,Plavix,sanofi,aventis,Kyowa,Hakko,Amino,Acids,China,Hospira,Taiyo,Quintiles,So-net,Sonet,M3,Strategy-Kun,Futagawa,Mukaida,FJPWA,sanofi-aventis,Ryukaikon,Korosho,Ciproxan,Legionella,Bayer,RSL,BISifrol,NBI,Clarith,Legionella,Taisho,GSK,Rotavirus,Rotarix,Bayer Yakuhin,House Foods,NHI,Price,Revision,Hayashibara,Alzheimer,Vaccine,Reed,Maurer,Explanatory,JapicCTI,JCROA,Iwasaki,EFPIA,Kyowa Hakko,Astellas,Dynogen,CRO,Uwoi,BELL SYSTEM,Mori,PMDA,BELLSYSTEM,Sato,Acne,Treatment,Dalacin,Kenkocom,Sumitomo,Kobashou,Meiji,Seika,Philip,Carrigan,JPA,Influenza,Heart,Transplants,Hamano,Foundation,Abilit,ChemSensing,Colorimetric,Sensors,MONODIOX,Monofilament,Suture,Meiji Seika,Alfresa,Smith,Nephew,Wound,Management,Algoderm,Terumo,MicroVention,Falco,Biosystems,HitzCOSMIC,Toyo Chuken,ApoPlus,Smith&Nephew","No.1983 Contents")

st++; thePage[st]=new Array("1982_mar_6.pdf","pdf/2006_3/","1982 March 6","Pfizer,Japan,Appoint,President,CEO,GSK,Vaccine,Business,Japan,Europe,MPC,Lequio,Pharma,Zione,Yuhan,South,Korea,Chugai,Immortalized,Cell,Line,Cambrex,Kyowa,Hakko,Parkinson,Britannia,Bayer,Yakuhin,Anticancer,Femara,Novartis,Pharma,MediciNova,Iwaki,Takada,Actos,Patent,Nippon,Shinyaku,BMS,Pravachol,Nihon,Chouzai,Maruho,Stromectol,Banyu,Fuji,Film,Perseus,Proteomics,Mediceo,Paltac,FJPWA,Tamiflu,JPMA,DSP,Ambisome,Astellas,Vesicare,Ranibizmab,Orphan,Korosho,Provisional,Delivery,Measures,Provisional,Delivery,Futagawa,Roche,Herceptin,Pediatric,Relenza,Priority,Review,Fondaparinux,APIs,Wyeth,Pneumococcal,Vaccine,UK,Childhood,Immunization,Program,Bayer,Onyx,PIII,Lung,Cancer,Nexavar,Aromasin,Maintains,QOL,Breast,Cancer,IES,HGF,Gene,Therapy,AnGes,MG,PhRMA,LSG,MPI,Research,Kyowa,Medex,Remnant,Lipoprotein,Measurement,Kit,Roche,Diagnostics,Genome,Sequencer,System,bioMerieux,NucliSens,easyMAG,EBIS,Obtains,Electron,Beam,Sterilization,PerioDock,Commercialize,HRF,Biomarker,Takara,Biotechnology,Dalian,Becomes,Wholly,Owned,Subsidiary,Takara,Bio,Nipro,Establishes,New,Office,Singapore,JPMA,Publishes,Data,Chemotherapy,Specialists,JSMO,RAPS,Dispensing,Injectables,JMA,LDP,Karasawa,Statistics,MR,Education,Mizuno,MREAC","No.1982 Contents")

st++; thePage[st]=new Array("1981_feb_27.pdf","pdf/2006_2/","1981 February 27","Roche,Diagnostics,JMCoE,Program,Medicine,Products,DSP,Okamoto,Replidyne,Comarket,Faropenem,Medoximil,Daiichi,Asubio,Toho,Hamada,France,Environment,AFII,Mr-Kun,QOL-Kun,So-net,M3,NBI,CNS,Sonet,MRKun,Irom,LTT,Biopharma,MediBIC,Companies,Suganuma,HiroBSFutagawa,Female,MRs,GSK,Educational,Depression,Patients,JGPMA,Korosho,API,Medical,Fees,JMA,JPA,Discussions,Chuikyo,JNA,Kenporen,Social,Security,Systems,Kawasaki,Medical,Spending,US,FDA,NDA,Garenoxacin,Toyama,Chemical,EC,Marketing,Macugen,Pfizer,FDA,Eisai,sNDA,Aricept,Mitsubishi Chemical,Albrec,Consultation,Prescription,Fees,Expenditure,Dialysis,Influenza,Kyorin,KRP-203,Novartis,Takeda,Hematide,Affymax,AstraZeneca,IPAS,Study,Iressa,Orientals,Systems,Probabilistic,Discovery,Tanuma,PMDA,Multiple,Preliminary,Interviews,Santen,Preliminary,Glaucoma,Estrogens,Increase,Heart,Disease,Wyeth,Interim,PMS,Apnission,Eisai,Gamma,globulin,Kawasaki,Disease,Vaccines,Orphan,Gout,Treatment,GSK,Asthma,Fuji,Keizai,Moncef,Slaoui,Chairman,Tatsuji,Iga,JSHP,Fresenius,Dialyzers,Olympus,Taisho,Ophthalmic,Iris,CL,Special,Container,ASKA,Manufacturing,Approval,GRELAN,BIT,Drugstores,JACDS,Paltac,Osaka,Agaricus,Fuji-Keizai,Health,Food,Supplements,FujiKeizai,INTAGE,Novartis,LTT Biopharma,Toyama Chemical,Dainippon,Sumitomo,Dainippon Sumitomo,Roche Diagnostics,Mitsubishi","No.1981 Contents")

st++; thePage[st]=new Array("1980_feb_20.pdf","pdf/2006_2/","1980 February 20","Chugai,NHI,Price,Revision,Tamiflu,Split,Off,Manufacturing,Division,Korosho,Eisai,Exclusive,Rights,Prialt,Europe,Seibule,Sanwa,Kagaku,Managerial,Pfizer,Labor,Union,UI,Zensen,Bargaining,Sessions,FJPWA,PMAT,Seminar,Ikegami,Sankyo,Mori,Astellas,Taisho,Media,Zepharma,Seikagaku,AnGes,MG,Terminate,Codevelopment,NFkB,Decoy,Oligo,Carna,Biosciences,Daiichi,Asubio,Bio,Fujitsu,FIP,PMS, Taisho,Yomeishu,Seizo,Alfresa,SPD,Medical,Institutions,Bankrupt,TDB,FTC,Ethical,Drug,Business,Practices,Healthcare,Reform,Cabinet,Bill,Providers,Mandatory,Receipts,Chuikyo,Merck,Cervical,Cancer,Vaccine,Priority,Review,FDA,UCB,Keppra,EMEA,Alglucosidase,Designated,Orphan,Drug,HRF,Pathophysiology,Endometriosis,OPMA,Teleconference,System,PMDA,Medwatcher,Japan,Admired,Pharma,Companies,Reed,Maurer,APDD,Infrastructure,TR,Fukushima,Clinical,Research,Angell,Publication,Seminar,PMS,Results,Atorvastatin,Japanese,Asians,Basically,Acceptable,Mori,Southeast,JAPIC,Seminar,Tsuji,screening,Banyu,Patients,Sleep,OPINION,Romancing,Philip,Carrigan,Fuji,Biomedix,Kit,Diagnose,Malignancy,Colon,Cancer,HIV,Measurement,Method,Developed,Artificial,Kidney,Market,Fuji,Chimera,European,Commission,Chiron,Novartis,JASDI,Cancer,Patients,ADRs,Ito,Toranomon,Hospital,PMA,COML,Director,Pharmacists,Hatanaka,Early,Discovery,Treat,OCD,GSK,Seminar","No.1980 Contents")

st++; thePage[st]=new Array("1979_feb_13.pdf","pdf/2006_2/","1979 February 13","Mochida,Toho,Quintiles,ECG,Analysis,India,Sucampo,AMITIZA,Intendis,Sysmex,America,ACL,Laboratories,Ibe,JSMI,OTC,Banyu,Detailing,CareNet,eDetailing,Mediceo,Paltac,Pfizer,Capsugel,Xcelodose,Capsule,System,Dainippon,Sumitomo,ASKA,RFID,Tags,Viagra,Zoo,Database,Software,Miyakoshi,China,Chugai,Actemra,Pollinosis,Settlement,Accounts,Prescription,Anticancer,Agent,GCP,Compliance,Inspections,Relenza,CDFS,HLW,PMDA,ADR,Chuikyo,Frustrating,Outcome,Industry,Exceptional,NHI,Price,IRBs,Teikoku,Seiyaku,Altea,Therapeutics,License,Astellas,Prostate,Cancer,Treatment,Ferring,AnGes,MG,Patent,HGF,Gene,Bioventures,Search,Anticancer,Candidates,Teijin,Hokkaido,Nanotechnology,Biotechnology,Alliance,CHS,Discovery,Infrastructure,National,Burden,Wako,Pure,Chemical,Fecal,Occult,Blood,Analyzer,FOBITWAKO,DPC,Management,Korosho,Weight,Gain,Pregnant,Nursing,Mothers,JGPMA,JPMA,Job,Sharing,Nationwide,Delivery,Nakagawa,Opportunity,Rummelt,Sandoz,Switch,Sankyo,Lamisil,AT,JSMI,Measures,Stimulate,Kenko,com,Explanation,System,Internet","No.1979 Contents")

st++; thePage[st]=new Array("1978_feb_6.pdf","pdf/2006_2/","1978 February 6","Sysmex,Takeda,Management,Japanese,Strengths,Toyama,T-3811,Astellas,DongA,Korea,Meiji,Seika,Specifications,Eisai,European,UK,Sumitomo,Summit,MediChem,Medisa,Shinyaku,Sawai,Ihoken,China,JPMA,Handbook,Asian,Lipitor,Adverse,Reactions,Novartis,Lifestyle,Diseases,Lonza,Bioproducts,UCB,Kompass,Japan,Kommarket,Pfizer,DainipponSumitomo,Sumitomo,Pollinosis,Allegra,Allelock,Kyowa,Hakko,Alesion,NBI,Exceptional,Foreign,Atypical,Antipsychotic,Abilify,Otsuka,Silodosin,Dysuria,Kissei,Femara,Breast,Cancer,Nidek,Tosufloxacin,Eye,Drops,Serono,Japan,Follitropin,MHH,Lead,Chemical,Sankyo,Loxonin,Poultice,Obsessive,Compulsive,Disorders,Paxil,GSK,Paxil,Study,Group,IRBs,Tamiflu,Niwa,Santen,PAPILOCK,Mini,Ophthalmic,Solution,OPINION,Philip,Carrigan,Astellas,Inventorship,Ochiai,Paul,King,JPMA,Licensing,US,Ajinomoto,sNDA,Nateglinide,Biguanides,Shanghai,Genomics,Organon,GNI,Medidata,NIBIO,Animal,Chuikyo,Coverage,PET/CT,Safety,Info,Theophylline,Pacemakers,Nipro,Beckman,Coulter,Catchphrases,JSMI,PFSB,Switch,OTC,Pharmacy,Internet,CV,JHSF,Metabolic,Syndrome,Korosho,Fujii","No.1978 Contents")

st++; thePage[st]=new Array("1977_jan_30.pdf","pdf/2006_1/","1977 January 30","AMO,Sankyo,Daiichi,MCHC,Diagnostics,Mitsubishi,Merge,Chugai,Toyobo,CareNet,Kowa,Hypercholesterolemia,So-net,M3,MR-Kun,Eisai,Dispute,Supply,Generics,Full,Strengths,Chuikyo,Replacement,Current,Prescription,Original,Generic,Bioequivalent,Masada,Taiyo,Lipo,PGE1,Preparation,Nichi-iko,Specifications,Package,Insert,Paroxetine,CDFS,PhRMA,Ira,Wolf,Representative,Maurer,Healthcare,Insight,Reed,Maurer,Keiji,Nakamura,Astellas,Inventorship,Ochiai,Paul,King,JPLA,Bioventures,Matsumoto,PAL,Switch,OTC,Revise,Marketing,System,Pharma,Delegates,Kusaka,Lehman,Brothers,Takeda,PII,Antiobesity,ATL-962,PIII,antidiabetic,SYR-322,DDS,LTT,Bio,Pharma,PI,Nanoplatin,NanoCarrier,JASDI,Yamazaki,Sosei,SOT-375,Josai,Clinic,Hair,Asthma,Somusho,Municipal,Dispatch,NSAIDs,Toothache,Hodanren,GSK,Clavamox,Pediatric,Baxter,Sevoflurane,Rohto,Pranoprofen","No.1977 Contents")

st++; thePage[st]=new Array("1976_jan_23.pdf","pdf/2006_1/","1976 January 23","Meiji,Seika,Generic,Oral,Carbapenem,ME1211,Kyowa,Hakko,Anticancer,Eli,Lilly,Replidyne,Faropenem,Daiichi,Asubio,Toho,Sawai,Nichi-iko,Kyowa,JGPMA,JPMA,Yoshida,Union,Banyu,Sankyo,Heart,Attack,KAI-9803,LAB,Inhaled,Fentanyl,Teikoku,Seiyaku,Bayer,Nuvelo,Collaborate,Alfimeprase,AstraZeneca,Lawsuit,Taiyo,Integration,Daiichi,Sankyo,Prescription,Form,Matsutani,HPB,PMDA,Miyajima,Influenza,Tokyo,Positive,Avian,Flu,Antibody,Korosho,GL,Sanwa,Kagaku,Postprandial,Hyperglycemia,Treatment,Seibule,Zepharma,OTC,Eurax,Dexa,Ointment,Stocks,Jean,Bruno,Bouee,Vascular,Calcification,Vascular,Atherosclerosis,Keiji,Nakamura,Shionogi,Purdue,Analgesics,SCCRE,Ethics,IRB,Medicines,PhRMA,Procedures,Insurance,Implantable,Pump,Intrathecal,Infusion,Medtronic,PET,CT,System,GE,Yokogawa,Medical,System,Kissei,Free,Style,Freedom,Kissei,Bio,Rad,Pasteur,Nipro,Guatemala,City,Immunoassay,Market,Report,Fuji,Keizai,Therapeutic,Materials,JPA,NPhA,Dispensing,Premiums,Patients,Abolished,Nursing,Hospitals,Expected,Participate,DPC,Eligibility,Criteria,FD,Patients,Abdominal,Distention,Postprandial,Hyperglycemia,Promotes,Arteriosclerosis,Statistics,April,2005,Preliminary,November,Sankyo,Bio-Rad,FujiKeizai,Nichiiko,Teikoku Seiyaku","No.1976 Contents")

st++; thePage[st]=new Array("1975_jan_16.pdf","pdf/2006_1/","1975 January 16","Takeda,FPMAJ,Importance,Companies,Aoki,JPMA,PFSB,Review,Staff,Fukui,Korosho,NHI,NDA,RA,Adalimumab,Eisai,Abbott,Astellas,Hyponatremia,Treatment,Vaprisol,Submits,NDA,Tacrolimus,Modified,Release,Formulation,Novartis,Glivec,Peg-Intron,Rebetol,Combination,Aricept,Orodispersible,MRP,EU,Abilify,Tamiflu,Flu,Prevention,Children,Pfizer,Varenicline,Priority,Albumin,Ig,Preparations,Support,Orphan,Vaccine,ADR,IITs,Relenza,PFSB,Spain,Portugal,List,vCJD,Countries,Nippon,Shinyaku,Licenses,CML,NS,INNOVIVE,Transfers,Shares,BTV,BASF,Food,Business,Conventional,Antipsychotics,Zyprexa,Accuracy,FlexPen,Novo,Nordisk,PharmaDesign,Euroscreen,Kayaku,BELLSYSTEM,SMO,BELL,Cell,Hokkaido,Chugai,Roche,Kiosk,Kobashou,Sowa,MOSS,Institute,Stake,Pure,Green,SSP,Preferential,OTC,Replace,Noscapine,Bio,ventures,Morishita,AnGes,MG,JMA,IIT,Training,Information,Supply,JMACCT,IIT,Micardis,PharmaDesign,Published,Astellas,NBI,NIBIO,Silico,Discovery,Bottom,Tornado,Kazufumi,Ohashi,Olympus,Cangen,Biotechnologies,Collaboration,J&J,Transfer,Wound,Dressing,ALGODERM,Smith,Nephew,Kobayashi,Medical,ISO,Pharmacotherapy,Specialists,JSMO,Deficit,Deteriorates,Somusho,Guidance,Audits,Copayment,Fuji,keizai,Hospitals,Obstetricians,Pediatric,Emergency,Secondary,Emergency","No.1975 Contents")

st++; thePage[st]=new Array("1974_jan_2.pdf","pdf/2006_1/","1974 January 2 & 9","PhRMA,Innovative,Newton,Crenshaw,Reed,Maurer,Sugio,Seko,Budget,MOF,PFSB,HPB,Tamiflu,NHI,Price,Long,listed,JPMA,Chukyo,Generics,Original,JGPMA,FJPMA,JMA,Dispensing,Pharmacies,JPA,Wholesalers,Negotiations,Invoice,Frustrations,LDP,JMPF,Society,MTX,JIA,Asthma,Prevalence,Monkasho,Children,Dentists,SJP,Korosho,Pediatric,JPS,Aricept,Eisai,Survival,Rates,Upgrade,Quality,IRBs,IT,Strategy,HQ,Strategy,SymBio,TAP,Prevacid,Novartis,OTC,Validity,Daiichi,Patent,Levofloxacin,Kissei,JCR,Kaken,Fiblast,Spray,China,Nisshin,Kyorin,Indisetron,SK,Chemicals,Kuhnil,Marketing,Rights,Kyorin,Ketas,Eye,Drops,South,Korea,Sosei,Sublicenses,SOH,Sandoz,Hexal,Stem,Cell,Kobe,Bayer,Low,Carbon,Roche,Successful,CERA,Factor,Xa,Inhibitor,Antibody,Against,Influenza,A,Virus,Kirin,Brewery,Aromasin,Accelerate,BMD,Pfizer,Taxotere,Regimens,Recurrence,Breast,Cancer,Lochol,Lowers,Risk,CV,Events,Renal,Transplant,Novartis,Enbrel,Progression,Destruction,Wyeth,AstraZeneca,Safety,Pulmicort,Blockbusters,Sheehan,Avastin,Stomach,Takiuchi,Tanabe,Seiyaku,Combination,Measles,Rubella,Vaccine,MEARUBIK,Safety,Management,ACCJ,Improvement,Review,Medical,Devices,Dainippon,Sumitomo,Noise,Resistant,ECG,SANYO,Electric,Gene,Design,Nucleic,Acid,Medicine,Production,System,Guidant,Japan,Begins,Enrolling,SPIRIT,Eiken,Chemical,Hitachi,AMO,Awarded,Infringement,Alcon,Yashima,Pure,Bio,Hills,Saito,Science,Park,White,Paper,Japan,Experienced,Natural,Population","No.1974 Contents")